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ABSTRACT  
Cataract is a potentially reversible cause of childhood blindness which is responsible 
for at least 15% of the world’s blind children. Primary intraocular lens (IOL) implantation 
is the most important recent innovation in the management of childhood cataract, and 
has been widely adopted despite unanswered questions regarding best practice, visual 
benefits and adverse outcomes. 
In order to answer these questions, an epidemiological study was undertaken through 
systematic, standardised data collection through a national clinical network, the British 
Isles Congenital Cataract Interest Group. 
At the time of submitting this thesis, data are available for 236 children. IOL 
implantation was undertaken in the majority of children over 6 months old, but aphakia 
was the preferred option for younger children, due in part to the higher than anticipated 
frequency of other ocular anomalies.  
Overall primary IOL implantation conferred no visual benefit for children with unilateral 
cataract, but may be associated with better visual outcome following bilateral cataract 
surgery, whilst increasing the risk of the need for further surgical procedures under 
general anaesthetic, which may adversely impact on future cognitive development. 
16% of all children developed glaucoma during the first postoperative year with age at 
surgery being the most significant factor. The potential eventual burden of aphakic and 
pseudophakic glaucoma is considerable, and these findings should encourage debate 
about the balance between the risk of amblyopia and the risk of glaucoma, as well as 
future research on this blinding complication  
Refractive planning and outcome in early life pseudophakia is highly variable. There is 
a pressing need for standardisation of refractive planning and continuous national 
monitoring of refractive outcomes, similar to that which exists in adult cataract surgical 
practice. 
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Follow up studies of this unique inception cohort will provide further information on 
longer term outcomes and their impact on educational and personal development.  
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1. INTRODUCTION  
Cataract, or clouding of the eye’s natural crystalline lens, is a significant and potentially 
reversible cause of childhood blindness. Early intervention affords children with 
congenital or infantile cataract the best opportunity of good visual outcome. Following 
surgical extraction of the lens, the impact of the loss of focusing power on early 
childhood visual development also necessitates visual rehabilitation through optical 
correction, which has traditionally been achieved with glasses and / or contact lenses.  
Replacement of the lost focusing power using primary implantation of an artificial 
intraocular lens (IOL) is the most important recent innovation in the management of 
congenital and infantile cataract. This intervention, originally developed for adults in the 
seventh and eighth decades of life, is being increasingly adopted for young children 
despite a paucity of systematic investigations of outcomes. There are unanswered 
questions regarding the benefits and risks of IOLs in early childhood (children aged 2 
years and under), and the safety and efficacy of different surgical techniques.  
The aim of the study reported in this thesis is to address these questions through an 
investigation of the outcomes in a nationally representative inception cohort of children 
undergoing cataract extraction with or without intraocular lens implantation aged ≤2 
years old in the United Kingdom and Ireland.  
 20 
2. BACKGROUND  
Whilst removal of the cloudy lens is essential for the restoration of functional vision in 
children with visually significant congenital and infantile cataract, intraocular surgery 
during the first two years of life results in an ‘insult’ to the eye during a critical stage of 
development of the structure and function of the visual system.  
 
2.1. The anatomy and development of the eye and visual system
  
The eye can be divided into anterior and posterior segments, with the naturally clear 
crystalline lens forming the dividing plane (Figure 1).  
 
2.1.a. The anatomy and pre-natal development of the lens 
The lens consists of an optically optimal arrangement of fibres (Figure 2) within a 
supportive capsular bag, held in place by equatorial suspension cables, the ciliary 
zonules. Tension on the capsule, created by the ciliary body muscles and transmitted 
through the zonules, can change the shape and focusing power of the lens (a process 
termed accommodation).  
 21 
 
Figure 1. Anatomy of the eye, shown in sagittal (vertical) section  
The lens sits between the anterior and posterior segments of the eye, supported by the zonules 
(z*). 
Modified from image from National Eye Institute library, National Institute of Health 
 
 
 
 
Figure 2. Cross section through the lens  
showing migration and lengthening of lens fibres, image courtesy of Apple et al
1
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In humans, the lenses first appear on day 33 of gestation, as vesicles which fill with 
fibres to become the central lens fetal nucleus.2;3 More lens fibres form beneath the 
capsule, lengthen and migrate to form the outer lens cortex. Fetal nutrient vasculature 
nourishes the developing lens (Figure 3). These vessels regress in the second 
trimester, disappearing altogether by birth at term. At term, although the lens is 
functionally transparent the different lamellae are visible through an examining 
microscope.  
 
Figure 3. The fetal intraocular vasculature  
This anastamotic nutrient network disappears by full term birth.  
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2.1.b. The anatomy and development of the anterior and posterior 
segments 
2.1.b.i. Anterior segment 
The most easily visible part of the anterior segment, the iris, is itself the anterior section 
of the pigmented layer of the eye, the uvea, which continues posteriorly as the ciliary 
body. Whilst the adult iris, seen under magnification, resembles a hilly landscape with 
deep crypts and flattened peaks, the neonatal iris is flatter and more vascular, and the 
optically empty centre, the pupil, is smaller.2;4  Over the first six months of life, the iris 
muscles mature, and may, as a result, change colour.  
The ciliary body is a thick doughnut of tissue lying behind the iris. The ciliary body is 
not only the effector of accommodation, but also creates and secretes aqueous fluid. 
Aqueous flows into the anterior chamber through the pupil, providing optically clear 
hydrostatic support as well as nutrition and immunological support. 
A transparent dome, the cornea, sits atop the anterior segment. The cornea’s 
transparency is again due to optically optimal cellular organisation, supported by the 
active continuous removal of water and electrolytes undertaken by the innermost layer 
of cells, the corneal endothelium. The normal adult horizontal corneal diameter is 
approximately 11.5mm, and this adult size is usually reached within the first year of 
life.5  
Internally, the iris and cornea meet at the iridocorneal angle. Drainage of aqueous 
occurs at the angle, through a series of sieves, the trabecular meshwork.  The internal 
pressure of the eye, or intraocular pressure, depends on the egress of fluid from the 
eye. Thus abnormalities of the angle may result in high intraocular pressures, which 
may then result in destructive changes, negatively impacting on vision. Although 
studies of fetal ocular development consistently report on the posterior movement of 
the ciliary body (moving the iris root away from the cornea, thus widening the angle) 
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and on the differentiation of the trabecular meshwork membranes and development of 
the post-meshwork vascular drainage channels during the third trimester,3;6-8 less is 
known regarding the normal post-natal development of the angle. In neonates, in 
comparison to children aged over 1 year old, the iridocorneal angle opening is narrower 
and the trabecular meshwork less differentiated and the angle and the iris are less 
pigmented. Thus, crucial development of the angle occurs at some point during the first 
year, but the window of time within which they occur during this period is unclear.3;9  
 
2.1.b.ii. Posterior segment   
Behind the lens sits the gelatinous vitreous hyaloid body. Within the otherwise 
transparent vitreous gel runs a potential track, the footprint of the main embryological 
nutrient vessel, the fetal posterior hyaloid artery. The anterior face of the gel lies almost 
in contact with the posterior face of the lens.3 
In the frequently used analogy of the eye as a camera, the neural-retina, a layer of 
photosensitive cells at the back of the eye, is the film. At the centre is the fovea, which 
is responsible for detailed vision. A hierarchical system of cells passes information from 
the outer to inner retina. The innermost retinal cells, the ganglion nerves, then leave 
the eye as a cable of fibres. This optic nerve, which passes through the apex of the 
bony orbital socket of the skull, then travels on to the cerebrum.  
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2.1.c. The growth and development of the globe in childhood  
The mean axial length of the neonatal eye is 16.8mm, whilst mean adult length is 
23mm10;11 (Figure 4). The majority of this postnatal growth takes place in the first two 
years of life, with most growth occurring in the first 6 months. Corneal curvature also 
changes: the cornea becomes flatter with time, with most change occurring over the 
first 36 months of life.11  These changing parameters contribute to the early childhood 
changes in the focusing (refractive) state of the eye 
 
 
 
Figure 4. Postnatal growth of the globe 
modified from Fledelius.10.  
The majority of postnatal growth takes place in the first two years of life, with most 
growth occurring in the first 6 months. 
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2.1.d. Emmetropisation 
The focusing power of the eye is determined not only by how light rays are bent or 
refracted by the ocular surfaces (steeper more curved ocular structures bend light 
more), but also the distance light rays travel between the ocular refracting surfaces and 
the final focal point at the retina. The essential ocular focal determinants, which all 
change significantly in the first two years of life, are therefore:  
 the curvature of the cornea  
 the curvature of the lens 
 the axial length of the eye, and within this the distance between the cornea and 
lens (anterior chamber length or depth) and distance between the lens and the 
retina.  
The ocular focusing power or refractive state of the two eyes of any one individual is 
usually broadly similar. A significant inter-ocular refractive difference is called 
anisometropia.  
The focusing power of the normal neonatal eye results in a long sighted state of 
refraction or hypermetropia. Over the first 2 years of life, globe elongation and 
flattening corneal curvature move the focusing system away from hypermetropia and 
towards myopia, or short sightedness, with axial elongation playing the primary role. 10-
12 Ideally, this ‘myopic shift’ ends with the eye at emmetropia, a neutral midpoint 
refractive state (Figure 5). The process is thus termed emmetropisation.  
 
 
 27 
Figure 5. Changing refractive (focusing) state with globe elongation 
As the eye lengthens axially, the infant eye undergoes emmetropisation, or a ‘myopic shift’ from 
an initially hypermetropic state  
 
 
 
The factors influencing emmetropisation are not yet fully understood, but animal and 
human models have shown that whilst it is sensitive to genetic factors,13 
emmetropisation is an active bio-feedback process, with retinal stimulation acting as 
the sensory component driving the structural changes which result in altered refraction 
states. Vertebrates reared in complete darkness fail to emmetropise normally.14 
Deprivation of visual form in vertebrates reared with high power lenses (creating 
unfocused, blurred images)15;16 and in human infants with form deprivation due to 
ophthalmic disease also results in abnormal emmetropisation, usually in the form of 
myopia due to abnormal axial elongation.17-19 Infants with impaired accommodative 
responses have been found to be more likely to develop myopia due to axial 
elongation,20 and an association exists between childhood refractive error and ciliary 
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body thickness.21 Thus there may also be a role for the ciliary muscle in the sensory 
arc of the emmetropisation process, with poor accommodation inducing blur which 
drives ocular remodelling.   
The effector arms of the emmetropisation process are also unknown. Structural 
changes may be due to scleral remodelling orchestrated by metalloproteinases22;23 
with primary sites at the posterior pole of the eye24 and / or the area behind the ciliary 
body,25 but as ciliary body thickness is associated with emmetropisation, ocular 
remodelling may also be effected by structural changes in the middle, uveal lining of 
the eye.      
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2.1.e. The visual pathways 
The optic nerves travel posteriorly from the eyes to meet centrally within the cranium at 
the optic chiasm, where there is a re-organisation of fibres which delivers to each 
hemisphere visual information from each eye’s ipsilateral vertical hemi-field of vision, 
rather than information only gathered from the ipsilateral eye. The fibres travel within 
the hemispheres as the optic tract with the final destination being the occipital visual 
cortex (although further, complex higher level processing occurs upstream of the visual 
cortex). As visual information traverses across the length of the cerebrum to synapse 
within an area at the back of the brain, a wide range of cerebral disease and disorders 
can have a profound effect on vision.26  
 
 
2.1.f. Summary  
The eye is a complex structure within the visual system which focuses and processes 
light. The first two years of life is a time of rapid development of the anatomy and 
physiology of the ocular structures.  
.  
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2.2. Vision and visual impairment 
The primary aim of intervention for congenital and infantile cataract is the restoration of 
functional vision. Vision is an age related function, which rapidly matures during the 
first few years of life as the anatomy and circuitry of the visual pathways develop. 
Normal visual function is an important aspect of child health, and visual impairment has 
a significant impact on the affected child’s developmental, educational and 
socioeconomic experiences, during childhood and beyond. 
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2.2.a. Normal visual function  
2.2.a.i. Acuity  
Acuity is the ability to resolve visuo-spatial cues – that is, to visually discriminate the 
edges of objects in space. The closer together the edges or the finer the detail, the 
better the resolution and acuity needed to discriminate them.  
 
2.2.a.ii. Visual acuity metrics 
In early childhood (the first few years of life) acuity can be quantified using gratings or 
optotypes (symbols such as shapes, numbers and letters) as described in detail in 
section 2.2.c, page 38. 
 
Grating acuity  
Black and white gratings of differing width, where width is measured in cycles per 
visual degree (cpd) can be used to quantify visual resolution. The higher the frequency, 
the better the acuity.  
 
Optotype acuity  
Standardised symbols or letters made up of lines of different widths can also be used 
to quantify acuity. Grating acuity (resolution) and optotype acuity (resolution and 
recognition) are not equivalent, as the higher level cognitive visual functions have an as 
yet unclear role in the recognition of the shapes used to test acuity. Good grating acuity 
in early infancy is not a guarantee of good optotype acuity in later life, and optotype 
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acuity matures faster than grating acuity in the first five years of life. 27 Optotype acuity 
is measured using one of two scaling systems:  
 The LogMAR scale uses a logarithmic conversion of visual resolution to create 
a linear scale of vision, which allows for statistical analysis of visual outcome. 
As log10(1)=0, a LogMAR acuity of 0.0 is ‘normal’ acuity, whilst 1.0 LogMAR 
signifies a tenfold decrease in resolving power (log10(10) = 1). Thus each 0.1 
step signifies a linear decrease in resolving power. A negative LogMAR score 
indicates a ‘better than normal’ acuity.  
 The Snellen scale uses a geometric scale to quantify resolving power, 
expressed as a fraction or as a decimal. A child who at a distance of 6 metres 
can only see and read a symbol which a ‘normally’ sighted child would have 
been able to see at 60 metres distance will have a vision of 6/60. The Snellen 
fraction can be converted into a LogMAR ‘score’ by taking the logarithm of the 
inverted snellen fraction (thus 6/60 Snellen acuity is equivalent to log10(60/6) or 
log10(10), that is1.0 LogMar, and 6/6 Snellen is equivalent to 0.0 LogMar, table 
1).  
There is often confusion between the Snellen and LogMAR scales and the Snellen and 
‘LogMAR’ charts (charts which give LogMAR acuity scores without the need for 
conversion). For example, in the United Kingdom, the charts most commonly used to 
measure adults acuity use the Snellen scale. These Snellen charts (there is no one 
standardised Snellen chart) use variable numbers of symbols per line, with irregular 
progression of letter sizes between lines and irregular line spacing.28;29 Consequently, it 
is difficult to use acuity scores as measured by Snellen charts in the statistical analysis 
of visual outcome. 
A more qualitative or gross measurement of vision is useful when vision is too poor for 
such assessment scales. Subjects can be described as having perception up to the 
level of ‘counting fingers’ ‘hand movements perception’ or ‘perception of light’ (Table 1).
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Table 1. A comparison of the different acuity scales in use 
            Snellen, LogMAR and grating acuity. 
 
Optotype acuity   Grating acuity equivalent  
Snellen  
(geometric scale) 
LogMAR 
(linear scale) 
Cycles per degree  
(geometric scale) 
6/4.8 -0.1 - 
6/6 0.0 - 
6/7.5 0.1 - 
6/9 0.2 - 
6/12 0.3 15 
6/15 0.4 13 
6/18 0.5 10 
6/24 0.6 8 
6/30 0.7 6 
6/36 0.8 5 
6/48 0.9 4 
6/60 1.0 3 
Count fingers (CF) - Able to count fingers at a given distance 
Hand movements (HM) - Able to perceive a hand waved near the face 
Perception of light (PL) - Able to perceive the presence or absence of light 
No perception of light (NPL) or absolute blindness 
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2.2.a.iii. Other visual functions  
The other components of normal visual function include:  
Depth perception or stereopsis, which requires correspondence between the vision in 
both eyes and between the movements of both eyes. Ocular deviation, or strabismus 
(‘squint’), is associated with loss of stereopsis (and in children strabismus is often 
associated with significantly poorer vision in the deviated eye). 
Visual field, which is the total area of space perceived when the eyes and head are 
stationary. The sensitivity of the field is greatest centrally and drops off towards the 
periphery. 
Contrast sensitivity is the ability to discriminate between areas of difference luminance. 
Discerning black images on a white background requires less contrast sensitivity than 
discerning grey images on a slightly lighter grey background: visual function may be 
very different in differing illumination conditions for children with abnormal contrast 
sensitivity.   
The perception of colour is also part of vision, as are higher level visual functions such 
as motion perception and face recognition. 
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2.2.b. The development of vision  
Vision improves rapidly over the first few years of life. Newborns have an average 
acuity of approximately 1.5 LogMAR, which improves to an average acuity of 0.5 
LogMAR by 12 months of age, and  0.35 LogMAR by  24 months of age 30;31 (Figure 6).  
 
 
Figure 6. Visual maturation in childhood showing the rapid improvement in the first year 
of life 
and the slower rate of improvement as the child ages. Modified from Salomao et al.30. 
The size of the data point reflects the number of tested children in each age group 
(total 646 children) 
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2.2.b.i. The sensitive periods of visual development  
Hubel and Wiesel’s Nobel prize-winning studies in the 1950s’ described the result of 
experimental monocular visual deprivation of kittens of different ages. They 
demonstrated that following deprivation during a ‘susceptible’ period,  there was a 
sharp decline in the number of visual system neurons driven by the deprived eye, 
resulting in unequal cerebral ocular dominance.32  
The development of mammalian sensory modalities involves a crucial sensitive period, 
a time window during early development when experience has a profound effect on the 
consequent structure and function of the brain. Prior to the sensitive period is the latent 
period, during which the earliest phases of visual development are independent of 
visual stimuli.33;34 Within the sensitive period is a critical period, during which 
experience is absolutely necessary for the creation of neural networks and subsequent 
normal function (box 1).33 Normal development of the visual communication pathways 
thus requires the presentation of a focused image to the higher level systems during a 
sensitive developmental period. There may be overlapping sensitive periods for the 
different visual modalities such as form perception, ocular dominance, face perception, 
or motion perception.33;34 
Box 1. The phases of plasticity which define the sensitive period. Modified from Hooks et 
al33.  
 
Pre critical latent  period: the initial formation of neuronal circuitry that is not dependent on visual 
experience 
 
Critical period: distinct onset of plasticity in response to visual stimulus, so that visual experience 
is absolutely necessary for normal development and subsequent normal function 
 
Sensitive period: the window of development during which initially formed circuitry can be 
modified by experience, with less plasticity exhibited with the duration of the window 
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Should the image presented to the retina and higher level systems during the sensitive 
period be defocused, due to uncorrected refractive error, or blurred, due to cataract, 
the visual system will fail to develop to its full potential. This failure to achieve visual 
potential is called amblyopia.  
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2.2.b.ii. Amblyopia 
Amblyopia can arise secondary to blur from defocus (refractive amblyopia, which may 
be related to anisometropia), a failure to maintain a straight gaze (strabismic 
amblyopia) or structural disorders of the eye, such as cataract, which obscure incoming 
images, (form deprivation amblyopia).  
Amblyopia can be bilateral, but is much more commonly unilateral, with the visual 
cortex “preferring” the eye which presents the least blurred or defocused image during 
the sensitive period. The treatment of amblyopia requires early management of the 
cause of reduced vision, and management of unilateral amblyopia also requires visual 
penalization of the better seeing fellow eye. This can be achieved with an adhesive eye 
patch or contact lens to occlude the non-amblyopic eye, or chemical penalization of 
vision in that eye (using topical cycloplegic eye drops which paralyse the eye’s 
accommodative ability, thus preventing focused viewing).   
In humans, the critical sensitive periods for ocular dominance and form perception start 
just after birth.35 The duration of the critical period is unclear, although some evidence 
from children born with treatable visually obscurative defects suggests that the critical 
visual development windows close sometime during or after the second month of life,36-
38 and that the critical windows for ocular dominance open and close earlier than the 
window for development of resolution/acuity.37;39-41  The development of the visual 
systems remains progressively less sensitive until the age of 8.  As evidenced by 
studies of amblyopia treatment in late childhood, in some individuals, the period of 
plasticity extends beyond this age.33;42;43  
In order to detect a child’s response to amblyopia management, or to any intervention 
aimed at improving vision, some assessment of visual function is necessary. 
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2.2.c. Assessing vision in childhood  
As described earlier, visual ability develops over time (figure 5), accompanied by the 
development of other capabilities with intellectual and motor function maturation. 
Methods for the assessment of visual function therefore differ with the stages of 
development in early childhood.  
 
2.2.c.i. Neonates  
A normally sighted neonate will have a Central, Steady gaze which she can Maintain 
for brief periods (sometimes abbreviated to CSM fixation), but she will have limited 
ability to maintain sustained fixation on objects, or to perceive fine detail or colour. Over 
the first days of life children develop first the ability to fix their gaze on visual stimuli and 
then to pursue moving stimuli (Fix and Follow vision).44 Highly contrasting images, 
such as black and white stripes or checkerboard patterns, are most visually stimulating.  
 
2.2.c.ii. Infants and toddlers (and other pre or non-verbal 
children).   
The preferential interest which infants display in high contrast (black and white) 
patterned images can be used to quantify acuity in pre-verbal children from the second 
week of life. Boards with a window of gratings (of progressively higher frequency / 
thinner width) on one half and gray background on the other are presented to infants. 
Acuity can be tested with both eyes open (binocular acuity), or tested individually for 
each eye (monocular acuity) with grating acuity card systems such as the Teller cards 
(Figure 7, page 41) giving acuity levels in cycles per degree (as discussed in section 
2.2.a.ii). A child aged 12 months should be able to achieve at least 0.8 LogMAR (the 
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average vision being 0.5 LogMAR), whilst a three year old should be able to achieve 
0.5 LogMAR using the Teller preferential looking cards (Table 2, page 41).  
The normative data cited above arise from two studies: a study of 646 children aged 
from 2 to 36 months of age who were assessed by one of 8 examiners who themselves 
had been assessed as achieving ‘errorless performances’ in the grating card 
technique30 and a study of  460 children aged between 1 month and 4 years old who 
were each assessed twice by two study examiners. 31 The latter study demonstrated 
excellent between-examiner and between-testing reliability (no clinically or statistically 
significant variation in test findings). 
Grating acuity cards may not be interesting enough to keep the attention of toddlers 
(children aged 1 year to 3 years).45 Preferential looking techniques can also be used 
with optotype image boards such as the Cardiff cards, which use white shapes 
bordered by black bands situated on either the top of bottom half on of a grey board 
(Figure 7). Cardiff cards were originally designed to bridge the gap between ‘resolution 
and recognition’46and have been validated for use in children aged 12-36 months.45;46.  
Acuity levels are recorded either as Snellen fractions or as LogMAR scores. A child 
aged 12 months should be able to achieve at least 0.8 LogMAR, whilst a three year old 
will be able to achieve 0.3 LogMAR using Cardiff card testing (Table 3, page 41). 
The Cardiff card acuity norms arise from a 1994 study estimating the acuity in 231 
children aged between 12 and 36 months. Binocular and monocular acuity levels were 
assessed by a single examiner, but the generalizability of the findings are somewhat 
adversely affected by the investigator’s success rate for monocular acuity assessment, 
which was 41% for children aged 12-18 months and no higher than 73% for children 
aged18 to 30 months.46  
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Figure 7. Preferential looking tests 
for acuity / resolution. A.Teller cards and B. Cardiff cards 
 
 
 
Table 2. Mean and lower limit of normal range of acuity for children aged 12 to 36 
months on Teller grating card preferential looking assessment 
Adapted from Salamao199530 
 
Age 
(months) 
Monocular acuity (LogMAR) Binocular acuity (LogMAR) 
 
Mean 
acuity 
Lower limit of 
95% normal 
range 
Mean acuity 
Lower limit of 
95% normal 
range 
12   0.5 0.8 0.4 0.8 
18  0.5 0.7 0.4 0.8 
24  0.4 0.7 0.3 0.7 
30 0.3 0.7 0.2 0.6 
36 0.3 0.3 0.2 0.5 
 
 
Table 3. Mean and lower limit of normal range of acuity for children aged 12 to 
30+ months on Cardiff acuity card assessment 
Adapted from Adoh 199446 
 
Age 
(months) 
Monocular acuity (LogMAR) Binocular acuity (LogMAR) 
 
Mean 
acuity 
Lower limit of 
95% normal 
range 
Mean acuity 
Lower limit of 
95% normal 
range 
12  0.6 0.8 0.6 0.9 
18  0.4 0.7 0.4 0.6 
24  0.2 0.5 0.3 0.4 
30  0.1 0.3 0.2 0.3 
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2.2.c.iii. Older children – object or optotype recognition  
Several different optotype methods are in use, including the Cardiff cards, Kays picture 
cards, Lea symbols and the Snellen and Early treatment diabetic retinopathy study 
charts for literate children (as indicated by its name, the ETDRS test was designed by 
ophthalmic investigators to overcome the deficiencies of Snellen charts in the analysis 
of visual outcome, as discussed in section 2.2.a.ii, 31). Due in part to the recognition 
skills required, optotype acuity testing is unreliable in children under two years old.30   
 
2.2.c.iv. The comparability of different acuity tests 
The different tests used to measure acuity in young children measure different 
functions (resolution with or without recognition) and therefore are not directly 
comparable.27;45 When undertaken in the first years of life, the normative values of 
these tests can, however, be used to determine whether a child falls outside an 
expected level of acuity, 30;31;45;46 although the Teller acuity test may underestimate 
visual loss in amblyopic children.47;48 
  
2.2.c.v. The predictive power of early childhood acuity tests 
Longitudinal studies have provided evidence of the good predictive power of normal 
Teller acuities for children without ocular or neurological conditions,47;48, although there 
is no longitudinal evidence of the predictive power of Cardiff card acuity assessment 
undertaken in early childhood. 
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2.2.c.vi. Qualitative assessments of visual function in early 
childhood  
Due to developmental and behavioural constraints, it may not always be possible to 
quantify the acuity of infants and toddlers. In these cases, other signs may be used to 
determine the presence of a significant visual functional problem:  
 The absence of vision dependent or vision-directed behaviour – such as smiling 
in response to silent parental smiles 
 An infant’s strong and prolonged objection to occlusion of one eye over another 
may provide a clue to the possible presence of uniocular reduced vision.   In 
cases of severe uniocular visual impairment, this objection to occlusion can 
make the assessment of uniocular acuity challenging.  
 Strabismus (with deviation of the poorer seeing eye), an associated finding in 
cases of unilaterally or bilaterally poor vision.  
 Nystagmus (involuntary movements of the eyes), an associated finding in 
bilateral visual loss.   
 
2.2.c.vii. Electrodiagnostic testing  
Electrodiagnostic testing (electroretinograms, ERGs, which record activity within the 
retina and visual evoked potentials, VEPs, which record activity through the post-retinal 
pathways) can be used to estimate visual potential. Visual stimuli are presented, and 
the child’s physiological response is evaluated. The level of activity is compared to 
normative data to provide an indication of the child’s visual potential.  
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2.2.d. Visual impairment and blindness 
In adults and older children acuity levels (and to a lesser degree the visual field) are 
used in the official definition of visual impairment. The World Health Organisation 
(WHO) defines visual impairment as blindness if vision is worse than 3/60 with both 
eyes open, severe visual impairment if vision is worse than 6/60 or there is severe 
peripheral field loss, and moderate visual impairment if vision is worse than 6/18 or 
there are moderate visual fields defects.49 
Whilst there is no legal definition of sight impairment in the UK, government guidelines 
state that impairment is ‘substantial and permanent handicap (due to) defective 
vision caused by congenital defect or illness or injury’, and children can be 
registered as having partial or severe sight impairment using the criterion described in 
Table 4.  Registration of a child’s visual impairment enables family access to financial 
benefits and other practical support including assessment of the child’s educational 
needs and possible future vocational need (although registration is not a pre-requisite 
for a vision-related educational needs assessment). As vision in the better seeing eye 
is used to formally define impairment, a child with poor visual outcome from unilateral 
cataract and a normal contralateral eye would not be formally registered as visually 
impaired. 
Table 4. UK criteria for the registration of individuals as visually impaired 
 
 Best achievable acuity with both eyes open  
Sight impairment 
(previously termed 
partially sighted)  
3 / 60 to 6 / 60 with a full field of vision  
Up to 6 / 24 with moderate reduction of field of vision or central blur  
Up to 6 / 18 with very reduced field of vision or hemianopia 
Severe sight impairment 
(previously termed 
blindness) 
Less than 3 / 60 with a full visual field  
Between 3 / 60 and 6 / 60 with severe reduction of field of vision  
6 / 60 or better with very reduced field of vision 
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2.2.d.i. The impact of visual impairment 
Visual impairment and blindness (VI/BL) impacts on society as well as the individual 
due to the cost of medical and social support for the child and the adult she becomes, 
as well as the loss of potential employment related income.  
Although individuals with unilateral impairment have good acuity with both eyes open, 
when compared to individuals with bilaterally normal vision those with unilateral 
amblyopia have an increased lifetime risk of bilateral visual impairment due to loss of 
acuity in their better-seeing eye.50;51 
 
 
2.2.e. Summary  
Children have a finite developmental window during which the visual system must be 
presented with a clear and focused image to enable them to fulfil their visual potential. 
If this development is interrupted by disorders which affect the presentation of a good 
visual image, permanent visual impairment may occur (amblyopia).  
Normal vision requires the integration of a number of visual functions. However acuity, 
arguably the most important modality, forms the basis of the taxonomy for the 
classification of individuals as non-impaired, impaired, severely impaired or blind.  
Accurate assessment of visual acuity in infants and toddlers is difficult, and a there 
exists a variety of different tests for use in children under 5 years old.  
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2.3. Congenital and infantile cataract 
Childhood cataract can affect the child from birth (congenital cataract) or in the first 
year of life (infantile cataract). Cataract can be unilateral or bilateral, with some 
individuals exhibiting asymmetric bilateral cataract. 
 
2.3.a. Incidence of congenital and infantile cataract in the United 
Kingdom  
The estimated UK incidence of cataract in the first year of life is 2.5 per 10,000 (95% 
confidence interval 2.1 – 2.9), and by the age of 5 the cumulative incidence of 
congenital and infantile cataract is 3.2 / 10,000.52 These estimates are drawn from a 
1995/96 population based study involving two national active surveillance schemes, 
which identified 248 children (aged under 16 years) newly diagnosed with congenital or 
infantile cataract in one year, of which 66% had bilateral disease. 188 of the 248 
children were diagnosed in the first two years of life.52  
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2.3.b. The global burden of congenital and infantile cataract 
It is estimated that 15% of the world’s blind children are blind due to cataract.53 
Determining the burden of childhood cataract in developing countries is made difficult 
by the lack of infrastructure and methodological challenges of conducting population 
based research. Some evidence of the burden of childhood cataract comes from 
investigations into the causes of impairment in children educated at schools for the 
blind (Table 5).  
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Table 5. The proportion of childhood blindness due to cataract in low and 
middle income countries 
 using the prevalence of cataract blindness within schools for the blind 
 
The wide range in proportion of blind school students with cataract reported in Table 5 
(from 6-33%) is indicative of the wide variety in both the frequency and causes of visual 
impairment across the world, reflecting the global patterns of the overall health and 
survival of children as well as the socio-economic developmental status of the region 
  Number of children 
examined 
Proportion 
Indian subcontinent  
North India, 200854 703 10% 
Northeast India, 200355 376 11% 
Bangladesh, 200756 1935 33% 
West India, 200757 1985 6% 
Rest of Asia 
Malaysia, 200158 358 22% 
Indonesia, 200759 165 13% 
Sub-saharan Africa 
Nigeria, 200360 142 30% 
Ethiopia, 200361 260 9% 
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2.3.c. Aetiology of congenital and infantile cataract 
Cataractous opacity of the naturally clear lens due to disturbance of the biochemical or 
physical structure of the crystalline lens fibres occurs secondary to a range of genetic, 
developmental or traumatic insults, and children with congenital and infantile cataract 
form a heterogeneous group (Table 6), although for the majority of children with 
congenital and infantile cataract in the UK, the aetiology remains unknown (idiopathic 
disease).   
 
Table 6. The causes of congenital and infantile cataract in the United Kingdom 
in order of decreasing incidence  
Adapted from Rahi et al 200062 
 
The underlying aetiological factors differ for bilateral and unilateral cataract: whilst over 
90% of unilateral cataract identified by Rahi et al was idiopathic, only 38% of children 
with bilateral cataract had idiopathic disease. Conversely hereditary disease was more 
common in bilateral cataract (56%) than unilateral cataract (6%).63 Hereditary cataract 
can be passed on through dominant, recessive or X-linked inheritance (most commonly 
autosomal dominant) and can consist of isolated cataract, or cataract seen with 
associated ocular or systemic disease.64 Cataract is also a feature of non-inherited 
genetic disorders such as trisomy 21 (also known as Down syndrome).65  
I. Idiopathic isolated* cataract (*no other disorder) 
II. Idiopathic cataract with associated ocular disorder 
eg: microphthalmia, persistent fetal vasculature  
III. Hereditary isolated* cataract (*isolated =no systemic disorder) 
Autosomal dominant, autosomal recessive, or X-linked 
IV. Hereditary or sporadic genetic cataract with associated disorder (including chromosomal)  
eg. Trisomy 21, oculo-renal disorder of Lowe, Cockayne syndrome 
V. Prenatal biological or environmental exposure  
 eg: prenatal rubella, maternal corticosteroid exposure 
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Intrauterine insult to fetal lens development through infectious agents (cytomegalovirus, 
herpes or rubella viruses, for example) is now an uncommon cause of congenital 
cataract in industrialised countries, but important due to the preventable nature of the 
disease (eg through immunisation programmes). Globally, infectious causes of cataract 
have more significance.66 Intrauterine hyperglycaemia (due to gestational diabetes)67 is 
another possible cause.   
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2.3.d. Phenotypic classification of cataract  
Rather than an exhaustive list of the possible morphological variations of early 
childhood cataract, an effective classification system for visually significant cataract can 
be created using the area, degree and type of opacity seen.2;3;68 The phenotype or 
morphology of lens opacity is partly dependent on the timing of the insult to the lens 
within the period of lens development.2;3;68;69  
 Nuclear cataract is opacity of the central fetal lens, which indicates an insult to 
the developing lens at an early embryological stage 
 Lamellar or zonular cataract is shell like opacity of the secondary lens fibres in 
the layers or zones around the nucleus, indicative of an insult to the lens at a 
later embryological stage  
 Anterior cataract, which can involve the anterior face of the capsule 
 Posterior cataract which can again involve the capsule, and may involve fetal 
vascular remnants 
 Cortical cataract, opacity of the outer cortex, is usually indicative of post-natal 
insult to the lens 
 Total cataract, where the opacity involves the whole of the lens. This may be as 
a result of the progression of a different form of cataract 
Other structural abnormalities of the anterior or posterior segment can be seen with 
congenital cataract: thus another classification system of cataract involves the 
presence or absence of an associated ocular abnormality. The most common 
abnormalities seen with cataract are microphthalmos, microcornea and persistent fetal 
vasculature. 
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In some cases, the opacity is not of a sufficient degree to affect vision. These visually 
insignificant cataracts have a wide range of possible phenotypes, ranging from blue 
dots scattered across the lens to Y shaped opacities at the points where the lens fibres 
meet to form suture lines.  
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2.3.d.i. Microphthalmos  
Microphthalmos is an abnormally short eye due to a failure of globe development, and 
is defined as an axial length less than two standard deviations from normal, or an axial 
length outside of the 95% range of normality.2;3;70 This has been broadly defined as an 
axial length of less than 19mm in a 1 year old or less than 21mm in adults.2 As the axial 
length of a child’s eye changes significantly in the first two years of life, age at axial 
length measurement is an important factor in determining whether the child’s eye is 
microphthalmic (box 2). Many previous investigators who have reported on the 
frequency of microphthalmos in congenital and infantile cataract or outcomes following 
cataract surgery have failed to use the existing normative data on infant axial length 
(Table 7) to define microphthalmos, or have failed to give a definition 71-80;80-84 making it 
difficult to undertake comparisons.  
 
As well as cataract, other structural globe anomalies affecting the iris, retina and optic 
nerve are associated with microphthalmos. The condition can be bilateral or unilateral, 
and may be hereditary, with almost 50% of children with microphthalmos having an 
associated systemic disorder.86 
 
Box 2: Age related definition of microphthalmos, using the norms as reported in Fledelius 96 
10 Larsen 1971:85 Mutti 2005, Blomdahl 1979 and Gordon 1985  
 
<20mm if aged 2 years or older 
<19mm if aged 6months or older 
<18mm if aged 3months or older 
<17.5mm if aged 1month or older 
Axial length <15.5mm at any age 
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2.3.d.ii. Microcornea 
Again, the definition of microcornea is dependent on age at measurement of horizontal 
corneal diameter (HCD). Microcornea has been defined as HCD <9.5mm, or  <10mm  
in a child over 1 month old 87 or HCD <10.5 in a child under 4 months old.5;79;81  
However, as microcornea has been described as a significantly small cornea which is 
more than two standard deviations from normal or outside the 95% predicted normal 
range2;81;87;88, using the existing normative data (Table 7) microcornea should be 
classified as a horizontal corneal diameter of <9.5mm at any age, HCD <10 if aged 
over 1 month old, or HCD  <10.5mm in children over 6 months old, in an eye with a 
normal axial length (as almost all microphthalmic eyes have similarly abnormally small 
corneal diameters).2;89 Microcornea may be inherited, and may again be associated 
with other globe abnormalities including persistence of the fetal vasculature.  
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Table 7. Summary of the findings of studies of the normative values of ocular axial length and horizontal corneal diameter in the first 2 
years of life 
Description 
Longitudinal 
study 
Cross sectional studies Cross sectional studies 
  
Study 
Mutti et al 200512 
Larssen 
197085 
Blomdahl 
197990 
Gordon et al 
198511 
Kiskis et al 
198589 
Blomdahl et al 
197990 
Hymes et al 
192991 
Wallace & 
Plager 19965 
Age 
  
Mean axial length in mm, standard deviation SD          (and number 
of children / eyes examined) 
Horizontal cornea diameter in mm, standard deviation SD (and number 
of children / eyes examined) 
Term 
  
- 
16.8, 0.6 SD        
(43 children) 
16.6                     
(28 children) 
16.7, 0.6 SD         
(23 children) 
- 
9.8 mean    (28 
children) 
10.04 / 9.9 mean 
boys / girls, 0.2 
SD (17 eyes) 
9.75 mean   (n 
not reported) 
1 month 
  
- - - 
19.2, 0.7 SD           
(11 eyes) 
9.4 (2.5% lower 
limit)                           
(33 children) 
- 
10.6 mean, 0.1 
SD (19 eyes) 
- 
2 months 
  
- - - - - - - 
3 months 
  
19.0, 0.6 SD (222 
children) 
- - - - - - 
6 months 
  
20.2, 0.6 SD (222 
children) 
18.2               
(2 eyes) 
- - 
10.5 (2.5% lower 
limit)                           
(33 children) 
- - 
9 months 
  
- 
19.1               
(4 eyes) 
- - - - - - 
12 to- 24 months 
  
- 
20.6, 0.5 SD 
(36 eyes) 
- 
20.2, 0.3 SD                 
(8 eyes) 
10.5 (2.5% lower 
limit)                           
(33 children) 
- - - 
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2.3.d.iii. Persistent fetal vasculature  
Persistent fetal vasculature, or PFV, is a spectrum of clinical features caused by failure 
of the normal regression or apoptosis of the intraocular fetal vasculature (Figure 3, 
page 22).92 PFV is a common ocular abnormality in unilateral cataract, reported to  
occur in almost a fifth of cases.62 Bilateral cases of PFV, which are much less common, 
are often hereditary, and often associated with systemic abnormalities.92;93  
PFV was previously termed persistent hyperplastic primary vitreous (PHPV), due to the 
characteristic feature of a plaque of remnant tissue sitting on the posterior face of a 
cataractous lens, attached to a persistent stalk of hyaloid vasculature. However, any 
part of the fetal vasculature can persist, resulting in iris, pupillary, or optic nerve 
vascular remnants. 92 More severe manifestations involve fibrosed, tightened remnant 
tissue dragging the ciliary processes centrally with resultant detachment of the retina or 
dislocation of the lens.92;93 Rarely, cataractous eyes with PFV also develop 
destructively high pressures within the eye due to abnormal drainage of aqueous 
(glaucoma) resulting in a painful blind eye.94 In these cases, cataract extraction may be 
undertaken in order to prevent a painful condition rather than to improve visual function.  
Other congenital ocular anomalies associated with cataract include anterior segment 
developmental anomalies (ASDA) in which the cornea, iris and angle structures fail to 
develop normally, and congenital glaucoma.  
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2.3.e. The natural history of congenital and infantile cataract 
Without surgery, children with visually significant cataract (opacity sufficient to obscure 
incoming visual information) have little chance of good form vision in that eye. 
 
 
2.3.f. The prevention of childhood cataract blindness in the United 
Kingdom  
2.3.f.i. Primary prevention  
Primary prevention of cataract blindness in the UK involves genetic counselling of 
affected families, counselling of mothers of children with Trisomy 21, and the rubella 
immunisation programme to prevent the occurrence of maternal gestational infection. 
However, as the majority of congenital and infantile cataract in the UK is of unknown 
aetiology, the scope for primary prevention is currently limited and secondary and 
tertiary strategies play a greater role in the prevention of childhood cataract blindness 
due to cataract.  
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2.3.f.ii. Secondary prevention 
Early detection and early treatment is key to the prevention of blindness in the 
management of congenital and infantile cataract.  
 
Detection  
Although prenatal and ultrasound and MRI diagnosis of cataract is possible from 
gestational week 1495, there is no evidence on the sensitivity or specificity of prenatal 
radiological diagnosis of cataract.96-98 Thus, the earliest time that visually significant 
cataract can be excluded reliably is post-natally. Detection of cataract depends on the 
examination of the ‘red reflex’, this being the unobscured orange-red glow when light 
shining into an eye is reflected back by the retina. Lens opacity prevents this reflection. 
The importance of the early detection of cataract is reflected by the Department of 
Health’s formal inclusion of the red reflex test within the neonatal and 6 week 
postpartum infant health checks.99 In the British 95/96 cohort 66% of children 
diagnosed in the first 2 years of life were detected by 8 weeks.100 
Cataracts which develop later in infancy or which are not detected by screening may 
also be detected through frank leukocoria (white pupil due to a dense cataract) a 
change in visual behaviour or development of a strabismus in unilateral cases with the 
visually deprived eye turning in or outwards.2 
 
Treatment 
Approaches to treatment are described below. However surgical intervention may be 
considered inappropriate in cases where the visual potential of the eye is poor due to 
dense amblyopia following delayed diagnosis of congenital unilateral cataract, or due to 
 59 
ocular or neurological disease, or where there is concurrent life-threatening systemic 
disease. In some situations, for example cataract with glaucoma due to persistent fetal 
vasculature, removal of the lens is necessary for other clinical indications despite no 
visual potential.  
 
2.3.f.iii. Tertiary prevention  
Once a child has developed established visual impairment or blindness due to cataract, 
management involves minimising the limitations imposed on the child, with continued 
specialist ophthalmic input, provision of low vision care, special and specific 
educational support, and habitation and mobility training to assist activities of daily 
living.  
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2.3.g. Surgical management of congenital and infantile cataract 
2.3.g.i. Recent history of surgical management  
Prior to the 1960s,  ophthalmologists considered it safer to delay surgery until the infant 
eye was larger and more developed, in order to reduce the risk of the technical 
challenges and per operative complications associated with surgery on a small eye, 
and the potential post-operative complications of operating on immature eyes.101  
Improved understanding of visual development and the sensitive period led to 
surgeons undertaking earlier surgery, and in particular a greater emphasis on post-
operative visual rehabilitation for children with unilateral cataract.102   
The next challenge was the achievement of safe but thorough removal of the 
cataractous lens in order to prevent the physical and inflammatory mediated damage 
caused by lens remnants.1 The eye is a watertight structure: when a surgical wound is 
made in order to enter the eye, aqueous leaks out, leading to a loss of anterior 
chamber depth. Thus, safe cataract surgery requires the continuous maintenance of 
pressure in the anterior chamber, in order to keep a space in which to operate.  This is 
achieved using irrigating fluid, pumped into the eye to balance fluid lost from the 
wounds, or lost when the lens is removed from the eye. In the mid 70’s, an automated 
vitrector cutting machine, designed to remove the gelatinous vitreous gel by ‘cutting 
and sucking’ simultaneously, was cautiously used to remove the lens in paediatric 
cataract surgery. In children, the lens is often thick and ‘gummy’, and the ability to ‘cut 
and suck’ using a vitrector hand piece, which is also has an irrigation function, led to 
improved removal of the cataractous lens. The use of the vitrector also made possible 
the safe removal of the anterior section of the vitreous gel, which could move forwards 
following paediatric cataract surgery, leading to complications such as glaucoma and 
retinal detachment.103;104 Other developments, such as ophthalmic viscoelastic gel 
devices (OVDS) capable of maintaining the shape of the anterior chamber,105 
improvements in operating microscopes and surgical techniques for dealing with the 
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capsule of the lens106 have all resulted in further improvements in the risk / benefit ratio 
for early intervention for congenital and infant cataract.106-108 
 
2.3.g.ii. Modern surgical management  
Paediatric cataract surgeons 
In the United Kingdom, currently, paediatric ophthalmic surgeons first train in adult 
surgery before sub-specialising in paediatric surgery. Cataract surgery is the most 
common procedure undertaken by general ophthalmologists, accounting for over a half 
of all ophthalmic procedures undertaken in the UK,109 and progression within the junior 
levels of ophthalmic training requires the achievement of a quota of completed adult 
cataract procedures. This is the background of all paediatric ophthalmic surgeons in 
the UK and (many of the paediatric surgeons in the developed world), and there is a 
resultant diffusion of techniques and instrumentation from adult cataract surgery into 
paediatric practice.  
 
Paediatric cataract surgery  
In paediatric cataract surgery the surgeon is aiming to create entrance points into the 
eye and a space in which to operate in order to remove the lens, whilst simultaneously 
limiting post-operative inflammation.  
The pupil is dilated pre-operatively with topical medication to allow access to the lens. 
The main surgical wound is created either through the periphery of the cornea or 
through the sclera, following which irrigation fluid, or an oculoviscous device (OVD) is 
used to maintain anterior chamber depth.105;107;108  The OVDs are classified by their 
level of viscosity: low, medium, high viscosity or fracturable (fracturable being 
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superviscous OVD, analogous to the fracturable nature of chocolate cooling within a 
fridge, becoming more viscous until it reaches a stage where it snaps under pressure) . 
The use of higher viscosity OVDs (such as Healon®5 and Healon GV ®) have been 
associated with ocular hypertension due to inadequate removal following adult 
intraocular surgery.110  
The lens is accessed via an opening in the capsule – a capsulotomy. Uncontrolled 
capsulotomy results in irregular edges to the capsulotomy, which can become radial 
tears which extend to the zonules, creating an unstable lens body from which safe lens 
removal is extremely difficult. Several different capsulotomy methods are in use in 
modern paediatric cataract surgery, including  
 diathermy, in which heat used is used to rent the capsule beneath a layer of 
supportive oculoviscous gel which also acts as protection against thermal 
corneal trauma  
 vitrectorhexis, where the vitrector is used to punch through the capsule111-113  
 capsulorhexis, a technically demanding manual circular tearing of the capsule 
face undertaken beneath a layer of supportive oculoviscous gel; capsulorhexis 
results in a smooth edged circular opening 
Following capsulotomy, the lens is removed either through an automated method (with 
the vitrector) or a manual method of aspiration, leaving the eye in an aphakic (literally, 
‘without lens’) state.105 
In children the posterior face of the capsule invariably and rapidly opacifies following 
cataract extraction.1;3;105;107;114;115 Thus, many surgeons undertake removal of the 
central portion of the posterior capsule at primary surgery.  This is accompanied by 
removal of the anterior section of the vitreous gel (anterior vitrectomy). The ideal timing 
for posterior capsulotomy, that is whether primary capsulotomy or later secondary 
capsulotomy is best, has been a subject of debate, with some investigators arguing 
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that, as secondary capsulotomy can be undertaken as a non-invasive procedure using 
laser, it is safer and less traumatic than primary capsulotomy, and may reduce the risk 
of further complications.80 However, laser capsulotomy is not always successful and 
further intraocular surgery may be needed. Other investigators argue that the 
amblyogenic potential of an opaque posterior capsule necessitates primary removal, 
which also avoids the possible need for a second intraocular procedure.104-106;108;116;117 
Following surgery, antibiotics may be injected into or around eye as prophylaxis against 
infection.  Steroids are also injected into and / or around the eye to reduce 
inflammation. Post operatively topical (eyedrop) steroid and mydriatic (pupil dilating) 
medications are used to control inflammation and prevent the formation of inflammatory 
pupil adhesions (synechiae). 105 
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2.3.g.iii. Per operative complications  
Iris trauma  
Per operative iris trauma may occur directly, through instrumentation, or indirectly, 
through acute fluctuations of pressure caused by the flow of fluid into and out of the 
eye during surgery (barotrauma). The iris may also prolapse through the operating 
wound during surgery.  Iris trauma results in inflammation,118 may result in bleeding 
from iris vessels (hyphaema) which leads to further inflammation, and may results in 
damage to the drainage systems in the iridocorneal angle. 
 
Anterior and posterior capsule tears  
Tears to the anterior and posterior capsule during capsulotomy do not in themselves 
lead to adverse outcomes for children, but the tears may lead to further complications 
due to inability to safely remove lens material.  
 
Other per operative complications 
Other complications include corneal trauma, which can result in vision-threatening 
cloudiness of the cornea, vitreous haemorrhage, which can result in increased 
inflammation and obscuration of vision. 
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2.3.h. Visual (re)habilitation following surgical management  
 
2.3.h.i. Occlusive therapies for amblyopia  
Children with unilateral cataract (or with significantly asymmetric bilateral cataract) 
require therapy for amblyopia following cataract extraction, in the form of eye patch 
occlusion of the better seeing eye. Children who resist patching may require other 
methods such as insertion of an occlusive contact lens or cycloplegic penalisation of 
the non-amblyopic eye. The amount of occlusion (measured in hours per day, or 
percentage of waking time) depends on the degree of amblyopia and the age of the 
child,119;120 and treatment is prescribed until the amblyopia improves, or until the 
sensitive window effectively closes (between 7-9 years of age).120  The optimal amount 
and duration of post cataract surgery occlusion is unclear. The first few years of life, the 
time at which the child’s neuroplasticity is greatest, and thus her potential response to 
occlusion is highest 119-121 is also the time during which the accurate assessment of 
acuity is most challenging.   
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2.3.h.ii. Refractive correction  
The post-operative focusing power of the natural lens must be replaced so that a 
focused image is presented to the higher visual systems. Even relatively short periods 
of deprivation within the early sensitive period can result in severe or dense amblyopia 
in aphakic infants.  Whichever method is chosen to correct aphakia, the changing 
dimensions and consequent changing refractive state of the growing infant eye need to 
be considered.  
 
Aphakic glasses  
Glasses are a relatively inexpensive option for the replacement of lens focusing power. 
However, the necessary density and thickness of these lenses make them heavy and 
cumbersome for the infant face. There are also optical problems, as these high power 
lenses magnify centrally by 20% to 30% resulting in orientation problems due to poor 
depth perception122;123 and blurring of the peripheral field.122;124 This makes them 
unsuitable for monocular aphakia, as the differing magnification of image size is 
challenging when the child has both eyes open.  
 
Aphakic contact lenses  
Aphakic contact lenses enable an improved and more constant visual rehabilitation, 
resulting in better central vision and field of vision than aphakic glasses.71;124  Lenses 
are usually cleaned, inserted and replaced by parents, the majority of whom describe 
initial difficulty with insertion and removal although most quickly become adept at 
handling them.125-127 However difficulty of use and high costs can lead to failure to use 
aphakic contact lenses in up to a third of families in industrialised countries.125;126;128 
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Child resistance to contact lens insertion is a particular issue in those children aged 2-5 
years,125 as maturing self-awareness and improving manual dexterity conspire to make 
life difficult for the parents of aphakic toddlers. Centres which focus on parental 
education and support do report improved concordance with contact lens use.125 
Serious complications of contact lens use such as infection and corneal opacity are 
rare.125;128 However, contact lenses are expensive and require frequent changes and 
follow up checks.126;129 A further obstacle to their wider adoption in low income 
countries is the need for a clean water supply to ensure hygienic use.129 
 
Intraocular lens implantation  
In theory, artificial intraocular lens (IOL) implantation offers a permanent state of full or 
partial refractive correction. Implantation of an IOL into the emptied capsular bag can 
occur as part of primary surgery (i.e. immediately following cataract extraction), or 
secondary implantation can occur later in childhood or in adulthood, greatly reducing 
the required corrective refractive power. Secondary IOL implantation can be technically 
demanding due to intraocular inflammatory capsular bag changes following primary 
surgery, and the remaining practised options, anterior chamber IOLs or the suturing of 
IOLs into place, can result in IOL dislocation or significant inflammation and glaucoma 
due to iridocorneal angle trauma. 130-133 
The potential benefits of primary intraocular lens implantation are better visual 
rehabilitation without the visual field defects of glasses and amblyogenic risk of poor 
compliance or refitting needs of contact lenses, less long term expense for populations 
in the developing world and the removal of the need for later secondary surgery to 
implant an IOL. However, there is limited robust evidence that these benefits are 
realised in young children 
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2.3.i. Summary 
Congenital and infantile cataract is a rare disease which adversely impacts on visual 
development, and which often co-exists with other ocular disorders and systemic 
disorders which further impact on visual and global development.  
Adult cataract surgery is the dominant procedure in ophthalmic practice, and is a force 
for technical innovations which have often diffused into paediatric cataract surgery.  
Due to the amblyogenic nature of congenital/infantile cataract early intervention is 
essential, but visual rehabilitation is key. Focusing power needs to be replaced, and 
over the past few decades, for children aged under 2 years, this has been achieved 
predominantly with aphakic contact lenses and glasses.   
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2.4. Outcomes following congenital and infantile cataract 
surgery 
2.4.a. Evaluating the existing evidence on outcomes  
It is challenging to place the study reported in this thesis within the context of the 
existing literature on outcomes following congenital and infantile cataract surgery. 
Comparisons with the existing evidence are difficult due to the methodological 
variations and limitations of the published studies. These limitations include 
misclassification bias, selection bias, confounding and lack of statistical power to 
determine the role of chance  
 
2.4.a.i. Bias 
Selection bias: Misclassification and varying definitions of 
disorders and outcomes 
The misclassification of non-diseased / non-affected individuals as diseased / affected 
(or vice versa) has a profound effect on the subsequent analysis of the frequency of 
disease or the associations with possible causative factors. For example, 
microphthalmos, microcornea and glaucoma following cataract surgery have all been 
defined in numerous ways in the existing literature.75;78;134 
 
Selection bias: heterogeneity of study populations 
Children with congenital and infantile cataract form a varied group, and the populations 
investigated within the literature reflect this heterogeneity. Investigators have either 
limited their study populations to children with isolated cataract (no other ocular or 
systemic disorder)80;87;135-138 or to children with cataract associated with microphthalmos, 
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microcornea or persistent fetal vasculature.70;139;140 Included (or excluded) children may 
have different risk factor profiles for the development of different post-operative 
outcomes, differences which are not always appropriately dealt with at analysis. This 
case mix adversely impacts on attempts to compare the findings of different studies, 
and on the generalisablity of individual study findings.   
The majority of the studies on outcomes have been retrospective and most have failed 
to report how many children were lost to follow up, or on the case mix of those 
children.5;70;72;73;77;79-84;87;135;137-169 Consequently, these studies are at risk of 
ascertainment bias.  
 
2.4.a.ii. Confounding 
Prior investigations of the potential associations of child and surgery specific factors 
with favourable and adverse outcomes following congenital and infantile cataract have 
not always considered the issue of confounding.80;166 In order to reduce the risk of 
confounding, the possibilities of complex relationships between clinical variables and 
outcomes must be considered and investigated during analysis. Methods used to 
address confounding include stratification, but the most robust way of investigating the 
relationship between multiple, possibly interrelated clinical variables such as age, 
ocular findings and family history is to undertake multivariate analysis.79;170;171 In this 
way, the independent effect of one variable on the risk of a particular outcome once 
other variables have been taken into account can be ascertained, as can the direction 
and size of effect one variable has on another variable’s association with the risk of the 
outcome.  
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2.4.a.iii. Levels of evidence 
The hierarchy of evidence (reflecting the hierarchy of study methodology) can be used 
to consider the strength of the evidence on outcomes following surgery. Methods used 
in the study types at the “top” of the hierarchy are more likely to minimise bias and 
confounding (Table 8). However, the hierarchy is not an inflexible construct, as study 
methodology is no guarantee of study quality: the level within the hierarchy of an 
individual study may be graded down on the basis of ‘study quality, imprecision, 
indirectness’,172 and the level of a review of studies may be graded down because of 
inconsistencies between studies, or because the size of the reported effects are very 
small. Conversely, the level may be graded up if there is a large effect size. 
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Table 8. Levels of evidence 
from the Oxford Centre of evidence based medicine172  
 
 
2.4.a.iv. Chance  
Congenital and infantile cataract is rare, and adverse outcomes following surgical 
treatment are rarer.  When a disease or an outcome is uncommon, it can be a 
challenge to obtain the sample size needed to demonstrate statistical significance for 
even potentially large effects. Much of the existing literature on outcomes following 
surgery consists of case series on relatively small numbers of children and hence is 
prone to chance findings. 71;82;83;83;84;139;150;153;157;173-184 
Level of 
evidence 
Outcomes investigated Study methodology 
1 
(Highest 
level) 
Prognosis Systematic review of inception cohort studies 
Treatment benefits 
Treatment harms 
Systematic review of randomised trials 
Rare treatment harms 
Systematic review of case control studies or studies 
revealing dramatic effects 
2 
Prognosis Inception cohort study 
Treatment benefits 
Randomised trial or observational study with dramatic 
effect 
Treatment harms Systematic review of nested case control or dramatic effect 
Rare treatment harms 
Randomised trial or observational study with dramatic 
effect 
3 
Prognosis Cohort or control arm of randomised trial  
Treatment benefits 
Treatment harms 
Rare treatment harms 
Non randomised controlled cohort / follow up study 
4 
Prognosis Systematic review of case-series 
Treatment benefits 
Systematic review of case-control studies, historically 
controlled studies 
Treatment harms 
Rare treatment harms 
Case-control studies, historically controlled studies 
5 
(Lowest 
level) 
Prognosis 
Treatment benefits 
Treatment harms 
Rare treatment harms 
Opinion without explicit critical appraisal, based on limited / 
undocumented experience, or 
based on mechanisms 
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2.4.b. Visual outcomes following congenital and infantile cataract 
surgery  
There now follows a summary of the existing evidence on visual outcome following 
surgery for bilateral and unilateral congenital or infantile cataract. The terms used for 
the database searches for this review are appended (Appendix N). 
2.4.b.i. Bilateral cataract 
Whilst the majority of children with bilateral disease will not have normal vision post 
operatively,64;171 surgery can prevent visual impairment in approximately a third of 
children64;71;176 (table 6). Severe visual impairment or blindness affects up to 33% of 
children following surgery.64;176;177 In Chak et al’s171 follow up study of 113 children 
initially identified by UK surveillance in1995/6,52  five years following bilateral surgery 
the median visual acuity was 6/18 Snellen. Although children had been aged between 
5 days and 12 years at surgery, the median age at surgery of 4 months indicated that 
the majority of these children underwent surgery early in life.    
2.4.b.ii. Unilateral cataract 
Compared with those with bilateral cataract, children with unilateral disease generally 
experience worse visual outcomes in the operated eye due to the additional 
amblyogenic drive of competition from the better-seeing eye.171;177;178;185 Post 
operatively, between a third and a half of children will have severely impaired vision or 
worse, and moderate to severe visual impairment in the operated eye is the usual 
outcome (table 7).171;174;177;179-181;185  Chak et al reported that for the 40 children who 
had undergone surgery following diagnosis of cataract in 1995/6 (with a median age at 
surgery of 3 months) the median acuity in the operated eye five years after surgery was 
6/60.171  Parental concordance with occlusion of the fellow eye is of key 
importance.120;171;186 
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Table 9. Visual outcome following bilateral cataract surgery  
binocular acuity or acuity in better eye  
 
Study 
Level of 
evidence 
N 
(children) 
Age at surgery Follow up 
Visual outcome 
Notes 
no impairment 
severe impairment or 
worse 
Chak 2006171 2a 113 
4.6 months 
(median ) 
7 years (median) Median acuity 0.6 (moderate impairment)  
Magnusson et al 
200278 
3a 28 <1 year  > 12 years Mean acuity 0.3 (no impairment)  
Hing et al 199071  3b 26 <12 months 3 years (mean) 54% achieved vision better than 6/24 
No visual impairment in 83% of children 
operated on in first 2 months of life 
Robb et al 1992187 3b 30 <24 months > 3 years 37% 7%  
Kugelberg et al 1992188 3b 7 < 3 months 5 years (mean) 43% 29%  
Neumann et al 1993174 3b 11 8 months (mean) 
60 months 
(mean) 
64% 9%  
Bradford et al 1994176 3b 23 <6 months 6 years (mean) 43% 14%  
Lesueur et al 1998177 3b 11 4 months (mean) 
77 months 
(mean) 
17% 11% Mean vision 0.7 (moderate impairment) 
Lundvall et al 200284 3b 13 <12 months > 4 years 54% 8% 
Also studied 9 children with other systemic / 
ocular abnormality: 56% severe visual 
impairment 
Francis et al 200164 3b 172 < 2 years Not reported 34% 33%  
HeHua 189 et al 2007 3b 38 
<12 months, 
mean 5.6m 
9 years (mean) Mean vision 0.25 (no impairment) 
All children had secondary IOLs after 2 yrs of 
age 
Birch 190et al 2009  3b 37 
10 weeks (mean) 
<31 weeks 
10 years (mean) Mean vision 0.4 (no impairment) 
Worsening of visual outcome with every 1 
week increase in age up to age of 14 weeks 
Lorenz et al 1991191 4 9 < 1 year > 5 years 32% 22%  
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Table 10. Visual outcome in operated eye following unilateral cataract surgery 
  
Study 
Level of 
evidence 
N 
(children) 
Age at surgery Follow up 
Visual outcome 
Notes 
no impairment 
severe impairment 
or worse 
Chak et al 2006171 2a 40 
3 months 
(median) 
7 years (median) 
Median visual outcome 1.0 (severe 
impairment) 
 
Lambert et al 2004180 3a 13 9 weeks (mean) 4 years (mean) 17% - 27% blind in operated eye 
Drummond et al 
1989179 
3b 14 < 6 months >5 years 43% 37%  
Wright et al 1992181 3b 13 < 9 weeks >1 year 13% -  
Neumann et al 1993174 3b 11 4 months (mean) 5 years (mean) 18% 73% 
all children with good visual outcome underwent 
surgery in first month of life 
Thompson et al 
1996192 
3b 12 < 13 weeks > 4 years  Mean acuity 1.3 (severe impairment)  
Birch et al 1998178 3b 17 < 30 weeks >7 years 
Aged under 8 weeks at surgery mean vision 0.4 (no impairment); age over 8 weeks vision 
0.9 (moderate impairment) 
Lundvall et al 200283 3b 30 < 12 months >4 years 20% 80% 
All children with 0.1 vision or better underwent 
surgery aged <3 months 
Birch et al 2005185 3b 5 4 months (mean) 4 years (mean) 
Mean visual outcome 0.4 (no 
impairment) 
 
Chen et al 2010193 3b 15 <6 weeks >5 years 50%  25%   
Allen et al 201074 3b 62 5 weeks (mean) >7 years 6% 27% 
Children who underwent surgery aged ≤2weeks 
had vision 0.4 (no impairment) 
Lesueur et al 1998194 4 9 6 months (mean) 3 years (mean) 11% 56% mean outcome 1.0 (severe impairment) 
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2.4.b.iii. Age at surgery and other determinants of good visual 
outcome  
The age at surgery has consistently been reported to be the most important 
determinant of visual outcome: the later the surgical intervention, the worse the visual 
outcome.64;71;171;174;178;185. The highest level evidence on the impact of age on outcome 
comes from Chak et al’s study, which reported that decreasing age at surgery results in 
reduced relative odds of poorer visual outcome: relative odds = 0.99 unilateral 
cataract (CI 0.96 – 1, n=40) and 0.98 bilateral (CI 0.94 – 1, n=109).171 Another smaller 
prospective study reports that between 0 and 14 weeks of age visual acuity decreases 
by 1 LogMAR line for each 3 weeks of delay in undergoing bilateral surgery. 195 The 
idea of a window of developmental sensitivity, which gradually closes over the first 
years of life, fits well with this evidence of the importance of early intervention for 
cataract. However, the start point and the duration of the critical window within the 
sensitive period (see box 1, section 2.2.b, page 36) is unclear.  If there is a critical 
period during which visual stimulus is absolutely necessary for development of function, 
then restoration of clear focused vision before the end of this period will give the child 
the best chance of good vision, and surgery during the latent pre-critical phase would 
theoretically help the child to escape the risk of amblyopia altogether.  
The critical periods for form perception and for cerebral ocular dominance (at particular 
risk in unilateral cataract) may close before the 8th week of life, as evidenced by reports 
from small retrospective case series studies. These suggest that normal vision in the 
operated eye is more common in children with unilateral cataract operated on before 7 
weeks of age (4/11, 36%) versus children operated on after 7 weeks (0/12) 180; further, 
strabismus and nystagmus is more common in children with unilateral and bilateral 
cataract undergoing surgery later than 7-8 weeks of age versus surgery before 7 
weeks of age 166. A weakly bilinear relationship between increasing age at surgery and 
the decreasing level of post-operative visual outcome has been reported in two small 
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retrospective studies (45 children with unilateral cataract, and 37 with bilateral cataract) 
with a steeper decline in outcome with increasing age (suggesting closure of a critical 
window for form perception) beginning at 6 weeks old for unilateral cataract, 36 and 14 
weeks for bilateral cataract.195 However, the possibility of a non-linear relationship was 
not investigated. The latent pre-critical periods may end within the first month of life: 
surgery before 3-4 weeks of age is associated with a lower rate of the indicators of 
poor visual acuity, strabismus and nystagmus.195;196  
Visual outcome after paediatric cataract surgery also depends on several other factors 
including the: 
 co-existence of other ocular anomalies – abnormalities which directly impact on 
acuity, such as retinal disorders or microophthalmos,70;197 , and abnormalities 
which are associated with poorer outcome vision due to the increased risk of 
per and post-operative complications following cataract surgery  such as 
persistent fetal vasculature.176;198;199  
 effectiveness of and concordance with amblyopia treatment, especially for 
children with unilateral cataract119 
 effectiveness of and concordance with refractive correction74 
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2.4.c. Early post-operative complications of congenital and infantile 
cataract surgery 
 
2.4.c.i. Inflammation 
Post-operative anterior segment inflammation, the immune response to the trauma of 
intraocular surgery, is much brisker in children than in adults following cataract 
surgery.1;115 Inflammation can result in the deposition of inflammatory proteinaceous 
fibrin membranes in the eye, adhesions between the iris and capsule (pupil synechiae), 
and inflammatory damage to the trabecular meshwork (trabeculitis). Post-operative 
drops are used to control inflammation, and excessive inflammation (as indicated by 
membranes, synechiae or congested iris vessels) is treated with intensive topical 
steroid regimes, periocular steroids or intraocular anti-inflammatory agents, depending 
on the severity.105 Inflammatory membranes may require surgical removal.  
 
2.4.c.ii. Post-operative iris prolapse 
The iris muscle may prolapse through a surgical wound which  re-opens following 
surgery, with consequent post-operative inflammation and possible trauma to the angle 
through tension on the root of the iris at the iridocorneal uveal meshwork.9   
 
2.4.c.iii. Endophthalmitis  
A very rare but devastating complication of intraocular surgery is intraocular infection, 
endophthalmitis.200 The estimated UK incidence following adult cataract surgery is 
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0.14%, or one case per 700 procedures.201 The incidence in children is unknown. 
Endophthalmitis is difficult to treat, and generally has a very poor visual prognosis.201;202  
 
2.4.c.iv. Acute pupil block  
The anterior vitreous gel or retained lens matter (which, when released from the 
containment of the capsule, becomes hydrated and swollen) may move forwards, 
shallowing the anterior chamber and blocking the pupillary opening and ‘closing’ the 
iridocorneal angle. This prevents the egress of aqueous fluid, thus causing an acute 
rise in intraocular pressure. If sustained, the intraocular hypertension results in 
destructive changes to ocular tissue, in particular the optic nerve (glaucoma). Pupil 
block is treated with surgical removal of the blocking material. In the longer term, the 
iridocorneal angle may remain closed despite surgical treatment, due to inflammatory 
adhesions formed between the iris and cornea during the acute phase.  
Over the past few decades, rates of post-operative closed angle glaucoma following 
early childhood surgery have declined following the introduction of vitrectomy 
techniques allowing more thorough removal of the cataract and anterior vitreous.9;183  
In adults, incomplete per-operative removal of the superviscous OVD gel types (Healon 
GV, Healon 5) has been associated with early transient elevations in intraocular 
pressure.110 
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2.4.d. Late post-operative complications of congenital and infantile 
cataract surgery 
Late post-operative complications are those which occur after the first post-operative 
month.2 The most significant sight threatening complications following early childhood 
cataract surgery are glaucoma, and the formation of opacification across the visual axis. 
Other possible late complications include detachment of the retina. 64;71;106-108 
 
2.4.d.i. Post-operative visual axis opacity  
Although primary posterior capsulotomy and anterior vitrectomy removes the central 
section of the capsule and anterior gel, post-operative opacification across the central 
axis of vision can still develop due to the proliferation of microscopic populations of 
remnant lens fibres. 1;203   
 
Definition and classification  
Visual axis opacity (VAO) can occur due to proliferation at the anterior or posterior 
capsular planes, and can take one of two forms: 
 Pearls, or swollen lens fibre remnants which form bladder like cells, which are 
semi-opaque 
 Fibrosis, with opacified metaplastic lens fibre remnants which have constrictive 
as well as proliferative properties, thus leading to phimosis (narrowing) of the 
anterior or posterior  capsulotomy openings.1  
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In addition, following significant post-operative inflammation the visual axis can be 
obscured by membranes of organised inflammatory material crossing the pupil 
margin.1;115 
 
Prevalence 
It has been reported that between 9% and 22% of children will develop VAO during the 
first post-operative year.114;165;204 
 
Associated factors 
Post-operative inflammation (which may be due to surgical iris trauma), and inadequate 
removal of lens matter increases the risk of proliferative and inflammatory VAO. 1;117;204-
208 
 
Treatment 
Once VAO develops, prompt treatment with laser therapy or, more commonly, further 
intraocular surgery 114;117;165;180;209 is indicated to prevent the development of amblyopia. 
Where inflammatory membranes cover and occlude the pupil, urgent treatment may be 
necessary to release pupil block. 105 
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2.4.d.ii. Post-operative ocular hypertension and glaucoma 
Paediatric post-operative glaucoma is a sight threatening disease in which ocular 
damage occurs secondary to elevated intraocular pressure (ocular hypertension) which 
is in turn secondary to damage to the aqueous drainage pathways in the iridocorneal 
angle. The damage to the angle can either be of a closed angle type, where there is 
loss of access to the drainage angle due to apposition / adherence of the iris and / to 
cornea (as seen in pupil block episodes), or open angle type, where there is an open 
but dysfunctional drainage pathway.2;9;137;158;183 Since the 1980s, rates of post-operative 
closed angle glaucoma following early childhood surgery have reduced following the 
introduction of microsurgical and vitrectomy techniques which allow safer and more 
thorough removal of the cataract and anterior vitreous. The problem of open angle 
glaucoma, which presents more insidiously, has gained increased attention.210  
 
Definition and classification  
Ocular Hypertension  
The average infant intraocular pressure ranges from 5mm of mercury (mmHg) to 
21mmHg varying with the method used to measure pressure, whether the child is 
awake, and the use of certain anaesthetic agents.2;211;212 Ocular hypertension is 
therefore an intraocular pressure of >21mmHg. However, as individuals who have 
undergone early childhood cataract surgery have thicker corneas than ‘normal’ 
individuals, which results in artificially elevated measurements of intraocular pressure, 
141;142;213 a measured ocular hypertension may not reflect a ‘true’ ocular hypertension. 
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Glaucoma 
The British Infantile and Childhood Glaucoma study group, which consists of paediatric 
ophthalmologists specialising in glaucoma, has concluded that the appropriate 
definition of childhood glaucoma should put the emphasis on the destructive sequelae 
of ocular hypertension on the ocular structures, rather than the degree of hypertension 
diagnosed (box 3). 
 
Box 3. The British Infantile and Childhood Glaucoma study group definition of glaucoma:  
‘the presence of a combination of clinical signs consistent with high IOP (≥21mm Hg), such as: 
optic disc cupping ≥0.3 (signifying optic atrophy) or disc asymmetry ≥0.2, progressive disc 
cupping (thinning), buphthalmos, enlarged corneal diameter, corneal oedema, Descemet’s 
membrane splits / Haab’s striae (signs of corneal stretch), visual field defects (due to the 
neuropathy), and progressive myopia’. 214 
 84 
Prevalence 
Due to the different definitions in use within the literature on secondary glaucoma after 
cataract surgery, including those listed in box 4 overleaf, it can be difficult to compare 
studies to determine with certainty the prevalence of secondary glaucoma after 
childhood cataract surgery. However, following childhood cataract surgery, it is likely 
that between 10% and 25% of aphakic eyes will develop glaucoma by the 10th post-
operative year.79;80;166;170;215;216 The population based and large scale longitudinal 
studies of outcomes following congenital and infantile cataract surgery consistently 
show that the frequency of glaucoma increases with the duration of follow up,78;216 with 
approximately 5% of operated eyes developing secondary glaucoma each year.170 In 
addition, secondary glaucoma is now the most common sight threatening post-
operative outcome of childhood cataract surgery, accounting for a third of all secondary 
childhood glaucoma in industrialised countries such as the United Kingdom.214 
 
 
Box 4. Differing definitions of glaucoma within the existing literature 
the presence of ‘elevated pressure (IOP>21mmHg) AND signs of that elevated 
pressure’5;82;134;136;139;157-160;217;218  
the presence of ‘elevated pressure (IOP>25mmHg) AND signs of that elevated pressure’ 
75;78;165;166  
the presence of ‘elevated pressure (not defined) AND signs of that elevated pressure’80;156  
‘elevated intraocular pressure (<21mmHg)’ 162-164  
‘elevated intraocular pressure (<25mmHg)’ 9;72;73;79;87;137;140;167-169;183)  
‘elevated IOP OR signs of elevated pressure’.77;81;161 
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Associated factors 
As stated earlier, in a large number of studies, there has been a misclassification of the 
outcome of interest (with isolated ocular hypertension considered as glaucoma) with 
subsequent possible biased analysis of the clinical associations of aphakic glaucoma. 
There is, however, robust evidence that increasing age at surgery is protective against 
the risk of glaucoma.  
 
Age at surgery – the key risk factor for developing secondary aphakic 
glaucoma? 
A 10 fold increase in age at surgery (for example, from 3 days old to 30 days old at 
surgery) may be associated with a 60% reduction in the risk of developing glaucoma. 
When other factors have been accounted for (using multivariate analysis) age at 
surgery is either the only significant or the most significant risk factor for developing 
glaucoma. 72;79;87;88;170;170  
It is increasingly recognised that determining the ‘ideal’ age at cataract surgery for an 
individual child requires balancing the risk of amblyopia with the risk of glaucoma, but 
there is no robust evidence of a ‘threshold’ age for early life cataract surgery, that is, an 
age at which the risk of developing subsequent glaucoma drops significantly. The 
strongest available evidence puts a threshold age well beyond the age of the 
postulated ‘critical period’: Rabiah et al and Swamy et al used an ad hoc cut off of 9 
months of age, and reported that age under 9 months conferred an increased risk of 
glaucoma (n=322 children, hazard ratio =7.0 [CI 3/6 – 13.7] and n=234 children, hazard 
ratio=2.9 [CI 1.3 – 7.7] respectively following multivariate analysis).79;87  
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Other risk factors for developing aphakic glaucoma 
Microphthalmos and microcornea have been reported as risk factors for glaucoma 
following univariate analysis, 78 but not following multivariate analysis, suggesting that 
when the age of the child is taken into consideration, the size of the eye is not a 
significant independent risk factor for the future development of aphakic glaucoma. 
However, this may also reflect the small study populations in these studies, and the 
resultant lower power to detect statistically significant clinical associations.  
Persistent fetal vasculature (PFV) has not consistently been found to be a significant 
risk factor,87;166 but the phenotypology of PFV is so variable that the case mix may be 
responsible for the absence of robust reported associations.   
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Treatment 
The treatment of paediatric glaucoma involves topical and oral anti-hypertensive 
medication, laser ablation of the ciliary body to shut down aqueous production, and 
intraocular surgery which may involve the implantation of a drainage device to lower 
IOP.210 Secondary glaucoma following cataract surgery is difficult to manage, and the 
majority of children require multiple interventions.136;158;210 It can result in severe visual 
impairment in almost a half of affected children with the outcome in some cases being 
worse than the outcome in un-operated cataract.78;136;137 
A paper reporting the detailed findings of a systematic review, undertaken as part of 
the research for this thesis, of the existing evidence on secondary glaucoma following 
childhood cataract surgery is appended to this thesis (Appendix A) as are the search 
terms used for the review (Appendix N). 
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2.4.d.iii. Other complications 
The other potential late complications of early childhood cataract surgery include:  
 decentralisation of the pupil due to iris trauma or inflammatory iris 
adhesions,107;219 which can impair vision should the pupil edge obscure the 
visual axis 
 detachment of the retina due to tractional forces acting through the vitreous gel: 
an uncommon complication following modern cataract surgery involving more 
controlled manipulation of the vitreous gel220 
 macular oedema: swelling of the central area of the retina is an uncommon and 
usually self-limiting complication107  
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2.4.e. Refractive change following surgery  
Cataract extraction in infancy, the period of relatively rapidly occurring changes in 
ocular structure, can impact on the further growth of the eye and consequently the 
emmetropisation process. Although animal models of the outcome of lens extraction 
demonstrate retardation of ocular growth, in human infants the impact of lens extraction 
is usually in the direction of a myopic shift due to excessive axial elongation.221;222 223;224 
The mechanisms behind this alteration in ocular growth are unclear, and will remain so 
until the process of emmetropisation in normal eyes is more fully understood. This 
abnormal elongation may be in response to visual blur due to uncorrected myopia, but 
has been shown to occur in aphakic eyes with ‘normal’ vision.225  It may be due to 
postoperative complications, either directly (in glaucomatous eyes) or indirectly (where 
the complication leads to visual derivation). It may also be a consequence of the impact 
on emmetropisation of the loss of accommodation with removal of the crystalline lens. 
Or, it may simply be that cataractous eyes are essentially abnormal and thus exhibit 
abnormal growth patterns.  
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2.4.f. Summary 
The heterogeneity of disease and outcome classification as well as study design and 
study populations within previous observational studies of outcomes following cataract 
surgery in early childhood have made comparisons or systematic review difficult, and 
meta-analysis extremely difficult. 
However, there is good evidence that with current treatment approaches just over 50% 
of children will have some visual impairment following surgery for bilateral cataract, and 
over 50% of children will have severe visual impairment in the operated eye following 
surgery for unilateral cataract. Aphakic glaucoma is the most important complication 
following paediatric cataract surgery, with surgery during the first two years of 
childhood resulting in a lifetime increased risk of the development of this sight 
threatening and challenging condition. Age at surgery is the probably the most 
significant risk factor for glaucoma, but this risk should be balanced by the risk of dense 
amblyopia if surgical intervention is delayed.  
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2.5. Primary intraocular lens implantation   
IOLs consist of a central optic section, and flexible haptic ‘legs’ which provide the 
intraocular support (Figure 8) The optic and haptics may be made up of the same (one 
piece IOL) or different (three piece IOL) materials. Biocompatibility is the ability of a 
material implanted in the body to ‘exist in harmony with the surrounding tissue without 
causing deleterious change’.226 Cataract extraction has been practised since 1000BC, 
but patients with cataract had to wait until the 1950s for a biocompatible, manipulable 
material capable of safely replacing the lens’ lost focusing power. As with the 
development of penicillin, tetanus immunisation and blood transfusion,227 warfare was 
the driving factor behind the development of a biocompatible intraocular material: 
modern intraocular materials (box 5) are descendants of the fragments of blown-out 
Perspex windscreen which were observed to stay inert within the eyes of injured World 
War II RAF pilots.228 
Age related cataract is the most common cause of impaired vision in adults aged over 
65 years old, and in 2009, in England, 320,000 adults underwent implantation with an 
intraocular lens.229  Primary IOL implantation is routine practice in adult surgery, who 
can expect excellent visual results following surgery, with 95% of otherwise healthy 
eyes achieving 6/12 vision or better, 109 and sight threatening complications occurring 
in less than 5%.109  However, intraocular lens implantation has until recently been 
exceptional practice in paediatric cataract surgery (specifically in children aged under 8 
years old) due to the difficulties inherent in the safe and effective implantation of an IOL 
within an environment which is at its most pro-inflammatory stage, a structure which is 
undergoing significant change, and a child who is experiencing rapid visual and global 
development.107  
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Figure 8. Intraocular lenses 
 (A) showing the optic and flexible supportive haptic portions, and (B) & (C) showing 
the optic and haptic dimensions for the IOLs most commonly in use in the developed 
world. 105 
 
Box 5: Modern IOL materials 
 PMMA, or poly methyl methacrylate: Rigid, less biocompatible than silicone acrylic, the 
most economic IOL material, and most in use in the developing world226 
 Hydrophilic acrylic: Foldable (therefore require a smaller wound for implantation), less 
capsule biocompatibility than other hydrophobic acrylic203;230 
 Hydrophobic acrylic: Foldable, highest biocompatibility231 
 Silicone: Foldable, less capsule compatibility than hydrophobic acrylic232 
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2.5.a.  The issues surrounding surgical planning for IOL 
implantation in children versus implantation in adults 
 
2.5.a.i. Intraocular lens sizing   
Modern IOLs (such as those illustrated in Figure 8) measure from 12-13.5mm in haptic 
diameter, and have been designed so that they are able to sit securely within the adult 
capsular bag (which is approximately 10.5mm in diameter) without causing undue 
stretch or distortion.203  
Whilst the adult capsule measures 10.5mm in adulthood, however, the mean neonate 
capsule diameter is considerably smaller at 7mm, although it grows to 9mm by 2 years 
of age and 10mm by 5 years.226 As such, most IOLS designed for use in adults are too 
large for the infant eye, however IOL implantation in post mortem infant eyes, show 
‘acceptable’ levels of stretching with smaller IOLs (haptic diameters of 12mm and optic 
diameters 5-6mm across).233 
 
2.5.a.ii. Patient selection  
At present, any adult who is able to undergo cataract surgery is selected for IOL 
implantation in all but the most exceptional cases, for example, where there has been 
traumatic damage to the capsular bag and iris with no resultant secure positioning 
possible for the IOL.2  
There is at present no consensus on the children most likely to benefit from or most 
likely to experience complications following primary IOL implantation. However, some 
practitioners have argued that children at a greater risk of glaucoma (such as children 
with Lowe oculorenal syndrome associated cataract) should not receive IOLs.107;234 
Other children unlikely to receive IOLs are those with small eyes (although there is no 
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consensus on which size of eye is ‘too small’ for safe IOL implantation) or those in 
whom the capsule is too unstable to support the lens, such as those with significant 
persistent fetal vasculature.105;106;235  
 
2.5.a.iii. Refractive planning 
Biometry  
In adults, the selection of the power of the implanted IOL is dependent on the pre-
operative dimensions or biometrics of the eye. Biometry, a non-contact scanning of the 
eye which measures the curvature of the cornea and length of the globe, is undertaken, 
and these various parameters are entered within one of several eponymous formulae 
in order to calculate the necessary prosthesis power. Four different formulae are in use 
in adults in the UK: the Sanders, Retzlaff and Kraff third generation (SRK/T), Holladay, 
Haigis and Hoffer Q 236 237 238 equations, with the Hoffer Q and Haigis equations being 
recommended by the Royal College of Ophthalmologists for adult eyes less than 22mm 
in length. These formulae have been developed and refined using the parameters and 
outcomes of adult eyes. The most commonly used formulae, the Hoffer Q and the 
SRK/T, have been designed to be further individualized for patients using either ocular 
data (specifically anterior chamber depth for the Hoffer Q238) or a surgeon specific 
adjustment (the A constant ) derived from refractive outcome data from previous 
patients 236.  
Whilst biometry in adults is a fast, simple non-contact procedure, requiring adults to 
focus on a fixation light whilst the automated measurements take place, young children 
cannot be expected to comply in this way. Thus, contact methods of measuring the eye 
whilst the child is held securely, sedated or anaesthetised have been developed. 
Ultrasonic axial length measurement, which is necessary for biometry, requires contact 
with the ocular surface either with a probe or through a globe immersion device. 
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Contact methods have been shown to have reduced accuracy when compared to 
immersion techniques, possibly due to inadvertent flattening of the front of the eye.239  
Paediatric cataract surgeons have not yet reached a consensus regarding the best 
method of choosing a power calculation formula. The four different formulae in use are 
all based on assumptions about the shape of the adult eye and the position of the IOL 
implant after surgery in adults.237;240 These formulae are less accurate in predicting 
outcomes for children,241;242 242;243 as the shape of the eye differs significantly in infancy 
and changes as the eye grows, with significantly less accuracy at the extremes of axial 
length and corneal curvature. The relationship between the biometrics, the formula 
choice and the accuracy of the power calculation are unclear.  
 
Power selection  
In adults, the lens power and refractive outcome is selected following discussion with 
the patient regarding whether they would prefer to be focused for distance work 
(emmetropia) or focused for near work (mild myopia). Following surgery adults either 
use reading or distance / driving glasses for additional post-operative focusing 
respectively.  
In paediatric surgery, the surgeons can either select a lens power which leaves the eye 
emmetropic or one which leaves the eye in the normal infant state of hypermetropia, so 
that the growth of the eye and ‘myopic shift’ will result in a final refractive state near 
emmetropia.106;244  
The myopic shift in paediatric pseudophakic eyes is larger than that seen in aphakic 
eyes, due in part to the optical effect of a fixed lens power in a growing eye: as the eye 
becomes larger, the IOL shifts further away from the retina, inducing myopia to a 
degree relative to the power of the lens. Axial elongation following paediatric cataract 
surgery has been reported by several small scale studies to be, however, more 
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variable in pseudophakic eyes than in aphakic eyes,245-250 which may indicate some 
other impact of IOL implantation on ocular growth and emmetropisation.  
It is difficult to judge which eyes will develop a significant refractive surprise following 
IOL implantation in infancy. A child’s pre-operative axial length, post operative 
keratometry, the power of the implanted IOL and the presence of other ocular disorders 
do not appear to correlate well with the degree of myopic shift.251-253 Age has been 
shown to be an influencing factor: the younger the patient, the larger and the more 
unpredictable the myopic shift.252;254;255   
Due to the uncertainties regarding which IOL power formula to use and the degree of 
the paediatric pseudophakic myopic shift, investigators have reached differing 
conclusions regarding the most appropriate refractive outcome to aim for in primary 
IOL power selection for children undergoing surgery in the first two years of life. For 
example, the suggested refractive goals for children aged under 2 months old range 
from +10 dioptres105 to +8 dioptres106 to +7D256, whilst the goal for children aged 5 
years old is +5 dioptres.105;182;219;257  
 
2.5.a.iv. Per operative procedure 
In paediatric and in adult eyes the intraocular lens is ideally placed within the capsule: 
however, this is technically demanding and may be made impossible by per-operative 
capsular bag damage. In these cases, if an IOL is to be used,  surgeons may place the 
haptics in the sulcus, the space between the peripheral iris and the anterior capsular 
face.105 It is unclear if this intraocular fixation method, which if undertaken in early 
childhood results in contact between the IOL haptics and the immature iris and irido-
ciliary area, is associated with adverse outcomes.  
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2.5.a.v. Management of post-operative inflammation  
Following routine adult cataract surgery with or without intraocular lens implantation, 
four times daily to twice daily topical corticosteroid drops are used over the first post-
operative month in order to control inflammation (Royal College of Ophthalmology 
guidelines, 2009). Following cataract surgery in the first two years of life, the 
particularly pro-inflammatory state of early childhood necessitates more frequent 
instillation of post-operative steroid drops.107 In addition, despite the biocompatibility of 
IOL materials, IOL implantation may result in increased post-operative inflammation, 
due to the inevitable iris trauma inflicted when attempting to insert an IOL with a 5-6mm 
optic diameter through an infant pupil which even at maximal dilation is less than 
7.5mm in diameter.258 Most surgeons advocate additional intraocular or periocular 
steroid medication following IOL implantation in early childhood. 105;106;259;260  
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2.5.b. Post-operative visual re(habilitation)  
Amblyopia is not an issue in the post-operative management of cataract in adults and 
children over 8 years old, in contrast with its particular importance for children who 
undergo surgery in the first two years of life, a time when amblyopia intervention is 
most effective. Whilst occlusion therapy remains the same for children undergoing 
surgery with IOL implantation for unilateral cataract,261 refractive correction following 
surgery for unilateral or bilateral is different, as pseudophakic children do not require 
the full refractive power of the natural crystalline lens. However, where post-operative 
hypermetropia or emmetropia has been achieved, pseudophakic children, who are 
unable to accommodate, will require refractive correction in order to focus on near 
objects such as toys, parental faces or print. Refractive correction will also be needed if 
there has been a ‘refractive surprise’, an unexpected refractive result following IOL 
implantation.  
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2.5.c.  Visual outcomes following primary IOL implantation in 
children ≤2 years old 
The existing studies on outcomes for children under 2 undergoing primary IOL 
implantation are generally limited by relatively small numbers, with the majority of these 
studies involving fewer than 20 children,177;182;185;186;253;262-266 and retrospective study 
designs with resultant incomplete datasets necessitating narrow focus on particular 
outcomes or inability to fully investigate child or surgery specific determinants of 
outcomes.144;153;247;267-271 
Nevertheless, it appears that visual outcomes following primary IOL implantation in 
children under 2 compares favorably to outcomes with aphakic contact lenses.185;186;272 
Vision is either not significantly different or, in children with unilateral cataract, is slightly 
better, as the reduced refractive difference between the two eyes is thought to reduce 
the amblyogenic drive.253;185 However, there is often a selection bias at play, as the 
cohorts undergoing primary IOL implantation are carefully selected and thus tend to be 
those with a better visual prognosis due to absence of other ocular anomaly or 
development of cataract at later stages of infancy outside the critical sensitive 
period.185;247;152; 270; 148; 153 
Two groups have undertaken a more systematic and direct comparison of outcomes 
with and without IOLs and have exclusively studied infants with unilateral congenital 
cataract undergoing surgery in the first 6 months of life.272, 180 Autrata et al272 reported 
improved vision in 18 infants implanted with IOLs (0.43 LogMar) versus 23 children 
managed with contact lenses (0.53 LogMar), but the postoperative interocular 
difference in vision between the cataract and fellow eyes was significantly higher in the 
contact lens group (0.48 Log MAR versus 0.23 LogMar) in this non randomized 
prospective cohort study. This suggests a stronger amblyopic drive in the contact lens 
group which could explain the poorer visual outcome in this group.  
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The infant aphakia treatment study 
Recently, investigators have reported the findings of a randomized controlled trial, the 
Infant Aphakia Treatment Study (IATS).273 The IATS group involved 20 surgeons 
across 12 centres which allocated 114 children aged less than 7 months at the time of 
surgery  to either cataract surgery and contact lens correction, or surgery with primary 
IOL implantation. The median age at surgery was 1.8 months within both groups, and 
the surgical procedure consisted of a vitreous cutter or manual tear capsulotomy, lens 
aspiration, posterior capsulotomy and anterior vitrectomy. Acrylic hydrophobic IOLs 
were used in all pseudophakic eyes. Following surgery children received topical 
steroids four times daily for one month. 
At one year following surgery, following training and formal assessment of examiner 
performance, travelling study examiners assessed the visual acuity of recruited 
children using Teller grating acuity cards. IOL implantation was not associated with 
better acuity at this early stage – there was a trend towards better acuity for children 
within the aphakic group but this did not reach statistical significance (median LogMAR 
acuity contact lens group, 0.80; IOL group, 0.97; p=0.19).  
As a randomized controlled study, the IATS is able to provide evidence at the highest 
level on the impact of IOL implantation in infancy within the context of surgical practice 
within the included North American hospitals, but is not able to provide information on if 
and how the other potential determinants of post-operative vision impact on children 
undergoing surgery with IOL implantation. These determinants, which may impact 
differentially on children undergoing surgery with and without IOL implantation, include 
refractive planning (refractive outcome and biometry method and degree of post-
operative refractive correction), surgical technique, IOL type, the use of anti-
inflammatory medication (and their impact on adverse outcomes such as glaucoma 
and visual axis opacity) and ocular parameters such as axial length and corneal 
diameter. The IATS is also unable to report on outcomes following bilateral primary IOL 
implantation 
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In summary, although the IATS has created a valuable source of clinically relevant 
information for the practice of IOL implantation in infants with unilateral cataract, the 
study does not inform practitioners in the British Isles as to the national patterns of 
practice of IOL implantation following bilateral and unilateral cataract surgery, the 
frequency of adverse events following IOL implantation, or the child and treatment 
specific factors which impact on outcomes following primary IOL implantation in early 
life. 
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2.5.d. Adverse outcomes following primary IOL implantation in 
children ≤2 years old  
2.5.d.i. Post-operative open angle ocular hypertension and 
glaucoma  
Despite initial speculation, intraocular lenses (IOLs) have not been found to confer 
protection from the risk of secondary glaucoma.170 Papers which have reported a lower 
prevalence of glaucoma following IOL implantation have been based on children who 
have been carefully selected for surgery , commonly those who are older at surgery, 
144;161;167 and in whom glaucoma is less likely to develop. It could be theorised that the 
presence of an intraocular foreign body could adversely affect the development of the 
aqueous drainage pathways through inflammation mediated damage to the angle, but it 
could also be theorised that the IOL protects the anterior segment from any damaging 
factors released from the vitreous body, and that it offers some support to the 
developing angle structures. It is however also possible that IOL implantation in very 
young children may be associated with a greater risk of glaucoma, possibly due to the 
increased inflammation which may result. The IATS investigators have reported that 
whilst glaucoma occurred in more pseudophakic eyes than aphakic eyes following 
surgery for unilateral cataract, (12% IOL eyes, 5% aphake eyes), this difference did not 
reach statistical significance (p=0.32).274 273 As described earlier, the IATS is unable to 
comment on the impact of other variables such as different surgical methodologies and 
post-operative steroid regimens on the  risk of developing post-operative glaucoma. 
Another group has recently reported an increased risk of glaucoma following due to 
aborted IOL implantation necessitating explantation at primary surgery. 81 
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2.5.d.ii. Post-operative visual axis opacity  
Capsular opacity is more common, and occurs earlier following surgery with 
IOLs,180;186;208;270;275 as a consequence of the pro-inflammatory state of infancy and 
scaffold effect of an intraocular foreign body.1;276  Between 54% and 94% of children 
implanted with an acrylic hydrophobic lens (the most biocompatible) develop visual axis 
opacity in the first year of life.144;180;182;203;267;277 Primary IOL implantation thus commits 
the child, family and surgeon to secondary surgical procedure(s) in the majority of 
cases. The consequence of further surgery to remove capsular opacity, with regards to 
visual results and incidence of further complications, is unclear.180;186;208;270;275  
The IATS randomized trial investigators reported that visual axis opacity occurred in 
43% of pseudophakic children versus 2% of aphakic children, and that  pupillary 
inflammatory membranes occurred in 30% of pseudophakic children but did not occur 
at all in the aphake group.274 
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2.5.d.iii. Post-operative refractive change: the ‘myopic shift’
  
The myopic shift is a normal process, in which refractive change ideally results in an 
emmetropic result for the initially hypermetropic infant (as described in section 2.1.d, 
page 26) The aphakic eye also undergoes this shift, which can be described either as 
the gross refractive change in dioptres, or described as the rate of refractive change 
(the gross myopic shift adjusted by the change in age over the period in which change 
occurs).  
Pseudophakic children who are aged less than 2 years old at surgery appear to 
undergo an exaggerated myopic shift, with a resultant myopic state, which may be 
severe. As with the normally developing eye, and the aphakic eye, the primary effector 
of the myopic shift seen in pseudophakic children is globe axial elongation.248;253;254 The 
pseudophakic myopic shift is not only large252;254 but also shows considerable 
variance.246-249;251-255;257 The reported mean myopic shifts range from three257  to 
seven251 dioptres, with follow up ranging from one253 to seven years.254. The shift is 
devoid of consistent correlation with either a child’s preoperative axial length or the 
implanted IOL power.251-253 Age at surgery is the significant influencing factor with 
younger children exhibiting larger and more unpredictable myopic shifts.251;252;254;255 
Other possible causes of myopic shift in pseudophakic children include glaucoma, 
amblyopic visual deprivation, and normal axial elongation in the presence of a fixed 
lens power.  However, reported studies only examine a small number of children each 
– between 11 and 34 children, with resultant loss of ability to examine putative 
associations between clinical factors and refractive outcome. 
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The adoption of paediatric IOL implantation  
The critical dynamics which may promote the adoption of new medical technologies 
include the patients’ demand for change (such as the difficulties which some parents 
have with aphakic contact lenses and glasses), the low cost to surgeons and hospitals 
of learning and using the new technology (IOLs are already in widespread use within 
the UK).278 IOL implantation has gradually become accepted practice for older 
children.279 In 1966, Binkhorst undertook primary IOL implantation in a 2 year old girl. 
The visual outcome was poor, and the surgery was later complicated by retinal 
detachment.280 In 1977, Hiles described poor outcomes with the use of IOLs in children 
aged 1-2 years old: traumatic bleeding in the anterior chamber and severe 
inflammation.281 These surgeons used anterior chamber fixation of intraocular lenses, 
with lenses fixed to the iris anterior to the pupil. These early cautionary tales dissuaded 
surgeons from implanting IOLs in early childhood.104;107 In the early 1990s, as surgical 
technological advances made it possible to retain a child’s capsule in order to retain 
support for a posterior chamber IOL, practitioners again began to use IOLs in the 
youngest children, despite the challenges of size, immaturity and inflammation.  
In 1993, a survey of members of the American Society of Cataract and Refractive 
Surgery and the American Association for Pediatric Ophthalmology and Strabismus 
reported that only 19% of respondents would advise IOL implantation for a child under 
2 years old.282 By 2003, up to 89% of members of the same societies would 
recommend IOLs for these children although only 12% of surgeons who had used an 
IOL in a child aged less than 2 years had implanted a child aged less than 7 months 
old.283  
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2.5.e. Summary 
Surgical innovation consists of either a new procedure which uses an existing device, 
or a new device used in an existing procedure. Intraocular lens implantation for children 
under 2 years old has aspects of both: although IOLs are the most commonly 
implanted medical prosthesis, and have a strong safety record for the population for 
which they were first designed (adults aged over 65 years old) an IOL within the small, 
immature and pro-inflammatory eye of early childhood is a device which is 
fundamentally different from an IOL within a mature eye.  
IOL implantation has been used in children aged over 2 years old since the 1950s, with 
initial uptake only by surgical ‘innovators’ or ‘evangelists’, followed by gradually 
increasing uptake due to improvements in managing inflammation, IOL design and 
refractive planning. IOLs are now being used in children under 2 years old, with 
evidence of a more rapid adoption pattern despite unanswered questions surrounding 
the refractive changes in the first two years of life, patient selection and possible 
adverse outcomes. Standardised information on practice and outcomes is needed in 
order to ensure the best results for these children.  
 107 
2.6. Epidemiological investigation into outcomes following 
cataract surgery in children under 2: methodological issues
  
2.6.a. Rare diseases and rarer outcomes: the challenges of chance, 
bias and confounding 
Rare diseases are those with a prevalence of less than 5 in 10,000 of the population. 
Together they number 6,000 - 7,000 disorders and collectively they affect 5% of the 
population.284 The great challenge of any study into outcomes following surgery for an 
uncommon diseases such congenital and infantile cataract is the creation of a study 
population which is representative of the total population at risk. 
 
2.6.a.i. Chance 
In order to investigate outcomes following interventions for rare disorders, study 
designs which increase the number of potential cases are necessary, to increase 
sample size and reduce sampling error.  
 
2.6.a.ii. Bias 
Children with rare diseases tend to cluster in specialised centres, enabling study 
recruitment, but these centres also tend to manage the more complex cases. As these 
centres may either have better outcomes due to more experienced clinicians, or worse 
outcomes due to a case mix with the more severe cases, selection bias may result. 
Cases of early childhood cataract must therefore be recruited as widely as possible.  
 
Whilst multicentre studies can increase the sample size, there is still a potential for bias. 
Selection bias can result due to non-participation, and measurement bias can result if 
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different outcomes and data are assessed within different centres. Uniform and 
systematic collection of information can strengthen the validity of findings.  
Another source of bias is in the classification of outcomes: systematic collection of 
information with clear, consistent diagnostic or outcome (for example, glaucoma) 
definition is imperative.  
 
2.6.a.iii. Confounding 
Investigation of factors associated with outcomes following a rare intervention can be at 
risk of confounding. A randomised control trial would limit the risk but it would be an 
expensive and time consuming undertaking and it is unclear how willing families and 
clinicians would be to participate in a clinical trial of IOLs versus contact lens 
management.  
Whilst standardised data collection from a multi-centre collaborative network enables a 
larger and broader sample, management differences within the network introduces 
further variables which may affect the outcomes of interest, although regression 
analysis with models using surgery specific variables can help to address potential 
confounding . The use of a clinical research network brings other challenges, in 
particular ensuring that the methodology of case identification, recruitment and data 
collection is fit for purpose when applied diverse and/or numerous clinicians 
participating in the network. 
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2.6.b. Identifying cases 
2.6.b.i. Centralised national databases of activity 
NHS information centres which collect data from NHS trusts on the activities 
undertaken within their hospitals are a potential method of ascertaining information 
about congenital and infantile cataract surgery. 
Hospital Activity Statistics 
The United Kingdom National Health Services (NHS) publish annual summary 
measures of hospital activity through the Hospital Episode Statistics (HES) agency for 
NHS England,285 Patient Episode Database for Wales (PEWD) agency for NHS 
Wales286 and Hospital Activity Statistics (HAS) agencies for NHS Scotland and 
Northern Ireland.287;288 These summary measures are used in a variety of 
administrative and financial pathways, including Government Treasury negotiations for 
NHS funds, the allocation of funds within the NHS, and the identification of trends in 
specific conditions or performance of operative procedures.289  As the information 
collected for individuals includes the primary diagnosis and the treatment received in 
hospital, these centralised measures of activity within UK hospitals are a potential 
source of data on children ≤2 years old undergoing cataract surgery, and undergoing 
intraocular lens implantation.  
The information on treatment and diagnosis returned to the central database is first 
entered into hospital databases by hospital administrative staff using diagnostic codes 
taken from the International Classification of Diseases49 and operative codes defined 
by the Office of Population Censuses and Survey.290 The codes are recorded by 
medical staff within the medical records, or are derived by administrative staff from 
recorded clinical information. With regards to potentially bilateral surgical procedures 
such as ocular surgery, separate episodes are recorded for each eye rather than a 
single episode for a single individual undergoing bilateral surgery.  
 110 
 
The 2008/9 Department of Health audit into clinical coding accuracy for the NHS 
England HES identified an overall clinical coding error of 12.8%, with poor clinical 
documentation, inadequate training of hospital coders and inadequate involvement of 
clinical staff in the coding process contributing to in inaccurate or incomplete data 
entry.289 Thus, the HES, PEWD and HAS databases may not be a robust source of 
data on the number of children.  
 
 
Coding of cataract surgery  
The Office of Population Censuses and Survey (OPSC)-4 four character coding system 
consists of one letter followed by three digits. Whilst the letter indicates the anatomical 
site for the procedure, the following two digits indicate the procedure type, with a third 
digit adding a more precise description. The letter ‘C’ is used to indicate ophthalmic 
surgery, ‘C7’ indicates surgery on the anterior chamber of the eye and on the lens, the 
codes C71, C72, C74, C75 and C77 indicate the different possible surgical lens 
extraction and IOL implantation methods. Within in each of these three character 
groups there is further subdivision. Thus, there are at least 13 possible codes for 
cataract surgery in children ≤2 years old, and 4 codes for the description of IOL 
implantation (Table 11).  
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Table 11. Three character and four character Office of Population Censuses and 
Survey classification codes 
for adult and paediatric cataract removal and IOL implantation.  
Three character OPSC code Four character OPSC subcodes 
C71: Extracapsular extraction 
of lens 
C71.1 Simple linear extraction of lens 
C1.2 Phacoemulsification of lens 
C71.3 Aspiration of lens 
C71.8 Other specified extracapsular extraction of lens 
C71.9 Unspecified extracapsular extraction of lens 
 
C72: Intracapsular extraction 
of lens 
C72.2 Suction extraction of lens 
C72.8 Other specified intracapsular extraction of lens 
C72.9 Unspecified intracapsular extraction of lens 
 
C74: Other extraction of lens 
C74.3 Mechanical lensectomy 
C74.8 Other specified other extraction of lens 
C74.9 Unspecified other extraction of lens 
 
C77: Other operations on lens 
C77.8 Other specified other operations on lens 
C77.9 Unspecified other operations on lens 
 
C75: Prosthesis of lens 
C75.1 Insertion of prosthetic replacement for lens  
C75.4 Insertion of prosthetic replacement for lens using suture fixation 
C75.8 Other specified prosthesis of lens 
C75.9 Unspecified prosthesis of lens 
 
 
There is no national guidance as to which code to use for the most commonly 
performed types of cataract extraction in children (lens aspiration or lensectomy, with 
or without vitrectomy).   
In summary, although there exists a centralised database of procedures undertaken in 
NHS hospitals (including cataract surgery in children ≤2 years old), its nature makes it 
unsuitable as a data source for the ascertainment of cases for a prospective study, and 
incomplete or inaccurate coding and possible regional variation in coding of surgery 
may make it inappropriate as a robust source for assessing activity.  
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2.6.b.ii. Surveillance network: the British Isles Congenital 
Cataract Interest Group  
Surveillance, or the “systematic collection and collation of data on a health related 
event with dissemination of analysis and findings”, is a key weapon in the 
epidemiological arsenal. The state of ‘continued watchfulness’ described by Langmuir 
in 1963291 is especially useful when investigating rare diseases. Whilst passive 
surveillance involves only the reporting of relevant cases, active surveillance is the 
ongoing monitoring of the entire population at risk, providing a more precise description 
of distribution. Both forms of surveillance are ‘active’ processes for the reporting 
clinician, but true active surveillance requires the establishment of a collaborative 
network with a central monitoring unit searching for cases or the confirmation of the 
absence of cases through peripheral units which are able to identify and report on the 
population at risk. Active surveillance, whilst more costly than passive surveillance, is 
less likely to result in the under-reporting of cases and thus gives a more 
representative clinical picture.  
Active surveillance systems are well established in the UK and have been successful in 
both the paediatric and ophthalmic fields, (the British Paediatric and British Ophthalmic 
Surveillance Units, BPSU and BOSU). 1n 1995, the British Congenital Cataract Interest 
Group was created (Appendix B; this collaborative research network, made up of 
consultants with an interest in the disease, has published work on the detection, 
distribution and management of congenital and infantile cataract.63;170;171;292;293 As many 
of the BCCIG members perform surgery on children with cataract, this network is well 
suited to forming the reporting base for a national study of early childhood cataract 
surgery and primary intraocular lens implantation.  
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2.6.c. Statistical analysis of hierarchical data 
In a child with bilateral cataract, the outcome of the right eye is more likely to be 
associated to the outcome of the left eye than to the outcome of another eye in another 
individual. If these correlations are not taken into account, there may be resultant errors 
in study findings, usually in the form of inaccurately small p values and narrow 
confidence intervals. Some studies have dealt with this by ignoring one eye of an 
individual with bilateral disease, or pooling information from both an individual’s eyes, 
but in the study of a rare disease, these options are unsatisfactory. Tools for dealing 
with the ‘2 eyes, 1 person’ inter-eye correlation issue include regression analysis 
modelling of outcome in one eye adjusting for the outcome in the fellow eye, or 
modelling the inter-eye correlation separately. Multilevel or random effect modelling 
can explicitly deal with the issue of within participant clustering of data, by 
differentiating between the ‘ocular’ and ‘individual’ level data during analysis. There is 
also correlation between repeated measures within an individual over time, as recorded 
in longitudinal case studies, and this can also be addressed using a multilevel 
modelling approach. 
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2.6.d. Investigating outcomes following intervention in early 
childhood 
In the management of congenital and infantile cataract, as in much of paediatric 
ophthalmology, vision is the primary functional outcome of concern. As vision develops 
over many years following the intervention concerned, an investigation of outcomes 
needs to take into consideration whether a longitudinal design can be achieved and 
maintained, in particular the challenges of maintaining collaborative research groups 
and the continued involvement of participating families and children.   
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3. AIMS  
The research reported in this thesis was undertaken to investigate factors associated 
with visual outcomes and complications following primary IOL implantation in a 
nationally representative cohort of children undergoing congenital / infantile cataract 
surgery in the first two years of life.  
The primary objectives were to address the following questions:  
In relation to visual outcome:  
 What are the early visual outcomes following bilateral or unilateral primary 
intraocular implantation in the first two years of life?  
 What are the child or treatment specific factors associated with good visual outcome 
following surgery with and without intraocular lenses? 
In relation to complications: 
 What is the incidence of per-operative complications with primary IOL implantation, 
and what are the associations with child and treatment specific factors? 
 What is the incidence of glaucoma and visual axis opacity in the first year following 
surgery with and without IOL implantation, and what are the child and treatment 
specific variables associated with these complications? 
 What is the incidence of other complications such as severe post-operative 
inflammation, IOL dislocation and infection in the year following primary IOL 
implantation?  
In relation to refractive outcome: 
 What are the refractive outcomes following primary IOL implantation? 
 What are the associations between initial refractive outcome and treatment-specific 
and child-specific factors? 
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 What are the patterns of refractive change of the infant eye following cataract 
surgery with a primary IOL? 
 
Finally, in undertaking this study it was intended to establish a novel inception cohort 
of children in whom investigations of long term visual, educational and psychosocial 
outcomes can be undertaken in the future. 
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4. METHODS 
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4.1. Introduction  
This chapter describes study design, with case ascertainment through a national active 
surveillance network, standardised data collection and analyses undertaken.  
 
4.2. National survey of current practice of primary intraocular 
lens implantation in children under 2 years old 
 
4.2.a. Introduction  
Although the BCCIG had been established in 1995, it was necessary to update the 
network and to ensure the completeness of the reporting base. In addition, although 
practices in North America regarding the use of intraocular lenses in early childhood in 
have been reported,283 the current patterns of practice relating to primary IOL 
implantation in children ≤2 years old in the UK and Ireland were not known. 
Consequently, at the outset of this study a postal survey was carried out to establish 
how many children ≤2 years old were undergoing cataract surgery annually, which 
specialists (other than those who are already members of the BCCIG) were managing 
these children, and which consultants were undertaking primary IOL implantation in 
these children. The survey also sought information on the current management 
practices with regards to primary IOLs: these findings were intended to inform the 
design of the study data collection forms. 
The paper reporting the findings of this survey is appended (Appendix C), but the 
details are summarised here. 
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4.2.b. Methods 
In October 2008, 960 consultants comprising all members of the BCCIG (renamed the 
British Isles Congenital Cataract Interest Group to acknowledge the contribution of 
consultants from the Republic of Ireland), all consultant members of the Royal College 
of Ophthalmologists and Irish consultant ophthalmologists with a known interest in 
congenital cataract, were contacted using postal questionnaires accompanied by hand 
addressed cover letters and postage paid reply envelopes. Members of the BCCIG 
who did not respond to the mailing were sent reminders.  
Respondents were asked:  
 Do you manage children aged ≤2 years with congenital/infantile cataract?   
 In the past year, approximately how many children aged ≤2 years with newly 
diagnosed congenital/infantile cataract have you managed?   
 In the past year, in approximately how many children aged ≤2 years with 
congenital/infantile cataract have you undertaken cataract surgery?  
 In the past year, in approximately how many children aged ≤2 years with 
congenital/infantile cataract have you undertaken primary intraocular lens 
implantation?  
 which IOL(s) and IOL power calculation formula(e) do you use, and where do you 
place your IOL? 
 which surgical techniques or approaches do you prefer? 
 Do you routinely measure axial length post operatively? 
 If you DO undertake primary IOL implantation in these children what are your 
exclusion criteria for IOL implantation in children under 2?  
The last question, on exclusion criteria, requested a free text answer format, whilst the 
other questions had pre-defined categorical, numerical or binomial yes/no answers 
with a tick box format.  
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4.2.c. Statistical analysis  
Descriptive analysis of responses was undertaken. Free text answers on exclusion 
criteria were coded to enable descriptive analysis. 
 
4.2.d. Results  
32 of the 960 distributed questionnaires were returned as undeliverable. 709 (76%) of 
the remaining 928 contacted consultants replied to the survey between October 2008 
and January 2009. 47 (7%) of the 709 respondents stated that they operated on 
children ≤2 years old, estimating that over the preceding year they had operated on a 
total of 301 children altogether. 6 (13%) of the 47 surgeons did not perform primary IOL 
implantation in any child ≤2. The 41 surgeons who did perform primary IOL 
implantation estimated that in the preceding year they had operated on 268 children 
(116 with unilateral, 152 with bilateral cataract), undertaking primary IOL implantation in 
65% (Table 12).  
Table 12. Surgical management of children ≤2 with cataract  
number of children undergoing surgery as estimated by respondents 
How many children ≤2 years old have you operated on over the last year? (47 surgeons) 
 Unilateral cataract Bilateral cataract Total 
Median 2 2.5 5 
Range (min to max) 0-10 0-15 0-25 
Total 133 168 301 
In how many children ≤2 years old have you performed primary IOL implantation over the last 
year?    (41 surgeons) 
 Unilateral cataract Bilateral cataract Total 
Median 2 1 2 
Range  0-8 0-14 0-19 
As a proportion of 
children undergoing 
surgery 
75% 
(87/116) 
57% 
(86/152) 
65% 
(173/268) 
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4.2.d.i. Exclusion criteria  
Exclusion criteria for primary IOL implantation in children ≤2 were provided by 36 of the 
41 respondents. 6 (17%) surgeons did not mention any ocular anomaly amongst their 
stated exclusion criteria.  23 (64%) described specific anomalies which would prevent 
them from implanting an IOL. Of these, 16 cited short axial length or microphthalmos, 
with 5 specifying different lengths below which they would not implant (16, 18 and 
20mm). Anterior and posterior segment anomalies were exclusion criterion for 12 and 
14 respondents respectively. 7 (19%) respondents considered the presence of any co-
existent ocular anomaly to be sufficient cause for exclusion. Thus, microphthalmos is 
an exclusion criteria for 64% (23/36) of respondents, anterior segment anomaly 53% 
and posterior segment anomaly 58%. 9 (25%) cited microcornea, with surgeons again 
specifying differing corneal diameters, either below 9mm (3 respondents) or 10mm (3 
respondents). 7 (19%) cited persistent fetal vasculature (PFV) or persistent 
hyperplastic primary vitreous (PHPV), with 5 of the 7 specifying ‘significant’ PHPV.  
Other stated exclusion criteria included abnormal capsular support (10/36 or 28%), 
glaucoma (7/36, 19%) and previous intraocular inflammation (uveitis, 3/36, 8%). 
The age of the child was cited by 6/36 (17%) of the 36 respondents. Different minimum 
age limits were used: 12 months, 6 months and 1 month old minimal ages by 3, 2 and 
1 respondent respectively. Thus, 25% (9/36) of respondents would not perform primary 
IOL implantation in any child under 1 year old. 7 (19%) of the consultant 
ophthalmologists commented on parental preference as an exclusion criterion for 
primary IOL implantation. 
4.2.d.ii. Details of routine surgical management 
All respondents used a hydrophobic acrylic IOL, with 90% using one of four ‘Acrysof’ 
model IOLs (Table 13). 70% reported using the SRK/T formula for IOL power 
calculation, with 37% using it in combination with the Hoffer Q formula. 6 respondents 
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specified that they used either formula, dependent on the axial length of the child.  With 
regards to routine surgical technique, 90% of surgeons used limbal / corneal wounds 
for surgery; manual capsulotomy techniques were used by 88%; posterior 
capsulotomies were created by all but 1 surgeon. Of those using posterior 
capsulotomies, 78% also performed anterior vitrectomy with 16%. The majority of 
respondents (71%) do not routinely post-operatively measure the axial lengths of 
pseudophakic children. 
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Table 13. Details of surgical management 
Number of respondents (n=41) 
IOL model    
 Acrysof acrylic hydrophobic lens 37 
  3 piece (MA60 or MA30 models) 27 
  Single piece (SA60, SN60 models) 8 
 AMO acrylic hydrophobic lens 4 
 HoyaVA acrylic hydrophobic lens 1 
IOL power calculation formulae  
 SRK/T  28 
 Hoffer Q  21 
  SRK/T + Hoffer Q 14 
 Holladay I  6 
 SRK II   3 
 Haigis  1 
IOL placement   
 In the bag  40 
 Optic capture  1 
Wound creation   
 Limbal / corneal   36 
 Scleral  8 
 Limbal or scleral  2 
Anterior capsulotomy technique   
 Manual  36 
 Diathermy  4 
 Vitrectorhexis  3 
Posterior capsulotomy and vitrectomy   
 No posterior capsulotomy  1 
 Posterior capsulotomy without vitrectomy  9 
 Vitrectomy  42 
Post-operative axial length routinely measured post operatively  
 Yes  12 
 No  29 
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4.2.e. Discussion 
The findings indicated that at the start of  the present study, primary intraocular lens 
implantation in children ≤2 had been adopted by the majority of the responding 
surgeons who manage children with cataract in the United Kingdom / Ireland. There 
existed concordance of surgical approach, with most surgeons choosing an AcrySof 
hydrophobic acrylic IOL, manual curvilinear anterior capsulorhexis, limbal or corneal 
wound access and posterior capsulotomy with anterior vitrectomy: this uniformity would 
enable a robust examination of outcomes following surgery.  
However, the variability with regards to exclusion criteria suggests that there was 
disparity of opinion on which children would benefit from primary IOL implantation, and 
which children were at least risk of complications and poor outcome. Whilst this 
disparity may have been be due to differing personal preferences within a relatively 
new and evolving field, it may also have been a reflection of absences within the 
evidence base on the practice of primary IOL implantation in children ≤2.  
The estimated total of 301 children undergoing cataract surgery over the preceding 
year, as reported by the consultants, may have been an overestimate: previous work 
undertaken by Rahi et al identified 165 children undergoing cataract surgery in the first 
two years of life between 1995 and 1996.293 However, the findings of this survey 
indicated that it should be possible to obtain at least 200 children undergoing surgery 
over a two year recruitment period for the present study. 
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4.3. Establishment and maintenance of the surveillance network 
Consultants who managed children under 2 with cataract but who were not yet 
members of the BCCIG were invited to join the group and to contribute to the study. 
Preferred contact details (telephone, email or postal) were established, and contact 
was made with allied ophthalmic clinical staff (orthoptists, opticians, or clinical nurse 
specialists) at the core study hospitals (those which reported that they had operated on 
over 9 children with cataract over the preceding year). Pre-paid addressed response 
envelopes were used throughout, enabling more efficient postal communication within 
the network.  
Draft study protocols and other study documentation (eg participant information sheets 
and consent forms) were distributed to all members of the network for comments.  
The study research fellow had the responsibility for the maintenance of the network 
during the case ascertainment and data collection phases of the study, through the 
regular communication with consultants.  
 
4.4. Case definition  
The case definition for the study was: any child resident in the British Isles undergoing 
cataract surgery in the first two years of life with or without primary intraocular lens 
implantation undergoing primary surgery between 1st January 2009 and 31st December 
2010.  
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4.5. Case identification and ascertainment through the BCCIG 
reporting base 
Consultants were asked to use study identification sheets (Appendix D) to inform the 
research team of eligible children under their care due to undergo cataract surgery 
through active surveillance: consultants were contacted at least every two months and 
asked to report on whether they had recently managed an eligible child, or to confirm 
that they had not managed an eligible child. In addition the core centres were visited at 
least three times during the recruitment period, and theatre booking or operating 
records were checked by the study research fellow to ensure full case ascertainment.  
Consultants also used electronic mail to notify the research team of an eligible child. 
Case ascertainment for children managed at Great Ormond Street Hospital and 
Moorfields Eye Hospital was primarily performed by the study research fellow, with 
support from the managing consultants, through regular surveys of hospital theatre 
planning records. In some cases, the research team were first notified of an eligible 
child through the receipt of a completed family consent form.  
 
4.6. Recruitment and consent 
The families of eligible children were first approached by their managing consultants, 
either in person or postally. Consultants advised the parents of the aims and design of 
the study, and gave parents recruitment packs containing information sheets, consent 
forms and family background questionnaires as well as contact details for the research 
team (Appendix E). The background questionnaires, which elicited socio-demographic 
details, were developed through previous work by the BCCIG. Consent forms and 
questionnaires were returned to the research team using provided pre-paid response 
envelopes (thereby limiting the burden on participating families). Families of children 
cared for at the Great Ormond Street and Moorfields Eye Hospitals were also 
approached by the study research fellow. Following receipt of a completed consent 
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form, the research team informed the managing ophthalmic team of the family’s 
consent so that formal data collection could begin (Figure 9).  
 
Figure 9. The process of recruitment and data collection 
 
 
 
 
EVENT ONE 
Identification of potential participant at listing for 
cataract surgery: child aged ≤ 2 with congenital or 
infantile cataract with and without IOL 
MT completes patient 
identification sheet, and gives 
participant study information  
 to family 
 
EVENT TWO 
Family consents to participation 
Sends consent form to ICH 
EVENT THREE 
Child enrolled into IOLu2 
 RT informs MT and participant's 
GP 
EVENT FOUR 
Child undergoes cataract surgery  
EVENT FIVE 
Child is 6 months post op 
MT completes data collection 
instruments (DCIs) (Books 1 & 2) 
and sends to RT*  
Role of managing 
ophthalmologic team 
(MT) 
Role of research team 
(RT) 
RT communicates with MT to 
ensure availability of data 
collection instruments (DCIs)† 
EVENT SIX 
Child is 12 months post op 
MT completes and returns 
first post op DCI (Book 3)*  
MT completes and returns last 
post op DCI (Book 4)*  †Research Team regularly contact the managing 
ophthalmologist to ensure that they have the necessary forms 
*Research fellow collected clinical data for some participants 
RT reminds MT that 
child has reached          
6 or 12 month 
milestone  
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4.7. Data collection  
Information was collected using at preoperative and specified postoperative time points 
using specially designed proforma.  
 
4.7.a. Data collection instruments 
The data collection instruments are appended to the thesis (Appendix F). The 
information needed to answer the research questions comprised the following:  
 Demographic information 
including child’s date of birth, ethnicity, hospital and NHS number. 
 Pre-operative clinical information 
including age at diagnosis and at surgery, aetiology of cataract, visual function, 
(including presence of pre-operative strabismus or nystagmus) and co-existence of 
ocular disorders and systemic disorders. 
 Operative planning information 
including use of an intraocular lens, and reasons for not using an IOL, biometric 
parameters, formula used for IOL power calculation and the expected post-operative 
refractive outcome 
 Per operative clinical information 
including surgical techniques used (wound position, anterior and posterior 
capsulotomy, method of  lens aspiration, anterior vitrectomy), IOL model and power, 
use of prophylactic anti-inflammatory and antibiotic medication, and details of any 
intra-operative complications  
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 Post-operative clinical information 
including occlusion therapy, contact lens and glasses use, visual outcome, refractive 
outcomes, and any post-operative complications (time of occurrence, severity and 
management) 
 
4.7.a.i. Development of the data collection instruments (DCIs) 
The DCIs were kept concise to improve response rates from clinicians. Ease of 
completion was aided by the use of tick boxes where possible, with the selection 
options for tick box answers being informed by the results of the national survey of 
practice (section 4.2.d, page120). 
Piloting of the forms was initially carried out by the study research fellow, using the 
clinical records of children who had previously undergone cataract surgery. The forms 
were then further piloted by experienced trainee ophthalmologists, who were asked to 
comment on the wording of the questions and the length and format of the 
questionnaire. Also, these trainees were asked to enter data using the same sets of 
clinical notes in order to determine inter-observer variation. Following this process, the 
layout and content of the form was altered to more closely follow the structure of 
clinical case notes. Information for right and left eyes was more explicitly organised into 
right and left handed columns, reflecting clinical note convention. Date formats were 
defined (DD/MM/YY). Questions which requested unnecessary information were 
refined (for example, questions on IOL material type and IOL design were replaced 
with a single question on IOL model type). More tick box choices were introduced to 
limit free text entry wherever possible. In addition, the time points of post-operative 
data collection were reduced (from 3, 6, 9 and 12 months) to 6 months and 12 months. 
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Further refinement of the content and layout took place firstly through consultation with 
the consultants at the core study hospitals, and then within the wider collaborative 
network. Following this, study specific nosology was developed. For example, post-
operative visual axis opacity was to be recorded as pearls, fibrosis or inflammatory 
membrane using tick boxes, and a definition of glaucoma was included within the form 
to limit misclassification. Concordance with occlusion therapy or the wearing of 
refractive correction was graded as poor, good or very good, with definitions again 
given within the form. The finalised forms were then re-distributed within the BCCIG, 
and consultants were asked to confirm that they routinely collected the dataset which 
was intended to be captured by the data collection instruments. 
The DCIs were printed onto carbonless copy paper to enable the instant creation of 
duplicates to be kept by the managing consultants. Pre and per operative forms were 
combined into one form (Book 1), as certain pre-operative investigations (measurement 
of horizontal corneal diameter, biometry) were often undertaken immediately prior to 
cataract surgery.  
 
4.7.b. Data collection process 
All consultants were regularly sent additional copies of the pre and per operative data 
form (Book 1 and Book 2), and were sent the 6 month (Book 3) and 12 month (Book 4) 
post-operative collection forms as required (figure 9). DCI were completed either by the 
managing consultant or by a senior trainee ophthalmologist, and completed forms were 
posted to the research team. Data collection was also undertaken by the research 
fellow where necessary. In these cases, surgeons were asked to prospectively enter 
the full dataset of required information into the notes.  
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To assist the prospective entry of per operative data, a pro-forma for paediatric cataract 
surgery was created for the use of study centres (Appendix G). These proforma were 
subsequently adopted for the formal routine recording of paediatric cataract surgery 
within clinical notes by three hospitals (Great Ormond Street Hospital, Moorfields Eye 
Hospital and Birmingham Children’s Hospital), and have also been adopted within 
these Trusts to document surgery for children not recruited to this study.   
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4.8. Ethics and research governance 
4.8.a. Ethics approval  
The study was approved by the UCL/UCLH type III research ethics committee. Ethics 
approval for research within the Republic of Ireland was granted separately by the 
relevant Health Authorities in Cork and Dublin.  
 
4.8.b. Research governance approval 
Following identification of the centres at which early childhood cataract surgery took 
place, and confirmation of the consultant’s interest in joining the research network, 
governance approval was sought locally from each relevant Health Care Trust. This 
was a laborious process due to considerable variation in the documentation requested 
by the research and development departments at 42 different Trusts, despite the 
standardisation of the process as intended by the National Research Ethics Services. 
For example, trusts asked for a median of 4 (range 0 – 10) other forms or pieces of 
documentation. The median time from first contacting the research department to last 
request for further documentation was 15 days (maximum 126) and from first response 
from the research department to the granting of local governance approval 70 days 
(maximum 174 days).  
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4.9. Data management  
4.9.a. Data protection 
Paper forms with identifiable data were held in a different location to paper forms 
containing clinical data. All clinical study data were anonymised by assigning unique 
identification numbers for study documents and for the study database. All electronic 
and paper data files were held in secure conditions and identifiable individual level data 
were never transferred by email. The study personal computer was password protected, 
and the electronic databases were password protected and encrypted. 
 
4.9.b. Data validation  
Data collection forms were checked on receipt by the study research fellow, and 
inconsistencies or omissions were followed up with the relevant clinician.  
 
4.9.c. Database design  
Demographic, pre, per and, post-operative information databases, based on the data 
collection form layout, were designed in Microsoft Access. Relationships were created 
between the databases using the study ID numbers.  
 
4.9.d. Data entry  
Data were entered into the databases by the study research fellow. Free text data were 
entered verbatim.  
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4.9.d.i. Validation of entered data 
Validation rules were created within the Access database to prevent data entry errors, 
such that entered numerical values (e.g. horizontal corneal diameter, biometric 
parameters) and dates were limited to a reasonable range. Drop down lists were 
created for variables where there were more than two tick box options.  
Prior to analysis, dates of referral, presentation to team, biometry, surgery and post-
operative event were checked for chronological consistency.  Minimum and maximum 
values were checked for numerical data to ensure that the data were plausible. Free 
text information was checked for inconsistency prior to coding for analysis.  
 
4.9.d.ii. Data verification  
The study research fellow rechecked a random sample of incoming data, cross-
referencing the paper data collection forms, electronic database and edited ‘cleaned’ 
datasets within the computer analysis programme. The random sample was selected 
using the Microsoft excel random list generator. 10% each of pre-operative, per 
operative and 6 and 12 month post-operative data were checked. Of the 58 forms 
reviewed, only 4 had errors which had not been dealt with by the in-built validation 
rules: for one date, the month and day had been transposed; in one child, the refractive 
outcomes for the right and left eye had been transposed on data entry, and the other 
two errors were spelling mistakes within the free text section.   As the 58 forms had a 
total of 23,432 entries, the error rate was 1.7 per 10,000, much lower than the generally 
accepted error rate of 10 per 10,000294 
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4.9.e. Data coding: the creation of variables for analysis  
In all cases, although the creation of new derived variables was undertaken in order to 
aid analysis, the original variables were also retained within the dataset.  
 
4.9.e.i. Demographic and parental background data 
There were two ethnicity data sources: hospital or clinician based descriptions, (as 
entered into the data collection instruments), and self-reported descriptions (as entered 
into the parental background questionnaire). Self-reported parental ethnicity has been 
used to describe the child’s ethnicity for the children described in this study.  
 
4.9.e.ii.  Pre-operative data 
Date of birth 
Gestational age at birth was used to adjust date of birth to give a corrected gestational 
age for axial length or horizontal corneal diameter measurement. This enabled 
differentiation between eyes which were small due to the age of the child versus eyes 
which were small due to a developmental abnormality. Ages at surgery, diagnosis of 
post-operative complications or measurement of post-operative ocular biometrics were 
determined using actual date of birth (i.e. not corrected for gestational age). 
Aetiology and associated non-ocular disorders 
Three mutually exclusive categories were created for the analysis of associated 
factors: idiopathic, hereditary ocular, and hereditary with systemic features /   
chromosomal aetiology.  
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The presence of a non-ocular disorder was dichotomised, with additional binomial 
variables created for the presence of a ‘significant’ systemic disorder: a cardio-
respiratory, metabolic or neurological disorder. 
Phenotypic classification  
Cataract morphology was coded into primary and secondary morphological categories. 
For primary morphology, the categories were nuclear, posterior, lamellar, anterior and 
cortical, and additional non locus-specific categories (partial, dense, total) where 
opacity loci was indeterminable. 
Axial length 
Although microphthalmos was coded as a binary yes/no variable using the definition 
given in section 2.3.d.i, page 53, two additional derived variables were created:  
‘significant microphthalmos’ (axial length <16mm) and interocular axial length 
difference. Also, the numerical value of axial length was used as a quantitative trait. 
Horizontal corneal diameter (HCD) 
Although microcornea was also coded as a binomial yes / no variable using the 
definition given in section 0, page 54, an additional variable was created, ‘significant 
microcornea’ (HCD <9.5mm), and horizontal corneal diameter was also used as a 
quantitative trait. 
Persistent fetal vasculature (PFV) 
PFV was classified as one of these three mutually exclusive categories:  
1. Isolated posterior capsular plaque / persistent posterior tunica vasculosa  
2. Anterior PFV only (persistent iridohyaloid / pupillary membrane / anterior tunica 
vasculosa) 
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3. Complex PFV (‘posterior plaque plus other sign’).  
Within the complex PFV category, the presence of other signs (anterior PFV, persistent 
hyaloid artery, centrally dragged ciliary processes, optic nerve head hypoplasia / 
dysplasia, macular abnormalities, retinal detachment) were dichotomised as present or 
absent.  
Anterior and posterior segment abnormalities 
As well as anterior and posterior segment anomalies being dichotomised separately as 
absent / present, anterior segment and posterior segment PFV were classified as 
anterior and posterior segment abnormalities respectively. Pre-operative pupil 
synechiae were also classified as an anterior segment abnormality.  
Significant co-existent ocular abnormality  
Children’s eyes were also classified as either having or not having a significant co-
existent ocular abnormality: ‘HCD<9.5mm, axial length <16mm, anterior PFV or 
complex PFV, or other anterior segment or posterior segment abnormality’.  
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4.9.e.iii. Per operative data 
Surgeon  
A new dichotomised variable was created based on the level of the surgeon’s exposure 
to cataract surgery in children under 2 over the 2 year study period. Surgeons were 
categorised as ‘high exposure / experience’ if they had operated on at least 10 eyes 
over the study period. All eyes of children who had been ascertained during the study 
period were included for the generation of this variable independent of whether the 
children were or were not recruited into the study. 
Surgical techniques 
As the survey of practice had indicated that the majority of surgeons used the same 
combination of surgical techniques, a new combination binary variable ‘standard 
surgery’ was created (‘standard’ surgery = limbal or corneal wound + manual 
capsulorhexis + automated lens aspiration + primary capsulotomy + anterior 
vitrectomy).   
Eyes which had undergone surgery were also categorised by the type of viscoelastic 
device (OVD) used: No OVD; low or medium viscosity OVD; high viscosity OVD; or 
fracturable high viscosity OVD.  
Per operative complications  
Per-operative complications were additionally coded as either sight threatening or non-
sight threatening complications whilst retaining the original variables. The only 
complication classified as non-sight threatening was an anterior capsular tear not 
extending past the lens equator.  
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Per- operative corticosteroids  
Eyes were categorised into one of four groups: those receiving no per-operative 
steroid; those receiving one of either intraocular or subconjunctival or other per-orbital 
steroids; those receiving intraocular plus subconjunctival or other per-orbital steroid; 
and those receiving intraocular plus subconjunctival plus other per-orbital steroid.   
Post-operative corticosteroids  
Eyes were categorised as receiving either more than/equal to or fewer than 2 hourly 
drops with nightly steroid ointment following surgery. The use of systemic steroid post 
operatively was dichotomised (yes / no). 
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4.9.e.iv. Visual outcome 
Visual acuity  
Teller acuity in cycles per degree (cpd) was converted into Teller logMAR 
(logMAR=log10(30/cpd)) and Cardiff card snellen scores were converted into Cardiff 
card logMAR (logMAR= log10(1/snellen fraction)). Due to the difficulty of comparing 
results from disparate visual acuity tests, whilst the original data were retained as an 
ordinal variable, acuity was categorised into an ordinal scale (using the normative age 
related values described in section 2.2.c.ii, page 39) as follows:  
5. Better than mean acuity for age  
4. Worse than mean acuity but within normal range for age 
3. Worse than lower limit of normal range but able to fix on visual target on quantitative 
visual assessment, or able to follow visual stimuli on qualitative visual assessment  
2. Showing no interest in quantitative visual assessments, unable to follow on 
qualitative visual assessment, but showing behaviour which suggests some ability to fix 
on visual stimuli (‘Fix’ on fix and follow testing) 
1. Will not take up fixation, but perceives light 
0. No perception of light 
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4.9.e.v. Adverse outcomes 
Glaucoma  
Children were classified as having either  
no glaucoma 
ocular hypertension 
glaucoma with pupil block event 
open angle glaucoma  
  
Visual axis opacity 
Dichotomous categories were created for the presence of pearls, fibrosis, anterior 
capsular contraction or inflammatory membranes. Children were then also 
dichotomised as either having or not having ‘true’ visual axis opacity (pearls, fibrosis, 
and contraction).  
 
4.9.e.vi. Refractive outcome 
A variable measuring prediction error (PE) was created through the subtraction of the 
actual immediate refractive outcome (spherical equivalent of refraction carried out 
within 1 month of surgery) from the planned refractive outcome.  
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4.10. Analysis   
Findings of descriptive analysis on outcomes and possible associated factors are 
presented as proportions for binary or categorical data, with 95% confidence intervals 
where appropriate, and medians, standard deviations, ranges and interquartile ranges 
for continuous data.  
Statistical analyses were performed using STATA SE 10/11 (Stata Corp, Chicago 
Illionois). Children with unilateral cataract were analysed separately from those with 
bilateral disease. In children with bilateral cataract the correlation of paired eye data in 
the analysis of visual outcomes, refractive and post-operative adverse events were 
dealt with by clustering within-child variables.  
If the following assumptions are made:  
recruitment of at least 250 children, of whom 60% have undergone surgery for bilateral 
cataract, and of whom two thirds have undergone IOL implantation (as suggested by 
the national survey of practice) 
a frequency of glaucoma of up to 32% of children with bilateral cataract at eight years 
following surgery without IOL implantation in the first two years of life88;138;170 
this study will have a statistical power of 42% (with a significance level of 0.05) for the 
detection of a doubling of the odds of glaucoma by the eighth post-operative year 
following bilateral cataract surgery (odds ratio 2.0) with IOL implantation as compared 
to aphakia at the level of the child, and statistical power of 75% for the detection of an 
association at the level of each operated eye (without  within child clustering). Thus, the 
probability of false negative findings lies somewhere between 25% and 58%.*  
(*power calculation undertaken using Epi Info™ 7 (Centers for Disease Control and 
Prevention, Atlanta USA).  
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4.10.a. Visual outcome  
The association between visual outcome and child / treatment specific factors was 
analysed using ordinal regression for vision as an ordered categorical outcome. 
The factors considered were:  
IOL implantation, age at diagnosis, time from diagnosis of cataract to surgery, 
socioeconomic status, (gestational) age at surgery, age at visual assessment, axial 
length, horizontal corneal diameter, compliance with occlusion and correction, surgeon 
and the presence or occurrence of microphthalmos, interocular axial length difference, 
a significant ocular anomaly, pre-operative nystagmus or strabismus, medical disorder 
or impairment, standard surgery, per-operative complication, post-operative visual axis 
opacity, glaucoma, other complication or secondary intraocular procedure. For 
outcomes following bilateral cataract surgery, asymmetry of opacity was also 
considered as a potential predictor of outcome. 
Prior to univariate regression analysis, correlations between the potential predictors of 
visual outcome were investigated using non-parametric tests (χ2, Mann Whitney U, 
Kruskal-Wallis and Spearman’s correlation coefficient) with test outcomes associated 
with p values of <0.05 considered to be evidence supporting a correlation. 
Multivariate models were then created first using the most significant variables from the 
univariate analysis, as judged by the estimated size of the effect of the potential 
predictor on visual outcome as well as the p value. Wald values were examined to 
determine the change to the fit of the model with the addition of each new variable to 
the model. The aim was to create the simplest multivariate model, and significant 
correlations between potential predictors were used to determine the predictor which 
was most appropriate / biologically plausible for inclusion into the model. Once all 
significant variables were added to the model, they were dropped in turn and the 
consequent effect on model fit was examined. Variables which did not change the fit of 
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the model on removal from the model were considered on the basis of biological 
plausibility before being removed from the final model.  
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4.10.b. Per and post-operative events  
The associations between potential predictors and the occurrence of per operative 
complications, ‘true visual axis opacity (VAO)’, inflammatory VAO and glaucoma were 
estimated using logistic regression. A similar method to that used to undertake 
univariate and multivariate regression on acuity outcomes was used, with a priori 
consideration of correlation between potential predictors estimated using non-
parametric tests.  
The potential predictors of per-operative complications considered in the analysis were:  
(gestational) age at surgery, axial length, significant interocular axial length difference, 
horizontal corneal diameter, surgeon, the presence of persistent fetal vasculature, 
microphthalmos, microcornea, significant ocular abnormality, the use of oculoviscous 
devices and IOL implantation. 
The potential predictors of visual axis opacity considered were:  
(gestational) age at surgery, axial length, horizontal corneal diameter, surgeon, the 
presence of persistent fetal vasculature , per op iris trauma, per op IOL explantation, 
post-operative inflammation, the use of manual anterior capsulotomy, posterior 
capsulotomy, IOL implantation, IOL power, single piece IOLs, IOL fixation position, per 
operative heparin, post op intensive steroid drops, and post op systemic steroid.  
The potential predictors of glaucoma are:   
(gestational) age at surgery, cataract morphology, axial length, significant interocular 
axial length difference, horizontal corneal diameter, surgeon, the presence of persistent 
fetal vasculature, per op iris trauma, per op IOL explantation, post-operative 
inflammation, post-operative inflammation or post-operative intraocular surgery, the 
use of posterior capsulotomy, oculoviscous devices, IOL implantation, post op intensive 
steroid drops, and post op systemic steroid. 
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The estimated effect of clinical factors on the immediate post-operative refractive 
outcome (prediction error) for children undergoing primary IOL implantation were 
modelled using linear regression methods.  
The potential predictors of refractive prediction error considered were: (gestational) age 
at surgery, corneal curvature, corneal astigmatism, anterior chamber depth, axial 
length, significant interocular axial length difference, horizontal corneal diameter, 
surgeon, the presence of anterior segment abnormality, and the use of oculoviscous 
devices, posterior capsulotomy, anterior vitrectomy, wound suture, single piece IOL, 
and IOL fixation position, IOL power and calculation formula. 
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4.11. Identification of cases of cataract surgery and intraocular 
lens implantation in children under 2 years old in the United 
Kingdom using the National statistical database 
In order to compare the level of ascertainment achieved by the active surveillance 
network with the ascertainment of cases achieved through data collection undertaken 
by NHS Trusts and returned to a central database, requests for data on the number of 
children undergoing cataract surgery were made to the NHS information centres for the 
four member states of the United Kingdom. The Central Statistics Office Ireland does 
not collect this level of data from publicly funded hospitals in the Republic of Ireland.  
 
4.11.a. Identification of eligible codes 
As discussed in section 2.6.b.i page109, there is no national agreement on which 
OPCS code to use for children undergoing cataract surgery (either lens removal from 
the capsule, or lens removal with posterior capsulotomy / anterior vitrectomy). Thus, all 
of these codes for lens removal were used in the data request.  
 
4.11.b. Data request 
England 
An HES data extraction request was made to the NHS Information Centre for health 
and social care (NHSIC) through the Hospital Episode Statistics online service 
(enquiries@ic.nhs.uk). Data were extracted to these specifications:  
Data year:  2009 & 2010 
Measures: Clinical data: Number of episodes with a main or secondary 
Procedure/Intervention 
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With the fields: Number of patients aged 0 -1 years and 1-2 years; 4 digit OPCS code; 
Primary care trust area of treatment 
Limited to the following OPCS codes: Procedures under 'C71' (EXTRACAPSULAR 
EXTRACTION OF LENS); Procedures under 'C72' (INTRACAPSULAR EXTRACTION 
OF LENS); Procedures under 'C74' (OTHER EXTRACTION OF LENS); and Procedure 
'C75' (INSERTION OF PROSTHETIC REPLACEMENT FOR LENS).  
A tabulated HES data extract was then created by the NHSIC and provided as an 
encrypted electronic tabulation. 
Northern Ireland 
An email request was made through the NHS Northern Ireland Hospital Information 
Branch [statistics@dhsspsni.gov.uk] for the ‘totals’ reports for procedures under the 
three digit OPCS codes 'C71', 'C72','C74', and 'C75' for children aged 2 years or under 
at surgery, for the years 2009 and 2010.  
 
Scotland 
An email request was made through the NHS Scotland Information Services Division 
[NSS.isdSCT@nhs.net] for the ‘totals’ reports for procedures under the three digit 
OPCS codes 'C71', 'C72','C74', and 'C75' for children aged 2 years or under at surgery, 
for the years 2009 and 2010.  
Wales 
An email request was made to PEWD through NHS Wales Informatics 
[PDIT.Requests@wales.nhs.uk] for the ‘totals’ reports for procedures under 
'C71', 'C72','C74', and 'C75' for children aged 2 years or under, for the years 
2009 and 2010. 
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5. RESULTS 
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5.1. Introduction  
 
The distribution of the surveillance network and characteristics of the families of the 
children on whom data have been collected are described here.  
Descriptive analyses are presented regarding the clinical features of the children 
undergoing surgery, the practices undertaken, and outcomes following surgery with 
and without IOL implantation. These findings are followed by multivariate analysis of 
the factors associated with good visual outcome and adverse outcomes following 
surgery, and refractive changes following IOL implantation. 
Findings of a comparison between the ascertainment of cases through the surveillance 
network, and the national databases of clinical activity are presented. 
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5.2. Case ascertainment and recruitment  
 
5.2.a. Distribution of recruiting centres 
Participant identification was undertaken by 45 of the 47 paediatric ophthalmologists 
initially identified by the national survey of practice (section 4.2). A further six 
consultants were identified afterwards (3 through late responses to the national survey, 
1 through existing members of the BCCIG, and 2 consultants who started their posts 
after January 2009).  
Thus, a total of 51 surgeons across 32 centres identified children for recruitment to this 
study: 1 centre in the Republic of Ireland, 1 in Northern Ireland, 2 in Wales, 4 in 
Scotland and 24 in England. The distribution of these centres is shown in Figure 10.  
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Figure 10. Distribution of the recruiting centres, with a colour code for the 
number of children identified by the centre during the 2009/2010 study 
period 
(GOSH: Great Ormond Street Hospital; RDEFT: Royal Devon and Exeter 
Hospital)  
*At asterixed centres ascertainment was checked by the study fellow (ALS) 
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5.2.b. Case notification  
334 children undergoing surgery for cataract were reported between January 2009 and 
January 2011. 19 of these children were ineligible for inclusion (due to being aged over 
2 years at surgery, diagnosis of secondary cataract or non-residence in the British 
Isles). Thus 315 eligible children underwent surgery for congenital and infantile cataract 
(Figure 11).  
 
5.2.c. Consent and recruitment to study  
306 of the 315 families of eligible children were approached for consent. 243 of the 306 
(79.4%) families had consented to their child’s inclusion within the study (Figure 11) by 
the time of the submission of this thesis (August 2011). Nine families were not 
approached for consent, due to social / care issues or inability of the managing 
consultant to collect the full study dataset. 6 children underwent surgery after the end 
of the recruitment period (December 2010): however, the families of these children 
were identified and approached by their consultants during the study period.  
The proportion of families giving their consent at each recruiting centre ranged from 
100% to 0% (Figure 12, page 155).  
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Figure 11. Case ascertainment and recruitment flow chart 
 
 
Eligible (cong/infant cataract) 315    
   ↓ 
Families of 9 children not 
approached 
Approached for consent  306    
   ↓ 
9 families refused, 54 yet to reply (as 
of August 2011)  
Formally recruited 243    
   ↓    
Total with pre and per-operative data 
236 
(373 eyes)    
       
 141 (278 eyes)  95 (95 eyes)  
 Bilateral cataract   Unilateral cataract   
 ↓ ↓  ↓ ↓  
 IOL Aphake  IOL Aphake  
 
57  
(113 eyes) 
84  
(165 eyes)  52 eyes 43 eyes  
 40.4% 59.6%  54.7% 45.3%  
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Figure 12. Recruitment and data collection across the collaborating hospitals 
0% 20% 40% 60% 80% 100%
Cheltenham General (1)
Coventry (1)
James Cook, M iddlesborough (1)
Kings, London (1)
Nottingham (1)
Western Eye, London (1)
Countess of Chester (2)
Oxford Eye (2)
Bradford  (3)
Huddersfield (3)
North Staffordshire (3)
Royal Victoria Newcastle (3)
Southampton (2)
Sunderland Eye (3)
St James, Leeds (4)
Royal Devon & Exeter (7)
Bristol Eye (9)
Moorfields, London (11)
Sheffield Children's (11)
Leicester (12)
Alder Hey, Liverpool (19)
Addenbrookes, Cambridge (21)
Birmingham Childrens (29)
Manchester Royal (35)
Great Ormond Street, London  (82)
- ENGLAND -
Royal Aberdeen (1)
Ninewells, Dundee (2)
Yorkhill, Glasgow (2)
Princess Alexandra, Edinburgh (8)
- SCOTLAND -
Cardiff University (4)
- WALES -
Royal Victoria Belfast (12)
- NORTHERN IRELAND -
Our Lady, Dublin (7)
- REPUBLIC OF IRELAND -
-- TOTAL 306 children --
Not consented
Consented, no data
Consented with data
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5.3. Data collection  
As of August 2011, pre and per operative data collection instruments have been 
completed for 236 of the 243 recruited children. The proportion of consented children at 
each recruiting centre for whom data has been collected ranges from 33% to 100% 
(Figure 12).  
Of these 236 children, 141 had bilateral cataract, 95 had unilateral cataract. 57, 
40% of children with bilateral cataract underwent primary IOL implantation, as did 52, 
55% of children with unilateral cataract. These 236 children comprise the study sample 
for the descriptive analyses undertaken on demographic, pre-operative clinical and per-
operative clinical characteristics, and the statistical analyses of per operative adverse 
events.  
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5.4. Comparison of IOLunder2 United Kingdom ascertainment 
with national databases of hospital activity 
 
Of the 326 children reported by the BCCIG as having undergone cataract surgery aged 
≤2years, 320 underwent surgery between January 2009 and December 2010 for 
unilateral (135 children) or bilateral (185 children) cataract (total 501 eyes, or episodes 
of cataract surgery).  
At the time of submitting this thesis, data were available from the NHS Hospital 
Episode Statistic database (England) and the NHS Wales information centre on the 
numbers of episodes of cataract surgery in children age 2 years and under occurring 
during 2009 and 2010 and data were unavailable from the NHS information centres for 
Scotland and Northern Ireland for episodes which occurred during 2010. Over these 
periods, 187 episodes of ‘extracapsular’ cataract surgery, 274 episodes of ‘other 
extraction of lens’ and 1 case of an ‘intracapsular’ cataract surgery were reported by 
NHS Trusts to their central national database centres, making a total of 462 episodes. 
Over the same period, 477 episodes of cataract surgery were identified through active 
surveillance undertaken through the BCCIG (Table 14).       
 158 
 
 
Table 14. Comparison of ascertainment through national database and 
through IOLu2 surveillance 
  England Scotland Northern 
Ireland 
Wales Total 
NHS information centre 
ascertainment  
 of episodes cataract surgery  
     
 2009 & 
2010 
2009 2009 2009 & 
2010 
 
C71 – Extracapsular extraction  161 8 9 9 187 
C72 – Intracapsular extraction  1 0 0 0 1 
C74 – Other extraction of lens 256 7 1 10 274 
Total cataract extraction  418 15 10 19 462 
C75 – Intraocular lens implantation   134 9 9 4 156 
IOLunder2  
active surveillance 
     
 2009 & 
2010 
2009 2009 2009 & 
2010 
 
Ascertainment of episodes of 
cataract surgery   
436 18 11 12 477 
Cases of IOL implantation recruited 
through active surveillance and 
included within this study sample 
146 3 5 4 158 
 
As shown in Table 14, in England, Scotland, and Northern Ireland, more cases were 
ascertained by collaborating clinicians within the BCCIG network than were ascertained 
through hospital data returns to the NHS, whilst in Wales, fewer cases were 
ascertained. This under-ascertainment is due to failure to enrol one hospital in Wales at 
which paediatric cataract surgery was undertaken.    
Within the Republic of Ireland, only one of the three eligible centres identified by the bi-
national survey of practice were enrolled to the study. Thus, children undergoing 
cataract surgery in the first 2 years of life in Ireland are under-represented within this 
study.  
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5.5. Descriptive analysis  
5.5.a. Demographic characteristics of the study population 
 
5.5.a.i. Gender 
47% (111/236) of children who underwent surgery are female.  
 
5.5.a.ii. Self-reported ethnicity  
The majority of children (73%) come from families of White ethnicity, as shown in Table 
15. Whilst there are no significant differences between children who underwent surgery 
with or without IOL implantation, in comparison to national data on the ethnicity of 
children born between 2005 and 2008 (which is the latest available dataset for the 
national patterns of ethnicity of live births) a higher proportion of children within the 
described cohort are from families of Asian ethnic origin (p<0.05, 95% confidence 
interval of difference between proportions 0.05% - 6.4%). However, over the past 
decade there has been an annual increase in the proportion of national live births born 
to non-White ethnicity families, so more recent data may reveal that the ethnicity 
distribution of this cohort is not significantly different from the national distribution. 
 
5.5.a.iii. Family structure and socioeconomic status 
In comparison to the national average, a higher proportion of recruited families were 2 
parent families (89% versus 75%, p<0.05, 95% CI 9.1% - 17.9%) and a higher 
proportion of parents / carers had achieved degree or higher degree level education 
(p<0.005, 95% CI 14.3 – 27.6%). However, a higher proportion of mothers of recruited 
children were aged under 21 years (p<0.05, 95% CI 2.2 – 8.5%), although 17% 
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(40/236) of parents declined to answer this question. Again, there were no significant 
differences socio-economic parameters between children who had undergone surgery 
with or without IOL implantation.
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Table 15. Demographic characteristics for included children  
Data sources for population references: Office of National statistics (ONS), NHS numbers for babies (NN4B) 
*statistically significant difference to national proportion p<0.05)
    IOL, n=109 Aphake, n=127 Total, n=236 Population reference 
Gender:   Female 49, 45% (35.9 - 54.1%) 62, 48.8% ( 40.3 - 57.4%) 111, 47% (40.8 - 43.4%) 48.7% ONS 2009295 
Ethnicity: Missing 5, 4.6% (1.7 - 10.5%)  13, 11.4% (6.6 - 18.7%)  18 NN4B/ONS 2008296 
 White 83, 81.4% (72.7 - 87.8%) 89, 78.1% (69.6 - 84.7%)  172, 72.8% (66.9 - 84.6%) 70.1% 
 Mixed 1, 1% (0 - 5.8%) 3, 2.6% (0.6 - 7.8%)  4, 1.9% (0.6 - 4.8%)   
 All Asian / Asian British 14, 13.7% (8.2 - 21.9%) 15, 13.2% (8.0 - 20.7%)  29, 13.4% (9.5 - 18.7%)* 9.0% 
 Indian  1, 1% (0 - 5.8%) 5, 4.4% (1.6 - 10.1%)  6, 2.8% (1.1 - 6.7%)   
 Pakistani  9, 8.8% (4.5 - 16.1%) 6, 5.3% (2.2 - 11.2%) 15, 6.9% (4.2 - 11.2%) 3.7% 
 All Black / Black British  1, 1% (0 - 5.8%) 5, 4.4% (1.6 - 10.1%)  6, 2.8% (1.1 - 6.7%)  5.1% 
Family structure: parental        ONS 2009297 
 Missing  15, 13.8% (8.4 - 21.6%) 22, 17.3% (11.7 - 24.9%) 37   
  Lone parent family  14, 11.7% (6.5 - 19.9%) 8, 7.6% (3.7 - 14.5%) 22, 11.1% (7.4 - 16.2%)* 25.3% 
Family structure: children        ONS 2009297 
 Missing  3, 2.8% (0.6 - 8.1%)  7, 5.5% (2.5 - 11/1%) 10   
  >2 children 20, 18.9% (12.5 - 24.4%)  23, 19.2% (13.1 - 27.2%)  43, 19% (14.4 - 24.7%)  22.7% 
Accommodation type: Missing 5, 4.6% (1.7 - 10.5%)  13, 11.4% (6.6 - 18.7%)  18 
2001 census households with 
dependents 
  Self own / private rent 81, 79.4% (70.5 - 86.2%)  83, 72.8% (63.9 - 80.2%)  164, 75.9% (69.8 - 81.2%)  80.8% 
Parental education: Missing 10, 9.2% (4.9 - 16.2%)  15, 11.8% (7.2 - 18.7%)  25 ONS 2001298 
 None 7, 7% (3.2 - 14.15)  13, 11.6% (6.8 - 18.9%)  20, 9.5% (6.2 - 14.3%)  20.1% 
 Olevel/Alevel/Cert/Other 47, 47.5% (37.9 - 57.2%)  44, 39.3% (30.7 - 48.6%)  91, 43.1% (36.6 - 49.9%) 57.6% 
  Degree /Higher Degree 45, 45.5% (36 - 53.3%)  55, 49.1% (40 - 58.2%)  100, 47.4% (40.8 - 54.1%)* 22.1% 
Maternal age:  Missing 11, 10.9% (5.6 - 17.3%)  29, 22% (16.4 - 30.4%)  40 ONS 2009297 
 <21 years 3, 3.2% (0.7 - 9.3%)  7, 7.1% (3.3 - 14.3%)  10, 5.2% (2.7 - 9.4%)* 0.6% 
 21 - 30 42, 44.2% (34.6 - 54.2%)  49, 48% (38.3 - 57.7%)  89, 46.1% (39.2 - 53.2%)  46.7% 
 31 - 40 45, 47.4% (37.6 - 57.3%) 39, 39.8% (30.4 - 49.7%)  84, 43.5% (36.7 - 50.6%)  43.3% 
  41+ 5, 5.3% (2 - 12%)  5, 5.1% (1.7 - 11.7% ) 10, 5.2% (2.7 - 9.4%)  3.8% 
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In comparison to the national measures of multiple indices of deprivation,  a larger 
proportion of families of children recruited to the study lived within areas of relative 
deprivation, with 28% living in areas which fell within most deprived national quintile 
(Table 16, difference from national proportion reaches statistical significance p=0.05).  
 
Table 16. Postcode-derived deprivation measure for family residence (index of 
multiple deprivation quintile) 
*difference between study population and national distribution reaches statistical 
significance 
**difference between IOL and aphake groups reaches statistical significance 
 
Total, 
n=236 
95% CI of 
proportion  
IOL, 
n=113 
Aphake, 
n=127 
95% CI of 
difference in 
proportions 
Missing  28, 12% - 18, 16% 14, 11%  
Living in the most deprived 
areas (highest deprivation 
score quintile) 
59, 28%  
21.9 - 34%* 
(p=0.05) 
17, 18% 41, 36% 
-30 to -6%** 
(p<0.01) 
2nd quintile 39, 18.5% 13.2 - 23.8% 19, 20% 19, 17% -7 to +14% 
3rd quintile 37, 17.5%  12.4 - 22.7% 17, 18% 19, 17% -9 to +12% 
4th quintile 32, 15.2%  10.2 - 20% 15, 16% 17, 15% -9 to +11% 
Living in the least deprived 
areas (lowest  deprivation 
score quintile) 
44, 20.8% 15.3 - 26.4% 27, 28% 17, 15% 
+2 to +25%** 
(p=0.03) 
 
IOL implantation was associated with the postcode derived index of deprivation for 
recruited children for whom these data were available, with a higher proportion of 
children from least deprived areas, and lower proportion from the most deprived areas 
undergoing IOL implantation (Table 16).  
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5.5.a.iv. Summary  
Children have been recruited through 51 managing consultants across 30 hospitals in 
the United Kingdom and 1 hospital in the Republic of Ireland, and 79.4% of the 
approached families of eligible children have to date agreed to their child’s inclusion to 
this study.  
Of the 236 children who form the study sample for the analyses described here, 109 
underwent IOL implantation. There were no significant differences in the demographic 
characteristics of the families of children selected for surgery with IOL implantation 
compared to those who underwent surgery without IOL implantation with regards to 
ethnicity, family structure or parental education. However, children from families living 
in the most deprived areas of the UK were less likely to have undergone primary IOL 
implantation.  
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5.5.b. Pre-operative clinical characteristics  
 
5.5.b.i. Laterality  
Of the 141 children with bilateral cataract significant asymmetry of lens opacity was 
noted in 26 children or 18% (more dense in the right eye in 15 children with asymmetric 
cataract, 58%, and in the left eye in 11 children). 
Of the 95 children with unilateral cataract, 46 were affected by cataract in the right eye 
(48%). 
 
5.5.b.ii. Morphology 
For the majority of children (187/236, 79%) cataract morphology was described 
according to lens strata (nuclear, posterior, lamellar, anterior or cortical) (Table 17). For 
the remaining 49 children, cataract was described as dense, total or partial. 
Nuclear cataract was the most common morphology in bilaterally affected children (73, 
52%). Posterior opacity or nuclear cataract were the most common morphologies 
amongst children with unilateral disease. 
Amongst children who underwent IOL implantation (in comparison to children who did 
not undergo IOL implantation) posterior lens opacity was a more common morphology 
in bilaterally affected children, and nuclear lens opacity was a less common 
morphology in both bilaterally and unilaterally affected children (Table 17). 
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Table 17. Morphology of lens opacity in bilateral and unilateral cataract 
 
 Bilateral cataract Unilateral cataract  
 Total IOL Aphake p* Total IOL Aphake p* 
Nuclear  
73 
51.8% 
23 
40.4% 
50 
59.6% 
0.03 
29 
30.5% 
20 
38.5% 
9 
20.9% 
0.08 
Posterior 
20 
14.2% 
12 
44.4% 
8 
9.5% 
0.08 
37 
39% 
17 
32.7% 
20 
46.5% 
0.2 
Lamellar  
13 
9.2% 
7 
12.3% 
6 
7.1% 
0.4 
5 
5.3% 
2 
3.9% 
3 
6.9% 
0.7 
Anterior 
4 
2.8% 
2 
3.5% 
2 
2.4% 
0.99 
5 
5.5% 
4 
7.7% 
1 
2.3% 
0.4 
Total lens  8 4 4 0.7 7 5 2 0.5 
Cortical 1 0 1 0.99 0 0 0 - 
Dense* 22 9 13  8 1 7  
Partial* 0 0 0  4 3 1  
Total 141 57 84  95 52 43  
*p values for test of significant difference between IOL and Aphake groups 
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5.5.b.iii. Associated ocular abnormalities 
The most common co-existent ocular abnormalities were microphthalmos (152/236 
children, 64.3%, with 56/236 or 24% children having severe microphthalmos), 
microcornea (affecting 25% of children without microphthalmos) and persistent fetal 
vasculature (24%, 56/236 children).  
As shown in Table 18, in comparison to children in the aphake group, amongst the 
bilaterally affected children who were selected for primary IOL implantation there were 
significantly lower proportions with co-existent  microphthalmos, microcornea or 
anterior segment ocular abnormalities. 
 
Table 18. Frequency of co-existent ocular abnormalities in children with bilateral 
cataract 
 
 
IOL  
57 children 
Aphake  
84 children  p  
95% CI of difference 
between proportions  
Microphthalmos 
  
64.9%  96.3%   
(95% CI 51- 76%) (86.7 - 99.7%) <0.001 18.7% - 44.7% 
Axial length <16mm  
3.9% 42.7%   
(0.3 - 13.%7) (30.2 – 55%) <0.001 26.3% - 50.3% 
Microcornea 
  
0% 50%   
(0 - 10%) (29.0 - 70.9%) <0.001 37.8% - 60.5% 
Persistent fetal 
vasculature 
7% 9.5%   
(2.3 - 17.2%) (4.7 - 17.9%) 0.76 - 
Anterior segment 
abnormality 
7% 19%   
(2.3 - 17.%2) (11.9 - 28.8%) 0.051 0.1% - 22.6% 
Posterior segment 
abnormality  
3.5% 6%   
(0.3 - 12.6%) (2.2 - 13.5%) 0.7 - 
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Similarly, for children with unilateral cataract (as shown in Table 19), amongst the 
children who were selected for surgery with primary IOL implantation, there were 
significantly lower proportions with co-existent  microcornea and anterior segment 
ocular abnormalities. There were also fewer children with persistent fetal vasculature. 
 
Table 19. Frequency of co-existent ocular abnormalities in children with 
unilateral cataract 
 
IOL  
52 children  
Aphake  
43 children  p  
95% CI of 
difference between 
proportions  
Microphthalmos 
  
28% 44.8%   
(17.4  - 41.8%) (28.4 - 62.5%) 0.13 - 
Axial length <16mm 
20% 17.2%   
(0 - 11.5%)  (7.1 – 35%) 0.79 - 
Microcornea 
  
6.9% 33.3%   
(0.9 – 23%) (16.1 - 56.4%) 0.003 8.9% - 40.5% 
Persistent fetal vasculature 
30.8% 65.1%   
(21 - 45.5%) (40 - 77.6%) 0.001 14.2% - 50.9% 
Anterior segment abnormality 
11.5% 44.2%   
(5 - 23.3%) (30.4 - 58.9%) <0.001 14.8% - 48.6% 
Posterior segment 
abnormality  
5.8% 7%   
(1.4 - 16.3%) (1.7 - 19.3%) 0.99 - 
 
These co-existent ocular abnormalities will now be described in more detail.  
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Axial length and microphthalmos 
Bilateral cataract  
 
Ultrasound axial length measurement was undertaken in significantly more children 
who were selected for surgery with IOL implantation: 57/57, 100%, versus 61/84, 
72.6%, p<0.0001, 95% CI difference in proportion between the two groups or CIDIP 
16.9% - 37.8%).  
Axial length, uncorrected for age, ranged from 15.04mm to 24.3mm for those who 
underwent IOL implantation, and between 12 and 21mm for the children in the aphake 
group.   
114 children underwent bilateral axial length measurement. 89 (78.1%) were affected 
by microphthalmos in either both or one eye (Table 20) with a significantly higher 
proportion of microphthalmic children within the aphake group than within the IOL 
group: 96.3% versus 64.9% (p=0.005, 95% CIDIP 11.3% - 40.2%).  
Only 4 children (4%) had an interocular axial length difference greater than 1.5mm. 
Of the 114 children, 26 (22.8%) had axial lengths of less than 16mm, with again a 
significantly higher proportion of children in the aphake group having this degree of 
microphthalmos: 42.1% versus 3.9% (p<0.0001, 95% CI DIP 24% - 51.8%). 
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Table 20. Microphthalmos and severe microphthalmos in eyes of children with 
bilateral cataract  
in the a) IOL group and b) aphake group  
 
a) IOL group, n=57 Left eye 
  
Not 
affected Microphthalmos 
Severe 
Microphthalmos 
Right 
eye 
Not affected  20 4 0 
Microphthalmos 1 30 0 
Severe Microphthalmos 0 0 2 
     
b) Aphake group, n=57 Left eye  
  
Not 
affected Microphthalmos 
Severe 
Microphthalmos 
Right 
eye 
Not affected 5 0 4 
Microphthalmos 0 28 0 
Severe Microphthalmos 0 2 18 
 170 
Unilateral cataract  
As with children with bilateral cataract, ultrasound axial length measurement was 
undertaken in significantly more children who were selected for surgery with IOL 
implantation: 49/52, 94.2%, versus 30/43, 69.8%  (p=0.002, 95% CI DIP 9.2% - 39.8%).  
Axial length, uncorrected for age, ranged from 15.6 to 23.9mm (contralateral non-
cataractous eye 16 – 22.3mm) for those who underwent IOL implantation and between 
15 and 20.8mm for the aphakic group (contralateral non-cataractous eye 17.3 – 
20.2mm). 
27 children had microphthalmic eyes on ultrasound measurement (34.2%) and 6 had 
axial lengths <16mm (7.6%). A smaller proportion of the children who were selected for 
IOL implantation had axial lengths <16mm (2% versus 17.2% in the aphake group, 
p=0.02, 95%CI DIP 4.2 – 28.9%) and had microphthalmic cataractous eyes (28% 
versus 44.8% in the aphake group, but this difference does not reach statistical 
difference, p=0.14). 
All children who were aged under 1 month at diagnosis of unilateral cataract had a 
smaller cataractous eye, whilst half (52%) of the oldest children in the group (those 
aged over 6 months at diagnosis) had a larger cataractous eye at the time of biometry. 
More children in the aphake group had a cataractous eye which was 1.5mm smaller 
than the contralateral non-cataractous eye (Figure 13). However, this difference did not 
reach statistical significance.  
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Figure 13. Interocular axial length difference in children with unilateral  cataract 
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Clinical microphthalmos versus USS (ultrasound scan) axial length 
Of the 197 children who underwent USS measurement, 31 children were diagnosed 
with ‘clinical microphthalmos’ by managing consultants, but 2 of these 31 children were 
found to have normal axial lengths for age. When compared to the classification 
system of microphthalmos on USS measurement, clinical determination of 
microphthalmos in bilateral cataract has a positive predictive value of between 83% 
and 100% and a negative predictive value of 26% (Table 21). In unilateral cataract, the 
positive predictive value is lower, at 83%, and the negative predictive value is improved, 
at 43%. The 4-by-4 tables from which these figures have been derived are appended 
(Appendix H). 
With regards to the predictive power of the clinical determination of microphthalmos for 
axial length of less than 16mm on USS measurement, the positive predictive value is 
lower for both unilateral and bilateral cataract, but there are fewer false negatives for 
the prediction of a small eye with clinical determination, with a negative predictive value 
of 88% for bilateral cataract, and 100% for unilateral cataract (Table 21). 
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Table 21. Predictive power of clinical assessment of microphthalmos in detecting microphthalmos, ocular axial length <16mm or 
microcornea 
 Bilateral cataract Unilateral cataract 
 Positive predictive value  Negative  predictive value PPV NPV 
 RE LE RE LE RE LE RE LE 
Microphthalmia 
93.8 100 31.6 26.3 83.3 85.7 47.7 42.9 
(69.7-100) (76.1-100) (23.2-41.4) (18.6-35.7) (41.8-98.9) (46.7-99.5) (31.5-63.3) (24.4-63.5) 
Axial length 
<16mm 
68.8 73.3 88.8 86.9 33.3 28.6 97.1 100 
(44.2-86.1) (47.6-89.5) (80.9-93.8) (78.7-92.3) (9.3-70.4) (7.6-64.8) (83.8-100) (81.8-100) 
Microcornea 
75 86.7 80.3 78.5 50 50 84.6 83.3 
(50-90.3) (60.7-97.5) (69.8-87.8) (68.1-86.2) (18.8-81.2) (18.8-81.2) (65.9-94.5) (60 -95) 
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Horizontal corneal diameter (HCD) and microcornea 
HCD measurement was undertaken in the majority of children. Amongst children with 
bilateral cataract, HCD was measured in 75% of children in both the IOL (43/57) and 
aphake groups (63/84). Amongst children with unilateral cataract HCD was also 
measured in a similar proportion of children: 77% of the IOL group (40/52) and in 
67.4% of the aphake group (29/43).  
HCD ranged from 9 to 12mm for children selected for IOL implantation, and 7 to 12mm 
for children selected for aphakia.  
 
Bilateral cataract  
38 of the 106 children with HCD measurements (35.8%) had microcornea.  Of these, 9 
children had isolated microcornea without microphthalmos (25% of all children without 
microphthalmos). Microcornea was a significantly less common finding amongst 
children who underwent IOL implantation (Table 18). 
Severe microcornea or HCD <9.5mm affected 11 of the 38 children with microcornea 
(10.4% of all 106 children). No child with severe microcornea underwent primary IOL 
implantation. 
Unilateral cataract  
16 of the 69 children with HCD measurement had microcornea (23.2%), and 2 of these 
16 children (2.9% of all children) had severe microcornea. Again, no child with severe 
microcornea was selected for IOL implantation. Isolated microcornea (without 
microphthalmos) affected 2 of 29 children who underwent IOL implantation (6.9%) 
compared to 6 out of 18 children who were selected for aphakia (33.3%), a significant 
difference (Table 19).  
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Persistent fetal vasculature (PFV) 
56 children had persistent fetal vasculature (23.7%):  44 of the children with unilateral 
cataract (46.3%), and significantly fewer children with bilateral cataract (12 children, 
8.5%, p<0.0001, 95% CI DIP 29.7% - 51%). In comparison to children with unilateral 
PFV, a higher proportion of children with bilateral PFV associated cataract had iris / 
pupil / anterior capsular vascular remnants (75% versus 11%, p=0.01, 95% CI DIP 
20.6% - 71.2%) as shown in Figure 14.   
Amongst the children with bilateral cataract similar proportions of children in the IOL 
(4/57, 7%) and aphake (8/84, 9.5%) groups were affected by PFV.  Amongst 
unilaterally affected children significantly more aphake group children (65.1%) had PFV 
than in the IOL group (30.8%, p<0.001, 95% CI 14.2% - 50.9%).  More children within 
both the unilateral cataract and bilateral cataract aphake groups had anterior PFV or 
complex PFV than children within the IOL group (Table 22) but these differences were 
not statistically significant.  
Table 22.Proportion of children with the differing classifications of persistent 
fetal vasculature 
  Bilateral  Unilateral  
Total      IOL Aphake IOL Aphake 
None 53 76 36 15 180 
Persistent fetal 
vasculature 
4 8 16 28 56 
7% 10% 31% 65% 23.7% 
  Isolated 
retrolental 
1 1 6 12 20 
 2% 1% 12% 28% 8.5% 
 
Anterior PFV 
0 4 1 2 7 
 0% 5% 2% 5% 3% 
 
Complex PFV 
3 3 9 14 29 
 5% 4% 17% 33% 12.3% 
Total  57 84 52 43 236 
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Figure 14. Manifestations of persistent fetal vasculature in individual 
children with bilateral cataract  
RL: retrolental vascularisation; IR: iris / pupil / anterior capsule vascular 
remnants; CP: ciliary process traction; PA: persistent hyaloid artery; ONH: optic 
nerve head or retinal features 
 
 
Bilateral IOL  
4 children    
  RL IR CP PA ONH  
Child 1 + +        
2 + +        
3 + +        
4 +          
Total  4 3 0 0 0  
% 100 75 0 0 0  
       
 
Bilateral Aphake 
8 children    
  RL IR CP PA ONH  
Child 1 +     +    
2   +        
3 +          
4 + +   + +  
5   +        
6 + +   +    
7   +        
8   +        
Total 4 6 0 3 1  
% 50 75 0 38 13  
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Figure 15. Manifestations of persistent fetal vasculature in individual 
children with unilateral cataract 
RL: retrolental vascularisation; IR: iris / pupil / anterior capsule vascular 
remnants; CP: ciliary process traction; PA: persistent hyaloid artery; ONH: optic 
nerve head or retinal features 
 
 
Unilateral IOL  
16 children    
Unilateral Aphake  
26 children   
  RL IR CP PA ONH    RL IR CP PA ONH 
Child 1 +          1 +         
2 +          2 + +       
3 + +   +    3 +         
4   +        4 +         
5 +          5 +         
6 +     +    6 + + + +   
7 +     +    7 + +   + + 
8 +          8 +         
9 +     +    9   +       
10 +       +  10 +     +   
11 +     + +  11 + + + +   
12 +          12 +   +     
13 +     + +  13 +         
14 +          14 +     +   
15 +     +    15 +   +     
16 +          16 +         
Total 15 2 0 7 3  17 +         
% 94 13 0 44 19  18 + +   +   
       19 +     +   
       20 +   + +   
       21 +     + + 
       22 +         
       23 + + + +   
       24 +         
       25 +         
       26 +     +   
       27   + +     
       28 +   + +   
       Total 26 8 8 12 2 
       % 92 29 29 43 7 
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Anterior and posterior segment abnormalities 
Higher proportions of children in the aphake group had anterior and posterior segment 
abnormalities when compared to the IOL group. The details of the abnormalities found 
in children are shown in Table 23.  A significantly higher proportion of unilateral aphake 
children had anterior segment abnormalities (44% versus 12% of the unilateral IOL 
group, p=0.0004, 95% CI DIP 14.8% - 48.6%).  The four children with pre-operative 
glaucoma have been excluded from the analyses of glaucoma as an adverse post-
operative outcome.  
 
Table 23. Details of anterior segment disorders  
  Bilateral  Unilateral  
  IOL Aphake IOL Aphake 
None 53 (92.9%) 68 (80.9%) 46 (88.5%) 24 (55.8%) 
Corneal  1 9 1 4 
 Embryotoxon  0 6 0 2 
 Haze 1 2 1 1 
 Keratolenticular touch  0 0 0 1 
  Flat cornea 0 1 0 0 
Shallow Ant Chamber 0 8 0 1 
Iris / Pupil / Ant capsule 4 12 5 5 
 Persistent pupil membrane 1 2 1 0 
 Other ant manifestation PFV 2 6 1 2 
 Hypoplastic iris 0 2 3 2 
 Ectopia pupillae 1 0 0 1 
 Iridocorneal touch  0 1 0 0 
  Iris coloboma 0 1 0 0 
Lens 0 1 0 2 
 Microspherophakia 0 1 0 1 
  Ectopia lentis 0 0 0 1 
Pre-operative glaucoma 0 3 0 1 
  Total  57 84 52 43 
 179 
 
5.5.b.iv. Aetiology of cataract  
In 160 children (68% overall and 89% of all children with unilateral cataract), the 
aetiology of cataract was unknown. 6% of children had an identified hereditary 
systemic disorder, 7 children had Trisomy 21 (2 with unilateral cataract, 5 with bilateral 
cataract). There were no statistically significant differences in the aetiology of cataract 
in children who did and children who did not undergo IOL implantation.  
Table 24. Aetiology of cataract 
with p values for statistical tests of difference in proportion between the IOL and 
aphake group 
  *Congenital toxoplasma 
**Neonatal acquired hypercalcaemia 
 
 Bilateral  Unilateral  
Total   IOL Aphake IOL Aphake 
Idiopathic 
27 
47.4% 
48 
57.1% 
46 
88.5% 
39 
90.7% 
160 
68% 
   p=0.3  p=0.99  
Hereditary ocular 
25 
43.9% 
25 
29.8% 
1 
1.9% 
2 
4.7% 
50 
21% 
   p=0.11  p=0.6  
Hereditary Systemic 
3 
5.3% 
10 
11.9% 
1 
1.9% 
1 
2.3% 
15 
6% 
   p=0.24  p=0.99  
Non hereditary 
genetic / 
chromosomal  
2 
3.5% 
3 
3.6% 
4 
7.7% 
0 
9 
4% 
 p=0.99  p=0.12  
Other 
0 
1* 
1.2% 
0 
1 ** 
2.3% 2 
   p=0.99  p=0.45 1% 
Total  57 84 52 43 236 
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5.5.b.v. Systemic disorders and impairments 
54 of the 236 included children (23%) had a systemic abnormality, with a significantly 
higher proportion of disorders amongst the children with bilateral cataract: 43 of the 
141 children (30.8%) versus 11 of the 95 (11.6%) children with unilateral cataract 
(p<0.001, 95% CI DIP 8.3 – 28.4%). 15 children had some form of impairment: hearing 
impairment in 3 children, all of whom also had bilateral cataract, and global 
developmental delay in 12 children.  There was no statistically significant difference 
between the proportion of children in the IOL and aphake groups with a significant 
systemic disorder (Table 25). 
Table 25.  Systemic disorders and developmental impairments  
 Bilateral  Unilateral   
Total  
 IOL Aphake IOL Aphake 
Other systemic disorder 
15 
 27.8% 
28 
33.3 
8 
27.8% 
3 
7% 
54 
22.9% 
Impairment  
6 
10.5% 
6 
7.1 
2 
3.9% 
1 
2.4% 
15 
6.4% 
Significant systemic disorder 
or developmental impairment  
13 
 22.8% 
20 
 23.8% 
p=0.99 
6 
11.5% 
2 
4.7% 
p=0.29 
41 
17.3% 
Total  57 84 52 43 236 
 
For 24 of the 54 children with a systemic abnormality, there was a known association 
between congenital or infantile cataract and the co-existent systemic disorder (Table 
26). For the remaining 30 children, aetiology of cataract was unknown and the nature 
of any association with the co-existent systemic disorder was similarly unknown (Table 
27).  
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Table 26.  The identified systemic disorders associated with cataract  
 Children with cataract of hereditary systemic aetiology 
Number of children 
(Bilateral:Unilateral) 
Cockayne Syndrome 3 (2:1) 
Oculorenal syndrome of Lowe 2 (2:0) 
Congenital lactic acidosis 1 (1:0) 
Galactosaemia 1 (1:0) 
Hereditary hyperferritinaemia 1 (1:0) 
Incontinentia Pigmenti  1 (0:1) 
Rhizomelic chondrodysplasia punctata 1 (1:0) 
Muscle-Eye-Brain disease 1 (1:0) 
Congenital haemophagocytosis 1 (1:0) 
Other (unidentified hereditary disorders) 3 (3:0) 
Children with cataract of non-hereditary genetic / chromosomal 
aetiology   
Trisomy 21 7 (4:3) 
Wilms tumour-aniridia complex (WAGR)  2 (1:1) 
Other aetiology   
Secondary neonatal hypercalcaemia due to traumatic fat necrosis  1 (1:0) 
 
 
Table 27. Systemic disorders noted in children still awaiting a diagnosis 
BILATERAL CATARACT  UNILATERAL CATARACT 
Metabolic disorders 
Adrenal insufficiency, hypertension  Conjugated hyperbilirubinaemia 
Severe idiopathic metabolic disorder  (2)  
Neurological  
Cerebral atrophy, wrist drop   
Frontal lobe infarct   
Hypoxic ischaemic encephalopathy   
Posterior fossa cyst  
Rt facial palsy, hypotonia  
Schizencephaly   
Seizure disorder  
Vascular 
Congenital heart defect (2) Congenital heart defect 
Congenital heart defect and microcephaly  
Congenital heart defect, pulmonary hypertension   
Other  
Haemangioma on face Haemangioma on scalp  
Dysmorphic facial features  (2) Haemangioma on trunk  
Failure to thrive, hypospadias, dysmorphia Ovarian cyst  
Ureter dilation, dysmorphia Imperforate anus 
Polydactyly Haemophilia 
Exomphalos  
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5.5.b.vi. Pre-operative visual function 
Pre-operative vision was assessed in 112 of the 236 children.  Given the age of the 
children in the cohort (which will be described in section 5.5.c, page 186) it is 
unsurprising that the most common assessment was qualitative: whether the child 
could perceive light (undertaken in 10 children), could fix and follow light stimuli (58 
children) or maintain a central, steady maintained gaze (14 children). The preoperative 
visual assessments undertaken in children are detailed in Appendix I.  
All but one child within this cohort were able to at least perceive light prior to cataract 
surgery. Surgery was undertaken in 1 child with no perception of light (this child had a 
pre-operative retinal detachment, and surgery was undertaken to prevent pupil block 
glaucoma). This child has been excluded from the analyses on visual outcome.  
Formal quantitative visual acuity assessment was undertaken in 28 children (24 in the 
IOL group, 4 in the aphake group): the best achieved preoperative acuity was 0.9 
LogMAR (achieved by only 2 children, one with bilateral, and one with unilateral 
cataract, both in the IOL group). 
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Pre-operative nystagmus and strabismus  
There were no missing data within the cohort on the presence or absence of 
nystagmus and strabismus preoperatively.  
Overall, 36/236 children (15.2%) were noted to have pre-operative manifest nystagmus. 
Specifically, 31/141 children with bilateral cataract had nystagmus (22%). This 
constituted 15/84 in the aphake group (17.9%) and a larger proportion of children in the 
IOL group, 16/57 or 28.1% (a difference which was not statistically significant, p=0.21). 
Nystagmus was significantly less prevalent (p<0.001) amongst the children with 
unilateral cataract (5/95, 5.3%, 95% CI DIP 7.9 – 24.8%), and was found in a similar 
proportion of unilaterally affected children in the aphake (3/43, 6.9%) and the IOL (2/52, 
3.9%) groups. 
A constant divergent or convergent strabismus was noted pre-operatively in a 
significantly higher proportion of children undergoing surgery for unilateral cataract 
(18/95, 19%, versus 6/141, 4.3%, p<0.0001, 95% CI DIP 6.6% - 24%), and in a higher 
proportion of the children who underwent IOL implantation (19/109, 17.4% versus 
5/127, 3.9%, p<0.001, 95% CI DIP 5.7% - 22).  
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5.5.b.vii. Summary  
A similar proportion of children in the IOL and aphake groups were affected by other 
systemic disorders. However, a significantly lower proportion of children who were 
selected for primary IOL implantation had other ocular abnormalities overall (Figure 16, 
overleaf), and a lower proportion had severe manifestations of the most common 
abnormalities, microphthalmos, microcornea and persistent fetal vasculature. 
Conversely, pre-operative strabismus was a more common finding in children who 
underwent IOL implantation.   
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Figure 16. Venn diagrammatic scale representation of distribution of systemic 
disorders and ocular abnormalities  
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5.5.c. Age at diagnosis of cataract  
 
The age at diagnosis of cataract was missing in 32 children: 10 children in the bilateral 
IOL group (17.5%), 9 children in the bilateral aphake group (10.7%), 11 children in the 
unilateral IOL group (21.2%) and 2 children in the unilateral aphake group (4.7%).  
For these 32 children, the age at referral for cataract was used as a proxy for age at 
diagnosis of cataract.  The age at detection of a visual problem was known for all of 
these children, as was the age at referral for diagnosed cataract. For 27 of these 32 
children detection of a visual problem and referral for cataract occurred within two 
weeks of each other, and for 16 they occurred at the same age.  
 
Figure 17. Age at diagnosis of bilateral and unilateral cataract: cumulative 
proportion graph with age categorised into clinically relevant groups 
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50% of all children were less than 2 weeks old at the time of diagnosis of cataract 
(median age 13 days, range 0 – 679 days / 22.4 months). A higher proportion of 
children with bilateral cataract were diagnosed within the first week of life: 48% of 
children with bilateral cataract compared to 33% of those with unilateral disease 
(p=0.02, 95% CI DIP 2.5% - 26.6%).  Figure 17 shows the proportion of children 
diagnosed by clinically relevant milestones: the first week of life, which would include 
children diagnosed by the neonatal check, diagnosis prior to the 6 week health check, 
diagnosis between 6 -10 weeks of age, which would include children diagnosed by the 
6 - 8week health check, diagnoses up to 6 months of age, after which cataract is more 
likely to be infantile rather than congenital, unless there is delayed diagnosis. 
For children with bilateral cataract, median age at diagnosis of cataract was 4 days old, 
ranging from 0 – 507 days (16.8 months) for those in the aphake group. Children were 
older at diagnosis in the IOL group with a median age at diagnosis of 51 (1.7 months) 
days, ranging from 0 – 679 days (22.4 months).  
Similarly, for children with unilateral cataract, median age at diagnosis was older in the 
IOL group (median 153 days, 5.1 months, ranging from 0 – 671 days, 22.2 months) 
than the aphake group (median 9 days, range 0 – 464 days, 15.3 months). 
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5.5.d. Age at surgery  
For children with bilateral cataract, median age at surgery in the aphake group was 50 
days / 1.7 months, ranging from 0.4 – 16.8 months. Children were older at surgery in 
the IOL group: a median age 142 days / 5 months, ranging from 0.9 – 23.8 months.  
For children with unilateral cataract, median age at cataract surgery in the aphake 
group was 48 days / 1.6 months, ranging from 0.5 – 23.8 months. Children were again 
older at surgery in the IOL group, with a median age of 261 days / 8.6 months, ranging 
from 0.9 – 19.4 months.  
Of all children aged under 1 month old at surgery, 27% of children with bilateral 
cataract were selected for IOL implantation, whilst 50% of children with unilateral 
disease were selected. Amongst the group of children who were aged over 1 year old 
at surgery, a higher proportion of children were selected for IOL implantation: 63% of 
children with bilateral and 80% of children with unilateral cataract (Table 28). 
Table 28. Proportion of children undergoing IOL implantation by age at surgery 
  Bilateral cataract  Unilateral cataract  
Under 1 month (95% CI) 27.1% (9 - 57%) 50% (23.7 - 76.3%) 
1 - 6 months 30.2% (21.9 - 40%) 34% (23.7 - 47.9%) 
6 - 12 months 61.1% (38.5 - 79.7%) 93.3% (68.1 - 99.9%) 
12 - 24 months 62.7% (87.5 - 97.7%) 80% (57.8 - 92.5%) 
However, as the figure overleaf shows, with regards to the distribution of age at surgery 
within the subgroups, surgery was undertaken in the first month of life in similar 
proportions of children across the four treatment groups:  
10/84, 11.9% (95% CI 6.4– 20.7%) of children in the bilateral aphake group  
3/57, 8.8% (95% CI 3.4 – 19.4%) of children in the bilateral IOL group  
5/43 11.6% (95% CI 4.6 – 24.9%) of children in the unilateral aphake group  
6/52, 11.5% (95% CI 5.0 – 23.3%) of children in the unilateral IOL group.  
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Figure 18. Cummulative graph of age at surgery (age at first eye surgery if bilateral cataract) 
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Time to second eye surgery in bilateral cataract  
Within both the IOL and aphake groups, 50% of children underwent second eye 
surgery within a week (median time, 7 days in both groups), and 75% of children in 
both groups had surgery within 14 days (upper limit of interquartile range 8 days in the 
aphake group, 14 days the IOL group).  
 
5.5.d.i. Summary 
Within each of the four groups (bilateral aphake, bilateral IOL, unilateral aphake, 
unilateral IOL) a similar proportion of children underwent surgery in the first month of 
life. However, within this cohort, the children who were selected for IOL implantation 
were significantly older at diagnosis and at surgery than the children underwent surgery 
without IOLs.  
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5.5.e. Cited exclusion criteria for primary IOL implantation 
 
127 children did not undergo primary IOL implantation. In 46 children (36%), the young 
age of the child was the reason cited by the managing ophthalmologist, although the 
age threshold varied from 1 month of age to 2 years old (Table 29).  
As also shown in Table 29, the other common reasons for non-implantation of an IOL 
included short axial length (29, 23%) and short horizontal corneal diameter (50, 39%).  
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Table 29. Exclusion criteria for IOL implantation as cited by managing 
ophthalmologists 
  Freq. 
Percent of 121 children 
in aphake group  
Age 46 36.1% 
  Age <1m 5   3.9% 
  Age <6m 16   12.6% 
  Age <1y 20   15.7% 
  Age <2y 5   3.9% 
Microphthalmos / Axial length 29 22.8% 
  Microphthalmos, not defined 5   3.9% 
  Axial Length <16 18   14.2% 
  AxL <18 5   3.9% 
  AxL <19 1   0.8% 
Microcornea / HCD 50 22.1% 
  Microcornea, not defined 2   1.6% 
  Horizontal Corneal Diameter <10 11   8.7% 
  Microcornea HCD <9 15   11.8% 
PFV 22 17.3% 
Anterior segment abnormalities 8 6.3% 
  
Anterior segment developmental 
anomaly  
1   0.8% 
  Glaucoma 2   1.6% 
  Zonule instability 3   2.4% 
  Microspherophakia 1   0.8% 
  Shallow anterior chamber 1   0.8% 
Other 15 11.8% 
  IOL power unavailable 5   3.9% 
  Parental choice 2   1.6% 
  Poor visual potential 2   1.6% 
  Lowe oculorenal syndrome 2   1.6% 
  Haemophilia 1   0.8% 
  Anaesthetic risk  2   1.6% 
  Asymmetric biometry  1   0.8% 
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5.5.f. Surgical management  
95 eyes of the 95 children with unilateral cataract and 278 eyes of the 141 children with 
bilateral cataract underwent surgery during the study period and are described within 
this section. 4 children with asymmetric disease underwent cataract surgery in only one 
eye. In 2 children, first eye surgery had been undertaken prior to the start of the study 
period. 
208 eyes underwent cataract surgery without IOL implantation: 43 eyes of children with 
unilateral cataract, 165 eyes of the 84 bilaterally affected children.   
165 eyes underwent primary IOL implantation: 52 eyes of children with unilateral 
cataract, 113 eyes of 57 bilaterally affected children. 
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5.5.f.i. Biometry and refractive planning for IOL 
implantation  
Power calculation formula 
As described earlier, axial length, anterior chamber depth and the corneal curvature 
are required in order to undertake accurate IOL power calculation. Corneal curvature 
was recorded for 100/109 children undergoing IOL implantation (91.7%), whilst anterior 
depth was recorded for 50/59 children (84.7%, details given in Appendix J).  
For all but 11 children, biometry took place on the same day as cataract surgery, and 
for all children biometry took place within a week of surgery. 
In 91 of the 109 children in the IOL group, lens power was determined using one of 5 
recognised power calculation formulae. In the remaining 18 children, no calculation 
formula was used, with surgeons reporting that they had instead either used the 
highest power IOL available (30 dioptre lens, in 7 children) or used paediatric ocular 
axial length and departmental consensually determined guidelines to estimate the 
required implant power (11 children).  
The most commonly used formula was the Sanders Retzlaff Kraff third generation (or 
SRK/T) formula. In 31 of the 59 children for whom IOL power was calculated using the 
SRK/T formula, the formula was further individualised using the surgeon specific ‘A-
constant’ adjustment (52.5%), whilst in 14 of the 21 children for whom the Hoffer Q 
formula was used, the formula was further individualised using the child’s anterior 
chamber depth (66.7%). 
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Table 30. Choice of biometric formula for implant power calculation 
 
The Hoffer Q formula was used in 9/31 children with bilateral cataract and ocular axial 
lengths <20mm (29%) and 11/45 children with unilateral disease (24.4%).
    
Bilateral cataract 
(n=57) 
N, %, (95%CI)  
Unilateral 
cataract (n=52)  
Total (n=109) 
None 9, 15.8%  9, 17.3% 18, 16.5% (10.6 - 24.7) 
SRK/T        
 Individualised 15, 26.3%  16, 30.1% 31, 28.4% (20.8 - 37.6) 
 
Not 
individualised 
16, 28.1% 12, 23.1%  26, 23.9% (16.8 - 32.7) 
Total  31, 54.4  28, 53.8%  59, 54.1% (44.8 - 63.2) 
Hoffer Q       
 Individualised 6, 10.5% 8, 15.4%  14, 12.8% (7.7 - 20.5) 
 
Not 
individualised 
6, 10.5% 1, 1.9% 7, 6.4% 2.9 - 12.9) 
Total  12, 21.5% 9, 17.5% 21, 19.3% (12.9 - 27.7) 
SRK II 2, 3.5% 3, 5.8% 5, 4.6% (1.7 - 10.6) 
Holladay  2, 3.5% 3, 5.8%  5, 4.6% (1.7 - 10.6) 
Theoretic-T 1, 1.8% 0 1, 0.9% (0 - 8.3) 
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Planned refractive outcome 
The intended post-operative refraction for children with unilateral cataract ranged from 
0 to +13 dioptres post operatively, and from +0.4 to +18 dioptres in children who 
underwent IOL implantation for bilateral cataract.  
For both bilateral and unilateral cataract, the intended post-operative refractive 
outcome with IOL implantation was more hypermetropic for the younger children. 
Figure 19 and Figure 20 show that the trend was more apparent for children who 
underwent bilateral IOL implantation, and both figures also show that there was a wide 
range of intended outcome within the age groupings. 
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Figure 19. Intended refractive outcome following IOL implantation for 
children with bilateral cataract by age category at biometry 
Median aimed outcome marked with red squares 
0
5
1
0
1
5
2
0
P
la
n
ne
d 
re
fr
ac
tiv
e 
ou
tc
om
e
 in
 d
io
p
tre
s
0 - 1m 1m - 3m 3m - 6m 6m - 12m Over 12m
Age at biometry
 
 
Figure 20. Intended refractive outcome for children with unilateral cataract 
by age category at biometry 
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5.5.f.ii. IOL models used 
All but 1 of the implanted IOLs were hydrophobic acrylic type IOLs, with 105 of 109 
children undergoing implantation with an Acrysof® model IOL (Table 31). Three piece 
IOLs were most commonly used: 71 of the 109 children in the IOL group, 65.8%, 95% 
CI around proportion 56.5 – 74%). 
 
Table 31. Implanted IOL type, by model 
*2 children had MA60 lenses implanted into one eye and MA30 lenses implanted into 
the second 
∞Rayner C-flex is a hydrophilic acrylic lens: all other lenses are hydrophobic acrylic 
IOLs  
 
    
Optic 
diameter  
Haptic 
diameter  
Bilateral 
cataract 
n=57 
Unilateral 
cataract 
 n=52 
Total 
 
 n=109 
3 piece IOL            
 Acrysof MA60 6mm 13mm 27* 21 48 
 Acrysof MA30 5mm 12.5mm 14* 8 22 
 AMO Sensar 6mm 13mm 1 0 1 
 Hoya AF 6mm 12.5mm 0 2 2 
Total number of 
children 
    40* 31 
71 
65.8%  
(56.5 - 74) 
Single piece IOL            
 Acrysof SN60IQ 6mm 13mm 7 13 16 
 Acrysof SA60 6mm 13mm 8 8 20 
 AMO Technis 6mm 13mm 1 0 1 
 Rayner C-flex∞ 5.7mm 12mm 1 0 1 
Total number of 
children 
    17 21 
38 
34.2%  
(26.1 - 43.5) 
Missing  - - 0 0 0 
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5.5.f.iii. Techniques used in surgery with and without IOL 
implantation  
The techniques used in surgical practice are described at an eye level rather than a 
child level as the two eyes of individual children have in some children undergone 
differing surgical procedures, and have been operated upon by different ophthalmic 
surgeons.  
Standard surgery  
The appended flow charts (Appendix K) indicate how many eyes underwent which 
surgical algorithm with regards to surgical wound creation and capsule and vitreous 
management, but the important clinical details are summarised here:  
120/165 operated eyes (72.7%) in the IOL group underwent ‘standard’ surgery 
(corneal/limbal wound + manual capsulorhexis + primary posterior capsulotomy and 
anterior vitrectomy) but significantly fewer eyes,  69/208 or 33.2%,  in the aphake group 
underwent the same ‘standard’ surgery’ (p<0.0001, 95% CI DIP 29.7%  - 48.2%).  
Manual capsulorhexis was undertaken in 133 IOL eyes (80.6%) and 71 aphake eyes 
(34.1%, again a significant difference, p<0.0001). The vitrectomy hand piece was most 
commonly used to create a capsulotomy in aphake eyes (102 eyes, 49%) The method 
of capsulotomy used is the surgical step which differs most between the IOL and 
aphake groups: if the definition of ‘standard’ surgery is changed to include any form of 
capsulotomy,150 IOL eyes (90.9%) and 194 aphake eyes (93.3%) have undergone 
‘standard’ surgery. 
Primary posterior capsulotomy and vitrectomy was undertaken in all of the eyes in the 
IOL group and in the majority of eyes in the aphake group (155, 94%).  
 200 
5.5.f.iv. Adjunctive medical therapies 
Antibiotics 
206 of the 208 aphake group eyes (99%) and 149 of the 165 IOL group eyes (95%) 
received intraocular or subconjunctival antibiotics upon completion of primary surgery. 
 
Corticosteroids 
As shown in Table 32, the majority of eyes of included children within both the IOL 
(92%) and aphake (94%) groups received corticosteroids via either intraocular, 
subconjunctival, or other periorbital route upon completion of primary surgery. A larger 
proportion of eyes in the IOL group received corticosteroids via all three ocular routes 
(21.2% versus 0.5% of aphake eyes, p<0.0001, 95% CI DIP 14.8 – 27.6%).  
 
Table 32. Post-operative corticosteroids after primary surgery 
 
  IOL group eyes Aphake group eyes 
None 
13 
7.9% 
 (95% CI 4.6 - 13.1) 
13 
6.3%  
(3.6 - 10.5) 
Intraocular OR subconjunctival OR 
other periorbital 
88 
53.3%  
(45.7 - 60.8) 
147 
70.7%  
(64.1 - 76.5) 
Intraocular AND either subconjunctival 
OR other periorbital 
29 
17.6%  
(12.5 - 24.2) 
47 
22.6%  
(17.4 - 28.8) 
Intraocular AND subconjunctival AND 
other periorbital 
35 
21.2%  
(15.6 - 28.1) 
1 
0.5%  
(0 - 3.0) 
Total  165 208 
 
 201 
5.5.f.v. Post-operative medical therapies 
Corticosteroids 
Intensive post-operative steroid therapy, systemic corticosteroid and topical mydriatic 
drops were prescribed to similar proportions of eyes and children in the IOL and 
aphake groups (Table 33).  
 
Table 33. Post-operative medication for operated eyes  
 
 IOL eyes, n=165 Aphake eyes, n=208 
Intense topical corticosteroid  
7 
 43% 
77 
37% 
(95% CI 35.7 - 50.7%) (30.7 - 43.8%) 
Systemic corticosteroid 
21 
12.7%  
16 
7.7%  
(8.4 - 18.7%) (4.7 - 12.2%) 
Topical mydriatic agents 
157 
95.2% 
189 
90.9%  
(90.6 - 97.7%)  (86.1 - 94.1%)  
 
Amongst the children undergoing bilateral cataract surgery, 7 children in the IOL group 
and 6 children in the aphake group received two separate courses of oral 
corticosteroids (3 – 7 day courses following both first and second eye surgery for 
bilateral cataract).  
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5.5.f.vi. Summary 
Variation exists within the recruitment network with regards to the refractive planning 
undertaken for primary IOL implantation in the children described in this study: a wide 
variety of power calculation formulae are used, and there also exists a wide range of 
planned refractive outcome.  
Similar surgical techniques have been undertaken by recruiting paediatric 
ophthalmologists, although manual capsulorhexis was more commonly undertaken in 
eyes of children who underwent primary IOL implantation.  
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5.5.g. Per operative events 
 
5.5.g.i. Planned iris trauma 
Iris manipulation or planned iris trauma during surgery was more commonly undertaken 
in eyes of children who did not undergo IOL implantation (6 IOL group eyes, 3.6% 
versus 62 aphake group eyes, 29.8%, p<0.0001, 95% CI DIP 19.1 – 33%). As shown 
in Table 34, the most commonly undertaken procedures were. iridectomy (undertaken 
to prevent pupil block post-operative events) and pupil stretch (to allow greater per 
operative access to the lens. 
 
Table 34. Per operative planned iris trauma 
 
  IOL  Aphake Total 
None 
159 
96.4% 
 (92.1 - 98.5%) 
146 
 70.2%  
(63.7 – 76%)  304 
Iridectomy 
3 
1.8%  
22 
10.6%  25 
Pupilloplasty 
0 
 
2 
1% 2 
Stretch/hooks 
2 
 1.2%  
32 
15.4% 34 
Stretch/hooks + 
iridectectomy  
1 
 0.6%  
6 
2.9% 7 
Total 165 208 372 
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5.5.g.ii. Per-operative complications 
Sight threatening per operative complications occurred in 38 of the 373 operated eyes 
(10.2%) and more than one complication occurred in 2 eyes (0.5%). 
As shown in table, a higher proportion of IOL eyes experienced complicated surgery: 
26 eyes in the IOL group, 16% versus 12 eyes in the aphake group, 6% (p=0.002, 95% 
CI DIP 3.7 – 16.8%). The most commonly occurring complication for all eyes was iris 
prolapse (18 eyes, or 4.8%). Iris prolapse did not occur in any child aged more than 
100 days at surgery, and all eyes which experienced iris prolapse measured less than 
19mm at biometry.  
Table 35. Per operative complications 
 
  IOL, n=165 Aphake, n=208 
None 
139 
84.2%  
(77.9 - 89.1%) 
196 
94.2%  
(90.1 - 96.8%) 
Iris prolapse 
15 
 9.1%  
(5.5 - 14.6%) 
3 
1.4%  
(0.5 - 3.7%) 
IOL explant 
5 
3% 
- 
IOL exchange 
1 
0.6% 
- 
IOL through PC & dialled back 
3 
1.8% 
- 
AC Tear past equator 
1 
0.6% 
0 
PC rupture during IOL implantation 
1 
0.6% 
- 
Unintentional iris trauma 0 
5 
2.4% 
Vitreous haemorrhage  0 
3 
1.4% 
Hyphaema 0 
1 
0.5% 
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5.5.g.iii. Summary 
Within the described cohort, per operative complications, specifically iris prolapse, were 
more common during surgery involving IOL implantation. However, iris manipulation 
was more common during surgery which did not involve IOL implantation. 
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5.6. Completeness of post-operative data collection  
As of August 2011, data have been collected for 194 children who had reached their 6 
month post-operative milestone, and 147 children who had reached their 12 month 
postoperative milestone (Figure 21). The difference between the proportion of 
bilaterally affected children with 12 month follow up data in the IOL and aphake groups 
did not reach statistical significance (p=0.08); however significantly more children in the 
unilateral IOL group than in the unilateral aphake group had twelve month follow up 
data (p=0.03, 95% CI DIP 3% - 39.7%).   
 
 
Figure 21. Data collection flowchart 
 
141  95   
Bilateral cataract   Unilateral cataract    
IOL  Aphake  IOL  Aphake - Pre/per operative data 
57  84  52  43   
↓  ↓  ↓  ↓   
51  71  45  27 - 6 month data 
↓  ↓  ↓  ↓   
41  48  36  22 - 12 month data 
71.9%  57.1%  69.2%  51.2% - Proportion of children  
(59.1 - 82%) 
  
(46.5 - 67.2%) 
  
(55.7 - 80.2%) 
  
(36.8 – 65.4%) 
 
- 
 
 
95% confidence 
interval 
 
The 147 with 1 year follow up data thus compromise the study sample for the analyses 
on visual outcome and adverse events at 1 year following surgery. The 77 children in 
the IOL group forming the study sample for analyses on refractive changes in 
pseudophakic eyes.  
 
 207 
 
5.7. Visual rehabilitation following cataract surgery  
 
Data on non-surgical post-operative management of included children are available for 
316 eyes of 194 children. 
5.7.a. Refractive correction 
Refractive correction was prescribed to the majority of children, with 208 of the 316 
eyes receiving glasses, contact lenses or both within the first six post-operative months.  
 
Time to commencement of correction 
For those children who were prescribed refractive correction, correction was started 
within 2 weeks of surgery for 53 / 147 eyes of children within the IOL group (36.1%), 
and 120 / 168 (71%) of children within the aphake group (Table 36) . 
Table 36. Commencement of refractive correction (contact lenses or glasses) 
  
No 
correction  
Total wearing 
correction  
Date of 
commencement 
missing  
Corrected commenced 
within 2 weeks 
Bilateral cataract         
 
IOL = 102 eyes, 51 
children 
14 88 8 
36 eyes 
45%  
(34.6 - 55.9%)  
 
Aphake = 141 
eyes, 71 children 
6 136 0 
100 eyes 
73.5%  
(65.5 - 80.2%)  
Unilateral cataract          
 
IOL = 45 
eyes/children  
8 37 0 
17 
46%  
(31 - 61.1% ) 
  
Aphake = 27 
eyes/children  
0 27 0 
20 
74.1%  
(58.1 - 87.1%)  
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Type of correction 
At 12 months following surgery, with data available for 147 children as described in 
Table 37, 13% of children who had undergone surgery without IOL implantation were 
not wearing refractive correction (which was in some cases due to either poor 
compliance or poor visual potential consequent to pre-operative ocular or systemic 
disorders or post-operative glaucoma). 
Table 37. Refractive correction worn  
one year following surgery for a) bilateral and b) unilateral cataract 
 
Table 37a. Bilateral cataract  
IOL, n=41 children Aphake, n=48 children 
Contact 
lenses 
(CL) 
Glasses 
CL + 
Glasses 
No 
correction  
CL Glasses 
CL + 
Glasses 
No 
correction  
1 34 1 5 17 19 7 5 
2.4% 82.9% 2.4% 12.2% 35.4% 39.6% 14.6% 10.4% 
 
Table 37b. Unilateral cataract  
IOL, n=36 Aphake, n=22 
CL Glasses 
CL + 
Glasses 
No 
correction  
CL Glasses 
CL + 
Glasses 
No 
correction  
3 22 1 10 11 4 3 4 
8.3% 61.1% 2.8% 27.8% 30.7% 18.2% 13.6% 18.2% 
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Concordance with correction  
Data on concordance are available for all but 1 of the 123 children wearing contact 
lenses or glasses at 12 months post operatively.  
Amongst children who had undergone surgery for bilateral cataract, poor compliance 
with refractive correction was noted in 5 of the 36 children in the IOL group (13.9%) 
and 2/42 in the aphake group (4.8%, difference not statistically significant, p=0.24). 
Amongst children with unilateral cataract, poor compliance was noted in 7 of the 26 
children in the IOL group (26.9%) and 2/18 in the aphake group (11.1%, difference not 
statistically significant).  
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Adverse events with contact lens wear  
Amongst the 102 included children who wore contact lens correction during the first 
post-operative year, adverse events or problems with use were reported by 6/18 
(33.3%) families of children in the contact lens group and 27/83 families of children in 
the aphake group (32.5%). The most common problem was difficulty with inserting and 
removing the lens (Table 38). 
Specific ocular complications were noted in 6 children, all of whom were in the aphake 
group. 
Table 38. Adverse events  / problems with contact lens use amongst included 
children 
 
IOL group: 18 contact 
lens wearers 
Aphake group: - 83 
contact lens wearers 
None 
12 
66.7%  
56 
 67.5%  
Difficulty inserting & removing  
3 
16.7%  
15 
18.1%  
Frequent fall out 
1 
5.5%  
4 
4.8%  
Intolerance 
2 
11% 
2 
 2.4%  
      
Recurrent conjunctivitis 0 3, 3.6%  
Corneal ulcer 0 2, 2.4%  
Corneal abrasion  0 2*, 2.4%  
*totals >100% as one child was affected by more than one complication 
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Occlusion and other visual penalisation 
83 / 197, 42% of children (67 who had undergone surgery for unilateral cataract, 16 
bilateral cataract) underwent occlusion therapy within the first six post-operative 
months.  
At the 12 month post-operative milestone, 63/147 children (43%) were undergoing 
occlusion therapy. The majority, 47, of these children had undergone surgery for 
unilateral cataract. 
 
Type of visual penalisation 
Of the 47 children undergoing occlusion therapy at 1 year following surgery, 31 were in 
the IOL group, and 16 were in the aphake group, with no statistically significant 
difference in the proportion of children receiving occlusion therapy in the two groups.  
Table 39. Occlusion therapy at the 12 month post-operative milestone 
 IOL, n=36 Aphake, n=22 
Missing  0 0 
No occlusion  
5 
13.9%  
6, 
27.3%  
Patch fellow eye 29 14 
Atropine instillation fellow eye 2 0 
Occlusive contact lens fellow 
eye 
0 2 
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Time to commencement following surgery for unilateral cataract  
Similar proportions of children in the IOL and aphake groups started occlusion within 
two weeks of surgery: 20 children in the IOL group (69%) and 10 in the aphake group 
(62.5%).  
 
Concordance with penalisation 
As shown in Table 40, similar proportions of families of children in the IOL and aphake 
groups achieved good or very good concordance with prescribed occlusion. A higher 
proportion of children in the IOL group had poor concordance with penalisation, but this 
difference did not reach statistical significance (p=0.49).  
Table 40. Concordance with occlusion therapy 
 
 IOL, n=31 Aphake, n=16 
Missing  0 0 
Very good concordance 
17 
 54.8% 
10 
62.5%  
Good concordance  
4 
12.9%  
3 
18.8%  
Poor concordance 
10 
32.2%  
3 
18.8%  
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5.7.b. Summary 
Concordance with occlusion and refractive correction was similar within included 
children within the IOL and aphake groups, with similar time of commencement of 
occlusion for children with unilateral aphakia and pseudophakia.  
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5.8. Visual outcomes at one year following surgery   
5.8.a. Outcomes following surgery for bilateral cataract  
 
5.8.a.i. Compliance with visual assessment 
Amongst children with bilateral cataract, a higher proportion of children in the aphake 
group were able to comply with uniocular vision assessment (68% versus 81%, Figure 
22). Failure to comply with visual testing may have a unifactorial or multifactorial cause. 
Poor vision, a degree of developmental impairment, or a result of the difficulty in 
keeping the attention of young children may lead to noncompliance with visual 
assessment. In comparison to the children within the aphake group, the children within 
the IOL group were older at visual assessment (median age 47 months versus 37 
months old, Mann-Whitney U test of difference z score -4.4, p<0.001) with a similar 
proportion of children affected by significant systemic or developmental impairment 
(18% in the IOL group versus 20% in the aphake group, chi2 test of correlation p=0.69). 
Thus, poor visual outcome is a possible cause of the lower compliance within the IOL 
group.  The difference between the two groups, however, did not reach statistical 
significance (p=0.2, 95% CI of difference in proportions -5% to 30.5%).   
 
Similarly, a smaller proportion of children in the IOL group were able to comply with 
quantitative acuity assessments (52 eyes of 28 children, 68% of children in the IOL 
group, compared to 68 eyes of 36 children in the aphake group, 75% of children), 
although again this difference was not statistically significant.   
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Figure 22. Visual assessment undertaken at 1 year following primary 
surgery for bilateral cataract (89 children) 
 
IOL 
41 children 
 Aphake 
48  
Non 
compliance 
Compliance with visual 
assessment 
 
Non 
compliance 
Compliance 
13 28  9 39 
31.7% (54 eyes)  18.8% (75 eyes) 
   
 
 
 
  
27 
(52 eyes)  
Quantitative 
Assessment 
(QN) 
 
 
1 
(2 eyes) 
Qualitative 
Assessment 
(QL) 
 
  
36 
(69 eyes)  
QN  
3 
(6 eyes) 
QL 
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5.8.a.ii. Visual outcome 
At 1 year after surgery  28 of the 67 children who had complied with acuity 
assessments achieved binocular or ‘both eyes open’ vision within the age related 
normal range at 1 year after surgery (48%), with a higher proportion of children within 
the IOL group achieving the best levels of vision (Table 41, below). 
  
Table 41. Level of vision achieved at 1 year following surgery for bilateral 
cataract 
 IOL Aphake 
Missing outcome data due to 
noncompliance with formal 
assessment 
13 
32% 
(95% CI 19-47%) 
9 
19% 
(10-32.2%) 
Form perception  
28 
68% 
(53-81%) 
39 
81% 
(68-90%) 
Within normal range  
19 
46% 
(32-61%) 
9 
19% 
(10-32%) 
Better than mean acuity level for 
age 
13 
32% 
(19-47%) 
4 
8% 
(3-20%) 
Total  41 children 48 children 
 217 
Better uniocular acuity outcomes were also achieved within the IOL group. 32 IOL 
group eyes (61.5%) and 14 aphake eyes (20.6%, 10.8 to 30.4%) achieved a uniocular 
vision level within the age reported normal range: a significantly higher proportion 
(p<0.0001, 95% CI DIP 23.4% to 55.3%).  
All children who underwent surgery for bilateral cataract and who were able to comply 
with uniocular acuity assessment achieved a level of vision which allowed them to at 
least fix on visual stimuli. In addition, all children in the IOL group were able to 
demonstrate a degree of form perception. Over half of the children in the IOL group 
also exhibited vision which was better than the lower limit of the age reported normal 
range. In a third of children who had undergone IOL implantation, the visual outcome at 
1 year following surgery was an acuity level which was better than the reported age-
dependent mean (as shown in 
Table 42), whilst only 7% of children who had undergone surgery without IOL 
implantation exhibited this level of vision at 1 year.
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Table 42. Level of uniocular vision achieved at 1 year following surgery for 
bilateral cataract  
 
 IOL Aphake 
0 – Nil Perception of Light (NPL) 0 0 
1 – Light perception (PL) 0 0 
2 – Able to fix on visual stimuli 0 
1 
1.3%  
(0 - 4.0%) 
3 – Form perception but worse 
than lower limit for age 
22 
40.7% 
(95% CI 27.3 - 54.1%) 
60 
80% 
(70.8 - 89.2%) 
4 – Within normal range but 
worse than mean acuity 
11, 20.4% 
(9.4 - 31.3%) 
9 
12% 
(4.5 - 19.5%) 
5 - Better than mean acuity level 
for age 
21 
38.9% 
(25.6 - 52.1%) 
5 
 6.7% 
(0.9 - 12.4%) 
Total  54 eyes (28 children) 75 eyes (39 children) 
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5.8.a.iii. Strabismus and nystagmus 
15% of children with bilateral cataract had a constant strabismus at 1 year following 
surgery, with 20.2% having an intermittent or alternating strabismus.  
Excluding the children with pre-operative strabismus, 18.9% of children in the IOL 
group (7/37) and 10.4% children in the aphake group (5/48) (difference not statistically 
significant, p=0.4) had a post-operative constant strabismus.  
Post operatively, 38% of children (34/89) had manifest nystagmus, and 9% (8/89) were 
found to have latent nystagmus. Nystagmus was  reversed (no longer present post-
operatively) in  4 children with pre-operative manifest nystagmus.  
Excluding the children with pre-operative manifest nystagmus, there was a statistically 
significant association between the absence of nystagmus at one year and primary IOL 
implantation (Table 43) at a univariate level. 
 
Table 43. Nystagmus at one year following surgery 
 
Aphake 
n=40 children 
IOL 
n=31 children 
p 95% CI DIP 
Manifest nystagmus 
19 children  
47.5% 
4 children 
13.3% 
0.01 12.3%  - 51.2% 
Latent nystagmus 
3 children 
7.5% 
3 children 
10% 
0.4 - 
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5.8.b. Outcomes following surgery for unilateral cataract  
 
5.8.b.i. Compliance with visual assessment 
23 children in the IOL group and 13 children in the aphake group were able to comply 
with quantitative uniocular acuity assessments of the aphakic or pseudophakic eye, 
with 9 IOL group eyes (39%) and 3 aphake eyes (23%) achieving a vision level within 
the age reported normal range. There was no significant difference between the 
proportions of children who were able to comply with visual assessment, which may be 
a reflection of the relatively small sample sizes.  
Figure 23. Visual assessment undertaken at 1 year following primary surgery for 
unilateral cataract  
QN: quantitative assessment of visual acuity, QL: qualitative test of visual function 
IOL 
36 
 Aphake 
22  
Non compliance Compliance  Non compliance Compliance 
6 30  6 16 
16.7% 
 
 
 22.7%  
(7.5 – 32.3%)   (9.7 – 43.9%)  
 23 
QN 
7 
QL 
  13 
QN 
4 
QL    
  
 
 
As described in Table 44 (overleaf), all children in the IOL group attained vision of at 
least perception of light post operatively. Similar proportions of children in the IOL and 
aphakic group attained good or very good levels of vision at 1 year. 
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Table 44. Achieved visual level in pseudophakic or aphakic eye at 1 year 
following surgery for unilateral cataract 
with numbers, proportions of children and 95% confidence intervals of proportions 
 
 IOL Aphake 
0 – Nil Perception of Light (NPL) 0 0 
1 – Light perception (PL) 
2 
6.7% 
(95% CI 0 – 16%) 
1 
5.9% 
(0 - 17%) 
2 – Able to fix on visual stimuli 
3 
10% 
(0 - 21.1%) 
0 
3 – Form perception but worse than 
lower limit for age 
18 
60% 
(41.7 - 78.3%) 
12 
 70.6%  
(47.6 - 93.5%) 
4 – Within normal range but worse 
than mean acuity 
4 
13.3% 
(0.6 - 26.0%) 
1 
5.9% 
(0 - 17%) 
5 - Better than mean acuity level for 
age 
3 
10%             
(0 - 21.1%) 
2 
11.8% 
(0 - 28%) 
Total  30 eyes 16 eyes 
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5.8.b.ii. Strabismus and nystagmus 
At one year following surgery, 26 of the 58 children (44.8%) had a constant strabismus, 
and 12 (20.7%) had an intermittent strabismus.  
8 of the 58 children (13.8%) had a manifest nystagmus, and 4 (13.8%) exhibited a 
latent nystagmus.  
Excluding the children with pre-operative manifestations, there were no statistically 
significant differences between the proportions of children with post-operative manifest 
nystagmus (15.6% in the aphake group versus 8.8% in the IOL group, p=0.35) or 
constant strabismus (52.6% in the aphake group versus 35.7% in the IOL group, 
p=0.44), although there were higher proportions within the aphake group of affected 
children with these indicators of impaired visual function.  
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5.8.c. Factors associated with visual outcome 
 
5.8.c.i. Bilateral cataract  
The results of the assessment of correlation between the factors of interest in relation 
to visual acuity of children with bilateral cataract (as described in section 4.10.a) are 
shown in Table 45 overleaf.  
The details of the potential predictive factors are appended (Appendix L), as are the 
values of the tests for correlations between the factors (Appendix M).   
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Table 45. Correlations between factors of interest with regards to visual outcome for children with bilateral cataract 
Peach squares indicate a positive correlation. Blue squares indicate a negative correlation. *p value<0.1; **p value<0.05; ***p value<0.01; ****p value<0.001. Full details in Appendix M (0) 
 
Age 
diagn 
Time 
diagn 
Age 
surg 
Gest 
age  
AL HCD Microphthal IO AL Ocl abn 
Med 
disorder  
Strab Nystag 
Standard 
surgery  
Perop 
comp 
Exp. 
Surg 
Compl 
correctn 
VAO  Glauc 
Any 
comp 
Sec 
procedures 
Cataract 
asymm  
Time 
btwn  
Right 
eye 
IMD 
IOL implant ** * ** ** *** ** ***   ***   **   **     *         *     **  
Age at diagnosis   *** *** **** **** **   ***     * **                 *       
Time from 
diagnosis to surg 
    ** **             **         *                 
Age at surgery       - **** *** ****   **** * *** *     *     *     ** *     
Gest age surgery         **** **** **   **** * ***             *     ** *     
Axial length            **** -   -   **                   *** **   * 
HCD             -   -                               
Microphthalmos                 -   **                   *   *   
IO AL difference                         ***   ***   *     *         
Significant ocular 
abnormality  
                  *               *             
Medical disorder                                  *     *   *     
Pre op strabismus                       ****       *         ****       
Pre op nystagmus                               ***       *         
Standard surgery                            * ****                   
Peroperative 
complication  
                                                
Exp. Surgeon                                       **   ** 
Good compliance 
correction 
                                 *   *     
Post operative 
VAO  
                  - -         
Post op Glaucoma                                - -         
Any post op 
complication  
                      - *       
Secondary 
procedures 
                                       * *   
Cataract 
asymmetry  
                                          *     
Time between 
surgeries 
                                              * 
Right eye                                                 
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The children within this study sample who underwent IOL implantation were 
significantly older at diagnosis (p<0.01) and at surgery (p<0.01), were less likely to 
have a significant co-existent ocular anomaly (p<0.003).   
As would be expected, axial length and horizontal corneal diameter were strongly 
associated with each other (p<0.001) and both were associated with age at surgery 
(p<0.001). Correlations were also found between age at surgery (p<0.001) and the 
duration between diagnosis and surgery, with children diagnosed at a younger age 
having surgery sooner following diagnosis (p<0.05). Children who were diagnosed 
earlier were more likely to have a significant ocular anomaly (p=0.05) but were less 
likely to have pre-operative nystagmus (p=0.08, p=0.04). This suggests that within this 
study population pre-operative nystagmus may have been a sequelae of late diagnosis 
of early life cataract. Older age at surgery was associated with the presence of a 
significant medical disorder or developmental impairment (p<0.001). As there was no 
association with age at diagnosis, the relationship may be have been due to concerns 
regarding the effect of anaesthetic in young infants with another systemic disorder.  
The age at visual assessment undertaken one year after surgery correlated 
significantly (as would be expected) with factors which had correlated with the age at 
surgery, including IOL implantation, axial length and horizontal corneal diameter and 
presence of a significant ocular abnormality. 
The level of experience of the operating surgeon was associated with the undertaking 
of a ‘standard’ operating technique. This statistical correlation exists because the 
experienced surgeons operated on more eyes, and the most commonly used surgical 
steps were used to create the variable of ‘standard surgery’.  However, higher surgeon 
experience level was also associated with a shorter duration between first and second 
eye surgery (p=0.03).  
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Overleaf (Table 46) are the results of the univariate regression analysis of factors 
related to visual outcome.  
As described in Table 46, on univariate logistic regression analysis, IOL implantation, 
increasing age at diagnosis, surgery and at visual assessment, increasing axial length 
and horizontal corneal diameter (and thus the absence of microphthalmos) and the 
absence of a significant ocular abnormality were associated with increased odds of a 
better visual outcome at one year following surgery.  
In order to further examine the relationship between age at surgery and the odds of 
better vision, age at surgery was categorised into quartiles, the cut off points for which 
also correlated with clinically relevant milestones (5.9 weeks, 9.5 weeks and 6.2 
months). In comparison to age at surgery of less than 6 weeks, on univariate 
regression analysis age of greater than 6 months of age at surgery was associated with 
a greater odds of better visual outcome. This may have been due to a subset of 
children with infantile rather than congenital cataract who developed lens opacity 
outside the sensitive developmental window for amblyopia.   
A multivariate model was then constructed, as described in section 4.10.a. 
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Table 46. Univariate multilevel (adjusted for within child relationships) ordinal 
logistic regression of uniocular visual outcome in eyes of children with bilateral 
cataract  
  
Relative odds of 
better vision  95% CI  p 
IOL implantation undertaken 7.57 2.65 - 21.66 <0.001 
Increasing age at diagnosis (weeks) 1.03 1.01 – 1.05 0.008 
Increasing time from diagnosis to surgery 
(days) 0.99 0.99 - 1.003 0.7 
Increasing age at surgery (weeks) 1.02 1.00 – 1.04 0.013 
Increasing age at surgery corrected 
for gestational age (weeks)  1.02 1.00 - 1.04 0.013 
Log age surgery  1.8 1.1 – 3.0 0.02 
Increasing age at surgery categorised    
 Baseline (0- 5.9 weeks), n=38 1 - - 
 6 - 9.9 weeks, n=28 1.87 0.34 - 10.13 0.47 
 10 - 26 weeks, n=34 1.93 0.42 - 8.79 0.4 
 Over 26 weeks (6 months), n=33  7.68 1.55 - 38.03 0.012 
Increasing axial length (mm) 1.31 1.02 - 1.69 0.033 
Log axial length 190 0.9 - 12955 0.03 
Increasing horizontal corneal diameter 
(mm)  2.24 1.34 - 3.74 0.002 
Log horizontal corneal diameter 8.4 3 – 13.9 0.002 
Microphthalmos  0.26 0.09 - 0.73 0.011 
Interocular axial length difference (mm) 0.89 0.71 - 1.11 0.29 
Significant ocular anomaly  0.12 0.03 - 0.44 0.001 
Medical disorder / impairment  0.77 0.23 - 2.59 0.68 
Pre-operative strabismus 0.73 0.1 – 5.5 0.76 
Pre-operative nystagmus 0.61 0.15 - 2.38 0.48 
Standard surgery  1.19 0.49 - 2.83 0.7 
Per operative complication  1.12 0.43 - 2.94 0.82 
More experienced surgeon  0.79 0.32 - 1.98 0.63 
Good concordance with refractive 
correction 0.77 0.13 - 4.48 0.78 
Post-operative visual axis opacity  1.78 0.75 - 4.24 0.19 
Post-operative glaucoma 0.36 0.08 - 1.58 0.17 
Any post-operative complication  0.96 0.45 - 2.05 0.92 
Secondary intraocular procedures 1.39 0.64 - 3.05 0.41 
Cataract asymmetry  0.92 0.22 - 3.77 0.91 
Increasing time to second eye surgery 
(days) 0.99 0.99 - 1.00 0.56 
Right eye 1.02 0.98 - 1.07 0.32 
IMD Deprivation score 1.1 0.9 – 1.5 0.4 
Increasing age at visual assessment 
(weeks) 1.02 1.01 – 1.05 0.01 
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Table 47. Multivariate multilevel logistic regression analysis of uniocular visual 
outcome following bilateral cataract surgery 
 
 
Relative odds of better 
vision  95% CI  p 
IOL implantation  4.7 1.3 – 16.4 0.01 
Significant ocular anomaly  0.22 0.05 – 0.96 <0.05 
Increasing age at surgery (weeks) 1.01 0.98 – 1.02 0.94 
 
On multivariate analysis, IOL implantation was associated with a 4.7 times higher odds 
of better visual outcome at one year following surgery. 
As an association between worse post-operative visual outcomes and increasing age 
at surgery has been reported by many previous investigators, the absence of a 
significant association between age at surgery and visual outcome was explored using 
interaction terms. 
 
Table 48. Multivariate multilevel logistic regression analysis of uniocular visual 
outcome following bilateral cataract surgery with interaction term (age and IOL 
implantation) 
 
Relative odds of better 
vision  95% CI  p 
IOL implantation   9.2 1.8 – 48.7 0.009 
Increasing age at surgery in children 
who HAVE undergone IOL 
implantation  (in weeks) 
0.97 0.9 – 1.0 0.06 
Increasing age at surgery in children 
who have NOT undergone IOL 
implantation  
1.03 1.0 – 1.06 0.051 
Significant ocular anomaly  0.24 0.05 – 1.1 0.07 
 
The associations found between age at surgery and visual outcome approached but 
did not reach statistical significance, and were in different directions for children who 
had and who had not undergone IOL implantation. 
 229 
Sensitivity analysis of the impact of missing data on the analysis of visual outcome was 
undertaken. In model 1, missing data were imputed with data derived from regression 
analysis of the other clinical features (STATA multiple imputation method).  
As data which were missing due to noncompliance may reflect poor visual performance, 
in model 2, missing visual assessment data were imputed as vision worse than form 
perception (that is, visual outcome at the worse extreme) 
 
Table 49. Multivariate multilevel logistic regression analysis of uniocular visual 
outcome following bilateral cataract surgery, imputation Model 1 
 
Missing at random – multiple 
imputation model 
 
Relative odds of better 
vision  95% CI  p 
IOL implantation   3.6 1.71 – 7.58 0.001 
Increasing age at surgery (in weeks) 0.99 0.98 – 1.02 0.9 
Significant ocular abnormality  0.35 0.16 – 0.68 0.004 
 
 
 
Table 50. Multivariate multilevel logistic regression analysis of uniocular visual 
outcome following bilateral cataract surgery, imputation Model 2 
 
Missing data due to poor visual 
performance model 
 
Relative odds of better 
vision  95% CI  p 
IOL implantation   0.7 0.2 – 3.4 0.009 
Increasing age at surgery (in weeks) 1.01 0.98 – 1.1 0.39 
Significant ocular abnormality  0.63 0.3 – 1.4 0.26 
 
In model 1, as maybe expected in a model which computes missing data using 
regression paradigms drawing on the relationships between the missing variable and 
the other variables, the associations found using the real dataset remained. However, 
in model 2, testing the effect of the assumption that missing data was due to poor 
visual outcome, the positive association between IOL implantation and visual outcome 
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was no longer present. This reversal of effect direction may be in part due to the 
association between missing visual outcome data and IOL implantation (although this 
association had not reached statistical significance, as described in section 5.8.a.i, 
page 214).  
 As the presence of significant ocular anomaly may have been a confounder which was 
not adequately dealt with within the multivariable model, this population of children 
were excluded from dataset analysis in a further model. The results of univariate and 
multivariate analyses are shown overleaf. On multivariate analysis, within the subgroup 
of children who had cataract without another significant ocular anomaly, IOL 
implantation was still associated with higher odds of better visual outcome, as was 
younger age at surgery.   
In order to investigate the timing of surgery for, in particular, children diagnosed in the 
first month of life and who are thus candidates for early life surgery (surgery in the first 
month of life) the analyses was then limited to this group.  Within this group, younger 
age at surgery was again associated with better odds of better visual outcome but 
there was no evidence of significantly improved visual outcomes for children who 
underwent surgery in the first six weeks of life, whilst surgery after 6 months of age was 
significantly associated with poorer outcome. However, the study subgroup sample 
size used for this analysis is small.  
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Table 51. Univariate multilevel logistic regression analysis of uniocular visual 
outcome following bilateral cataract surgery in children without significant 
ocular co-morbidity 
  
Relative odds of 
better vision 95% CI p 
IOL implantation undertaken 5.2 1.5 – 17.9 0.009 
Increasing age at diagnosis (weeks) 1.01 1.0 – 1.01 0.07 
Increasing time from diagnosis to surgery 
(days) 0.99 0.99 – 1.0 0.4 
Increasing age at surgery (weeks) 1.01 0.99 – 1.02 0.2 
Increasing age at surgery corrected for 
gestational age (weeks)  1.01 0.99 – 1.02 0.2 
Log age surgery  1.4 0.8 – 2.4 0.2 
Increasing age at surgery categorised    
 Baseline (0- 5.9 weeks), n=17    
 6 - 9.9 weeks, n=14 2.1 0.2 – 19.3 0.5 
 10 - 26 weeks, n=12 0.9 0.1 – 7.4 0.9 
 Over 26 weeks (6 months), n=9 3.9 0.5 – 29.6 0.2 
Increasing axial length (mm) 1.2 0.9 – 1.7 0.2 
Log axial length 69.1 0.1 – 45976 0.2 
Increasing horizontal corneal diameter 
(mm)  1.4 0.7 – 3.2 0.3 
Log horizontal corneal diameter 91 0.03 – 301815 0.3 
Microphthalmos  0.4 0.1 – 1.4 0.14 
Interocular axial length difference (mm) 0.8 0.5 – 1.4 0.5 
Medical disorder / impairment  1.4 0.2 – 12.8 0.7 
Pre-operative strabismus 0.9 0.1 – 9.1 0.9 
Pre-operative nystagmus 0.8 0.2 – 4.0 0.8 
Standard surgery  2 0.7 – 5.9 0.2 
Per operative complication  1.4 0.4 – 4.4 0.6 
More experienced surgeon  1.0 0.4 – 2.9 0.9 
Good concordance with refractive 
correction 0.6 0.1 – 3.9 0.6 
Post-operative visual axis opacity  2.1 0.8 – 5.5 0.1 
Post-operative glaucoma 1.1 0.3 – 3.9 0.8 
Any post-operative complication  1.2 0.5 - 3 0.7 
Secondary intraocular procedures 1.2 0.5 – 2.7 0.7 
Cataract asymmetry  0.7 0.2 – 3.3 0.7 
Increasing time to second eye surgery 
(days) 1.0 0.99 – 1.0 0.6 
Right eye 1.04 0.9 – 1.2 0.6 
IMD Deprivation score 1.09 0.8 – 1.5 0.6 
Increasing age at visual assessment 
(weeks) 1.01 0.99 – 1.01 0.1 
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Table 52. Multivariate multilevel logistic regression analysis of uniocular visual 
outcome following bilateral cataract surgery in children without significant 
ocular co-morbidity 
 
Relative odds of better 
vision  95% CI  p 
IOL implantation  6.7 1.8 – 24.9 0.005 
Increasing age at surgery (weeks) 0.95 0.91 – 0.99 0.03 
Increasing age at visual assessment 
(weeks) 
1.01 1.0 – 1.01 0.03 
 
Table 53. Multivariate multilevel logistic regression analysis of uniocular visual 
outcome following bilateral cataract surgery in children without significant 
ocular co-morbidity and diagnosed in first month of life 
 
 
Relative odds of better 
vision 95% CI p 
Age as a categorical variable 
IOL implantation  25.2 1.7 – 369 0.02 
Increasing age at surgery categorised    
Baseline (0- 5.9 weeks), n=17 -   
6 - 9.9 weeks, n=14 1.6 0.04 – 10.1 0.7 
10 - 26 weeks, n=12 0.1 0.01 – 1.2 0.07 
Over 26 weeks (6 months), n=9 0.02 0.01 – 1.1 0.05 
Increasing age at visual assessment 
(weeks) 
1.0 0.9 – 1.1 0.2 
Age as a continuous variable 
Excluding significant ocular 
abnormality, diagnosed in first 
month of life 
Relative odds of better 
vision 95% CI p 
IOL implantation  14.5 1.6 – 130 0.02 
Increasing age at surgery (weeks) 0.94 0.9 – 0.99 0.03 
Increasing age at visual assessment 
(weeks) 
1.1 1 – 1.1 0.04 
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5.8.c.ii.  Unilateral cataract  
 
Correlations between the factors of interest in relation to visual acuity in the operated 
eye following surgery for unilateral cataract were assessed as shown in Table 54.  
As with bilateral cataract, there are significant correlations between age at surgery, age 
at diagnosis and ocular axial length and corneal diameter. The associations between 
IOL implantation and age at diagnosis, age at surgery, axial length, corneal diameter, 
and ‘standard’ surgical procedure are similar in direction, size and strength. Pre-
operative strabismus was strongly associated with older age at diagnosis and surgery. 
The presence of a medical disorder, a less common finding amongst children with 
unilateral cataract, is significantly correlated with the presence of pre-operative 
nystagmus. 
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Table 54. Correlations between factors of interest with regards to visual outcome for children with unilateral cataract 
Peach squares indicate a positive correlation. Blue squares indicate a negative correlation. *p value<0.1; **p value<0.05; ***p value<0.01; ****p value<0.001. Full details in Appendix M (0) 
 
Age 
diagn 
Time 
diagn 
Age 
surg 
Gest 
age  
AL HCD Microphth IO ALD 
Ocular 
abnorm  
Med 
disorder 
 Strab Nystag 
Stand 
surgery  
Per-op 
comp 
Exp. 
Surg 
 Compl  
occlusn 
Compl 
correctn 
 VAO  Glaucoma 
Any 
comp  
Sec 
proc 
Right 
eye 
IMD 
IOL implant **   *     **     **     * ***         *           
Age at diagnosis     **** **** **** ** ** ***     **   **     *   **     *     
Time from diagnosis to surgery     *** *** ** *   *             * ** * **   *** **     
Age at surgery       - **** ** ** **     **   ***   ** **   ***     ***     
Gestational age at surgery         **** ** *** *     ***   ***   ** **   ***     ***     
Axial length            *** - **** -   ***   *   **     ** ** * ***     
HCD             - ** -       **           *   *     
Microphthalmos               ** -       *   **     *     **     
Interocular axial length difference                       *           *     **     
Significant ocular abnormality                              *             **   
Medical disorder /  impairment                          *          *         
Pre operative strabismus                         ** *   * * *     **     
Pre operative nystagmus                            ** *           
Standard surgery                         *                 
Per operative complication                         *       *         
Experienced Surgeon                               **   ** **     
Good concordance  occlusion                       **     *       
Good concordance correction                                               
Post operative VAO                            - -     
Post op Glaucoma                                       - -     
Any post op complication                                         -     
Secondary intraocular procedures                                             ** 
Right eye                                                
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The results of univariate regression analysis of visual outcome in the operated eye are 
shown in Table 55 below.  
 
Table 55. Univariate ordinal regression analysis of visual outcome in the 
operated eye in children with unilateral cataract 
 
  
Relative odds of 
better vision  95% CI  p 
IOL implantation  2.22 0.67 - 7.30 0.19 
Increasing age at diagnosis (weeks) 1.03 1.0 - 1.06 0.08 
Increasing time from diagnosis to surgery  
(days) 1.02 1.00 - 1.03 0.03 
Increasing age at surgery (weeks) 1.02 1.00 - 1.05 0.02 
Increasing age at surgery corrected for 
gestational age (weeks) 1.03 1.00 - 1.04 0.02 
Increasing age at surgery (categorised)     
 Baseline (0- 5.9 weeks), n=11 1 - - 
 6 - 9.9 weeks, n=12 5.9 0.95 - 36.90 0.06 
 10 - 26 weeks, n=5 1.33 0.16 - 10.9 0.79 
 Over 26 weeks (6 months), n=16  15.03 2.42 - 93.2 0.004 
Increasing axial length  1.52 1.09 - 2.14 0.02 
Increasing horizontal corneal diameter  1.87 0.79 - 4.43 0.16 
Microphthalmos 0.27 0.07 - 1.01 0.05 
Interocular axial length difference 1.37 0.76 - 2.48 0.3 
Significant ocular abnormality  0.29 0.08 - 0.95 0.04 
Medical disorder /  impairment  0.32 0.04 - 2.6 0.29 
Pre operative strabismus - - - 
Pre operative nystagmus 1.6 0.22 - 12.2 0.63 
Standard surgery  1.7 0.53 - 5.43 0.37 
Per operative complication  0.26 0.06 - 1.06 0.06 
More experienced surgeon  0.33 0.1 - 1.1 0.07 
Good concordance with refractive correction 0.61 0.12 - 3.02 0.54 
Good concordance with occlusion therapy 0.61 0.15 - 2.47 0.49 
Post operative visual axis opacity  0.46 0.14 - 1.52 0.2 
Post operative glaucoma 0.14 0.02 - 1.1 0.06 
Any post operative complication  0.5 0.15 - 1.7 0.27 
Secondary intraocular procedures 0.41 0.13 - 1.36 0.15 
Right eye 0.64 0.21 - 1.99 0.44 
Age at visual assessment 1.02 1.00 – 1.04 0.02 
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The factors which were found to be significantly associated with better or worse odds 
for visual outcome were used to build a multivariate model. Children aged between 6 
and 10 weeks at surgery had the highest odds of better visual outcome: however, the 
wide confidence intervals shown in Table 56 are a reflection of the small number of 
children within the sample for this analysis.  There was no statistically significant 
evidence of an association between IOL implantation and an increased odds of better 
vision at one year following surgery for unilateral cataract.  
 
  
Table 56. Multivariate ordinal regression analysis of visual outcome in the 
operated eye in children with unilateral cataract 
 
Relative odds of better 
vision  95% CI  p 
Increasing age at surgery 
(categorised)  
   
Baseline (0- 5.9 weeks), n=8 -   
6 - 9.9 weeks, n=9 18.7 2 – 176 0.01 
10 - 26 weeks, n=8 4.8 0.5 – 51 0.2 
Over 26 weeks (6 months), n=11 1.91 0.1 – 67 0.7 
Increasing axial length  1.7 1.1 – 2.9 0.03 
Age at visual assessment 1.01 0.8 – 1.1 0.6 
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5.9. Adverse per operative events 
 
As described in section 5.5.g.ii, page 204, iris prolapse was the most common adverse 
event, affecting 18 eyes: 14 eyes of children with bilateral cataract (5%), and 4 eyes of 
children with unilateral cataract (4.2%).   
Statistical analysis of potential predictors of iris prolapse was undertaken. Initially, 
correlations between the factors of interest were assessed as shown in Table 57.  
 
5.9.a. Bilateral cataract  
With regards to the relationships between the potential predictors of iris prolapse (as 
shown in Table 57 overleaf), in addition to previously described correlations, for 
children with bilateral cataract there was an association between IOL implantation and 
the viscosity of the oculoviscous device used.  A more viscous OVD was used in a 
higher proportion of pseudophakic eyes (p=0.01 and these OVDS (Healon GV and 
Healon 5) were also less commonly used in microphthalmic eyes.  
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Table 57. Correlations between factors of interest with regards to per operative iris prolapse in children with bilateral cataract 
Peach squares indicate a positive correlation. Blue squares indicate a negative correlation. *p value<0.1; **p value<0.05; ***p value<0.01; ****p value<0.001. Full details in Appendix M (0) 
 
Age at 
surgery 
Gest age 
at surg 
Signif 
ocular 
abnorm 
PFV 
Axial 
length 
HCD 
AxL 
<16mm 
HCD 
<9.5mm 
Microphthal IO AL diff Microcornea 
Exp. 
surg 
Viscous 
OVD 
Right 
eye 
IOL implantation **** **** ****  **** **** **** *** ****  ** * **  
Age at surgery  - **** ** **** **** **** ** ****  ****    
Gestational age at 
surgery 
  ****  **** **** **** ** ****  **    
Significant ocular 
abnormality  
   - - - - - -  -    
Persistent fetal 
vasculature 
            **  
Axial length       *** - - -  -    
Horizontal corneal 
diameter  
 
 
   - - - * -    
Axial length <16mm       - - * -    
HCD <9.5mm        - ** -    
Microphthalmos          -  **** ** 
Intercocular axial 
length difference 
              
Microcornea               
Experienced surgeon                
Viscous oculoviscous 
device 
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As Table 58 below shows, on univariate analysis, IOL implantation and decreasing 
axial length were significantly associated with increased odds of per operative iris 
prolapse.  
 
Table 58. Univariate multilevel logistic regression analysis of iris prolapse in 
eyes of children with bilateral cataract 
 
 
Relative odds of 
iris prolapse 95% CI p 
IOL implantation  5.82 1.44 - 23.53 0.013 
Age at surgery unadjusted (weeks) 0.88 0.76 – 1.02 0.08 
Age at surgery adjusted for gestational 
age (weeks) 0.88 0.76 - 1.01 0.06 
Significant ocular abnormality  0.55 0.14 - 2.22 0.41 
Axial length in mm 0.73 0.57 - 0.94 0.016 
Horizontal corneal diameter in mm  0.97 0.56 - 1.47 0.69 
Axial length<16mm 1.18 0.27 - 4.32 0.91 
Microphthalmos 4.72 0.58 - 38.14 0.15 
Interocular axial length difference in mm 0.79 0.56 - 1.13 0.21 
Microcornea 0.84 0.19 - 3.78 0.82 
More experienced surgeon  3.87 0.73 - 20.38 0.11 
Viscous oculoviscous device -   
Right eye  1.02 0.49 - 2.10 0.97 
 
 
A multivariate model was constructed using the significantly associated factors. The 
decision was made to also include horizontal corneal diameter and age of child at 
surgery within the construction of a multivariate model, to examine the effect of 
including these biologically important factors which are both strongly correlated with 
ocular axial length. The factors which were included in the model of best fit are shown 
in the table overleaf.  
 240 
Table 59. Multivariate multilevel logistic regression analysis of iris prolapse in 
eyes of children with bilateral cataract 
 
 
 
Relative odds of iris 
prolapse 95% CI p 
Increasing axial length in mm 0.44 0.28 - 0.69 <0.0001 
IOL implantation  25.02 4.16 - 150.6 <0.0001 
 
 
 
IOL implantation is independently associated with a 25 times higher odds of per-
operative iris prolapse in children with bilateral cataract, and a longer axial length is 
also associated with a reduction in the risk of iris prolapse. In addition, rather than IOL 
implantation having a weaker association with iris prolapse once the effect of axial 
length is taken into consideration, IOL implantation is associated with a higher odds of 
iris prolapse (although the wide confidence intervals reflect the small sample size for 
analysis).  
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5.9.b. Unilateral cataract  
The correlations between the potential predictors of per operative iris prolapse in 
children undergoing unilateral cataract surgery are shown in Table 60 overleaf. In 
addition to previously described correlations, for children with unilateral cataract there 
was an association between the experience of the operating surgeon and the viscosity 
of the oculoviscous device used, with a more viscous OVD (specifically, Healon GV) 
used by a significantly higher proportion of experienced surgeons eyes (p=0.03). This 
may be due to the perceived effectiveness of this form of OVD, or may reflect the 
shared training history of the more experienced surgeons within this cohort.  
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Table 60. Correlations between factors of interest with regards to per operative iris prolapse in children with unilateral cataract 
Peach squares indicate a positive correlation. Blue squares indicate a negative correlation. *p value<0.1; **p value<0.05; ***p value<0.01; ****p value<0.001. Full details in Appendix M (0) 
 
Age at 
surgery 
Gest 
age at 
surg 
Signif 
ocular 
abnorm 
PFV 
Axial 
length 
HCD 
AxL 
<16mm 
HCD 
<9.5mm 
Microphthalmos IO AL diff Microcornea 
Exp. 
surgeon 
Viscous 
OVD 
Right 
eye 
IOL implantation *** **** **** *** **** **** * - * ***  * *  
Age at surgery  -   **** ****   ***      
Gestational age at 
surgery 
    **** ****   ****    *  
Significant ocular 
abnormality 
   - - - - - -  -    
Persistent fetal 
vasculature 
              
Axial length      **** - - - **** -    
Horizontal corneal 
diameter 
      - - -  -  *  
AxL <16mm        - - *** -    
HCD <9.5mm         - * -    
Microphthalmos          **** - *   
Interocular axial 
length difference 
             * 
Microcornea             *  
Experienced 
surgeon 
            ** * 
Viscous OVD               
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Table 61. Univariate logistic regression analysis of per operative iris prolapse in 
children with unilateral cataract 
 
 
Relative odds of 
iris prolapse 95% CI p 
IOL implantation -   
Age at surgery unadjusted (weeks) 0.97 0.9 - 1.04 0.33 
Age at surgery adjusted for gestational age 
(weeks) 0.97 0.9 – 1.04 0.33 
Significant ocular abnormality 0.49 0.05 - 4.86 0.54 
Increasing axial length in mm 0.63 0.32 - 1.24 0.18 
Horizontal corneal diameter 0.68 0.19 - 2.52 0.57 
Axial length<16mm 4.67 0.41 - 53.4 0.22 
Microphthalmos 2.32 0.22 - 22.5 0.5 
Interocular axial length difference 0.46 0.06 - 3.75 0.47 
Microcornea 1.73 0.15 - 20.5 0.66 
More experienced surgeon -   
Oculoviscous device -   
Right eye 1.07 0.14 - 7.91 0.95 
 
 
 
 
As all 4 eyes which experienced iris prolapse were eyes of children in the IOL group, 
and were eyes which had been operated on by experienced surgeons, and had 
undergone surgery with the same type of OVD device (Healon GV), it was not possible 
to estimate a univariate relative odds of iris prolapse with these factors . On univariate 
analysis none of the considered factors reached statistical significance. This may be 
due to the small number of episodes of iris prolapse within this group.  
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5.10. Adverse outcomes at one year following surgery 
 
 
5.10.a. Glaucoma 
At present, 12 month data is not available for any of the 4 children who had pre-
operative glaucoma. These children will be excluded from future analyses of post-
operative glaucoma within the study group.  
 
5.10.a.i. Bilateral cataract  
Glaucoma (without an acute or pupil block event) affected 9.6% of eyes (17/177) and 
15.7% of children (14/89) during the first post-operative year.  
Glaucoma and ocular hypertension were diagnosed in a higher proportion of children 
who had undergone surgery without IOL implantation, as shown in Table 62 overleaf.  
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Table 62. Occurrence of ocular hypertension related events in the first year 
following surgery for bilateral cataract 
 
  
IOL group  
 81 eyes of 41 children  
Aphake group  
 96 eyes of 48 children  
p  
 
95% CI of 
difference in 
proportions 
No IOP related 
complications  
75 
92.2%  
71 
73.5%  
0.001 7.6% - 29%  
Glaucoma 
4 
4.9% 
13 
13.7% 
0.07 7% - 32.8% 
 
6.8% - 39.5% (3 children, 4% ) (11 children, 22.9% ) 0.04 
Ocular 
hypertension  
2 
2.9% 
9 
9.4% 
0.002 -0.6% -  15.6% 
Transient IOP rise 0 
2 
2.1%  
0.5   
Pupil block event  0 
1 
1% 0.99   
 
2 of the 4 pseudophakic eyes (2 children) and 4 of the 13 aphakic eyes (3 children) 
required surgical therapy to manage their glaucoma.  
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5.10.a.ii. Unilateral cataract  
In the first post-operative year, glaucoma had been diagnosed in 8% of children in the 
IOL group, and 9% of children in the aphake group.  
Table 63. Occurrence of ocular hypertension related events in the first 
year following surgery for unilateral cataract 
 
  IOL - 36 children  Aphake - 22 children  P 
  
No IOP related complications  
26 
72.2%  
15 
68.2%  0.48 
Glaucoma 
3 
8.3%  
2 
 9.1% 0.63 
Ocular hypertension  
5 
13.9% 
4 
18.2%  0.6 
Transient IOP rise 
1 
 2.8% 
1 
 4.5% 0.99 
Pupil block event  
1 
 2.8%  
0 
0.99 
 
 
2 of the 3 pseudophakic eyes and 1 of the two aphakic eyes required surgical 
treatment for glaucoma.  
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5.10.a.iii. Factors associated with post-operative glaucoma 
 
Bilateral cataract  
The correlations between the factors assessed for an association with the occurrence 
of glaucoma in the first post-operative year are shown in Table 64 overleaf.  
In addition to the previously described correlations, the occurrence of per-operative 
planned or unintended iris manipulation or trauma was positively correlated with the 
presence of severe microphthalmos (p=0.01) microcornea (p=0.03), and younger age 
at surgery (p=0.01). As the role of primary iridectomy is to prevent angle closure 
glaucoma in small eyes, and pupil stretch is only required for small pupils, these 
associations were expected. There was strong evidence of an association between IOL 
implantation and post-operative inflammation (p=0.002). The association between 
inflammation and younger age at surgery (p=0.02) may reflect either the pro-
inflammatory state of early infancy, or the sequelae of the per-operative iris trauma 
which was undertaken in a higher proportion of younger eyes (the occurrence of post-
operative inflammation will be described in more detail in section 5.10.b). 
The surgical management undertaken by ophthalmologists correlated with child 
specific factors: the viscosity of the oculoviscous device used per operatively positively 
correlated with the occurrence of persistent fetal vasculature whilst negatively 
correlating with the presence of microphthalmos (although there was no correlation 
with axial length).  Different aspects of surgical management were also inter-correlated: 
the use of intensive post-operative topical steroid regimens and the higher experience 
level of the operating surgeon. 
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Table 64. Correlations between factors of interest with regards to occurrence of post-operative glaucoma in children with bilateral cataract 
Peach squares indicate a positive correlation. Blue squares indicate a negative correlation. *p value<0.1; **p value<0.05; ***p value<0.01; ****p value<0.001. Full details in Appendix M (0) 
  
Age at 
surgery 
Gest 
age 
Oc 
abnorm 
PFV 
Axial 
length 
HCD 
AxL 
<16mm 
HCD 
<9.5mm 
Microphthalm IO AL diff Microcornea 
Exp. 
Surg 
Viscous 
OVD 
Post 
caps'my 
Iris 
trauma 
IOL 
explant 
Intensive 
steroid 
System 
steroids 
Post op 
inflamm 
Sec 
proc 
Right 
eye 
IOL implantation  **** *** ****  **** **** **** **** ****  ****   *  - *  ** **  
Age at surgery  - ***  **** **** **** * ****  ***   *     **   
Gestational age at 
surgery 
  **  **** **** **** * ***  **   * **    *   
Significant ocular 
abnormality  
   - - - - - -  -    *       
Persistent fetal 
vasculature 
     **  **    *          
Axial length       **** - - -  -    ***       
Horizontal corneal 
diameter  
     - - -  -  * ** **    *   
Axial length <16mm       - -  -    ** **      
HCD <9.5mm        - ** -    ** -      
Microphthalmos           -  *  ***      * 
Interocular axial length 
difference 
                    * 
Microcornea               *     *  
Experienced surgeon                **  ** *    
Viscous OVD              *    *    
Posterior capsulotomy                    *   
Per op iris trauma                      
Per op IOL explant                       
Post op intensive  
steroid 
                 *    
Post op systemic 
steroid 
                   **  
Post op inflammation                    **** * 
Secondary procedures                      
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Table 65. Univariate multilevel logistic regression analysis of post-
operative open angle glaucoma in eyes of children with bilateral cataract  
  
Relative odds 
of post-
operative 
glaucoma 
95% CI 
 
P 
 
IOL implantation  0.33 0.1 - 1.1 0.07 
Increasing age at surgery (weeks) 0.93 0.89 - 0.97 0.002 
Adjusted age at surgery (weeks) 0.94 0.9 - 0.98 0.003 
 Baseline (0- 5.9 weeks), n=50 1   
 6 - 9.9 weeks, n=34 1.5 0.5 - 5 0.52 
 10 - 26 weeks, n=50 0.9 0.3 - 3.0 0.86 
 Over 26 weeks (6 months), n=43  - - - 
Significant ocular abnormality  1.72 0.7 - 4.4 0.26 
Persistent fetal vasculature 0.43 0.06 - 3.3 0.42 
Increasing axial length  0.88 0.7 - 1.0 0.14 
Horizontal corneal diameter  0.9 0.5 - 1.4 0.54 
Axial length  <16mm 1.2 0.4 - 3.2 0.78 
HCD <9.5mm 1.32 0.4 - 4.7 0.69 
Microphthalmos 0.89 0.3 - 3.1 0.85 
Interocular axial length difference 1.4 0.7 - 2.8 0.39 
Microcornea 3 1.0 - 8.8 0.05 
Experienced surgeon  1.4 0.6 - 3.6 0.49 
Viscous OVD 1.5 0.2 - 11.2 0.72 
Posterior capsulotomy  -   
Per operative iris trauma 1.6 0.6 - 4.1 0.37 
Per operative IOL explant  -   
Post-operative intensive steroid regimen  1.2 0.5 - 3.2 0.67 
Post-operative systemic steroids 0.85 0.1 - 7.1 0.88 
Post-operative inflammation -   
 
Microcornea and younger age at surgery were the only factors associated with higher 
odds of glaucoma at 1 year. As shown in the table above, due to insufficient sub 
sample sizes (insufficient numbers of children who underwent bilateral cataract surgery 
were affected by IOL explantation, post-operative inflammation, or had or intact 
posterior capsules at primary surgery) regression analysis was not possible for these 
three potential predictors of outcome.  
In addition, as none of the children who underwent surgery aged over 6 months 
developed glaucoma in the first year, it was not possible to determine a meaningful 
odds ratio for the relative odds of glaucoma at 1 year for this age group.
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Only age at surgery was associated with a higher odds of glaucoma following surgery 
on multivariate analysis (Table 66).  
Table 66. Multivariate multilevel regression analysis of post-operative 
glaucoma in eyes of children in the first year following surgery for 
bilateral cataract 
 
Relative odds of 
post-operative 
glaucoma 95% CI p 
Increasing age at surgery 
(weeks) 0.94 0.98 – 0.99 0.03 
Microcornea 2.2 0.69 – 7.1 0.18 
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Unilateral cataract  
 
The correlations found within the cohort of children undergoing surgery for unilateral 
disease are shown in Table 67 overleaf.  
As with the bilateral cataract group, there are correlations between different aspects of 
surgical practice: an intensive post-operative steroid regimens were used by higher 
proportions of the more experienced operating surgeons, and these surgeons were 
also less likely to use systemic steroids for their children post operatively (p<0.01). 
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Table 67. Correlations between factors of interest with regards to post-operative glaucoma in children with unilateral cataract 
Peach squares indicate a positive correlation. Blue squares indicate a negative correlation. *p value<0.1; **p value<0.05; ***p value<0.01; ****p value<0.001. Full details in Appendix M (0) 
 
Age at 
surgery 
Gest 
age 
Ocular 
abnorm 
PFV 
Axial 
length 
HCD 
AxL 
<16mm 
HCD 
<9.5mm 
Microphthalm IO ALD Microcornea 
Exp. 
Surg 
Viscous 
OVD 
Iris 
trauma 
IOL 
explant 
Intensive  
steroid 
System 
steroids 
Post op 
inflamm 
Sec 
proc 
Right 
eye 
IOL implantation  * * **** *** * *** * -   ***  * ** -      
Age at surgery  -   **** **   ** *  *       ****  
Gest age at surgery     **** *   ** *  *       ****  
Significant ocular 
abnormality  
   - - - - - -  -   **       
Persistent fetal vasculature      *         *      
Axial length       **** - - - **** - ***  *  * **  ***  
Horizontal corneal diameter        - - -  -          
Axial length <16mm        - - *** - *  **     **  
HCD <9.5mm         - * -   * -      
Microphthalmos          **** -     ** **  *  
IOALD              *     ** * 
Microcornea             *        
Exp. Surgeon              * *  ** *** * ** ** 
Viscous OVD                    * 
Per op iris trauma                ***     
Per op IOL explant                 *     
Post op intensive  steroid                     
Post op systemic steroids                     
Post op inflammation                   ** * 
Secndary procedures                     
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Figure 24. Univariate logistic regression analysis of glaucoma in the operated eye 
following unilateral cataract surgery 
 
  
Relative odds of 
glaucoma 
95% CI p 
IOL implantation  0.96 0.15 0.97 
Increasing age at surgery (weeks) 0.97 0.92 – 1.02 0.31 
Increasing adjusted age at surgery (weeks) 0.97 0.92 – 1.03 0.29 
Age at surgery (categorised)    
 Baseline (0- 5.9 weeks), n=14 1   
 6 - 9.9 weeks, n-16 2.4 0.2 - 28.7 0.5 
 10 - 26 weeks, n=7 2.4 0.1 - 42.8 0.56 
 Over 26 weeks (6 months), n=21  0.7 0.04 - 12.4 0.83 
Significant ocular abnormality  6.2 0.7 - 58.7 0.11 
Persistent fetal vasculature 0.7 0.12 - 4.9 0.78 
Increasing axial length  0.3 0.08 - 0.94 0.04 
Increasing horizontal corneal diameter  0.3 0.08 - 0.9 0.06 
Axial length <16mm 28 2.5 - 313.2 0.007 
HCD <9.5mm 17 0.84 - 343.7 0.07 
Microphthalmos -   
Interocular axial length difference 0.04 0.002 - 1 0.05 
Microcornea 3 0.4 - 23.5 0.3 
More experienced surgeon  2.9 0.3 - 28 0.34 
Viscous OVD 0.4 0.04 - 4.8 0.5 
Posterior capsulotomy  -   
Per op iris trauma 2.9 0.43 - 19 0.27 
Per op IOL explant  -   
Post op intensive  steroid 1.5 0.24 - 9.8 0.66 
Post op systemic steroids -   
Post op inflammation 5.3 0.81 - 34.7 0.08 
 On univariate analysis, although the size and direction of association for factors such 
as age at surgery and corneal size were similar to the associations found for glaucoma 
following bilateral surgery, the only factor which reached a statistically significant 
association was pre-operative axial length, with eyes measuring less than 16mm 
having a 28 times higher odds (with a wide confidence interval) of developing 
glaucoma in the first post-operative year.  
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Again, no child who was aged over 6 months old at surgery had developed glaucoma 
by the end of the first post-operative year.  
Overall, amongst the 19 children who had developed glaucoma (14 following bilateral 
cataract surgery, 5 following unilateral cataract surgery)  almost half (9/19 or 47%) of 
these children were aged under 6 weeks old at surgery. 
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5.10.b. Visual axis opacity  
 
 
5.10.b.i. Bilateral cataract  
During the first post-operative year, visual axis opacity necessitating surgical repair 
affected 42 of the 177 eyes of children who had undergone surgery for bilateral 
cataract (24%).  
Visual axis opacity in the form of pearls or fibrosis occurred in a significantly higher 
proportion of eyes of children in the IOL group.  The difference between the proportions 
of eyes affected by membranous visual axis opacity did not reach statistical 
significance (Table 68).   
3 eyes (3%) of children in the aphake group, and 4 eyes (6%) of children in the IOL 
group underwent 2 or more procedures in the first post-operative year.  
 
Table 68. Occurrence of visual axis opacity in children with bilateral cataract in 
the first post-operative year  
 
IOL group 
81 eyes of 41 children 
Aphake group 
96 eyes of 48 children 
p 
95% CI of 
difference in 
proportions 
Visual axis 
opacity involving 
pearls / fibrosis  
19 
23.5% 
 
(14 children, 34.2%) 
7 
7.3% 
 
(6 children, 12.5%) 
0.003 
 
 
0.02 
5.6% - 27.1% 
 
 
4.1% - 38.2% 
Membranous 
visual axis opacity  
11 
13.6% 
 
(8 children, 19.5%) 
5 
5.2% 
 
(5 children, 10.4%) 
0.053 
 
 
0.25 
-0.3% to 18% 
 
 
-5.9% - 24.8% 
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5.10.b.ii. Unilateral cataract  
27 of the 58 eyes of children with unilateral cataract underwent surgery for visual axis 
opacity in the first post-operative year (46.6%).  
A higher proportion of eyes which underwent IOL implantation were affected by visual 
axis opacity in the first post-operative year, and there was again a significant difference 
between the two groups in the proportion of children affected by proliferative VAO 
(pearls / fibrosis)  (Table 69). 
Table 69. Occurrence of visual axis opacity in children with unilateral cataract in 
the first post-operative year 
 
 IOL, n=36 eyes 
Aphake, 
n=22 eyes p 
Visual axis opacity involving pearls / 
fibrosis  
17 
47.2% 
4 
18.2% 0.047 
Membranous visual axis opacity  
7 
19.4% 
4 
18.2% 0.99 
 
 
4 children (18.2%) in the aphake group, and 8 children (22.2%)  in the IOL group 
underwent 2 or more procedures in the first post-operative year.  
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5.10.b.iii. Factors associated with VAO  
 
Bilateral cataract  
The variables assessed in the analysis of visual axis opacity included previously 
considered factors (Table 70) and the undertaking of a manual anterior capsulotomy, 
use of intraocular heparin, fixation of the implant, and use of a single piece rather than 
three piece implant.  
There were several correlations between the different aspects of surgical management: 
the use of manual capsulorhexis correlated with the use of a single piece IOL implant 
and intensive post-operative steroid regimens, as well as the experience level of the 
surgeon. The undertaking of a manual anterior capsulorhexis, a more controlled 
method of capsule manipulation also correlated with the undertaking of IOL 
implantation, which is to be expected as capsule integrity is essential if an implant is to 
be used. Accordingly, manual capsulorhexis correlated with axial length and horizontal 
corneal diameter.  
The use of intraocular heparin did not correlate with any other clinical factor.  
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Table 70. Correlations between factors of interest with regards to occurrence of visual axis opacity in children with bilateral cataract 
Peach squares indicate a positive correlation. Blue squares indicate a negative correlation. *p value<0.1; **p value<0.05; ***p value<0.01; ****p value<0.001. Full details in Appendix M (0) 
 Manual anterior capsulotomy Single piece IOL  IOL in bag  Per operative heparin  
IOL implantation  **** - -   
Gestational age at surgery         
Age at surgery *       
Persistent fetal vasculature     **   
Axial length  **       
Horizontal corneal diameter  ** * **   
Experienced surgeon  ***   ***   
Viscous OVD ** **   **** 
Posterior capsulotomy        - 
Single piece IOL  ****       
IOL fixed within the bag   *    
Per operative heparin          
Per operative iris trauma         
Per operative IOL explant    - -   
Post-operative intensive steroid **     * 
Post-operative systemic steroids   *     
Post-operative inflammation         
Right eye         
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The results of regression analysis of the occurrence of proliferative visual axis opacity 
(pearls, fibrosis or anterior capsular contraction) at 1 year following surgery are shown 
below.  
Table 71. Univariate multilevel regression analysis of proliferative visual axis 
opacity in eyes of children at one year following surgery for bilateral cataract 
 
  
Relative odds 
of visual axis 
opacity 95% CI p 
IOL implantation  3.9 1.4 – 11.1 0.01 
Age at surgery unadjusted (weeks) 0.98 0.96 – 1 0.15 
Age at surgery adjusted for gestational age 
(weeks) 
0.98 0.96 - 1 0.16 
Increasing category of age at surgery     
 Baseline (0 - 5.9 weeks), n=50 - - - 
 6 - 9.9 weeks, n=34 1.6 0.4 – 5.9 0.72 
 10 - 26 weeks, n=50 0.85 0.2 – 3 0.81 
 Over 26 weeks (6 months), n=43  0.39 0.1 – 1.6 0.19 
Persistent fetal vasculature 2.1 0.4 – 11.5 0.41 
Axial length 0.84 0.7 – 1 0.06 
Horizontal corneal diameter 1.2 0.8 – 1.8 0.3 
Experienced surgeon  1.3 0.5 – 3.6 0.6 
Manual anterior capsulorhexis 2.2 0.7 – 6.4 0.14 
Viscosity of OVD -   
Posterior capsulotomy -   
Single piece IOL  4.3 1.1 – 15.9 0.03 
Increasing IOL power 1.2 1.1 – 1.5 0.008 
Bag fixation 1.2 0.2 – 16.3 0.85 
Per-operative heparin  0.9 0.3 – 3.1 0.88 
Per-operative iris trauma 0.8 0.2 – 2.7 0.74 
IOL explantation  -   
Intense post op steroids 2.8 1.02 – 7.4 0.04 
Systemic steroids 1.1 0.2 – 5.8 0.91 
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As Table 71 shows IOL implantation, single piece implants, IOL power and intensive 
post-operative steroid regimens are associated with higher odds of visual axis opacity. 
Due to the interaction between all these factors and age at surgery, and the biological 
importance of age at surgery, this variable was also included in the construction of the 
multivariable model of best fit.  
 
 
Table 72. Multivariate multilevel regression analysis of proliferative visual axis 
opacity following surgery for bilateral cataract 
 
 
Relative odds 
of VAO 95% CI p 
IOL implantation  7.1 2.4 – 21.5 0.001 
Increasing age at surgery (weeks) 0.96 0.93 – 0.99 0.03 
 
 
Primary IOLs were associated with a 7 times higher odds of proliferative visual axis 
opacity, whilst increasing age at surgery by one week reduced the odds of proliferative 
VAO by 4%.  
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The relationship between single piece IOL implants and the risk of visual axis opacity 
was explored by undertaking analysis on those children who had undergone IOL 
implantation. The results of the multivariate analysis are shown in Table 73 below. 
 
 
Table 73. Multivariate multilevel regression analysis of proliferative visual axis 
opacity following surgery with IOL implantation for bilateral cataract in eyes  
 
Relative odds 
of VAO 95% CI  p 
Single piece IOL  4.1 1.0 – 17.3 <0.05 
Increasing age at surgery (weeks) 0.96 0.94 – 0.99 0.008 
Increasing IOL power 1.2 0.96 – 1.4 0.1 
 
 
 
Amongst children undergoing IOL implantation, single piece intraocular lens 
implantation was independently associated with a 4 times higher odds of proliferative 
visual axis opacity.  
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The results of regression analysis of the occurrence of membranous visual axis opacity 
at 1 year following surgery are shown below. No factors reached significance on 
univariate analysis.  
Table 74. Univariate multilevel regression analysis of membranous visual axis 
opacity in eyes of children at one year following surgery for bilateral cataract 
 
  
Relative odds of visual 
axis opacity  95% CI  p 
IOL implantation  2.9 0.9 – 9.2 0.08 
Age at surgery unadjusted (weeks) 1 0.98 – 1.02 0.83 
Age at surgery adjusted for gestational age 
(weeks) 
1 0.98 – 1.02 0.81 
Increasing category of age at surgery     
 Baseline (0- 5.9 weeks) 1   
 6 - 9.9 weeks 0.2 0.02 – 1.1 0.07 
 10 - 26 weeks -   
 Over 26 weeks (6 months)  0.7 0.2 – 2.4 0.6 
Persistent fetal vasculature -   
Axial length 0.89 0.7 – 1.1 0.37 
Horizontal corneal diameter 1.5 0.9 – 2.6 0.14 
Experienced surgeon  0.91 0.3 – 2.9 0.89 
Manual anterior capsulorhexis 1.1 0.4 – 3.3 0.8 
OVD 0.3 0.04 – 1.7 0.18 
Posterior capsulotomy 0.1 0.0 – 1.6 0.1 
Single piece IOL  3.8 0.8 - 18.5 0.11 
Increasing IOL power 1 0.9 – 1.1 0.3 
Bag fixation -   
Per-operative heparin  1.7 0.5 – 6.3 0.43 
Per-operative iris trauma 1.7 0.5 – 6.3 0.43 
IOL explantation  -   
Intense post op steroids 1.04  0.3 – 3.5 0.95 
Systemic steroids 2.1 0.4 – 11.3 0.39 
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Unilateral cataract  
 
The pattern of correlation between factors of interest again matched the patterns found 
amongst predictors of interest in the analysis of bilateral cataract outcomes. A newly 
found correlation (Table 75) was that between the use of intraocular heparin and the 
use of an intensive post-operative intensive steroid: this was due to practice within one 
hospital (which contributed the third largest single-site group of children to the study 
sample).  
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Table 75. Correlations between factors of interest with regards to occurrence of visual axis opacity in children with unilateral cataract 
Peach squares indicate a positive correlation. Blue squares indicate a negative correlation. *p value<0.1; **p value<0.05; ***p value<0.01; ****p value<0.001. Full details in Appendix M (0) 
 Manual anterior capsulotomy Single piece IOL  IOL in bag  Per operative heparin  
IOL implantation  *** - -   
Gest age at surgery ** **     
Age at surgery ** **     
Persistent fetal vasculature     *   
Axial length  * ***     
Horizontal corneal diameter  ** **     
Experienced surgeon  *       
Viscous OVD **   *   
Single piece IOL       
IOL fixed within the bag       
Per operative heparin          
Per op iris trauma *       
Per op IOL explant    - -   
Post-operative intensive  steroid     * * 
Post-operative systemic steroids     **   
Post-operative inflammation         
Right eye   * *   
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On univariate analysis and then on multivariate analysis, IOL implantation was 
independently associated with increased odds of visual axis opacity, as was 
younger age at surgery. 
Table 76. Univariate regression analysis of proliferative visual axis opacity 
following surgery for unilateral cataract 
  Relative odds of VAO 95% CI p 
IOL implantation  4.0 1.1 – 1.4 0.03 
Age at surgery unadjusted, (weeks) 0.97 0.95 – 0.99 0.03 
Age at surgery adjusted for gestational age, 
(weeks) 
0.97 0.95 – 0.99 0.03 
Increasing category of age at surgery     
 Baseline (0- 5.9 weeks), n=14 1   
 6 - 9.9 weeks, n=16 0.6 0.1 – 2.5 0.47 
 10 - 26 weeks, n=7 0.3 0.0 – 2.1 0.23 
 Over 26 weeks (6 months) , n=21 0.2 0.04 – 0.8 0.03 
Persistent fetal vasculature 0.4 0.2 – 1.2 0.1 
Axial length 0.7 0.5 – 1.0 0.06 
Horizontal corneal diameter 1.1  0.5 – 2.7 0.76 
Experienced surgeon  1.4 0.5 – 4.4 0.53 
Manual anterior capsulorhexis 1.4 0.4 – 4.2 0.59 
OVD -   
Posterior capsulotomy -   
Single piece IOL  6.2 1.4 – 27.1 0.01 
Increasing IOL power 1.1 0.99 – 1.2 0.09 
Bag fixation 0.5 0.1 – 3.2 0.54 
Per-operative heparin  0.6 0.1 – 5.8 0.63 
Per-operative iris trauma 0.5 0.1 – 2.2 0.4 
IOL explantation  -   
Intense post op steroids 0.2 0.1 – 0.98 0.05 
Systemic steroids 0.9  0.1 – 5.2 0.8 
 
 
 
Table 77. Multivariate regression analysis of proliferative visual axis opacity 
following surgery for unilateral cataract 
  Relative odds of VAO 95% CI p 
IOL implantation  6.3 2.7 – 19.0 <0.0001 
Increasing age at surgery unadjusted (weeks) 0.96 0.94 – 0.99 0.008 
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The relationship between single piece IOL implants and the risk of visual axis opacity 
was again explored for children with unilateral cataract. The results of the multivariate 
analysis are shown in Table 73 below. Although the association between IOL power 
and visual axis opacity did not reach statistical significance on univariate analysis, it 
was included within the multivariate model because of its significance in outcomes 
following bilateral cataract surgery.  
 
 
Table 78.  Multivariate regression analysis of proliferative visual axis opacity 
following IOL implantation for unilateral cataract 
 Relative odds of VAO 95% CI p 
Single piece IOLs 7.4 0.6 – 98.9 0.1 
Increasing age at surgery unadjusted (weeks) 0.93 0.88 – 0.99 0.02 
Increasing axial length  1.5 0.7 – 13.3 0.3 
Increasing IOL power  1.0 0.8 – 1.4 0.8 
 
 
 
For children undergoing IOL implantation during primary surgery for unilateral cataract, 
the association between single piece IOL implantation and occurrence of proliferative 
visual axis opacity did not reach statistical significance. However, the direction and size 
of the effect (with higher odds of proliferative visual axis with single piece implants) was 
similar to that found for children with bilateral cataract). 
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The results of regression analysis of the occurrence of membranous visual axis opacity 
at 1 year following surgery for unilateral cataract are shown below.  
Table 79. Univariate regression analysis of membranous visual axis opacity 
following surgery for unilateral cataract 
 
   
Relative odds of 
VAO  95% CI  p 
IOL implantation  1.08 0.3 – 4.2 0.91 
Age at surgery unadjusted 0.94 0.88 – 1.01 0.08 
Age at surgery adjusted for gestational age 0.94 0.89 – 1.01 0.08 
Increasing category of age at surgery     
 Baseline (0- 5.9 weeks) 1   
 6 - 9.9 weeks 0.6 0.1 – 2.9 0.52 
 10 - 26 weeks 0.3 0.03 – 3.2 0.32 
 Over 26 weeks (6 months)  0.09 0.01 – 0.9 0.04 
Persistent fetal vasculature 1.1 0.3 – 4.2 0.86 
Axial length 0.6 0.4 – 1.0 0.05 
Horizontal corneal diameter 0.6 0.2 – 1.8 0.36 
Experienced surgeon  8.4 0.99 – 71.1 0.05 
Manual anterior capsulorhexis 1.1 0.3 – 4.2 0.91 
OVD 0.6 0.1 – 6.4 0.64 
Single piece IOL  7.1 0.7 – 68.6 0.09 
Increasing IOL power 1.1 0.9 – 1.2 0.5 
Bag fixation 0.3 0.04 – 2.2 0.23 
Per-operative heparin  -   
Per-operative iris trauma 2.8 0.7 – 11.8 0.17 
IOL explantation  -   
Intense post op steroids 2.2 0.6 – 8.3 0.26 
Systemic steroids -   
 
 
There was no evidence of an (independent) relationship between IOL implantation, 
axial length or age at surgery with the odds of membranous visual axis opacity on 
multivariate analysis.   
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5.10.c. Other adverse events 
 
5.10.c.i. Bilateral cataract  
 
Fibrinous uveitis was three times more common in IOL eyes following surgery, affecting 
11.1% (9/81) IOL eyes (8 children) and 3.1% (3/96) aphake eyes (3 children) but this 
difference did not reach statistical significance (p=0.07, 95% CI difference in 
proportions -0.6% to 7.4%)  
In total, significant (requiring additional intervention) post-operative inflammation events 
or sequelae indicative of significant inflammation (membranous visual axis opacity and 
pupil synechiae) affected a significantly higher proportion of eyes of children in the IOL 
group: 19.8% (16/81) IOL eyes and 7.3% (7/96) aphake eyes (p=0.02, 95% CI DIP 2.4 
– 23.1%).  
Pupil irregularities were noted in 4 IOL eyes (4.9%) and 4 aphake eyes (4.2%).  
The other adverse events were vitreous haemorrhage (in 3 aphake group eyes and 2 
IOL eyes), iris incarceration within the wound requiring surgical repair (1 IOL eye, 1 
aphake eye), retained cortical matter requiring surgical removal (1 IOL eye), wound 
opening requiring surgical repair (1 aphake eye), and retinal detachment, which 
affected a child in the aphake group in association with bilateral persistent fetal 
vasculature.  
No child was affected by endophthalmitis following primary surgery: however, one child 
developed endophthalmitis following surgical intervention for aphakic glaucoma.  
One child in the aphake group was hospitalised with bacterial pneumonia acquired 
whilst on systemic steroid treatment following primary cataract surgery.  
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5.10.c.ii. Unilateral cataract  
There was no significant difference in the proportion of eyes in the IOL or aphake group 
affected by fibrinous uveitis (4/36, 11.1% of IOL children and 4/22, 18.1% of aphake 
group children, p=0.46). 
Significant post-operative inflammation affected almost twice as many children who 
had undergone IOL implantation (12/36, 33.3%) than aphake eyes (4/22, 18.2%) but 
this difference did not reach statistical significance (p=0.08).  
Pupil irregularities were noted in 3 IOL eyes (8.3%) but did not affect any children in the 
aphake group.   
The other adverse events were vitreous haemorrhage (in 2 aphake group children), 
wound opening requiring surgical repair (1 IOL child, 1 aphake child), and partial retinal 
detachment, which affected one child in the IOL group. 
No child was affected by post-operative endophthalmitis.    
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5.11. Refractive outcomes following primary IOL implantation 
  
5.11.a. Prediction error 
Planned refractive outcome and actual refractive outcome data are available for 70 of 
the 96 eyes in children with bilateral pseudophakia, and 36 of the 42 children with 
unilateral pseudophakia. Refractive outcome as measured in the first post-operative 
month was within a dioptre of planned outcome in fewer than half of operated eyes, 
44% (47/106), and the prediction error was greater than 2 dioptres in 29% of eyes 
(31/106). The occurrence of significant prediction error was similar in unilateral and 
bilateral pseudophakia (Table 80). 
Table 80. Prediction error 
  Bilateral pseudophakia Unilateral pseudophakia  
Planned refractive outcome missing  12 6 
Post-operative refractive outcome missing 14 2 
Total with data on prediction error 70 36 
  
Prediction error within 1 dioptre 
30  
43%  
17   
47%  
Prediction error with more myopic result:  
 >1 dioptre error 
12 
  17% 
6   
 16.7%  
 >2 dioptre error 
2  
  2.9%  
5   
   13.9%  
Prediction error with more hyperopic result:  
 >1 dioptre error 
28  
 40%  
11  
 30.6% 
 >2 dioptre error 
20  
    28.6% 
6  
16.7%  
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5.11.a.i. Factors associated with prediction error 
 
The results of the assessment of correlation between the factors of interest in relation 
to prediction error of children with bilateral and unilateral cataract are shown in the 
tables overleaf.  
There then follows the results of the univariate analyses of prediction error following 
primary IOL implantation in children with unilateral and bilateral cataract (Table 83 and 
Table 84). 
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Table 81. Correlations between factors of interest with regards to prediction error in bilateral pseudophakia  
Peach squares indicate a positive correlation. Blue squares indicate a negative correlation. *p value<0.1; **p value<0.05; ***p value<0.01; ****p value<0.001. Full details in Appendix M (0) 
  
Age at 
surg 
K 
K 
astig  
Axial 
length  
HCD 
AxL <16 
mm 
AxL <20 
mm 
HCD <9.5 
mm 
IO AL 
diff  
ACD  Forml 
IOL 
power 
Ant seg 
abnorm 
Visc 
OVD 
Post. 
caps 
Ant 
vitrect  
Wnd 
sutured 
Exp. 
Surg 
Single 
piece  
IOL in 
bag  
Right 
eye 
Gestational age at surgery - ****   **** **** **** **** **   *   **                   
Age at surgery   ****   **** **** **** **** **   *   **                   
Corneal curvature (K)       **** **** **** **** **       -                   
Corneal astigmatism         * *               *       *     
Axial length          **** - - -       -                   
HCD         - - - *       -                 
Axial length  <16mm             - -       - **                 
Axial length <20mm               -   * **** -                   
HCD <9.5mm           **   - - -           - -   
Interocular axial length 
difference   
                                          
Anterior chamber depth                        - **                 
Power calculation formula                             - ***   **       
IOL power                                 **   **     
Anterior segment 
abnormality  
                             
Viscous OVD                             ****         *   
Posterior capsulotomy                    ***         * 
Anterior vitrectomy                                            
Wound sutured                                         
Experienced Surgeon                                            
Single piece IOL                                            
IOL fixation within capsular 
bag  
                                        * 
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Table 82. Correlations between factors of interest with regards to prediction error in unilateral pseudophakia 
Peach squares indicate a positive correlation. Blue squares indicate a negative correlation. *p value<0.1; **p value<0.05; ***p value<0.01; ****p value<0.001. Full details in Appendix M (0) 
 
Age at 
surg 
K 
K 
astig  
Axial 
length  
HCD 
AxL 
<16mm 
AxL 
<20mm 
HCD 
<9.5mm 
IO AL 
diff  
ACD  Forml 
IOL 
power 
Ant seg 
abnorm 
Visc 
OVD 
Ant 
vitrectomy  
Wnd 
sutured 
Exp 
Surg  
Single 
piece  
IOL in 
bag  
Right 
eye 
Gestational age at surgery - ****   **** ****   ****     ** * **** *** *   **         
Age at surgery   ****   **** ****   ****     ** * **** *** *   **         
Corneal curvature (K)       **** ****   ****     ** ** - ***       *       
Corneal astigmatism                                       
Axial length          **** - - - **** ****   -           **     
HCD         - - -   ****   *** - *             
Axial length  <16mm             - - **** **   -                 
Axial length <20mm               - **** ***   -           **     
HCD <9.5mm           *   - - -         - -   
Interocular axial length 
difference   
                      ****           *   ** 
Anterior chamber depth                        -         *       
Power calculation formula                                         
IOL power                                   ***     
Anterior segment 
abnormality  
             **             
Viscous OVD                             ****   **       
Anterior vitrectomy                                      **** * 
Wound sutured                                
Experienced Surgeon                                        * 
Single piece IOL                                        * 
IOL fixation within 
capsular bag  
                                      * 
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Table 83. Univariate multilevel regression analysis on prediction error in bilateral pseudophakia 
  Correlation with myopic error 95% CI p Correlation with hyperopic error 95% CI p 
Age at surgery (in weeks) -0.01 -0.01 to 0.01 0.5 -0.02 -0.04 to -0.01 0.007 
Log age surgery  -0.05 -0.3 to 0.2 0.7 -0.8 -1.4 to -0.3 0.005 
Corneal curvature (K) 0.3 -0.2 to 0.8 0.3 0.6 -1.2 to 2.3 0.5 
Log corneal curvature 2.1 -1.7 to 5.9 0.3 3.9 -8.9 to 16.6 0.5 
Corneal astigmatism  0.5 -0.7 to 1.7 0.4 0.5 -1.4 to 2.3 0.6 
Axial length  0.01 -0.2 – 0.2 0.9 -0.4 -0.6 - -0.1 0.01 
Log axial  length  0.2 -2.9 to 3.3 0.9 -7.1 -12.3 to -1.8 0.009 
Horizontal corneal diameter     -0.1 -0.8 – 0.6 0.8 -0.4 -1.6 – 0.8 0.5 
Log HCD -1.1 -8.5 to 6.3 0.8 -4.1 -17.4 to 9.1 0.5 
Axial length  <16mm -0.4 -0.7 to -0.1 0.02 4.9 4.2 to 5.6 <0.001 
Axial length <20mm -0.04 -0.7 to 0.7 0.9 1.4 0.3 to 2.4 0.01 
Interocular axial length difference   0.6 0.05 to 1.2 0.03 -0.2 -1.1 to 0.8 0.8 
Anterior chamber depth  -0.2 -0.5 to 0.2 0.3 -1 -1.9 to -0.1 0.03 
Power calculation formula – Hoffer Q 0.2 -0.4 to 0.9 0.5 0.9 -0.8 to 2.7 0.3 
Power calculation formula – Holladay 1 -0.4 -0.8t o -0.05 0.03 1.0 -0.9 to 2.9 0.3 
Power calculation formula – SRK II - - - 1.9 1.1 to 2.8 <0.001 
Power calculation formula – SRK/T 0.5 -0.09 to 1.1 0.09 1.2 -0.2 to 0.4 0.08 
IOL power -0.01 -0.1 to 0.1 0.6 0.2 0.01 to 0.3 <0.001 
Anterior segment abnormality  -0.4 -0.7 to -0.1 0.02 0.9 0.1 to 1.6 0.02 
Viscous OVD 0.3 -0.3 to 0.8 0.3 0.1 -2.9 to 3.10 0.9 
Anterior vitrectomy  0.3 -0.3 to 0.9 0.4 -0.07 -1.6 to 1.5 0.9 
Experienced Surgeon  -0.04 -0.8 to 0.7 0.9 -1.1 -2.5 to 0.3 0.1 
Single piece IOL  0.9 0.4 to 1.5 0.001 1.4 -0.4 to 3.2 0.12 
IOL fixation within capsular bag  0.4 0.08 to 0.7 0.02 0.7 -1.6 to 0.13 0.09 
Right eye  -0.5 -1 to 0.03 0.06 -0.6 -1.7 to 0.4 0.2 
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Table 84. Univariate regression analysis on prediction error in unilateral pseudophakia 
  Correlation with myopic error 95% CI p Correlation with hyperopic error 95% CI p 
Age at surgery (in weeks) -0.01 -0.04 to 0.02 0.6 0.01 -0.01 to 0.02 0.4 
Log age surgery  -0.04 -0.9 to 0.9 0.9 0.1 -0.3 to 0.6 0.5 
Corneal curvature (K) -0.6 -2.9 to 1.6 0.5 -0.2 -1.2 to 0.8 0.7 
Log corneal curvature -4.4 -20.9 to 11.9 0.6 -1.2 -8.5 to 6.3 0.7 
Corneal astigmatism  -0.4 -2.2 to 1.3 0.6 -0.4 -3.0 to 2.3 0.8 
Axial length  0.01 -4.5 to 0.5 0.9 -0.07 -0.3 to 0.2 0.6 
Log axial  length  0.06 -9 to 9 0.9 -1.4 -5.9 to 3.1 0.5 
Horizontal corneal diameter     -1.1 -2.6 to 0.4 0.1 -0.5 -0.9 to -0.04 0.03 
Log HCD -12.6 -29.2 to 4.0 0.1 -5.6 -10.8 to 0.5 0.04 
Axial length  <16mm -   2.2 -0.4 to 4.8 0.1 
Axial length <20mm -0.04 -1.8 to 1.7 0.9 0.09 -0.9 to 1.2 0.9 
Interocular axial length difference   -0.2 -1.3 to 0.8 0.6 0.01 -0.3 to 0.3 0.9 
Anterior chamber depth  1.5 -5.4 to 8.3 0.6 -0.4 -1.1 to 0.4 0.3 
Power calculation formula – Hoffer Q -   1.1 -1.9 to 4.1 0.5 
Power calculation formula – Holladay 1 0.7 -2.7 to 4.1 0.6 0.5 -2.9 to 3.9 0.7 
Power calculation formula – SRK II -0.7 -3.5 to 2.0 0.6 -0.01 -3.5 to 3.4 0.9 
Power calculation formula – SRK/T 0.7 -1.3 to 2.9 0.4 1.2 -1.8 to 4.1 0.4 
IOL power 0.02 -0.2 to 0.2 0.8 0.03 -0.05 to 0.1 0.4 
Anterior segment abnormality  -0.5 -3.1 to 2.1 0.7 -0.5 -2.5 to 1.5 0.6 
Viscous OVD 0.3 -2.4 to 3.0 0.8 1.3 -2 to 4.6 0.4 
Anterior vitrectomy  0.9 -1.0 to 3.9 0.4 -1.3 -4 to 1.4 0.3 
Experienced Surgeon  0.5 -1.5 to 2.4 0.6 0.3 -0.8 to 1.5 0.6 
Single piece IOL  0.5 -9.2 to 1.8 0.5 -0.1 -1.3 to 1.1 0.9 
IOL fixation within capsular bag  0.7 -2.3 to 3.8 0.6 -2 -3.2 to -0.9 0.002 
Right eye  1.9 0.3 to 3.6 0.05 0.9 -0.04 to 1.9 0.06 
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On univariate analysis, in bilateral pseudophakia a myopic prediction discrepancy was 
associated with increasing intraocular axial length asymmetry, the absence of an 
anterior segment anomaly, use of a single piece implant, use of a power formula which 
is not the Holladay 1 formula, and fixation of the IOL within the capsular bag. A 
hyperopic discrepancy was associated with younger age at surgery, shorter axial 
length, increasing IOL power, the presence of an anterior segment anomaly and use of 
the SRK II power formula.  
In unilateral pseudophakia a hyperopic discrepancy was associated with shorter 
horizontal corneal diameters, and fixation of the IOL within the capsular bag. As Table 
81 and Table 82 show, relationships exist between age at surgery, ocular size, the 
presence of an anterior segment anomaly, power formula selection and IOL power. 
Multivariate regression analysis models were built for myopic and hyperopic refractive 
discrepancy following IOL implantation in bilateral cataract surgery, and hyperopic 
refractive discrepancy following IOL implantation in unilateral cataract surgery. 
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Table 85. Multivariate multilevel regression analysis of myopic prediction error in 
bilateral pseudophakia 
  
Correlation with myopic 
prediction error 95% CI p 
Increasing interocular axial length 
difference 
0.6 0.06 to 1.2 0.03 
Anterior segment anomaly  -0.3 -0.7 to 0.05 0.08 
Single piece IOL implantation  0.96 0.4 to 1.6 0.03 
 
 
Table 86. Multivariate multilevel regression analysis of hyperopic prediction error 
in bilateral pseudophakia 
  
Correlation with hyperopic 
prediction error 95% CI p 
Axial length less than 16mm 5.1 3.4 to 6.8 <0.001 
IOL power 0.3 0.05 to 0.5 0.02 
Anterior segment anomaly  2.9 0.4 to 5.4 0.02 
Power calculation formula – Hoffer Q 1.9 -0.4 to 4.3 0.1 
Power calculation formula – Holladay 1 2.1 0.4 to 3.9 0.02 
Power calculation formula – SRK II 2.9 1.8 to 3.9 <0.001 
Power calculation formula – SRK/T 2.8 0.7 to 4.9 0.01 
 
 
 
Table 87. Multivariate multilevel regression analysis of hyperopic prediction error 
in unilateral pseudophakia 
  
Correlation with hyperopic 
prediction error 95% CI p 
Increasing horizontal corneal diameter in 
mm 
-0.5 -0.9 to 0.05 0.07 
Bag fixation of IOL  -0.8 -1.8 to 0.1 0.07 
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On multivariate analysis, for bilateral pseudophakia, increasing interocular axial length 
difference and the use of a single piece IOL were associated with a more myopic 
discrepancy, whilst an axial length of less than 16mm, higher IOL power, and use of 
the SRK II, Holladay 1 or SRK/T formulae were independently associated with a more 
hyperopic discrepancy. 
In unilateral pseudophakia, shorter axial length was again associated with a more 
hyperopic refractive outcome, as was fixation of the IOL in a position other than the 
capsular bag.  
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6. DISCUSSION  
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6.1. Summary of key findings 
 
This thesis describes an inception cohort of infants and young children undergoing 
surgery for congenital and infantile cataract at a time when primary IOLs have been 
adopted for this age group despite unanswered questions regarding best practice, 
visual benefits and adverse outcomes. 
Active surveillance through the BCCIG has resulted in a nationally representative 
cohort of children aged ≤2 years undergoing surgery with IOL implantation and surgery 
without IOLs. More cases have been ascertained than were reported by NHS trusts to 
the central databases of hospital activity.  
Within this cohort of children, ocular anomalies co-existent with cataract were a 
common finding. Severe microphthalmos affected 1 in 5 of all children with (bilateral or 
unilateral) cataract and microcornea affected 1 in 10. Persistent fetal vasculature 
occurred more frequently than had been anticipated, with signs of PFV noted in half of 
all children undergoing surgery for unilateral cataract,.  
As would be expected for children aged ≤2 years old at surgery, cataract was 
diagnosed early in life. Almost a half of bilateral cataract and a third of unilateral 
cataract was diagnosed in the first week of life, presumably through the routine new-
born physical examination (NIPE). Over 75% of the cohort underwent surgery aged 6 
months or younger, and 1 in 10 underwent surgery in the first month of life. 
IOL implantation was undertaken in the majority of children over 6 months of age at 
surgery, but aphakia was the preferred option for the majority of younger children, due 
to the presence of other ocular anomalies as well as concerns regarding outcomes in 
young eyes.  
In children for whom pseudophakia is the selected management, there was 
considerable variation in the refractive planning undertaken by surgeons with regards 
to IOL power calculation formulae and refractive outcome.  
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During the first post-operative year, 80% of pseudophakic children required additional 
refractive correction (glasses or contact lenses). Contact lens related adverse events or 
complications occurred in similar proportions of aphakic and pseudophakic children.  
Among children who were able to comply with visual assessment testing, at one year 
following surgery for both unilateral and bilateral cataract, 60% of children in the IOL 
group and 20% of children in the aphake group achieved vision within the age related 
normal ranges.  
In children undergoing unilateral cataract surgery, there was an association between 
younger age at surgery and higher odds of better vision, but no association was found 
between primary IOL implantation and visual outcome.  
In children undergoing bilateral cataract surgery, IOL implantation was associated with 
higher odds of better vision on multivariate analysis, whilst the presence of a significant 
ocular abnormality was a predictor of a poorer visual outcome. On analysis of outcome 
for children with bilateral cataract without other significant ocular morbidity, younger 
age at surgery was associated with a higher odds of better visual acuity.  
There was no evidence of a threshold effect for children undergoing cataract surgery in 
the first six weeks of life when compared to surgery later in infancy. This was true for 
children undergoing unilateral and bilateral cataract surgery, and the subgroup of 
children with bilateral cataract without ocular co-morbidity, and for the subgroup of 
children with bilateral cataract diagnosed in the first month of life. 
Glaucoma had been diagnosed in 10% of all eyes and 16% of all children by the end of 
the first postoperative year, affecting a higher proportion of children with bilateral than 
unilateral cataract. Age at surgery was the most significant factor for children with 
bilateral cataract, with a 6% reduction in the odds of glaucoma for every 7 days  
increase in age at surgery. No child undergoing surgery aged 7 months or older 
developed glaucoma, and 47% of children who developed glaucoma were under 6 
weeks old at surgery. Greater axial length and horizontal corneal diameter, the other 
indicators of ocular growth, were associated with reduced odds of glaucoma. 
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24% of children underwent secondary surgical procedures within the first postoperative 
year for visual axis opacity. Increasing age at surgery was again protective against the 
development of VAO. IOL implantation was associated with significantly higher odds of 
proliferative visual axis opacity in children with bilateral and unilateral cataract. Single 
piece IOLs were associated with higher odds of developing proliferative VAO, 
specifically the ‘pearl’ form of postoperative proliferation.  
The predictability of refractive outcome for children undergoing IOL implantation in the 
first 2 years of life is poor. A hyperopic discrepancy of greater than 2 dioptres occurred 
in 29% of bilateral cataract eyes, 17% unilateral cataract eyes. A myopic discrepancy 
of greater than 2 dioptres occurred in 3% of bilateral cataract eyes, and 14% of 
unilateral cataract eyes. The use of the SRKII power formula, steeper corneal 
curvatures and shorter axial lengths were associated with hyperopic discrepancy.  
These findings are discussed in turn in greater detail in the following sections of this 
chapter.
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6.2. Ascertainment of children undergoing cataract surgery in 
the first two years of life 
 
In comparison to the national databases of activity, a good to excellent level of 
ascertainment of cases of cataract surgery in children aged 2 years or under (in the 
UK) has been achieved by the active surveillance programme undertaken through the 
British Isles Congenital Cataract Interest Group.  
The surveillance network also enabled high levels of completeness of study data. The 
findings reported here are thus generalisable to the population at risk, that is, all 
children undergoing cataract surgery in the first two years of life in the UK, and by 
extrapolation in the British Isles. 
 
6.2.a. Incidence of surgery for congenital and infantile cataract 
surgery for children ≤2 years old in the UK  
310 children underwent surgery aged 2 years or under in the UK between 1st Jan 2009 
and 31st December 2010. Using the number of live births between 2007 and 2010 
minus child mortality in the first year of life in 2007 as a denominator, the estimated 
annual incidence of surgery for congenital or infantile cataract in children aged under or 
equal to 2 years in the UK is 1 per 10,000 children (95% CI 0.9  – 1.13). The birth 
figure data may not be a fully robust denominator for all children alive and at risk during 
the study period, but it is the only available measure of the number of children at risk 
during this period.  
This overall incidence rate cannot be adjusted for ascertainment as there is no 
alternative independent  source of cases that would allow capture-recapture analysis to 
be undertaken.  
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The annual incidence of disease per se (congenital or infantile cataract) was 2.29 per 
10,000 in first year of life and 2.93 per 10,000 for children aged 0 – 5 years in 1995-
96.293 A contemporaneous disease incidence rate is unavailable, and it is possible that 
the incidence of congenital and infantile cataract in the first year of life has fallen due to 
wider pre-natal screening for congenital anomalies or reproductive counselling for 
families affected by hereditary cataract. There is, for example, evidence that wider 
screening for Trisomy 21 led to a reduction in the number of children born with Downs 
Syndrome between 1989 and 2008, due to more women opting for planned 
terminations.299 The proportion of the children with hereditary or chromosomal disease 
in this cohort of operated cases is lower than has been reported for the cohort of all 
children diagnosed with cataract.  Systemic disease may be preclude early life surgery 
for congenital cataract due to the risk of general anaesthetic. Thus, whilst this study is 
able to provide an estimate unadjusted incidence of cataract surgery, it is difficult to 
place it this estimate into the overall context of the incidence of congenital and infantile 
cataract. 
Nevertheless, cataract surgery in the first few years of life is an uncommon procedure, 
and research into outcomes requires an approach which is able to recruit a large and 
representative cohort, as achieved in this study 
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6.2.b. The role of active surveillance in the ascertainment of rare 
ophthalmic disorders 
The labour intensive active surveillance methodology used within this study is likely to 
have provided a more complete ascertainment than that possible through passive 
surveillance, enabling the confirmation of the absence as well as presence of cases. 
The regular contact and feedback system across an established national network of 
involved specialists was not overly onerous for reporting clinicians. The system is ideal 
for rare disease with limited numbers of specialists treating the disorder, although this 
requires the creation of a network and regular expansion attempts to ensure a 
comprehensive recruitment pool.  
The high response rates achieved by the methods used was due to in part to the initial 
survey of practice, which resulted in the recruitment of new consultants to the interest 
group as well as stimulating continued engagement by existing group members. This 
continued engagement was, importantly, underpinned by the prior investment of time 
and effort into research by members of BCCIG, and the outcomes of prior research.  
The creation and maintenance of large networks of specialists for the investigation of 
rare diseases is particularly important for ophthalmic research, and paediatric 
ophthalmic research. Rare diseases affect 5% of the UK population and as such are an 
important health care issue.284   
The value of ‘alliances between networks of specialists’ in the investigation of rare 
disorders has been recognised both by the UK’s Chief Medical Officer and by the 
European Union Scientific board.284;300 These alliances enable the creation of large 
cohorts of individuals with disorders of interest, reducing random error in subsequent 
investigations, and enable consensual standardisation of disease definition and 
standardised data collection, reducing systematic error. 
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Ophthalmologists have a significant role to play in the investigation of rare diseases: 
16% of ‘rare’ diseases registered on Orphanet (the peer-reviewed European database) 
have associated ophthalmic or vision related signs and symptoms. Although there are 
continued obstacles to multicentre research despite recent improvements in research 
governance bureaucracy, the BCCIG remains a replicable and desirable model for 
future research into rare (ophthalmic) disorders. 
The modern clinical research environment also calls for approaches involving groups of 
doctors rather than specialists working in isolation. Modern medicine has rightly 
prioritised evidence based practice and the patient journey, the quantification of the 
latter being dependent on patient centred research. This is true for all medical 
disorders, common and uncommon, and with regards to rare diseases, this evidence 
base is unattainable without multicentre studies.  
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6.3. Prospective studies of disease management  - the 
measurement effect  
 
Clinical research may lead to changes in practice through the dissemination of study 
findings, but also through the undertaking of the research itself. The practice of cataract 
surgery in children aged under 2 years by the clinicians involved in this study has 
changed during the study period, arguably as a result of their involvement in the 
research.  
 
6.3.a. Standardisation of clinical records in response to the 
study 
Standardised data collection is necessary to reduce systematic error in clinical 
research, but it also improves patient care through the prevention of the omission of 
clinically significant investigations (for example, pre-operative horizontal corneal 
diameter).  
Clinical record standardisation through the use of proforma derived from the data 
collection instruments occurred at 3 hospitals as a result of involvement in this study, 
with clinicians showing willingness to use study document to the mutual benefit of the 
research and clinical team.  
The work undertaken in this thesis thus provides evidence of the feasibility of future 
observational or interventional multicentre (paediatric ophthalmic) research. 
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6.3.b. Standardisation of clinical practice in response to the 
study 
There is direct evidence from the largest patient identification centre (Great Ormond 
Street Hospital) of standardisation of clinical practice: pre-operative assessments and 
post-operative steroid regimen for children undergoing cataract surgery were 
standardised as a discussion of results around study methodology.  
The standardisation of clinical practice, preferably underpinned by an evidence base, 
improves patient care through the reduction of clinical risk, but also assists 
investigations of outcome through the reduction of the number of possible confounders, 
and enables clinical audit and the maintenance of achieved standards. The consistent 
exposure of junior medical staff to best practice also supports medical education.  
There may also have been changes at other centres following the publication of the 
findings of the national survey prior to start of the recruitment period. A number of 
consultants undertook procedures different to those they had described in response to 
the national survey. In all cases, the direction of change was towards practices 
undertaken by the majority of respondents. Of 38 surgeons who responded to the 
national survey and who recruited children to the study of outcomes: 
 
 1 of the 4 who stated that they used a non-’AcrySof’ lenses in children aged ≤2 
years did in fact implant AcrySof IOLs during the study 
 2 of the 5 who stated that they used Holladay formula in practice used the 
SRKT formula 
 4 of the 8 who stated that they did not routinely undertake vitrectomy did 
undertake vitrectomy in all recruited children  
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This constitutes a movement towards a form of implicitly consensually agreed practice, 
although not underpinned by a debate on evidence base, in part due to the absence of 
robust evidence. 
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6.4. Ocular co-morbidity in children undergoing cataract 
surgery aged ≤2 years in the British Isles  
 
6.4.a. Microphthalmos and microcornea 
6.4.a.i. Main findings  
73% of children were affected by microphthalmos or microcornea.  
64% of children had axial lengths shorter than the age reported normal range or were 
diagnosed with microphthalmos by their managing consultant, and 24% of children had 
severe microphthalmos.  Both microphthalmos and severe microphthalmos were more 
common findings in bilateral than unilateral cataract. 
25% of children without microphthalmos were affected by microcornea.  
 
6.4.a.ii. Sources of bias 
Missing data  
Axial length measurements were missing in 16/95 (17%) and 23/141 (16%) children 
affected by unilateral and bilateral cataract respectively. These data may not be 
missing at random, with fewer children selected for aphakia and fewer of those who 
were diagnosed with ‘clinical microphthalmos’ undergoing axial length measurements. 
This may reflect a perceived lower risk of microphthalmos in these children, and thus 
the figures above may be an overestimation of the true proportion of children with 
congenital or infantile cataract who have microphthalmos.  
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Quality of data  
The identity of the clinician undertaking axial length measurement was not requested. 
The contact method of axial length measurement was used in 96% of cases, and the 
interobserver differences in the measurement of axial length through contact methods 
can be as large as 0.5mm, with potential technician dependent systematic inaccuracies 
in measurement due to differing placements of the ultrasound probe. Immersion axial 
length methods provide improved accuracy and repeatability, and are now described 
as ‘gold standard’ for adults.301;302 
Clinicians were asked to determine presence of ‘clinical microphthalmos’, which was 
particularly important for classifying children in whom axial length measurement was 
not undertaken. This study identifies the poor negative predictive power of clinical 
assessment of microphthalmos for age related abnormally short axial length in the first 
two years of life. This either represents a failure by clinicians to diagnose children who 
are potentially at risk of poorer outcome, or the inadequacy of the study definition of 
microphthalmos. The negative predictive power is, as expected, better for unilateral 
cataract, and is also better for eyes with axial lengths of <16mm. This reflects a higher 
rate of identification by clinicians of children at risk of poor outcome due to severe 
microphthalmos.  
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6.4.a.iii. Interpretation of findings 
If data on axial length are not missing at random, that is if eyes in which ultrasound 
measurement was not undertaken and clinical microphthalmos was not diagnosed are 
in fact ‘normal’, the estimated frequency of microphthalmos is 64% in children with 
bilateral cataract (91/141) and 34% in children with unilateral cataract (32/95).  
This is a higher frequency than previously reported. Rahi et al reported a frequency for 
isolated microphthalmos of 6% in bilateral cataract and 7% in unilateral disease, with 
ocular anomalies found in 14% of cataractous eyes of children aged 0 – 15 years at 
diagnosis.63 The cohort described in this thesis constitutes a study population which 
differs by age and inclusion criteria, and there is evidence from this cohort that children 
with ocular anomalies present earlier in life.  
Nevertheless, this finding that a majority of children with congenital and infantile 
cataract undergoing surgery in the first few years of life are also affected by 
microphthalmia should be interpreted in the light of the limited literature on the 
normative values of axial length in children under 2 years old.  
Microphthalmos is an indicator of the failure of global development, and of an insult to 
the eye at an early stage of development. It can impact on a child’s final visual outcome 
following surgery both directly due to poor ocular development and indirectly through 
the higher incidence of post-operative glaucoma. It is thus important to be able to 
classify microphthalmos in order to stratify the risk of poorer outcome in children with 
cataract. Diagnosing an abnormal biometric value using a ‘cut off point’, even an age 
adjusted cut off point, risks classifying normal values as abnormal and vice versa. 
Large data sources are needed in order to define normality in this way. For example, 
the determination of a cut off value for ‘normality’ for body mass index in children 
necessitated a sample of almost 200,000 children303   
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Such normative data are not currently available for axial length in children aged under 
2 years. Obtaining these data is challenging, as examination under sedation or 
anaesthesia is needed for accurate measurement. However, measurement is a non-
interventional procedure with no risk to the child. Thus large scale longitudinal studies 
of axial length involving children undergoing sedation or anaesthesia for other 
procedures are feasible.  
Until these normative data are available, it is important that clinicians are able to 
diagnose children at risk of poor outcomes due to severe microphthalmos, so that they 
can provide some level of prognostic counselling to parents. The findings of this study 
indicate that will only be possible if clinicians undertake pre-operative ocular ultrasound, 
as clinical assessment alone has an insufficiently strong predictive power. This 
currently under-utilised modality should be a mandatory pre-operative assessment, as 
it also enables the future diagnosis and management of glaucoma.  
The existing evidence supports that in the absence of other structural anomalies, 
diagnosis in children aged under 2 years with congenital and infantile cataract should 
be limited to:  
severe microphthalmos: an axial length of less than 16mm in children aged over 1 
month (gestational age)  
and possible microphthalmos, using the classification used within this study (section 
2.3.d.i, box 2), with confirmation of diagnosis on repeated axial length measurement 
once the child has  reached 2 years old with an axial length of less than 20mm .  
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6.4.b. Persistent fetal vasculature 
6.4.b.i. Main findings 
Persistent fetal vasculature affected almost half (46%) of all children with unilateral 
cataract and 9% of children with bilateral cataract. 
 
6.4.b.ii. Sources of bias 
As the older definition of persistent hyperplastic primary vitreous (PHPV) is less 
inclusive than the newer classification scheme for persistent fetal vasculature (PFV), 
information on the form of persistent vasculature noted was collected using the study 
data instrument. Thus this study is able to determine where the children with PFV 
would fit within the description of PHPV, allowing comparison with previous studies. 
 
6.4.b.iii. Interpretation of findings 
The proportion of children who underwent surgery for unilateral cataract who have 
associated PFV is significantly higher than previously reported. As children with 
unilateral persistent fetal vasculature may not undergo surgery due to either the 
absence of an associated visually significant lens opacity or the preclusion of surgical 
intervention due to poor prognostic features (such as retinal detachment) the overall 
incidence of persistent fetal vasculature may be even higher.  Rather than reflecting a 
‘true’ increase in the incidence of PFV (which would require a dramatic biological 
influence), the findings of this study suggest that there is improved identification of the 
signs of persistent fetal vasculature. Rahi et al reported that 22% of children aged 0 -15 
years diagnosed with unilateral cataract were affected by PFV,63 whilst investigators in 
Toronto reported the frequency to be 11%,304 but as touched on earlier, these study 
 295 
populations differ from the population described within this thesis. Some features of 
PFV may only be visible during removal of the cataractous lens, and children with 
persistent fetal vasculature may present earlier in life. Thus a study which recruits 
children undergoing surgery in early life may report a higher frequency of affected 
children. An Austrian study which prospectively recruited 31 children aged 0 – 15 years 
old with unilateral cataract reported that all of these children were affected by some 
feature of persistent vasculature.93  
The aetiology of PFV is poorly understood, but animal models have identified a role for 
the failure of both the macrophage orchestrated extrinsic apoptotic pathway305 and the 
tumour suppressor gene intrinsic apoptotic pathway306 in the pathogenesis of the 
persistence of the nutrient fetal vasculature.  One gene complex implicated in the 
failure of ocular fetal vasculature apoptosis via the intrinsic pathway is frizzled/wnt307, 
which codes for a transmembrane protein. This protein is also implicated in the allelic 
congenital human retinal vascular development disorders of Norrie disease and familial 
exudative vitreoretinopathy, with the latter being described clinically as a ‘hereditary 
form of retinopathy of prematurity (ROP)’. It has also been suggested that PFV is a 
result of failure of apoptosis due to reduced exposure to VEGF. This pathway has been 
supported by the changing patterns of VEGF receptors on mammalian fetal intraocular 
vasculature,308 and is a pathway of current clinical interest due to the emerging use of 
VEGF inhibitors as treatment for ROP. 
Primary prevention of unilateral cataract is of particular importance as visual outcomes 
remain poor, and understanding the aetiology of PFV may also increase the 
understanding of the vascularisation of the fetal retina and possibly of the entire fetal 
cerebral system. PFV is thus a worthy candidate for future genetic research: careful 
description of morphology with pre-operative clinical images would be required to 
clarify phenotype ahead of investigation into genetic markers of the disorder. 
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6.5. Practice of IOL implantation in children aged <2yrs 
 
6.5.a. Main findings  
Intraocular lens implantation is undertaken at primary surgery for the majority of 
children aged over 6 months with congenital and infantile cataract (90% of children with 
unilateral cataract, 80% of children with bilateral cataract) 
Amongst children who underwent surgery in the first 3 months of life and excluding 
those children with other ocular abnormalities, primary IOL implantation was 
undertaken in 40% of children (20/50) with bilateral cataract and 44% of children 
(37/84).  
However, the proportion of children undergoing cataract surgery in the first month of life 
is similar across the four ‘treatment groups’ (that is, unilateral cataract surgery with and 
without IOL implantation and bilateral cataract surgery with and without IOL 
implantation).  
 
6.5.b. Sources of bias 
There are no missing data on the ages of the children undergoing cataract surgery 
ensuring a robust data source for the analysis of the practice of IOL implantation 
across different age groups within the first two years of life.  
In addition, the recruitment base underpinning this multicentre study is sufficiently wide 
to support the argument that this is a true picture of national practice. However, it is 
possible that practitioners who chose not to undertake primary IOL implantation also 
chose not to collaborate with the study as a member of the BCCIG. As the 
ascertainment achieved by this study is better than national records of activity (cataract 
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surgery in children under 2 episodes recorded through national databases) this is 
unlikely to have had a significant impact on the findings. 
 
6.5.c. Interpretation of findings 
The paediatric ophthalmic community appears to be beyond the point of equipoise with 
regards to IOL implantation in children aged over 6 months, despite the existing 
uncertainties surrounding refractive planning and the impact of adverse events such as 
visual axis opacity.  
It has been suggested that the adoption of any new technology, or the adaptation of an 
existing technology, proceeds along an ‘S’ shaped curve.278  The ‘hawks’, ‘innovators’ 
or ‘mavericks’ (the terminology used being dependent on the position of the observer) 
within the community are the first to take up the new technology. The more cautious 
practitioners wait until either sufficient anecdotal evidence has been gathered or until 
more robust evidence on safety and efficacy is available before they take up the new 
technology. During this process of diffusion there may come a ‘tipping point’ at between 
20% and 30% adoption, following which there is more rapid adoption of the practice by 
the community.278 This rapid adoption can occur in the absence of a robust evidence 
base supporting the new intervention: a significant precedent for this is the adoption of 
modern adult cataract surgery techniques.  The first randomised trials comparing 
modern phacoemulsification cataract surgery (where the lens is broken up with 
ultrasound waves prior to removal and currently the most commonly performed 
operation in the NHS) and the long established extracapsular extraction method took 
place in the 1990s, at least a decade following the wide adoption of the newer practice 
in high income countries309-311 We appear, in the UK, to be at the tipping point with 
regards to primary IOLs in children undergoing cataract surgery aged 3 months or 
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younger (these are the children diagnosed with congenital cataract either through 
neonatal screening or the six to eight week infant screening programme).  
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6.6. Comparison of ascertainment through central NHS 
databases and through active surveillance 
 
6.6.a. Main findings  
More cases of cataract surgery in children aged ≤2 years old were ascertained through 
the active surveillance undertaken in this study than were ascertained through the NHS 
databases.  
There is under reporting of cataract surgery (undertaken in these children) by hospitals 
in England, Scotland and Northern Ireland, and under reporting of primary IOL 
implantation by hospitals in England 
The inaccuracies created by this under-reporting are compounded by the use of 
multiple codes across different hospitals for paediatric cataract surgery, and this is 
despite all recruited children undergoing the same form of surgery: lens aspiration with 
(or, less commonly, without) vitrectomy. 
 
6.6.b. Sources of bias 
Patient identity linked data were not available, therefore it was not possible to compare 
directly the NHS databases and the IOLu2 study samples at an individual level. Nor is it 
possible to undertake capture-recapture analysis, which would allow us to report an 
ascertainment adjusted incidence rate for cataract surgery in these children.  
 
6.6.c. Interpretation of findings 
The under reporting by hospitals of paediatric cataract surgery is consistent with 
previous reports of poor levels of completeness of centralised NHS ‘returned’ data for 
other specialities such as paediatric cardiothoracic surgery and adult oncology.  
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The NHS is currently facing significant re-organisation and financial constraints. 
Accurate coding of hospital activity is vital for primary care trust payment for activities 
undertaken and for efficient planning of hospital services. These findings suggest that 
NHS ophthalmic departments may be losing money by failing to ensure that their 
administrative system records their true level of activity. Clinical governance is part of 
the duties of every doctor, and consultants must take the responsibility of ensuring that 
the hospital administrative staff responsible for reporting their activity to the national 
database have the information they need to generate accurate and complete reports.  
The consultants undertaking cataract surgery in early life should also reach a 
consensual decision regarding which code is to be used for lens aspiration and 
posterior capsulotomy with or without vitrectomy, and to ensure that this decision is 
disseminated to coding administrators. This should be achievable using the 
communication pathways established by the BCCIG.  
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6.7. Parental willingness to participate in clinical research  
 
Future research into children undergoing primary IOL implantation, and indeed into any 
paediatric (ophthalmic) intervention, will be dependent on consent from affected 
families.  
This study necessitated the seeking of consent for enrolment at a difficult time for 
families, this time being soon after diagnosis of a life changing disorder which would 
involve surgical intervention. Despite this, 79% of families consented to their child’s 
involvement. 3% of families refused, and as of August 2011, 18% of families were yet 
to reply, which may reflect lack of willingness to participate.  
Thus parents are, in the majority, willing to participate in an observational study which 
is not of direct benefit to their child. This willingness is possibly a consequence of the 
perceived importance of study, although the strength of the relationship between 
parents and the managing clinical team is also likely to play a role.  
The degree to which parents are willing to participate in paediatric interventional 
studies, specifically randomised control trials of IOLs, is at this time uncertain. 71% of 
North American parents were willing to participate in the North American Infant Aphakia 
Treatment Study randomised controlled trial of intraocular lens implantation versus 
aphakic correction (IATS). The reimbursement of travel costs, free contact lenses and 
glasses, and extra financial support provided to the families participating in the IATS 
may have influenced parents’ willingness to participate in the trial. Evidence from 
previous studies also suggests that parents who consent to their child’s participation in 
research are motivated not only by altruism but also by the awareness that involvement 
in research strengthens their relationship with their health care service providers and 
affords them greater involvement in their child’s care. 312;313 
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To inform further studies which may arise due from the findings of this present study, 
investigators need further information on parental attitudes towards participation into 
ophthalmic research, in particular randomised controlled trials. This information will 
allow investigators to estimate the number of parents who will need to be approached 
to obtain a necessary study sample size. As systematic failures to recruit sub-groups of 
the potential recruitment pool negatively impacts on the representativeness of the study 
cohort, research into the possible determinants of parental attitudes will also be needed 
to identify any need for, and to help design, targeted recruitment methods to ensure 
adequate representation of families who would otherwise not take part in research.  
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6.8. Visual outcomes following surgery with and without 
primary IOL implantation  
 
6.8.a. Bilateral cataract  
6.8.a.i. Main findings 
For the children able to comply with formal visual testing, visual outcomes are within 
the age reported normal range for 19% of children in the aphake group, and 59% in the 
IOL group.  
On multivariate multilevel analysis, primary IOL implantation is independently 
associated with 5 times higher odds of better visual outcome. The same size of 
association is seen even when analysis is limited to the dataset of children without a 
significant ocular abnormality. However, when missing data were imputed on the 
reasonable assumption that inability to comply with visual assessment reflected poor 
visual outcome, IOLs were associated with a reduced odds of better visual outcome on 
multivariate analysis.     
 
 
6.8.a.ii. Sources of bias  
It is possible that the data on visual outcome are not missing at random. The failure to 
comply with visual assessment was significantly higher in the IOL group, despite this 
group having a higher median age at surgery in comparison to the aphake group, and a 
similar proportion of children with systemic disorders or developmental abnormalities.  
The difficulty of obtaining reproducible, accurate quantitative visual acuity data from 
preschool children is well recognised. The objective assessment of acuity in childhood 
is difficult due to within-child variability (discomfort / boredom / room illumination / 
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inattentiveness may alter a child’s performance) and the variability which may exists 
between examiners or acuity assessment procedures. Thus, ideally studies which 
investigate visual outcomes should use standardised acuity assessment methodologies 
undertaken and at an age where children are more able to verbally respond to visual 
assessment. There was no standardisation of acuity assessment within methodology 
described for the study within this thesis,  and whilst in all centres acuity measurements 
were undertaken by trained specialists (orthoptists) there was no formal assessment of 
examiner performance.  It is impossible to adjust for this potential measurement bias at 
the analysis stage, however, the author has attempted to ground the investigation of 
visual outcome within clinical practice by categorising vision into wide but clinically 
relevant bands using the best available evidence on normative values.  
 
6.8.a.iii. Interpretation of findings 
The proportion of children achieving ‘normal’ vision at one year following surgery with 
intraocular lens implantation is 60%, falling to 40% if the assumption that failure to 
comply with visual assessment is an indicator of poor vision is true. This latter figure, of 
40% attaining normal visual levels, is consistent with previously published data of 
outcome following cataract surgery (usually) without IOL implantation. Chak et al 
reported that 40%, and Francis et al reported that 34% of children had attained normal 
vision at 5 years after surgery.39;64 
These findings suggest that a large proportion of these children will be able to attend 
mainstream schooling (in the absence of other disorders) with some being able to read 
normal print, and the majority able to read some form of print. However, early visual 
outcomes are not a robust indicator of final visual outcome, and further follow up 
studies on this cohort are needed. Within a follow up study of the IOLu2 cohort, visual 
outcome should be assessed at 5 years following surgery (when all children are likely 
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to be of school age, and when visual outcome will be a firmer indication of adult visual 
function) and at 10 years following surgery (when all children will be in or approaching 
secondary education). The proportion of aphakic children with normal vision at one 
year following surgery is 20%. This low proportion is a reflection of the high proportion 
of these children affected by other ocular abnormalities. A small proportion of the 
bilateral aphakes will be able to read normal print, but the majority of the children 
achieved form perception and thus may be able to read some form of large print as 
older children and adults.  
It is unclear if the visual outcome is better for these children than it would have been if 
they had not undergone cataract surgery, particularly in the cases of children without 
dense, total or nuclear lens opacities. A randomised controlled trial of surgery versus 
conservative treatment for bilateral cataract may be able to provide the answer, 
although the ethical challenges inherent to the design of such a study are immense. 
For partial or lamellar cataract, a grading scale could be designed so that children with 
only a certain degree of lens opacity would be recruited to such a study.  
It is possible that primary IOL implantation, in comparison to aphakia, leads to 
improved visual outcome in children at 1 year following surgery. The higher odds of 
better visual outcome are independent of the presence of ocular abnormalities and the 
age of the child. There are no other similar studies into the associations between IOLs 
and visual outcome for bilateral cataract in children under 2 years old with which to 
compare the findings of the present study. It could be argued that the findings 
presented here demonstrate a need for a multicentre randomised controlled trial of IOL 
in children with bilateral cataract (which would recruit children with no other ocular 
abnormalities, no neurological disorders, with symmetrical cataract, and children aged 
3 months or under at surgery). Nevertheless, follow up studies on the IOLu2 cohort 
should also be able to provide robust evidence on the effect of primary IOL 
implantation on visual outcome for bilateral cataract in children aged ≤2 years.  
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6.8.b. Unilateral cataract  
6.8.b.i. Main findings 
60% of eyes in which IOL implantation was undertaken achieved normal vision at one 
year following surgery, whilst 20% of eyes which were not implanted achieved this level 
of vision. However, there was no independent association of IOL implantation with the 
odds of better vision, although the direction of the effect seen was similar to that seen 
in bilateral cataract.  
Although younger age at surgery was associated with higher odds of better vision, 
there was no evidence of a threshold effect, that is an age at surgery prior to which 
visual outcome at one year was significantly better.  
 
6.8.b.ii. Sources of bias 
Again, the missing data on visual outcome may not have been missing at random, as 
the children who did not comply with assessment may have had poor post-operative 
vision. In addition the sample population of children with one year visual outcome data 
was small, with consequent risk of random error.  
 
6.8.b.iii. Interpretation of findings 
These study findings are consistent with the finding of the IATS that there was no 
association between visual outcome and 1 year following surgery and the use of IOLs 
in children aged 6 months or under at surgery.  
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Further 1 year follow up data is awaited for the children described within this study, and 
the longer term follow up data from this cohort should also provide further evidence on 
the effect of IOL implantation on visual outcome.  
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6.9. Glaucoma following surgery with and without primary IOL 
implantation 
 
6.9.a. Main findings 
6.9.a.i. Bilateral cataract  
Although 5% of eyes (4% children) in the IOL group and 14% of eyes (23% children) in 
the aphake group developed glaucoma, there was no independent association 
between IOL implantation and the risk or hazard of post-operative open angle 
glaucoma during the first post-operative year.  
Increasing age at surgery, axial length and horizontal corneal diameter were all 
protective, that is associated with reduced odds of developing post-operative glaucoma. 
Glaucoma was only diagnosed in children who underwent surgery during the first 6 
months of life. This may have been due to chance, but as all of the children recruited to 
this study were under 2 years old at surgery a threshold effect cannot be ruled out. 
Surgery during the first 4 weeks of life was independently associated with 75% higher 
odds of developing glaucoma (OR 1.75, 95% CI 1.2 – 1.9, p=0.001), suggesting that 
the first month is a critically sensitive period for the development of post-operative 
glaucoma.  
 
6.9.a.ii. Unilateral cataract  
8% of IOL eyes, and 9% of aphake eyes developed glaucoma in the first post-operative 
year, and there was again no association between IOL implantation and post-operative 
open angle glaucoma, whilst increasing axial length and horizontal corneal diameter at 
surgery were again protective associations.   
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6.9.b. Sources of bias 
Disease misclassification prevents the investigator from robustly investigating the 
factors associated with the disease of interest. The data collection instruments did not 
request confirmation of the diagnosis of open angle glaucoma through gonioscopy, but 
used an established definition with presumption of gonioscopy, as surgeons were 
asked to classify glaucoma as ‘open angle’ rather than pupil block or closed angle.  
The assumption was therefore made that they were confident in this diagnosis. 
Nevertheless, non pupil block, apparent open angle glaucoma could in some cases be 
due to closed angle mechanisms such as the hydration of retained lens matter pushing 
the angle closed. The aetiology of such forms of glaucoma would be linked to surgical 
technique rather than to risk factors such as the age of the child.  
. 
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6.9.c. Interpretation of findings 
6.9.c.i. IOL implantation and the risk of post-operative 
glaucoma  
These study findings do not support previous reports of a protective association 
between IOL implantation and post-operative glaucoma, but as previously described 
these previous reports have lacked a robust approach. 
This suggests that the aetiology of post-operative open angle glaucoma is less likely to 
be associated with the loss of physical support to the developing angle, or the barrier 
effect of an IOL against potentially damaging factors from posterior segment. The focus 
should now be moved to the other posited pathological mechanisms.  
Over time, more cases of glaucoma will develop within this study cohort, therefore 
further data on IOL implantation as a predictor of post-operative glaucoma risk will be 
available through the longer term studies of outcome amongst the IOLu2 study cohort.  
 
6.9.c.ii. Balancing the benefits of early intervention with the 
risks of post-operative glaucoma 
The early age at diagnosis for many of the children in this cohort suggests that there 
may have been improvements within the national screening programme. However, 
whilst 129/171 children diagnosed in the first year of life were diagnosed in the first 
month of life in the 1995/6 national cohort study (75%),293 the proportion is similar (81% 
or 165/204) for this cohort. Nevertheless, a significant proportion of children are being 
diagnosed at an early age, affording clinicians the chance of undertaking surgery at an 
earlier age. 
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It is possible that there exists a ‘latent’ period prior to the start of the critical period of 
visual sensory development during which sensory deprivation has no impact on later 
visual development, and that cataract surgery which is undertaken prior to the end of 
the latent period limits the amblyogenic impact of lens opacity. This theory drives the 
impetus to undertake very early cataract surgery. Evidence from a small scale study 
suggested that for children diagnosed prior to 4 weeks of age, for each week after 1st 
month of age (the possible end of the latent period), visual outcome falls due to visual 
deprivation during the critical window.195 However, Chak et al reported that, for their 
population based cohort, whilst visual outcome following surgery worsened with 
increasing age at surgery, there was no threshold effect.39  
The key interpretation of this study’s findings regarding glaucoma is that although early 
infancy surgery (prior to 6 weeks of age) does not result in significantly better visual 
outcomes, surgery in the first 4 weeks of life does result in a significantly higher risk of 
post-operative glaucoma developing in first post-operative year  
It might be possible to further investigate the impact of early life cataract surgery on the 
risk of glaucoma through a clinical trial with different trial arms undergoing surgery at 
different ages, (for example prior to four weeks versus after 4 weeks) but ethics 
approval for such studies would be difficult to obtain. Thus large scale ‘natural 
experiments’ such as provided by this cohort may provide the highest level of evidence 
possible.  
 
6.9.c.iii. The prevalence of glaucoma following cataract 
surgery in children ≤2 years old 
Higher proportions of children were diagnosed with glaucoma in the first post-operative 
year than were reported in Chak et al, presumably due to the younger age at surgery in 
the IOLu2 cohort.  
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Assuming that 5% of eyes develop glaucoma each year, by 10 years 55% of operated 
eyes in the present cohort will have developed glaucoma. This is a considerable 
proportion: it is possible that for this cohort, children are more likely than not to develop 
iatrogenic glaucoma following congenital cataract surgery  
A greater understanding of the mechanism by which the insult of surgery causes 
glaucoma is urgently needed. This will require premorbid data on the angle through 
gonioscopy and ultrasound biomicroscopy imaging.  
Normative data on the development of the anterior segment, specifically the 
differentiation of the angle in the first few years of life, will be difficult to obtain and 
would require examination under anaesthetic or sedation, but would be of great value.  
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6.10. Visual axis opacity following surgery with and without 
primary IOL implantation 
 
6.10.a. Main findings 
6.10.a.i. Bilateral cataract  
24% of eyes (34% of children) which underwent IOL implantation developed 
proliferative visual axis opacity requiring surgery by the end of the first post-operative 
year, versus 7% of aphakic eyes. IOL implantation was independently associated with 
seven times higher odds of proliferative visual axis opacity (VAO) during the first post-
operative year. 
14% of eyes (20% of children) which underwent IOL implantation developed 
membranous VAO, compared to 5% of aphake eyes, with IOL implantation being 
independently associated with a four times higher odds of membranous VAO.  
The use of systemic steroids was not significantly associated with reduced odds of 
developing membranous (inflammatory) VAO, or indeed any form of visual axis opacity.  
Single piece IOLs were associated with higher odds of proliferative VAO, with a higher 
proportion of children having the ‘pearl’ form of VAO. 
 
6.10.a.ii. Unilateral cataract  
Following IOL implantation, 47% of eyes developed proliferative VAO, and 20% 
developed membranous VAO. 5% of children underwent more than one secondary 
surgical procedure (in the operated eye) for VAO in the first year. IOLs were again 
independently associated with higher odds of VAO. 
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6.10.b. Sources of bias 
Assumptions were made regarding the frequency of follow up across different centres, 
and frequency following surgery with or without IOLs. Centres which more frequently 
undertook IOL implantation may have had shorter follow up visit intervals, which may 
have increased the chance of diagnosing VAO in the first post-operative year. 
Also, data were collected on time at treatment for VAO rather than time at diagnosis – 
the assumption here being that treatment occurs soon after diagnosis. 
 
6.10.c. Interpretation of findings 
 
6.10.c.i. The impact on multiple intraocular procedures on 
long term development 
VAO has previously been recognised as a complication of IOL implantation in early 
childhood.144;166;273  
There is an apparent lack of awareness amongst the paediatric ophthalmic community 
regarding the emerging evidence on the association between multiple general 
anaesthetics in children under 2 years old and long term impairment of cognitive 
function.145;314-319  Preclinical animal studies report that general anaesthetic causes 
significant patho-histological damage to the developing mammalian brain.320;321 A 
relatively large population based cohort study (n=5357) from North America reported 
that the relative hazard of having a learning difficulty in late childhood was 1.59 (95% 
CI 1.06 – 2.36) following two or more episodes of general anaesthetic in the first 4 
years of life.322 Another large scale retrospective case controlled study (383 cases, 
5050 controls) reported adjusted hazard ratios of 2.3 (95% CI 1.3, 4.1) of cognitive 
impairments following general anaesthetic for hernia repair in the first 3 years of life. 323 
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It may be that there are as yet unidentified confounding factors contributing to these 
associations, but whilst there is the possibility of an association, multiple occurrences 
of general anaesthetic should be avoided for young children where possible. 
Ophthalmologists who undertake primary IOL implantation in the first two years of life 
must deal with the possible future ramifications of a total of four episodes of general 
anaesthetic for children with bilateral cataract (primary and secondary surgery for each 
eye) and the undertaking of multiple general anaesthetics in unilaterally affected 
children with no real improvement in unaided binocular vision.  
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6.10.c.ii. The use of systemic corticosteroids to reduce post-
operative inflammation  
Inflammatory membranes are the most apparent sequelae of significant post-operative 
inflammation, and there is no evidence that the use of systemic steroids is associated 
with lower odds or hazards of inflammatory visual axis opacity. The reported 
complications of systemic steroids in infancy include hyperglycaemia, infection, and 
developmental delay.324 One child in this cohort was affected by a significant infective 
illness whilst treated with systemic steroids, and the use of systemic steroids may also 
have delayed the timing of early life vaccinations for some children in the cohort.  
There is a risk of harm with systemic steroids, and no evidence of additional benefit, 
thus systemic corticosteroids should be used with caution in these children.  
With regards to the most effective post-operative regimen of topical steroids, 
randomised controlled trials of peri and post-operative corticosteroid delivery may be 
needed. These studies would require standardised objective assessment of the degree 
of post-operative intraocular inflammation: the presence of fibrin or inflammatory 
membranes, pupil synechiae and iris vessel dilatation.  
However, the cohort described in this thesis should also be able to provide the data 
needed (once one year follow up data collection is complete) to undertake further 
analyses into the associations between the different regimens of post-operative 
steroids and the occurrence of inflammatory sequelae necessitating surgical repair. In 
addition, the impact of inflammation and further surgery on the risk of glaucoma will be 
investigated through follow up studies of this cohort. 
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6.10.c.iii. Single piece IOL implantation and the risk of visual 
axis opacity 
This is the first study to report an association between single piece IOLs and the 
occurrence of VAO. Previous studies have studied outcomes in older populations or 
have not differentiated between VAO rates following implantation of different models of 
IOLs.277;325 The risk of increased rates of VAO in adults was, however, first theorized in 
reports from the 2003 European Society of Cataract and Refractive Surgery meeting, to 
be related to the ‘step’ between the optic / haptic junction acting as a potential focus for 
lens epithelial cell proliferation.326;327   
Further research such as randomised controlled trails of single piece IOLs in childhood 
may be useful: such a trial is currently underway in adults, but is unlikely to provide a 
definitive answer as the patterns of development of VAO (termed posterior capsular 
opacity or PCO in adults) are different in adulthood.  
The ‘natural experiment’ described in this thesis provides enough information to raise 
the issue within the paediatric ophthalmologic community. 
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6.11. Accuracy of refractive planning in children ≤2 yrs old 
  
6.11.a. Main findings 
There exists considerable variation in the use of power calculation formula, and in 
planned refractive power, with resultant variation in refractive outcome.  
There is poor predictability of refractive outcome for children, with 53% of unilateral 
pseudophakes and 57% of bilateral pseudophakes having a significant prediction error. 
Interocular axial length difference and the use of a single piece IOL were associated 
with a more myopic discrepancy, whilst an axial length of less than 16mm, higher IOL 
power, and use of the SRK II, Holladay 1 or SRK/T formulae were associated with a 
more hyperopic discrepancy. 
 
6.11.b. Sources of bias 
It can be difficult to achieve accurate retinoscopy assessment in an awake post-
operative infant, and thus the quality of the data may be in doubt.  
Only a small number of consultants undertook post-operative refraction within a month 
of surgery:  with such a small dataset it is difficult to exclude the role of random error. 
  
6.11.c. Interpretation of findings 
Previous studies243;301;328 have reported the absolute error without examining the 
direction of the discrepancy (myopic versus hyperopic). It is possible that different 
factors are in action with myopic discrepancy than with hyperopic discrepancy, as 
indicated by the opposing effect directions in the univariate analyses.  
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If IOLs are to be used routinely in children, ophthalmologists will need to establish a 
national audit programme similar to that set up for adult cataract surgery, and it should 
be mandatory to undertake post-operative refraction to determine refractive 
discrepancy. 
Follow up studies on the IOLu2 cohort should provide data on the consequences of 
refractive discrepancy (for example further surgery, visual outcome), particularly of high 
myopic errors.  
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6.12. Future directions of investigations into outcomes within 
the IOLu2 cohort  
 
The children recruited into this study and the systematically collected and categorised 
data regarding their pre, per and post-operative status form a valuable and unique 
source of information on outcomes following cataract surgery in children under two 
years old. Thus, the cohort generated by the IOLu2 study should be and will be used to 
provide data which may be able to support or refute key clinical hypotheses around 
visual and refractive outcome and adverse post-operative events.  
These further investigations will require ethics approval and research governance 
approval, as well as confirmation of informed consent from parents for the collection of 
further clinical data.  
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6.12.a. Visual outcome following bilateral cataract surgery 
 
Hypothesis 1: In comparison to aphakia, IOL implantation in children aged 
under 2 years with bilateral cataract is associated with better visual 
outcome 
 
Whilst the majority of children undergoing surgery for bilateral congenital or infantile 
cataract escape severe visual impairment almost two thirds of these children will 
become adults burdened by some degree of visual impairment. (Chak et al) Primary 
pseudophakia, with refractive correction constantly in place, may lead to better post-
operative visual results.  
Children within the IOLu2 cohort should form the basis of follow up studies of visual 
outcome. In order to limit selection bias, it will be necessary to exclude those children 
with ocular disorders which not only impact on visual potential but which also prevent 
the implantation of an IOL: axial length <16mm, HCD<10mm, significant persistent fetal 
vasculature and significant anterior or posterior segment pathology. It will also be 
necessary to exclude those children within the cohort who are unable to comply with 
visual assessment, and children with neurological disorders involving the visual 
pathways.  
Ideally, visual assessment should be undertaken by a small group of travelling 
examiners. However considering the geographical spread of the IOLu2 cohort, a more 
achievable aim would be assessments by examiners with appropriate experience (as 
judged by a senior central ‘head’ examiner). Assessment should be undertaken at an 
age when children are able to provide a robust verbal response to optotype acuity tests, 
such as over five years of age, using a standardised process involving the ETDRS 
LogMAR acuity charts for verbal children and grating acuity charts for the small number 
of non-verbal children who are not limited by neurological or developmental 
abnormalities.  
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The study cohort will be able to provide data not only on the strength and direction of 
the association between IOL implantation and post-operative vision, but also, through 
multilevel multivariable ordinal logistic regression analysis of logMAR vision, on the 
impact of factors described earlier within this thesis such as age at surgery, 
socioeconomic status, and post-operative complications.  
As undertaken within this thesis, as well as examination on the whole cohort, 
investigation of the subgroup of children diagnosed in the first month of life will also be 
performed (thus excluding children with infantile cataract in whom deprivation 
amblyopia may not be as profound).  
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6.12.b. Visual outcome following unilateral cataract surgery  
 
Hypothesis 2: In comparison to aphakia, IOL implantation in children aged 
under 2 years with unilateral cataract is associated with better visual 
outcome 
 
The most predictable outcome for children with unilateral cataract remains moderate or 
severe visual impairment in the operated eye. The group of children within this study 
cohort who have undergone surgery for unilateral cataract should and will be followed 
up in order to further investigate the predictors of good visual outcome.  
As well as the absolute visual acuity in the operated eye, the secondary outcome 
measure should also be the difference in acuity between this eye and its fellow, which 
may usefully be employed as a marker of the child’s visual potential.  
Whilst the exclusion criteria and outcome assessment remain the same for unilateral 
cataract, visual outcome following unilateral cataract surgery is made more complex by 
amblyopia. Thus, visual outcome assessment should not be undertaken until the age of 
8 years, when children have reached some level of visual stability and past which there 
is little chance of significant improvement of acuity through further visual rehabilitation. 
Also, the impact of concordance with amblyopia treatment will need to be assessed in 
a standardised manner in order to investigate the other associated factors. 
Concordance with occlusion should be measured using parental reports, parental 
diaries, or, more ideally an objective measurement such as an electronic monitoring 
system such as used in the PEDIG studies.329 However, as concordance throughout 
the first eight post-operative years and particularly the first three years will need to be 
considered, the use of compliance monitoring aids throughout the study follow up 
period would bring a considerable expense.  
 
 324 
6.12.c.  Refractive planning  
Hypothesis 3: An initial pseudophakic refractive outcome which matches 
the normal age adjusted refractive state / the refractive status of the fellow 
phakic eye is associated with better visual outcome following bilateral / 
unilateral cataract surgery 
 
The most appropriate post-operative refractive aim for early childhood pseudophakia is 
unclear. It is important to investigate the impact of refractive planning on visual  
development and final visual outcome.  
The primary outcome measure should be distance and near acuity measurements 
(undertaken according to a standardised study protocol as described above). 
Standardised data collection on the use of, compliance with and the nature of refractive 
correction will also be necessary, as it is possible that children who have been 
prescribed and are compliant with overcorrection of their residual refractive error (thus 
leaving them myopic and able to focus objects within their ‘near’ world) may have 
better visual development.  Comparative models of refractive change as stratified by 
the final visual outcome can be created, and as the refractive status may differentially 
impact on different age groups, effects within subgroups stratified by age at surgery will 
also need to be investigated.  
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6.12.d. Ocular growth 
 
Hypothesis 4. In comparison to aphakia, primary IOL implantation aged 
under 2 years is associated with a more normal rate of ocular growth 
 
Axial myopia consequent to post-operative marked axial elongation impacts not just on 
visual outcome but may also lead to visually impactful sequelae of high myopia 
(macular degeneration, retinal detachments). Serial axial length measurements of 
aphakic and pseudophakic eyes of children in the IOLu2 cohort should provide data on 
the impact of primary IOL implantation on the post-operative pattern of eye growth.  
The children from the IOLu2 cohort who will be able to contribute data to a study such 
as this are those who have not been diagnosed with glaucoma (which may lead to axial 
elongation), those who do not have trisomy 21 or any other disorder associated with 
musculoskeletal / collagen abnormalities, and those without a significant ocular 
abnormality (which may result in disordered ocular growth.  The outcome measure will 
be ocular growth as determined by serial ultrasound measurements. In order to 
standardise the measurement of axial length, a study protocol will need to determine 
whether contact or immersion techniques will be used, and the methodology of 
assessment (through closed lids / open eye contact, contact gel used, machine used, 
number of readings taken from each child to obtain an average reading) will also need 
to be standardised.  
A possible consequence of the dissemination of findings within this thesis may be 
stimulation of the discussion of the risks of general anaesthetic in early childhood to 
further cognitive development. As a result, fewer children may undergo examination 
under anaesthetic, which may lead to less available data on ocular length in the first 
years of life. 
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Multilevel multivariable longitudinal modelling should be used to investigate the impact 
of IOL implantation on ocular growth once known associated factors such as acuity 
have been taken into consideration 
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6.12.e. Secondary glaucoma 
 
Hypothesis 5. IOL implantation is associated with a lower prevalence of 
secondary post-operative open angle glaucoma   
 
Whilst the investigation of the pathogenesis of post-operative glaucoma is beyond 
using the IOLu2 study cohort is not possible, the cohort will be able to provide data for 
the investigation of the determinants of the most significant post-operative complication.  
The primary outcome measure will be the presence of open angle glaucoma as 
confirmed by gonioscopy and as diagnosed by the eighth post-operative year (the time 
point at which studies of visual outcome will be undertaken). The definition of glaucoma 
and the potential associated factors (including the impact of topical and systemic 
steroids) to be investigated will the same as those described within this thesis. One 
addition will be the investigation of the impact of child’s ethnicity (as defined by the 
family) on the risk of glaucoma.  
Modelling on the occurrence or absence of glaucoma and the time to glaucoma (cox 
survival analysis modelling) will be undertaken in order to investigate the differential 
impact of factors on the time to onset of glaucoma.  
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7.  CONCLUSIONS 
 
This study is an example of the power of collaborative work, which is essential in the 
investigation of rare disorders. Multi-centre research involving national networks of 
specialist practitioners are not only feasible but are also desirable, and the BCCIG 
should continue to act as a model for the establishment of future (paediatric) 
ophthalmic collaborative groups.  
Persistent fetal vasculature is significantly more common in children with cataract than 
previously reported, and is probably even more common if the population of 
unoperated cataract is considered. Despite the small numbers of children affected and 
the usually unilateral nature of the disease, it should be a focus for future research into 
the pathogenesis of unilateral cataract and the failure of vascular apoptosis in the fetal 
eye. 
IOL implantation may lead to better visual outcome for children with bilateral cataract.  
Clarification of the strength and robustness of this effect will be provided by further 
follow up studies on outcomes in this cohort.  
Post-operative glaucoma may go on to develop in the majority of children in whom 
cataract surgery is undertaken in the first year of life, particularly if undertaken in the 
first month of life.  The potential magnitude of the effect of this blinding disorder within 
the population of aphakic and pseudophakic is considerable, and the findings of the 
associations with early life surgery will be disseminated to ophthalmic surgeons, as will 
the finding that cataract surgery in the first month of life was not associated with 
significantly better visual outcome, in order to encourage debate about the balance 
between the risk of amblyopia and the risk of glaucoma. 
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IOL implantation has not yet been widely adopted for the majority of children aged 
under 6 months old at surgery. However, the widespread use of IOL implantation in 
children aged over 6 months suggests that we are past the point of equipoise for 
investigations into outcome in this age group children, despite the potential increased 
risk to future cognitive development with multiple general anaesthetic episodes for 
secondary surgery for visual axis opacity. Nevertheless, the ophthalmic community of 
surgeons who undertake cataract surgery in the first few years of life will be 
encouraged to consider the ramifications of repeated general anaesthetics in young 
children. 
Refractive planning for and refractive outcomes in children aged under 2 years old are 
overly dependent on individual practice or are unpredictable. There is a pressing need 
for a consensus based decision on refractive planning.  
The suggested five year and 10 year post-operative follow up studies of outcome in this 
unique inception cohort of children, supported by the BCCIG, will provide information 
on visual outcome, the natural history of the development of aphakic and pseudophakic 
glaucoma, the refractive growth patterns in pseudophakic eyes (information which may 
guide refractive planning for future pseudophakic children). It will also provide 
information on the impact of these outcomes on their educational and personal 
development.  
Overall, the findings presented in this thesis indicate that primary IOL implantation for 
children ≤2 years old conferred no visual benefit for children with unilateral cataract, but 
may have improved visual outcome for children with bilateral cataract, whilst increasing 
the risk of the need for further surgical procedures which may adversely impact on 
cognitive development. The time has come for a nationally shared recording system for 
visual, refractive and visual outcomes following early life cataract surgery with IOL 
implantation, similar to that which exists for adult cataract surgery. 
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9. APPENDICES 
Appendix A: Aphakic and pseudophakic glaucoma following paediatric cataract surgery 
(Paper in press, Der Ophthalmolge, accepted September 2010) 
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 Appendix C: Cataract surgery and primary intraocular lens implantation in children ≤2 
years old in the United Kingdom and Ireland: findings of a national survey  
(Published work) 
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Appendix D: National study of primary IOL implantation in children ≤2 years old 
(IOLunder2 study) notification forms  
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Appendix E: IOLunder2 study data collection instruments 
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Appendix F: IOLunder2 study parental / guardian information sheets and consent form 
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Appendix G: Hospital specific per operative data collection proforma 
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Appendix H: Four by four data tables 
for calculation of positive and negative predictive values in the comparison of clinical 
and ultrasound determined microphthalmos 
 
 
  
Microphthalmos 
on ultrasound    
Microphthalmos 
on ultrasound 
Bilateral 
cataract 
Right 
eye No  Yes  
Bilateral 
cataract 
Left 
eye No  Yes 
Clinical 
micro 
No 31 1  Clinical 
micro 
No 26 0 
Yes 67 15  Yes 73 15 
         
         
  
Axial 
length<16mm    
Axial 
length<16mm 
Bilateral 
cataract 
Right 
eye No  Yes  
Bilateral 
cataract 
Left 
eye No  Yes 
Clinical 
micro 
No 87 5  Clinical 
micro 
No 86 4 
Yes 11 11  Yes 13 11 
         
         
  Microcornea    Microcornea 
Bilateral 
cataract 
Right 
eye No  Yes  
Bilateral 
cataract 
Left 
eye No  Yes 
Clinical 
micro 
No 61 4  Clinical 
micro 
No 62 2 
Yes 15 12  Yes 17 3 
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Microphthalmos 
on ultrasound    
Microphthalmos 
on ultrasound 
Unilateral 
(cataract 
eyes)  
Right 
eye No  Yes  
Unilateral 
(cataract 
eyes) 
Left 
eye  No  Yes 
Clinical 
micro 
No 16 1  Clinical 
micro 
No 9 1 
Yes 18 5  Yes 12 6 
         
         
  
Axial 
length<16mm    
Axial 
length<16mm 
Unilateral 
(cataract 
eyes)  
Right 
eye No  Yes  
Unilateral 
(cataract 
eyes)  
Left 
eye  No  Yes 
Clinical 
micro 
No 33 4  Clinical 
micro 
No 21 5 
Yes 1 2  Yes 0 2 
         
         
  Microcornea    Microcornea 
Unilateral 
(cataract 
eyes)  
Right 
eye No  Yes  
Unilateral 
(cataract 
eyes)  
Left 
eye  No  Yes 
Clinical 
micro 
No 22 3  Clinical 
micro 
No 15 3 
Yes 4 3  Yes 3 3 
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Appendix I: Pre operative visual function:  
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<1 week old at assessment  1 week - 6 months  6m  - 24m 
IOL 17,  Aphake 51  IOL 21, Aphake 29  IOL 18, Aphake 4 
No assessment 
Qualitative 
assessment 
Quantitative 
assessment 
 No assessment 
Qualitative 
assessment 
Quantitative 
assessment 
 No assessment 
Qualitative 
assessment 
Quantitative 
assessment 
IOL - 11/17, 
64.7% 
IOL - 6 0 children  IOL -8/21, 38.1% IOL - 9 IOL - 4  
IOL - 5/18, 
27.8% 
IOL - 6 IOL - 7 
(41.2 - 82.3%) Aphake - 9   (20.7 - 59.2%) Aphake - 17 Aphake - 2  (12.2 - 51.2%) Aphake - 1 Aphake - 1 
Aphake - 42/51, 
82.4% 
   
Aphake - 10/29, 
34.5% 
   
Aphake - 2/4, 
50% 
  
(69.5 - 90.7%)    (19.9 - 52.67%)    (15 - 85%)   
Pre-operative visual assessments undertaken in children with bilateral cataract by treatment group 
 
 
<1 week old at assessment  1 week - 6 months  6m  - 24m 
IOL 11, 
Aphake 20 
 IOL 15, Aphake 19  IOL 26, Aphake 4 
No assessment 
Qualitative 
assessment 
Quantitative 
assessment 
 
No 
assessment 
Qualitative 
assessment 
Quantitative 
assessment 
 
No 
assessment 
Qualitative 
assessmen
t 
Quantitativ
e 
assessmen
t 
IOL - 8/18, 44.4% IOL - 3 0 children  
IOL - 7/15, 
46.7% 
IOL - 5 IOL  - 3  
IOL - 6/26, 
23.1% 
IOL - 10 IOL - 10 
(24.5 - 66.3%) Aphake - 6   (24.8 - 69.9%) Aphake - 10 Aphake - 1  
(10.7 - 
42.4%) 
Aphake - 2 Aphake - 0 
Aphake - 14/20, 70%    
Aphake - 8/19, 
42.1% 
   
Aphake - 2/4, 
50% 
  
(47.9 - 85.9%)    (23.1 - 63.8%)    (15 - 85%)   
Pre-operative visual assessments undertaken in children with unilateral cataract by treatment group 
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Appendix J: Biometric data  
 
 
Anterior chamber biometrics of included children 
 
    
Bilateral cataract 
(n=57)  
Unilateral cataract 
(n=52)  
Corneal curvature(mm)     
 Missing  4 5 
 Median  7.5 7.5 
  Range 6.4 - 8.3 6.4 - 8.4 
Corneal astigmatism (mm)   
 Missing  12 9 
 Median  0.3 0.3 
  Range 0 - 1.3 0 - 1.1 
Anterior chamber depth (mm)   
 Missing  30 29 
 Median  2.9 3.1 
  Range 1.5 - 4.5 1.6 - 4.5 
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Appendix K: Flowcharts of surgical procedures undertaken in operated eyes 
 
Surgical procedures used in children in the IOL group with bilateral or 
unilateral cataract 
 400 
 
Surgical procedures used in children in the APHAKE group with bilateral 
or unilateral cataract 
 401 
Appendix L: Description of variables used in statistical analyses of outcome 
 
IRIS PROLAPSE 
 
IOL  IOL implantation – binary categorical variable 
Age at surgery  Age at surgery uncorrected for gestational age, in days 
Gest age at surg Age at surgery corrected for gestational age, in days 
Significant ocular abnormality  
Presence of significant ocular anomaly – binary categorical 
variable 
Persistent fetal vasculature Presence of PFV– binary categorical variable 
Axial length  Pre operative axial length in mm  
Horizontal corneal diameter  Pre operative horizontal corneal diameter in mm 
AxL <16mm Axial length less than 16mm – binary categorical variable 
HCD <9.5mm HCD less than 9.5mm– binary categorical variable 
Microphthalmos Microphthalmic eye– binary categorical variable 
IO AL diff Interocular axial length difference in mm  
Microcornea Microcornea– binary categorical variable 
Exp. Surgeon  Surgeon operating on >10 eyes– binary categorical variable 
Viscous OVD  
Viscosity of OVD used per operatively – ordinal categorical 
variable 
Right eye Laterality of eye = Right – binary categorical variable 
 
VISUAL OUTCOME  
 
IOL implant IOL implantation  
Age at diagn Age at diagnosis in days 
Time from diagnosis to surg 
Time from diagnosis of cataract / referral for cataract to 
primary surgery, in days 
Age at surgery Age at surgery uncorrected for gestational age, in days 
Gest age surg Age at surgery corrected for gestational age, in days 
Axial length  Pre operative axial length in mm 
HCD Pre operative horizontal corneal diameter in mm 
Microphthalmos Microphthalmic eye 
IO AL diff Interocular axial length difference in mm  
Significant ocular abnorm  Presence of significant ocular anomaly  
Medical disorder /  impairment  
Presence of medical disorder or impairment – binary 
categorical variable 
Pre op strabismus 
Pre-operative constant strabismus – binary categorical 
variable 
Pre op nystagmus Pre-operative manifest nystagmus– binary categorical variable 
Standard surgery  Standard surgery – binary categorical variable 
Peroperative complication  
Occurrence of per-operative complication – binary categorical 
variable 
Exp. Surgeon  Surgeon operating on >10 eyes 
Good conc correctn 
Good concordance with contact lenses / glasses– binary 
categorical variable 
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Post operative VAO  Post operative visual axis opacity – binary categorical variable 
Post op Glaucoma Post operatie glaucoma– binary categorical variable 
Any post op complication  Any post operative adverse event – binary categorical variable 
Secondary IO procedures 
Secondary (post operative) intraocular procedure– binary 
categorical variable 
Right eye Laterality of eye = Right– binary categorical variable 
Good concordance occl 
Good concordance with occlusion therapy (unilateral cataract) 
– binary categorical variable 
Cataract asymmetry  
Asymmetric cataract at initial presentation (bilateral cataract) – 
binary categorical variable 
Time between surg Time between first and second eye surgery, in days (bilat cat) 
 
Visual axis opacity (VAO)   
 
IOL implantation  IOL implantation  
Gest age at surgery Age at surgery corrected for gestational age, in days 
Age at surgery Age at surgery uncorrected for gestational age, in days 
Persistent fetal vasculature Presence of PFV– binary categorical variable 
Axial length  Pre operative axial length in mm 
Horizontal corneal diameter  Pre operative horizontal corneal diameter in mm 
Exp. Surgeon  Surgeon operating on >10 eyes– binary categorical variable 
Manual anterior capsulotomy 
Manual anterior capsulorhexis (continuous circular 
capsulorrhexis or two incision push pull) – binary categorical 
variable 
Viscous OVD Viscosity of OVD used per operatively  
Posterior capsulotomy  Primary posterior capsulotomy undertaken  
Single piece IOL  Single piece IOL implanted – binary categorical variable 
IOL in bag  IOL implanted into capsular bag – binary categorical variable 
Per operative heparin  
Per operative intraocular heparin administration – binary 
categorical variable 
Per op iris trauma 
Per operative planned or unplanned iris trauma – binary 
categorical variable 
Per op IOL explant  IOL explanted per operatively – binary categorical variable 
Post op intensive  steroid 
Post operative prescription of intensive topical steroid regimen 
– binary categorical variable 
Post op systemic steroids 
Post operative prescription of systemic steroids– binary 
categorical variable 
Post op inflammation Post operative inflammatory event – binary categorical variable 
Right eye Laterality of eye = Right 
 
GLAUCOMA   
 
IOL implantation  IOL implantation  
Age at surgery Age at surgery uncorrected for gestational age, in days 
Gest age at surg Age at surgery corrected for gestational age, in days 
Significant ocular abnormality  Presence of significant ocular anomaly  
Persistent fetal vasculature Presence of PFV 
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Axial length  Pre operative axial length in mm 
Horizontal corneal diameter  Pre operative horizontal corneal diameter in mm 
AxL <16mm Axial length less than 16mm 
HCD <9.5mm HCD less than 9.5mm 
Microphthalmos Microphthalmic eye 
IO AL diff Interocular axial length difference in mm  
Microcornea Microcornea 
Exp. Surgeon  Surgeon operating on >10 eyes 
Viscous OVD Viscosity of OVD used per operatively  
Posterior capsulotomy  Primary posterior capsulotomy undertaken  
Per op iris trauma Per operative planned or unplanned iris trauma  
Per op IOL explant  IOL explanted per operatively  
Post op intensive  steroid Post operative prescription of intensive topical steroid regimen  
Post op systemic steroids Post operative prescription of systemic steroids 
Post op inflammation Post operative inflammatory event  
Sec IO procedures Secondary (post operative) intraocular procedure 
Right eye Laterality of eye = Right 
 
PREDICTION ERROR (discrepancy between planned and actual refractive outcome)   
 
Gest age at surgery Age at surgery corrected for gestational age, in days 
Age at surgery Age at surgery uncorrected for gestational age, in days 
K Corneal curvature in mm 
K astigmatism  Corneal astigmatism in mm 
Axial length  Pre operative axial length in mm 
HCD    Pre operative horizontal corneal diameter in mm  
AxL <16mm Axial length less than 16mm 
AxL <20mm Axial length less than 20mm 
HCD <9.5mm HCD less than 9.5mm 
IO AL diff Interocular axial length difference in mm  
ACDepth Anterior chamber depth in mm 
Formula IOL power calculation formula used – categorical variable 
IOL power Power of implanted IOL – numerical variable 
Ant segment abnormality  Presence of anterior segmental abnormality  
Viscous OVD Viscosity of OVD used per operatively  
Posterior capsulotomy  Primary posterior capsulotomy undertaken  
Ant vitrectomy  Primary anterior vitrectomy undertaken  
Wound sutured Surgical wound closed with suture 
Exp. Surgeon  Surgeon operating on >10 eyes 
Single piece IOL  Single piece IOL implanted  
IOL in bag  IOL implanted into capsular bag  
Right eye Laterality of eye = Right 
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Appendix M: Correlations between factors of interest with regards to visual, refractive 
and adverse outcome 
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VISUAL 
OUTCOME _ 
Bilateral 
Age at 
diagn 
Time diagn Age surg 
Gest age 
surg 
AL HCD Microphthal IO AL diff 
Signif ocular 
abnorm 
Med 
disorder / 
impair 
Pre op 
Strab 
Pre op 
Nystag 
Routine 
surgery 
Per-op 
comp 
Exp. Surg 
Good 
Compl 
correctn 
Post op 
VAO 
Post op 
Glauc 
Post-op 
comp 
Sec IO 
procedures 
Cataract 
asymmetry 
Time 
between 
surg 
Right eye IMD 
IOL implant 
-1    
p=0.05 
-1.5   p=0.1 
1.01   
p=0.01 
1.01  
p=0.01 
2.1     
p=0.001 
13.9  
p=0.02 
0.08   p=0.001 1.1  p=0.3 0.1  p=0.003 0.5  p=0.5 
6.6   
p=0.04 
3.1  p=0.2 5.5  =0.01 
1.3   
p=0.7 
1.9  p=0.2 1.6  p=0.1 2.1  p=0.3 0.9  p=0.9 1.0  p=0.9 1.5   p=0.4 2.9  p=0.1 -0.9   p=0.3 0.9  p=0.3 
7.5   
p=0.11 
Age at diagn  
-0.4 
p=0.002 
0.5   
p<0.001 
0.5  
p<0.001 
0.5 
p<0.0001 
0.3   
p=0.04 
2.1  p=0.4 
0.6  
p=0.007 
0.9   p=0.4 0.2   p=0.8 4.9  p=0.08 4.5  p=0.04 0.3  p=0.8 
-0.3  
p=0.8 
1.8   p=0.07 2.1  p=0.2 0.6  p=0.6 1.5  p=0.2 0.9  p=0.3 1.1  p=0.3 3.1  p=0.08 0.07  p=0.2 
0.03   
p=0.9 
6.4    
p=0.17 
Time from 
diagnosis to surg 
  
0.25  
p=0.05 
0.27  
p=0.04 
0.1  p=0.5 0.1  p=0.4 0.03   p=0.8 0.3  p=0.8 0.24   p=0.8 -1.2  p=0.3 7.9  p=0.02 0.3  p=0.5 1.1  p=0.3 
0.5  
p=0.6 
0.9  p=0.3 1.9  p=0.08 1.3  p=0.2 
-0.3  
p=0.9 
1.1  p=0.3 0.9  p=0.3 2.7  p=0.4 -0.9  p=0.3 0.2  p=0.9 11.1   
p=0.2 
Age at surgery    - 0.7  p<0.001 
0.5  
p=0.001 
2.5  p=0.0004 0.2  p=0.4 
3.3   
p=0.0009 
-1.8  
p=0.08 
9.8  
p=0.007 
2.2  p=0.1 -0.4  p=0.6 
0.8  
p=0.4 
1.5  p=0.1 0.5  p=0.5 0.8  p=0.4 
1.8  
p=0.06 
1.2  p=0.2 0.8  p=0.4 5.2  p=0.02 0.2  p=0.08 0.1  p=0.9 
3.8  p=0.4 
Gest age surg     0.7  p<0.001 
0.5  
p<0.001 
2.3  p=0.02 0.2  p=0.2 
3.2    
p=0.0001 
-1.8  
p=0.07 
9.5  
p=0.009 
1.8  p=0.2 -1.2  p=0.3 
1.2  
p=0.2 
1.3  p=0.2 p=0.3 0.4  p=0.7 1.5  p=0.1 0.9  p=0.4 0.7   p=0.5 4.5  p=0.04 0.2  p=0.1 0.1  p=0.9 
4.2    p=0.5 
Axial length       
0.7  
p<0.001 
5.4   p<0.0001 0.1   p=0.3 - 
-0.9   
p=0.4 
 1.5  p=0.2 -0.3  p=0.5 
0.8  
p=0.4 
1.3  p=0.2 0.04  p=0.8 0.8  p=0.4 1.1  p=0.3 1.1  p=0.3 1.4  p=0.2 8.3  p=0.004 0.3  p=0.04 
-0.1  
p=0.9 
8.9    
p=0.07 
HCD       3.5  p=0.004 0.1  p=0.7 - 0.2   p=0.8 0.3   p=0.6 1.6 p=0.2 0.6  p=0.5 
0.01  
p=0.9 
0.1  p=0.8 0.4  p=0.6 0.8  p=0.4 0.9  p=0.3 1.8  p=0.8 -0.5  p=0.6 0.2  p=0.7 -0.6  p=0.7 
-0.1  
p=0.99 3.7   p=0.4 
Microphthalmos        0.7   p=0.4 - 0.5   p=0.3 2  p=0.03 0.75  p=0.6 
0.57   
p=0.3 
1.2  
p=0.9 
0.9  p=0.9 0.9  p=0.9 1.2  p=0.8 0.9  p=0.9 1.3  p=0.6 0.4  p=0.9 0.3   p=0.1 2.2  p=0.3 0.8  p=0.1 
4.1    p=0.4 
IO AL diff         0.6   p=0.6 0.8  p=0.2 2.3   p=0.3 0.5  p=0.4 
-2.7   
p=0.006 
1.0  
p=0.3 
2.8  p=0.005 0.2  p=0.7 
1.8  
p=0.07 
-0.5  
p=0.6 
1.0  p=0.3 1.7  p=0.09 0.1  p=0.7 0.06  p=0.7 
-0.9  
p=0.4 0.1    p=0.9 
Significant ocular 
abnorm  
         2.1  p=0.1 0.8  p=0.9 0.9  p=0.8 1.1  p=0.9 
1.3  
p=0.6 
0.9  p=0.9 0.2  p=0.5 0.9 p=0.9 
3.7  
p=0.06 
1.5  p=0.3 0.9  p=0.8 0.4  p=0.3 1.0  p=0.3 1.0  p=0.8 
2.7   p=0.6 
Medical disorder /  
impairment  
          
1.6   
p=0.04 
2.1  p=0.3 1.8   p=0.3 
0.5  
p=0.3 
0.6  p=0.5 1.2  p=0.9 0.3  p=0.1 0.3  p=0.3 0.9  p=0.8 0.3  p=0.09 0.6  p=0.6 
1.006  
p=0.07 
0.9  p=0.3 
4.4   p=0.4 
Pre op strabismus            
16.3  
p<0.0001 
6.6  p=0.2 
2.4  
p=0.3 
1.9  p=0.4 4.5  p=0.1 1.8  p=0.4 1.6  p=0.5 
4.7  
p=0.09 
1.7  p=0.4 17.1 p<0.0001 0.1  p=0.9 
-1.36  
p=0.2 9.7   p=0.2 
Pre op nystagmus             1.4  p=0.2 
0.03  
p=0.9 
0.02  p=0.9 
11.1 
p=0.001 
1.1  p=0.3 0.2  p=0.7 0.1  p=0.7 2.9  p=0.09 1.6  p=0.2 -0.95  p=0.3 
0.02  
p=0.9 4.3   p=0.4 
Routine surgery               
2.2  
p=0.1 
5.8 
p<0.0001 
4.5  p=0.2 1.0  p=0.9 1.1  p=0.9 1.3  p=0.6 1.1  p=0.8 1.1  p=0.9 1.2  p=0.2 1.0  p=0.9 
5.7   p=0.2 
Peroperative 
complication  
              1.1  p=0.9 1.1  p=0.9 2.1  p=0.2 0.8  p=0.7 1.4  p=0.5 2.0  p=0.2 0.7  p=0.7 1.3  p=0.2 0.8  p=0.7 
5.1   p=0.3 
Exp. Surgeon                 1.6  p=0.6 1.4  p=0.4 1.2  p=0.8 1.5  p=0.3 0.9  p=0.8 0.4  p=0.2 2.6  p=0.02 0.9  p=0.9 16    
p=0.003 
Good Compl 
correctn 
                2.6  p=0.1 1.2  p=0.3 
0.02  
p=0.9 
2.7  p=0.1 0.05  p=0.8 -1.7  p=0.1 
0.07  
p=0.9 
6.4     
p=0.2 
Post operative 
VAO  
                 0.8  p=0.7 - - 0.7  p=0.6 -1.1  p=0.3 1.7  p=0.2 
3.1   p=0.5 
Post op Glaucoma                   - - 0.4  p=0.4 -0.4  p=0.7 
1.2   
p=0.7 3.1   p=0.5 
Any post op 
complication  
                   - 0.4  p=0.1 -1.1  p=0.3 0.8  p=0.8 
5.1   p=0.3 
Secondary IO 
procedures 
                    0.6  p=0.6 
-0.04  
p=0.09 
1.8  p=0.1 
8.9  p=0.3 
Cataract 
asymmetry  
                     1.7  p=0.1 
0.04  
p=0.8 
10.1   
p=0.4 
Time between 
surg 
                      0.0  p=0.9 
8.2   
p=0.08 
Right eye                         0.04   p=1 
 
 406 
VISUAL 
OUTCOME _ 
Unilateral  
Age at 
diagn 
Time 
diagn 
Age surg 
Gest age 
surg 
AL HCD Microphthal IO AL diff 
Signif 
ocular 
abnorm  
Med 
disorder / 
impair 
Pre op 
Strab 
Pre op 
Nystag 
Routine 
surgery  
Per-op 
comp 
Exp. Surg 
Good 
Compl  
occl 
Good 
Compl 
correctn 
Post op VAO  
Post op 
Glaucoma 
Post-op 
complication  
Secondary IO 
procedures 
Right eye IMD 
IOL implant 
2.2  
p=0.03 
0.4  p=0.7 -1 p=0.1 
1.002  
p=0.13 
1.3  p=0.2 
12.1  
p=0.02 
0.8  p=0.8 1.5  p=0.3 
0.2  
p=0.02 
0.3  p=0.6 0.8  p=0.7 2.6  p=0.1 
5.5  
p=0.001 
2.2  p=0.3 2.2  p=0.2 1.3  p=0.2 1.1  p=0.3 2.6  p=0.06 0.6  p=0.5 1.0  p=0.9   1.6  p=0.5 1.2  p=0.8 
0.8   
p=0.94 
Age at diagn   0.2  p=0.2 
0.9  
p<0.0001 
0.9  
p<0.0001 
0.7 
p<0.0001 
0.4  p=0.02 2.6 p=0.01 0.5  p=0.006 0.9   p=0.4 0.3  p=0.7 
20.7  
p=0.01 
2.0  p=0.4 
-2.8  
p=0.05 
0.7  p=0.5 1.2  p=0.2 4.4  p=0.1 0.9  p=0.3 2.8  p=0.006 0.8  p=0.5 0.4  p=0.7 2.6  p=0.08 0.3  p=0.8 0.8   p=0.9 
Time from 
diagnosis to surg 
    
0.5   
p<0.001 
0.6  
p=0.001 
0.4  p=0.01 0.3  p=0.09 0.1  p=0.5 1.7  p=0.08 -0.6  p=0.6 
0.04  
p=0.97 
4.7   p=0.9 1.9  p=0.4 0.9  p=0.3 
-0.01  
p=0.9 
1.5  p=0.1 
6.8  
p=0.03 
3.0  p=0.08 2.3  p=0.03 1.1  p=0.3 2.7  p=0.008 2.6  p=0.008 
-0.3  
p=0.8 
4.2   p=0.4 
Age at surgery       - 
0.6 
p<0.0001 
0.4  p=0.04 2.5  p=0.01 0.4  p=0.05 0.5  p=0.3 0.2  p=0.8 
17.8  
p=0.001 
2.1  p=0.3 
-2.7  
p=0.007 
0.9  p=0.4 
2.3  
p=0.02 
7.5  
p=0.02 
0.7  p=0.4 3.2  p=0.002 0.9  p=0.4 1.1  p=0.2 3.2 p=0.001 
-0.05  
p=0.9 
2.7  p=0.6 
Gest age surg         
0.6 
p<0.0001 
0.4  p=0.04 2.9  p=0.008 0.4  p=0.08 0.7  p=0.4 -0.2  p=0.9 
17.5  
p=0.002 
2.2  p=0.3 
-2.6  
p=0.008 
-0.3  p=0.7 
2.0  
p=0.05 
9.3  
p=0.01 
0.6  p=0.4 3.1  p=0.002 0.6  p=0.5 1.1  p=0.3 3.1  p=0.002 
-0.1  
p=0.9 
2.1   p=0.7 
Axial length            
0.6 
p=0.001 
4.8 p<0.0001 
0.8  
p<0.0001 
- 0.2  p=0.9 
12.1  
p=0.002 
1.5  p=0.5 
-1.7  
p=0.08 
1.1  p=0.3 
2.5  
p=0.01 
0.9  p=0.6 1.6  p=0.2 3.1  p=0.02 2.8  p=0.005 1.7  p=0.09 3.6  p=0.003 
-0.3  
p=0.7 
0.7     
p=0.9 
HCD             1  p=0.3 0.3  p=0.3 - -0.4   p=0.7 1.9  p=0.4 1.3  p=0.9 
-2.2  
p=0.03 
0.1  p=0.9 0.8  p=0.5 0.2  p=0.9 0.1  p=0.8 1.2  p=0.3 1.5  p=0.1 0.7   p=0.5 1.8  p=0.07 1.0  p=0.3 4.7   p=0.3 
Microphthalmos               3.5   0.04 - 0.4  p=0.4 1.3  p=0.7 1.4  p=0.5 0.3  p=0.1 1.2  p=0.8 
5.5  
p=0.02 
2.6  p=0.3 0.7  p=0.7 4  p=0.06 0.01  p=0.9 2.6  p=0.2 4.9  p=0.03 1.0  p=0.9 2.2   p=0.7 
IO AL diff                 -0.1 p=0.9 -0.6  p=0.5 1.9  p=0.4 2.1  p=0.1 -0.9  p=0.3 1.1  p=0.3 1.2  p=0.2 0.3  p=0.9 0.4  p=0.8 1.7  p=0.07 2.2  p=0.8 0.2  p=0.8 2.4  p=0.02 
-1.4  
p=0.2 
1.7   p=0.8 
Significant ocular 
abnorm  
                  0.4  p=0.5 1.2  p=0.9 2.5  p=0.3 0.6  p=0.4 0.6  p=0.5 
3.2  
p=0.09 
0.2  p=0.3 0.2  p=0.1 1.2  p=0.8 6.6  p=0.1 1.1  p=0.7 1.4  p=0.6 
3.8  
p=0.04 
4.8   p=0.3 
Medical disorder /  
impairment  
                    2.7  p=0.3 1.5  p=0.3 2.9  p=0.09 0.9  p0.9 1.7  p=0.6 0.7  p=0.6 2.7  p=0.5 0.5  p=0.5 -1.2   p=0.1 1.2  p=0.9 0.4  p=0.5 0.8  p=0.8 2.9  p=0.6 
Preop strabismus                       6.6  p=0.2 6.2  p=0.05 
10.1  
p=0.007 
0.4  p=0.8 
9.0  
p=0.06 
5.5  p=0.06 9.8  p=0.08 1.2  p=0.6 0.9  p=0.6 8.3  p=0.02 0.6  p=0.7 5.8  p=0.7 
Pre op nystagmus                         0.8 p=0.7 2.0  p=0.4 3.4  p=0.2 5.6  p=0.2 6.8  p=0.03 4.3  p=0.1 0.7  p=0.7 1.3  p=0.5 4.4  p=0.4 1.9 p=0.4 6.6  p=0.6 
Routine surgery                            1.5  p=0.6 2.9  p=0.1 5.2  p=0.2 4.7  p=0.2 0.7  p=0.6 0.4  p=0.3 0.9  p=0.9 0.6  p=0.4 1.5  p=0.5 3.1   p=0.6 
Peroperative 
complication  
                            3.6  p=0.1 0.2  p=0.2 0.4  p=0.5 2.8  p=0.2 5.2  p=0.1 2.5   p=0.3 2.5  p=0.6 
0.7   
p=0.7 
2.3  p=0.7 
Exp. Surgeon                                0.5  p=0.6 3.3  p=0.3 4.6  p=0.04 2.4  p=0.5 4.8   p=0.03 5.3  p=0.02 1.4  p=0.6 1.7  p=0.8 
Good concordance  
occlusion 
                  6.0 p=0.05 0.04  p=0.9 3.4  p=0.2 4.2  p=0.1 0.1  p=0.9 1.4  p=0.5 1.0  p=0.9 
Good concordance 
correctn 
                                  1.3  p=0.2 1.2  p=0.3 0.01  p=0.9 1.6  p=0.2 
0.005  
p=0.9 
7.4   p=0.5 
Post operative 
VAO  
                    2.5  p=0.3 - - 1.5  p=0.5 2.5   p=0.6 
Post op Glaucoma                                       - - 1.1  p=0.8 5.2   p=0.3 
Any post op 
complcn 
                                        - 1.2  p=0.8 4.7   p=0.3 
Secondary 
intraocular 
procedures 
                                          1.2  p=0.8 
27.3  
p=0.04 
Right eye  
                                            2.3  p=0.7 
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IRIS 
PROLAPSE - 
Bilateral 
Age at 
surgery 
Gest age 
at surg 
Signif 
ocular 
abnorm 
PFV 
Axial 
length  
HCD 
AxL 
<16mm 
HCD 
<9.5mm 
Microphthal
mos 
IO AL diff Microcornea 
Exp. 
surgeon  
Viscous 
OVD 
Right eye 
IOL 
4.4              
p<0.001 
4.5              
p<0.001 
-4.18              
p<0.001 
-0.42                
p=0.3 
8.51   
p<0.001 
8.82    
p<0.001 
-3.58      
p<0.001 
8.38        
p=0.004 
-3.52    
p<0.001 
1.0         
p=0.3 
-2.38     
p=0.02 
0.68        
p=0.09 
2.46     
p=0.01 
-0.26       
p=0.80 
Age at surgery   - 
-3.71    
p<0.001 
1.8                  
p=0.07 
0.74   
p<0.001 
0.50    
p<0.001 
-4.97   
p<0.001 
-2.18        
p=0.03 
-4.18    
p0.001 
0.03         
p=0.7 
-3.77    
p=0.001 
-0.11       
p=0.9 
4.55    
p=0.17 
0.05     
p=0.96 
Gest age at surg     
-3.46    
p<0.005 
1.65                   
p=0.19 
0.70     
p<0.001 
0.46      
p<0.001 
-4.66     
p<0.001 
-2.16     
p=0.03 
-3.9     
p<0.001 
0.03      
p=0.8 
-3.23     
p=0.04 
0.33        
p=0.7 
6.01     
p=0.16 
0.04    
p=0.96 
Significant ocular 
abnormality  
      - - - - - - 
-0.8      
p=0.42 
- 
-0.13     
p=0.9 
0.51    
p=0.66 
-0.57      
p=0.57 
Persistent fetal 
vasculature 
    
1.05               
p=0.29 
-0.8             
p=0.36 
0.00   
p=0.99 
1.38        
p=0.17 
0.78    
p=0.43 
-0.56     
p=0.57 
0.87      
p=0.38 
-1.09     
p=0.27 
3.38    
p=0.01 
-0.90      
p=0.37 
Axial length            
0.74     
p<0.001 
- - - 
0.13    
p=0.16 
- 
-0.37         
p=0.71 
1.36        
p=0.7 
-0.29       
p=0.76 
Horizontal corneal 
diameter  
      - - - 
0.07       
p=0.07 
- 
0.55       
p=0.59 
4.70          
p=0.19 
-0.07      
p=0.94 
AxL <16mm               - - 
-1.74        
p=0.08 
- 
0.56    
p=0.58 
-1.09    
p=0.28 
-0.83      
p=0.41 
HCD <9.5mm         - 
-2.32     
p=0.02 
- 
-0.55   
p=0.59 
1.27    
p=0.20 
-1.28     
p=0.20  
Microphthalmos                 
-1.11       
p=0.27 
- 
0.04          
p=0.9 
-20.32    
p<0.001 
-2.11      
p=0.04 
IO AL diff                   
-0.28     
p=0.78 
-0.23        
p=0.82 
3.96          
p=0.70 
1.2     
p=0.22 
Microcornea            
0.65    
p=0.52 
-0.66        
p=0.51 
-1.21    
p=0.23 
Exp. Surgeon                          
0.84      
p=0.4 
-0.13    
p=0.89 
Viscous OVD                           0.0   p=0.99 
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IRIS 
PROLAPSE 
- Unilateral 
Age at 
surgery 
Gest age 
at surg 
Signif 
ocular 
abnorm 
PFV 
Axial 
length  
HCD 
AxL 
<16mm 
HCD 
<9.5mm 
Microphthalmos IO AL diff Microcornea 
Exp. 
surgeon  
Viscous 
OVD 
Right eye 
IOL 
3.1        
p<0.002 
3.4        
p<0.001 
-3.97   
p<0.001 
-3.27    
p=0.001 
5.86   
p<0.001 
4.50   
p<0.001 
-2.01    
p=0.08 
- -1.64    p=0.1 
2.79    
p=0.005 
-0.94     
p=0.21 
1.63    
p=0.09 
1.8       
p=0.07 
-0.07      
p=0.94 
Age at surgery   - 
-1.51    
p=0.54 
-0.61      
p=0.54 
0.67   
p<0.001 
0.58   
p<0.001 
-0.75     
p=0.46 
-1.16      
p=0.25 
-3.26    
p=0.001 
0.44    
p=0.99 
-1.07        
p=0.2 
-0.95     
p=0.34 
7.90        
p=0.06 
0.13     
p=0.47 
Gest age at surg     
-1.20    
p=0.23 
-0.50       
p=0.6 
0.67     
p<0.001 
0.56      
p<0.001 
-0.70    
p=0.48 
-1.16    
p=0.25 
-3.21     
p<0.001 
0.42     
p=0.99 
-0.85     
p=0.39 
-0.79     
p=0.4 
6.11     
p=0.1 
0.77     
p=0.44 
Significant ocular 
abnormality  
      - - - - - - 
1.27     
p=0.2 
- 
0.84      
p=0.40 
0.97      
p=0.33 
1.09     
p=0.28 
Persistent fetal 
vasculature 
    
-0.80    
p=0.42 
-0.97          
p=0.33 
-0.50     
p=0.62 
2.06   
p=0.15 
-0.37     
p=0.71 
-1.12         
p=0.26 
0.57           
p=0.58 
0.56     
p=0.58 
1.41     
p=0.16 
0.95      
p=0.34 
Axial length            
0.67   
p<0.001 
- - - 
0.75    
p<0.001 
- 
-1.52        
p=0.13 
2.43     
p=0.5 
0.92     
p=0.36 
Horizontal corneal 
diameter  
          - - - 
0.46     
p=0.15 
- 
-0.56      
p=0.57 
1.74       
p=0.08 
-0.53     
p=0.60 
AxL <16mm           - - 
-3.23    
p=0.001 
- 
0.93        
p=0.35 
-0.50   
p=0.62 
-0.03    
p=0.97 
HCD <9.5mm             - 
-1.70        
p=0.09 
- 
-0.92        
p=0.36 
1.55     
p=0.12 
2.06     
p=0.15 
Microphthalmos                   
-4.97    
p<0.001 
- 
1.88     
p=0.06 
0.03         
p=0.5 
-0.13       
p=0.89 
IO AL diff                     
-1.43     
p=0.15 
1.11      
p=0.27 
1.48     
p=0.69 
1.97     
p=0.05 
Microcornea            
-1.21     
p=0.23 
-1.61      
p=0.1 
-0.57     
p=0.57 
Exp. Surgeon                          
2.17    
p=0.03 
1.72     
p=0.09 
Viscous OVD                           
0.0     
p=0.99 
 
 
 
 
 
 
 
 409 
GLAUCOMA 
- Bilateral  
Age at 
surgery 
Gest age 
Signif oc. 
abnorm 
PFV 
Axial 
length  
HCD 
AxL 
<16mm 
HCD 
<9.5mm 
Microphthalmos 
IO AL 
diff 
Microcornea 
Exp. 
Surg 
Viscous 
OVD 
Post 
caps'my  
Iris 
trauma 
IOL 
explant  
Intensiv  
steroid 
System 
steroids 
Post op 
inflamm 
Sec IO 
procedures 
Right 
eye 
IOL implantation  
3.2   
p=0.001 
2.99  
p=0.003 
-3.7  
p<0.0001 
-0.62  
p=0.5 
-4.8  
p<0.0001 
-4.9  
p<0.001 
-3.2  
p=0.001 
16.1  
p<0.001 
-3.01  p=0.001 
-0.1  
p=0.9 
-2.6   
p<0.001 
1.09   
p=0.3 
1.1  
p=0.13 
2.4  
p=0.1 
-1.05  
p=0.3 
- 
2.3  
p=0.07 
1.4 
p=0.7 
3.1  
p=0.02 
2.9  p=0.01 
-0.99  
p=0.3 
Age at surgery   - 
-2.7  
p=0.007 
-1.3  
p=0.2 
0.8  
p<0.001 
0.5  
p<0.001 
4.3 
p<0.001 
1.5  
p=0.1 
3.3  p=0.001 
0.04  
p=0.7 
2.7    
p=0.005 
0.6   
p=0.5 
4.1  
p=0.2 
1.7   
p=0.08 
-0.9  
p=0.3 
-1.4   
p=0. 
-0.3  
p=0.7 
-1.1  
p=0.3 
2  
p=0.04 
0.6  p=0.8 
0.1  
p=0.9 
Gest age at surg     
2.6  
p=0.01 
-1.1  
p=0.3 
0.8 
p<0.001 
0.4  
p<0.001 
4.2  
p=0.0006 
1.4  
p=0.1 
3.4  p=0.002 
0.05  
p=0.6 
2.4   p=0.01 
0.5  
p=0.6 
4.2  
p=0.2 
1.7  
p=0.1 
2.4  
p=0.01 
-0.8 
p=0.4 
-0.6  
p=0.5 
-0.8   
p=0.4 
1.4  
p=0.1 
0.04  p=0.9 
1.1  
p=0.9 
Significant ocular 
abnormality  
      - - - - - - 
0.4  
p=0.6 
- 
0.9  
p=0.90 
0.06  
p=0.9 
0.9  
p=0.3 
2.3  
p=0.1 
5.1  
p=0.3 
0.7  
p=0.4 
0.4  
p=0.3 
0.6  
p=0.3 
0.5  p=0.4 
0.03  
p=0.9 
Persistent fetal 
vasculature 
    
-0.3  
p=0.7 
2.5  
p=0.02 
1.4   
p=0.8 
10.8  
p=0.03 
1.3  p=0.8 
0.03  
p=0.9 
3.5  p=0.2 
0.3  
p=0.1 
3.9  
p=0.3 
0.2  
p=0.7 
1.9  
p=0.5 
0.2  
p=0.7 
0.9  
p=0.9 
1.7 
p=0.6 
1.9  
p=0.2 
1.0  p=0.9 
1.0  
p=0.3 
Axial length            
0.7 
p<0.001 
- - - 
0.07   
p=0.5 
- 
0.7  
p=0.4 
1.7  
p=0.6 
1.3  
p=0.2 
3   
p=0.002 
-0.7  
p=0.5 
0.1  
p=0.9 
0.2  
p=0.9 
-0.2  
p=0.8 
0.2  p=0.8 
-0.1  
p=0.9 
Horizontal corneal 
diameter  
       - - - 
0.003  
p=0.9 
- 
0.04  
p=0.9 
11.0  
p=0.1 
1.8  
p=0.07 
2.3  
p=0.02 
0.8  
p=0.4 
-1  
p=0.3 
-0.7  
p=0.5 
-1.7   
p=0.09 
-1.4  p=0.2 
-0.02  
p=0.9 
AxL <16mm             - - 
0.9  
p=0.5 
- 
2.2 
p=0.2 
0.3  
p=0.3 
3.4  
p=0.3 
3.4  
p=0.04 
5.3  
p=0.02 
0.9  
p=0.9 
0.6  
p=0.6 
1.0  
p=0.9 
0.7  p=0.6 
0.9  
p=0.6 
HCD <9.5mm          - 
-2.2  
p=0.02 
- 
1.4  
p=0.7 
2.8   
p=0.4 
0.2  
p=0.6 
3.7  
p=0.09 
- 
0.2  
p=0.2 
1.9  
p=0.5 
0.9  
p=0.9 
0.5  p=0.3 
0.9 
p=0.4 
Microphthalmos                   
1.0  
p=0.3 
- 
0.8 
p=0.7 
5.9  
p=0.1 
2.4  
p=0.6 
5.8  
p=0.03 
0.4  
p=0.5 
0.9  
p=0.8 
1.2  
p=0.8 
1.3  
p=0.6 
1.8  p=0.3 
0.8  
p=0.1 
IO AL diff                     -0.3  p=0.7 
0.5  
p=0.6 
1.5  
p=0.7 
-0.9  
p=0.3 
-0.5   
p=0.6 
0.2   
p=0.8 
0.1  
p=0.8 
0.4  
p=0.6 
0.5  
p=0.6 
1.1  p=0.3 
-1.5  
p=0.1 
Microcornea             
1.5  
p=0.4 
0.7  
p=0.8 
1.1  
p=0.3 
2.7   
p=0.06 
0.06  
p=0.8 
0.7  
p=0.6 
0.8  
p=0.7 
0.6  
p=0.4 
0.4  p=01 
0.9  
p=0.7  
Exp. Surgeon                          
1.6  
p=0.6 
1.9  
p=0.2 
3.5   
p=0.02 
0.3  
p=0.5 
4.4   
p=0.01 
0.3   
p=0.1 
1.2 
p=0.7 
0.7  p=0.5 
1.0  
p=0.9 
Viscous OVD                 
11.4  
p=0.1 
2   p=0.6 
0.8  
p=0.8 
2  p=0.6 
6.5   
p=0.09 
0.6  
p=0.7 
1.2  p=0.7 
0.2  
p=0.9 
Posterior 
capsulotomy  
                            
0.5   
p=0.5 
0.08  
p=0.8 
1.2  
p=0.3 
0.2  
p=0.6 
2.5  
p=0.1 
0.6  p=0.4 
2.0  
p=0.2 
Per op iris trauma                               
2.5  
p=0.5 
1.1  
p=0.8 
1.3 
p=0.7 
1.7  
p=0.4 
1.1   p=0.9 
1.2  
p=0.9 
Per op IOL explant                          
0.5  
p=0.5 
0.4  
p=0.5 
0.4  
p=0.4 
1.6  p=0.2 
0.4  
p=0.5 
Post op intensive  
steroid 
                                  
0.2  
p=0.1 
1.4   
p=0.5 
1.5   p=0.3 
1.1  
p=0.2 
Post op systemic 
steroids 
                          
1.3  
p=0.8 
3.3  p=0.04 
1.1  
p=0.3 
Post op 
inflammation 
                                      
5.4   
p=0.001 
2.1  
p=0.09 
Sec IO procedures                                         
1.1  
p=0.8 
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GLAUCOMA 
- Unilateral 
Age at 
surgery 
Gest 
age 
Signif oc. 
abnorm 
PFV 
Axial 
length  
HCD 
AxL 
<16mm 
HCD 
<9.5mm 
Microphthalmos IO AL diff Microcornea 
Exp. 
Surg 
Viscous 
OVD 
Iris 
trauma 
IOL 
explant  
Intensiv  
steroid 
System 
steroids 
Post op 
inflamm 
Sec IO 
procedures 
Right 
eye 
IOL implantation  
1.9  
p=0.06 
1.9  
p=0.06 
-3.4   
p=0.001 
-2.9   
p=0.004  
-1.8  
p=0.08 
-3.6   
p=0.0003 
-1.8  
p=0.07 
- -0.6  p=0.5 
-0.6  
p=0.6 
-2.7  p=0.007 
0.8  
p=0.4 
1.9    
p=0.1 
-2.2   
p=0.03 
- 
-0.1   
p=0.9 
0.2  
p=0.8 
1.2  
p=0.7 
0.9  p=0.4 
-0.2  
p=0.8 
Age at surgery   - 
1.1   
p=0.3 
0.008  
p=0.9 
0.6 
p<0.001 
0.3  
p=0.04 
0.2  
p=0.8 
-0.2  
p=0.8 
2.6  p=0.01 
0.3  
p=0.06 
0.03  p=0.9 
1.8  
p=0.07 
2.9   
p=0.4 
0.7  
p=0.5 
0.9  
p=0.4 
0.9   
p=0.4 
-1.4  
p=0.2 
1.4   
p=0.8 
3.5   
p=0.0004 
-0.2  
p=0.8 
Gest age at surg     
0.8  
p=0.4 
-0.2  
p=0.8 
0.6 
p<0.001 
0.3  
p=0.06 
-0.02  
p=0.9 
-0.1  
p=0.9 
2.3  p=0.02 
0.3  
p=0.1 
-0.2  p=0.9 
1.6   
p=0.1 
1.9  
p=0.6 
0.5  
p=0.6 
1.0  
p=0.3 
0.7   
p=0.5 
-1.4  
p=0.2 
1.3  
p=0.2 
3.5  
p=0.0005 
-0.4   
p=0.7 
Significant ocular 
abnormality  
      - - - - - - 
0.2   
p=0.8 
- 
2.3   
p=0.2 
1.1  
p=0.3 
5.6  
p=0.02 
1.9  
p=0.2 
1.5  
p=0.5 
0.6  
p=0.6 
1.5  
p=0.5 
1.5  p=0.5 
1.9  
p=0.9 
Persistent fetal 
vasculature 
        
0.5  
p=0.6 
1.6  p=0.1 
1.5  
p=0.7 
1.0  
p=0.3 
1.03  p=0.9 
0.6  
p=0.5 
2  p=0.3 
1.7  
p=0.4 
3   p=0.4 
2.2  
p=0.2 
2.7  
p=0.1 
1.5  
p=0.5 
2.9  
p=0.2 
1.04  
p=0.9 
0.7  p=0.6 
0.7  
p=0.5 
Axial length            
0.6  
p<0.001 
- - - 
0.7    
p<0.001 
- 
2.6   
p=0.009 
0.5 
p=0.9 
1.8  
p=0.07 
1.4  
p=0.2 
1.8   
p=0.08 
-2.1  
p=0.04 
0.8  
p=0.4 
3.2  p=0.002 
0.02  
p=0.9 
Horizontal corneal 
diameter  
          - - - 
0.3  
p=0.2 
- 
0.09  
p=0.9 
4.5  
p=0.2 
1.1  
p=0.3 
-0.1   
p=0.9 
-0.2  
p=0.8 
-0.1  
p=0.9 
0.1    
p=0.9 
0.9  p=0.4 
1.2  
p=0.2 
AxL <16mm               - - 
2.8   
p=0.005 
- 
2.3  
p=0.1 
3  p=0.4 
18.5   
p=0.02 
0.03   
p=0.8 
0.7  
p=0.8 
0.4  
p=0.5 
0.8  
p=0.8 
4.2   p=0.04 
3.1  
p=0.3 
HCD <9.5mm             - 
1.7  
p=0.1 
- 
0.2  
p=0.6 
0.5 
p=0.9 
3.1  
p=0.08 
- 
1.7  
p=0.2 
0.08  
p=0.8 
0.3  
p=0.5 
1.03   p=0.3 
1.0  
p=0.3 
Microphthalmos                   
4.1   
p<0.001 
- 
3.9  
p=0.04 
2  p=0.7 
1.6  
p=0.5 
0.9   
p=0.4 
4.5  
p=0.04 
5.9  
p=0.02 
2.4 
p=0.2 
3.2  p=0.06 
1.1  
p=0.9 
IO AL diff                     0.3  p=0.8 
0.9  
p=0.3 
0.2  
p=0.9 
1.6  
p=0.09 
1.1  
p=0.3 
0.6  
p=0.5 
-1.4  
p=0.2 
0.2   
p=0.8 
2.8  p=0.02 
-1.5   
p=0.1 
Microcornea             
0.5   
p=0.4 
6.3  
p=0.1 
1.6  
p=0.5 
0.2  
p=0.7 
1.7  
p=0.4 
1.0  
p=0.9 
0.4 
p=0.2 
0.5  p=0.3 
0.8  
p=0.7 
Exp. Surgeon                          
7.0  
p=0.1 
4  p=0.1 
0.5   
p=0.5 
4.2   
p=0.05 
10.7  
p=0.001 
3.7  
p=0.06 
3.2  p=0.04 
2.3  
p=0.1 
Viscous OVD                     
2.4   
p=0.5 
0.4  
p=0.9 
0.8   
p=0.9 
0.3  
p=0.4 
0.2  
p=0.3 
3  p=0.4 
6.3  
p=0.1 
Per op iris trauma                             
0.1  
p=0.7  
4.4  
p=0.03 
0.8  
p=0.8 
1.4  
p=0.6 
1.7  p=0.4 
1.1  
p=0.9 
Per op IOL explant                          
2.3  
p=0.1 
0.1   
p=0.7 
2.1  
p=0.2 
0.9  p=0.4 
1.1 
p=0.3 
Post op intensive  
steroid 
                                
0.4  
p=0.4 
2.2  
p=0.2 
0.8  p=0.7 
2.1  
p=0.2 
Post op systemic 
steroids 
                            
0.5  
p=0.5 
0.5  p=0.4 
0.5  
p=0.4 
Post op 
inflammation 
                                    4.9  p=0.02 
3.2   
p=0.06 
Sec IO procedures                                       
0.9  
p=0.8 
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VAO  - Bilateral  Manual ant cap Single piece IOL  IOL in bag  Per op heparin   VAO - Unilateral  Manual ant cap Single piece IOL  IOL in bag  Per op heparin  
IOL implantation  10.7   p<0.001 - - 2.3    p=0.2  IOL implantation  6.1     p=0.002 - - 0.6      p=0.6 
Gest age at surgery 1.002 p=0.11 1.001     p=0.6 1.002    p=0.5 1        p=0.3  Gest age at surgery 1.005    p=0.02 0.99    p=0.05 0.99   p=0.9 1.002    p=0.4 
Age at surgery 1.00     p=0.1 1.0001  p=0.5 1.002   p=0.5 1        p=0.3  Age at surgery 1.004    p=0.02 0.99   p=0.05 0.99   p=0.9 1.002     p=0.3 
Persistent fetal vasculature 0.9       p=0.9 2.7         p=0.5 0.04   p=0.05 1.8   p=0.2  Persistent fetal vasculature 0.6   p=0.4 0.4     p=0.3 0.2      p=0.1 0.4       p=0.5 
Axial length  -2.3          p=0.03 0.6        p=0.7 -0.7     p=0.9 0.06   p=0.9  Axial length  -1.6    p=0.1 3.2    p=0.001 0.3     p=0.8 -0.08       p=0.9 
Horizontal corneal diameter  -1.4   p=0.02 -1.9   p=0.06 -2.5    p=0.05 -1.5   p=0.5  Horizontal corneal diameter  -2    p=0.04 2.2     p=0.03 -0.9    p=0.3 -0.9    p=0.3 
Exp. Surgeon  3.4    p=0.003 0.4     p=0.2 7.8   p=0.005 2.2   p=0.2  Exp. Surgeon  2.5    p=0.1 1.7    p=0.7 1.3     p=0.8 0.6    p=0.6 
Viscous OVD 5.8  p=0.05 8.7     p=0.03 1.4    p=0.7 23.3    p<0.001  Viscous OVD 8.8     p=0.03 0.25   p=0.4 1.2    p=0.1 2.5    p=0.5 
Posterior capsulotomy  1.8   p=0.2 0.8    p=0.4 0.1    p=0.7 -  Single piece IOL  0.8    p=0.4       
Single piece IOL  24   p<0.0001        IOL in bag  1.1    p=0.3 0.2    p=0.7     
IOL in bag  1.3        p=0.3 2.1   p=0.1      Per operative heparin  0.3   p=0.6 0.002    p=0.9 0.3    p=0.6   
Per operative heparin  0.4      p=0.5 1.1   p=0.3 0.01  p=0.99    Per op iris trauma 0.3    p=0.1 1.1   p=0.9 0.7    p=0.4 4.4    p=0.2 
Per op iris trauma 1.04       p=0.9 1.3      p=0.8 1.8    p=0.2 1.8    p=0.4  Per op IOL explant  0.3     p=0.6 - - 0.7    p=0.4 
Per op IOL explant  0.7   p=0.4 - - 0.7    p=0.4  Post op intensive  steroid 0.7    p=0.5 1.1     p=0.9 2.6    p=0.1 7.8      p=0.09 
Post op intensive  steroid 2.3    p=0.05 1.6    p=0.5 4.5    p=0.04 2.9   p=0.09  Post op systemic steroids 0.6   p=0.5 1.1     p=0.9 0.1   p=0.05 3.3     p=0.3 
Post op systemic steroids 0.8   p=0.7 4.8    p=0.1 0.8     p=0.4 2.1   p=0.4  Post op inflammation 1.5     p=0.5 1.4    p=0.6 0.3   p=0.2 0.9      p=0.9 
Post op inflammation 1.8    p=0.3 1.9     p=0.4 1.4    p=0.2 2.2     p=0.11  Right eye 1.6    p=0.4 2.9    p=0.1 0.2    p=0.1 1.1    p=0.9 
Right eye 0.9     p=0.6 1.0      p=0.3 0.6     p=0.3 1.0   p=0.9       
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PREDICTION 
ERROR – 
Bilateral 
Age at 
surg 
K K astig  
Axial 
length  
HCD 
AxL <16 
mm 
AxL <20 
mm 
HCD 
<9.5 mm 
IO AL diff  ACD  Forml 
IOL 
power 
Ant seg 
abnorm 
Visc 
OVD 
Posterior 
caps 
Ant 
vitrect  
Wnd 
sutured 
Exp. 
Surg 
Single 
piece 
IOL  
IOL in 
bag  
Right eye 
Gest age at surgery - 
0.48     
p<0.001 
0.07    
p=0.54 
0.70     
p<0.001 
0.46      
p<0.001 
-4.66     
p<0.001 
-4.92   
p<0.001 
-2.16     
p=0.03 
0.03      
p=0.8 
0.25    
p=0.09 
1.78    
p=0.8 
-0.39    
p=0.01 
-0.42     
p=0.67 
6.01     
p=0.16 
1.36     
p=0.17 
-1.86    
p=0.07 
-0.009  
p=0.8 
0.33    
p=0.7 
-0.84    
p=0.6 
1.25     
p=0.21 
0.05     
p=0.96 
Age at surgery   
0.55  
p<0.001 
0.1    
p=0.37 
0.74    
p<0.001 
0.50   
p<0.001 
-4.97    
p<0.001 
-4.98   
p<0.001 
-2.18   
p=0.03 
0.03    
p=0.7 
0.25   
p=0.08 
1.71   
p=0.8 
-0.35    
p=0.01 
-0.45     
p=0.6 
4.55    
p=0.17 
1.29     
p=0.20 
1.5    
p=0.1 
-0.05    
p=0.8 
-0.11       
p=0.9 
-0.59   
p=0.6 
1.49   
p=0.3 
0.04    
p=0.96 
K     
0.02     
p=0.6 
0.71    
p<0.001 
0.66   
p<0.001 
-3.57   
p<0.001 
-4.32   
p<0.001 
-2.73   
p=0.03 
-0.10    
p=0.34 
0.28   
p=0.19 
7.25     
p=0.22 
- 
-0.92     
p=0.36 
1.91     
p=0.6 
0.12     
p=0.91 
-0.50     
p=0.61 
-1.63      
p=0.2 
-0.55    
p=0.58 
0.53    
p=0.46 
-0.46     
p=0.45 
0.06     
p=0.96 
K astigmatism     
0.02    
p=0.9 
-0.05    
p=0.67 
-1.74    
p=0.08 
-1.74   
p=0.09 
-0.40     
p=0.69 
0.11     
p=0.3 
-0.04    
p=0.09 
7.17    
p=0.42 
-0.07    
p=0.1 
1.96     
p=0.24 
2.12      
p=0.54 
-1.70    
p=0.09 
-1.29      
p=0.19 
-1.62     
p=0.2 
-0.35     
p=0.71 
0.36     
p=0.72 
0.96    
p=0.34 
-1.16     
p=0.15 
Axial length          
0.74     
p<0.001 
- - - 
0.13    
p=0.16 
0.32    
p=0.12 
5.40   
p=0.3 
- 
-1.81   
p=0.06 
1.36   
p=0.7 
0.69     
p=0.49 
-1.36   
p=0.17 
-0.34   
p=0.56 
-0.37         
p=0.71 
-1.75   
p=0.07 
1.03   
p=0.3 
-0.29       
p=0.76 
HCD         - - - 
0.07       
p=0.07 
0.24     
p=0.3 
0.89    
p=0.96 
-0.19     
p=0.2 
- 
4.70   
p=0.19 
1.08     
p=0.25 
-0.40    
p=0.69 
-2.27   
p=0.31 
0.55       
p=0.59 
-0.09   
p=0.97 
1.42     
p=0.15 
-0.07      
p=0.94 
AxL <16mm             - - 
-1.74        
p=0.08 
-1.18     
p=0.24 
-0.21   
p=0.84 
- 
2.47      
p=0.01 
-1.09    
p=0.28 
0.74      
p=0.39 
1.99     
p=0.16 
0.46   
p=0.65 
0.56    
p=0.58 
0.48     
p=0.79 
-0.93     
p=0.35 
-0.83      
p=0.41 
AxL <20mm               - 
-0.74    
p=0.46 
-1.66     
p=0.09 
3.4   
p<0.001 
- 
0.29   
p=0.79 
0.2    
p=0.9 
0.92     
p=0.36 
1.35   
p=0.18 
3.04     
p=0.08 
0.60   
p=0.55 
1.22    
p=0.22 
-0.28    
p=0.78 
-0.0    
p=0.99 
HCD <9.5mm           
-2.32     
p=0.02 
-0.71     
p=0.48 
- - - 
1.27    
p=0.20 
0.29    
p=0.59 
0.19      
p=0.55 
1.90   
p=0.06 
-0.55   
p=0.59 
- - 
-1.28     
p=0.20  
IO AL diff                   
-0.1   
p=0.61 
6.67     
p=0.25 
-0.13     
p=0.33 
-0.34    
p=0.73 
3.96          
p=0.70 
2.22      
p=0.14 
0.48     
p=0.62 
-0.93    
p=0.35 
-0.23        
p=0.82 
-0.8    
p=0.42 
-0.87      
p=0.42 
1.2     
p=0.22 
ACDepth                     
2.55    
p=0.64 
- 
-2.37   
p=0.02 
2.81   
p=0.42 
1.18     
p=0.24 
-0.61   
p=0.54 
-0.46    
p=0.5 
0.51    
p=0.6 
-0.29   
p=0.77 
-0.37   
p=0.7 
0.18    
p=0.86 
Formula                       
4.86    
p=0.43 
1.37   
p=0.17 
0.04        
p=0.97 
- 
-2.51 
HQ/ST 
p<0.01 
8.82      
p=0.11 
2.11    
p=0.03 
-1.52    
p=0.1 
-16.74    
p=0.5 
1.0    
p=0.32 
IOL power                         
-1.07   
p=0.28 
1.73   
p=0.63 
1.28     
p=0.20 
-0.55    
p=0.58 
-7.46    
p=0.04 
-0.77      
p=0.44 
2.94   
p=0.01 
-0.85   
p=0.38 
-0.38    
p=0.71 
Ant segment 
abnormality  
             
2.79      
p=0.43 
0.46    
p=0.49 
-0.11   
p=0.91 
-0.63    
p=0.53 
-0.95    
p=0.34 
1.50    
p=0.22 
-1.32  
p=0.19 
0.18    
p=0.86 
Viscous OVD                             
28.71   
p<0.001 
0.95     
p=0.35 
-0.69    
p=0.49 
0.84      
p=0.4 
1.40     
p=0.16 
-1.88   
p=0.06  
0.0   
p=0.99 
Posterior capsulotomy                    
3.11     
p=0.002 
0.55    
p=0.46 
3.07    
p=0.08 
-0.07       
p=0.94 
1.35     
p=0.18 
3.08    
p=0.08 
Ant vitrectomy                                  
0.14      
p=0.89 
-1.64    
p=0.1 
0.81   
p=0.4 
0.40    
p=0.67  
1.34     
p=0.18 
Wound sutured                                 
0.35    
p=0.73 
0.38     
p=0.54 
0.15    
p=0.70 
-0.8     
p=0.42 
Exp. Surgeon                                      
-1.37     
p=0.12 
1.90      
p=0.37 
-0.13    
p=0.89 
Single piece IOL                                        
0.91    
p=0.36 
1.40     
p=0.16 
IOL in bag                                          
-1.79     
p=0.07 
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PREDICTION 
ERROR – 
Unilateral 
Age at 
surg 
K K astig  
Axial 
length  
HCD 
AxL <16 
mm 
AxL <20 
mm 
HCD 
<9.5 mm 
IO AL diff  ACD  Forml 
IOL 
power 
Ant seg 
abnorm 
Visc 
OVD 
Ant 
vitrectomy  
Wnd 
sutured 
Exp Surg  
Single 
piece IOL  
IOL in 
bag  
Right eye 
Gest age at surgery - 
0.58    
p<0.001 
0.02     
p=0.29 
0.67     
p<0.001 
0.56      
p<0.001 
-0.70    
p=0.48 
-6.08     
p<0.001 
-1.16    
p=0.25 
0.42     
p=0.99 
0.37     
p=0.03 
7.79   
p=0.09 
-0.55    
p<0.001 
-2.68    
p=0.007 
6.11     
p=0.1 
-0.04   
p=0.98 
-6.66   
p=0.01 
-0.79     
p=0.4 
-1.26    
p=0.2 
0.41     
p=0.6 
0.13     
p=0.47 
Age at surgery   
0.59    
p<0.001 
0.03   
p=0.33 
0.67   
p<0.001 
0.58   
p<0.001 
-0.75     
p=0.46 
-6.10   
p<0.001 
-1.16      
p=0.25 
0.44    
p=0.99 
0.39     
p=0.02 
7.93    
p=0.09 
-0.53     
p<0.001 
-2.91    
p=0.003 
7.90        
p=0.06 
0.5     
p=0.6 
-5.96     
p=0.01 
-0.95     
p=0.34 
-1.27    
p=0.2 
-0.30    
p=0.6 
0.77     
p=0.44 
K     
-0.08   
p=0.5 
0.54   
p<0.001 
0.47    
p<0.001 
-1.49     
p=0.1 
-4.14    
p<0.001 
-0.52    
p=0.6 
0.26     
p=0.26 
0.51    
p=0.01 
11.79    
p=0.02 
- 
-2.97    
p=0.003 
2.83    
p=0.42 
1.10     
p=0.26 
-0.03    
p=0.86 
-1.78    
p=0.07 
-0.44      
p=0.66 
-0.36      
p=0.72 
0.18     
p=0.86 
K astigmatism     
0.008  
p=0.95 
-0.002   
p=0.96 
0.55     
p=0.57 
-0.55     
p=0.58 
0.88    
p=0.38 
-0.16    
p=0.26 
0.25    
p=0.32 
1.15    
p=0.89 
-0.11   
p=0.5 
0.77     
p=0.44 
1.27       
p =0.75 
1.41     
p=0.16 
-0.33    
p=0.3 
-0.65     
p=0.52 
-0.0       
p=0.99 
-0.04      
p=0.97 
0.26     
p=0.76 
Axial length          
0.67   
p<0.001 
- - - 
0.75    
p<0.001 
0.74    
p<0.001 
9.40   
p=0.06 
- 
-1.35   
p=0.18 
2.43     
p=0.5 
1.53   
p=0.12 
-1.60   
p=0.21 
-1.52   
p=0.13 
-2.55   
p=0.01 
-0.49   
p=0.63 
0.92     
p=0.36 
HCD       - - - 
0.46     
p=0.15 
0.79    
p<0.001 
5.68    
p=0.22 
-0.5   
p=0.006 
- 
1.74       
p=0.08 
1.15    
p=0.25 
1.7   
p=0.19 
0.56      
p=0.57 
-1.66   
p=0.1 
1.08    
p=0.28 
-0.53     
p=0.60 
AxL <16mm             - - 
-3.23    
p=0.001 
-2.48    
p=0.01 
0.72    
p=0.95 
- 
0.72   
p=0.47  
-0.50   
p=0.62 
-1.50    
p=0.13 
0.10    
p0.92 
0.93        
p=0.35 
1.4        
p=0.23 
0.17      
p=0.68 
-0.03    
p=0.97 
AxL <20mm               - 
-4.84     
p<0.001 
-3.18    
p=0.002 
0.68    
p=0.49 
- 
1.15   
p=0.25 
0.55  
p=0.58 
1.28     
p=0.26 
1.01         
p=0.3 
1.77    
p=0.33 
2.26       
p=0.02 
0.29  
p=0.78 
-0.67      
p=0.51 
HCD <9.5mm           
-1.70        
p=0.09 
-1.45   
p=0.15 
- - - 
1.55     
p=0.12 
0.09    
p=0.76 
0.34     
p=0.54 
-0.92        
p=0.36 
- - 
2.06    
p=0.15 
IO AL diff                   
0.35     
p=0.25 
2.70    
p=0.61 
-0.78    
p<0.001 
-0.29    
p=0.77 
1.48     
p=0.69 
1.59    
p=0.11 
-0.23      
p=0.63 
1.11      
p=0.27 
-1.73    
p=0.08 
-1.09    
p=0.27 
1.97     
p=0.05 
ACDepth                     
3.53     
p=0.47 
- 
1.11  
p=0.26 
2.39    
p=0.49 
-0.43   
p=0.67 
0.63   
p=0.42 
2.19    
p=0.06 
1.18    
p=0.24 
0.24    
p=0.8 
0.67     
p=0.51 
Formula                       
3.85   
p=0.42 
-0.03     
p=0.4 
-1.31        
p=0.2 
0.01  
2.02     
p=0.73 
1.46    
p=0.1 
-0.18    
p=0.86 
-0.01    
p=0.9 
0.04    
p=0.46 
IOL power                         
-0.46   
p=0.65 
2.31 
p=0.51 
-1.08    
p=0.28 
-1.35    
p=0.24 
0.53    
p=0.59 
3.80    
p=0.003 
0.91   
p=0.36 
-0.11    
p=0.91 
Ant segment 
abnormality  
             
7.7    
p=0.05 
-0.52    
p=0.6 
-1.08    
p=0.28 
0.96    
p=0.34 
0.37    
p=0.71 
-0.45    
p=0.66 
1.15      
p=0.25 
Viscous OVD                             
17.77   
p<0.001 
-0.13   
p=0.28 
2.17    
p=0.03 
-0.26     
p=0.8 
1.39     
p=0.16 
0.0     
p=0.99 
Ant vitrectomy                                
0.63    
p=0.43 
2.01    
p=0.16 
2.97    
p=0.09 
14.23     
p<0.001 
3.30    
p=0.07 
Wound sutured                        
0.17    
p=0.87 
1.82    
p=0.18 
0.03    
p=0.87 
-0.4     
p=0.68 
Exp. Surgeon                                    
0.44     
p=0.66 
-0.18     
p=0.86 
1.72     
p=0.09 
Single piece IOL                                      
0.72    
p=0.47 
1.76    
p=0.08 
IOL in bag                                        
-1.90    
p=0.06 
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Appendix N: Search terms for literature review reported within 
background chapter 
 
Search methods for literature review of visual outcome following cataract surgery in first 2 
years of life 
 
Types of studies considered 
Clinical studies of outcomes following surgery for congenital cataract undertaken within the first 
two years of life 
Clinical studies of outcomes following surgery for infantile cataract undertaken within the first two 
years of life 
  
Electronic search  
The PubMED database was searched.  The following search strategy / keyword terms were used:  
#1 “CATARACT” 
#2 “CATARACT EXTRACTION”  
#3 (#1 OR #2) 
#4 (#3 with a filter of ‘All Child 0-18yrs’) 
 
Selection of studies  
Study titles, then study abstracts, and then full text reports were assessed. At each stage, studies 
which were judged not to fit criteria A or B were excluded. Cases series involving fewer than 5 
children, and cases involving cataract surgery in low income countries were also excluded. 
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Search methods for literature review of glaucoma following cataract 
surgery in first 2 years of life 
 
Types of studies considered 
Clinical studies of outcomes / complications following childhood surgery for childhood cataract  
Clinical or basic science studies on anterior segment changes following childhood surgery for 
cataract  
 
Electronic search  
The PubMED database was searched.  The following search strategy / keyword terms were used:  
#1 “APHAKIC GLAUCOMA” 
#2 “CATARACT” AND “GLAUCOMA” 
#3 (#1  OR #2) 
#4 (#3 with a filter of ‘All Child 0-18yrs’) 
 
Selection of studies  
Study titles, then study abstracts, and then full text reports were assessed. At each stage, studies 
which were judged not to fit criteria A or B were excluded. Cases series involving fewer than 5 
children were also excluded. 
 
 
